Moreover O
, O
the O
in O
vitro O
binding O
of O
NF-κB B-protein
or O
Sp1 B-protein
to O
its O
target O
DNA B-DNA
was O
not O
affected O
by O
the O
presence O
of O
K-12 B-chemical
. O

No O
appreciable O
binding O
of O
Ly49C B-protein
to O
Db B-protein
could O
be O
detected O
in O
the O
cell-cell O
adhesion O
assay O
by O
antibody O
blocking O
or O
by O
employing O
cells O
from O
Kb O
/ O
mice O
that O
express O
Db O
normally O
( O
Figure O
3 O
and O
Figure O
4) O
. O

The O
yeast O
two-hybrid O
interaction O
assays O
indicated O
that O
filamin-A B-protein
does O
not O
bind O
to O
any O
integrin B-protein
β I-protein
subunit O
, O
whereas O
filamin-B B-protein
only O
interacts O
with O
β1A B-protein-isoform
. O

  O
Because O
FLICE2 B-protein
does O
not O
directly O
bind O
DR4 B-protein
or O
DR5 B-protein
, O
a O
yet O
to O
be O
identified O
adaptor O
molecule O
is O
presumably O
responsible O
for O
this O
linkage O
. O

We O
have O
thus O
examined O
whether O
actin B-protein-family
binding O
of O
fascin B-protein
can O
be O
regulated O
in O
a O
calcium-dependent chemical
way O
by O
controlling O
actin O
binding O
of O
caldesmon B-protein
with O
Ca2+/calmodulin protein
. O

Therefore O
, O
we O
cannot O
rule O
out O
that O
some O
variations O
in O
the O
binding O
of O
three O
apoE B-protein
isotypes O
to O
Abeta B-peptide
peptides O
will O
be O
found O
when O
other O
apoE O
preparations O
are O
used O
. O

When O
calmodulin B-protein
is O
added O
, O
the O
inhibition O
of O
fascin-actin protein
interaction O
by O
caldesmon B-protein
and O
TM O
becomes O
Ca2+ B-chemical
dependent O
because O
Ca2+/calmodulin B-protein
blocks O
actin O
binding O
of O
caldesmon O
. O

Briefly O
, O
the O
oligonucleotide O
library O
was O
incubated O
with O
fusion O
proteins O
bound O
to O
either O
GST-coated experiment-tag
bead-bound O
fusion O
proteins O
( O
GST-tag O
) O
or O
nickel/nitrilotriacetic B-chemical
acid I-chemical
matrix-bound O
fusion O
proteins O
( O
histidine-tag B-experiment-tag
) O
in O
a O
buffer O
containing O
20 O
mM O
Tris B-chemical
( O
pH O
8 O
. O
0) O
, O
50 O
mM O
KCl O
, O
1 O
mM O
DTT B-chemical
, O
0 O
. O
5 O
mM O
EDTA B-chemical
, O
10% O
glycerol O
, O
20 O
μg/ml O
BSA B-chemical
, O
and O
2 O
μg/ml O
poly(dI)⋅poly(dc) chemical
. O

Extracts O
were O
incubated O
with O
20 O
mug O
of O
Gst-RalGDS-RBD protein
precoupled O
to O
gluthathione B-chemical
beads O
to O
isolate O
GTP-bound chemical
( O
activated O
) O
Rap1 B-protein
. O

Cytoplasmic O
dynein B-protein-complex
binds O
the O
p150 B-protein
Glued I-protein
component O
of O
the O
dynactin B-protein-complex
complex O
through O
interaction O
between O
the O
NH2 O
terminus O
of O
its O
intermediate O
chains O
and O
the O
-helical O
coiled-coil O
region O
of O
p150 O
Glued O
( O
Karki O
and O
Holzbaur O
, O
1995 O
; O
Vaughan O
and O
Vallee O
, O
1995) O
. O

Structural O
features O
and O
RII B-protein-domain
binding O
assays O
suggest O
that O
amino O
acids O
511-530 O
in O
DAKAP200 B-protein
constitute O
an O
RII O
binding O
site O
. O

Mena B-protein
binds O
directly O
to O
Profilin B-protein-family
, O
an O
actin-binding protein-family
protein O
that O
modulates O
actin O
polymerization O
. O

Mirk B-protein
Binds O
to O
a O
Specific O
Region O
within O
the O
CBP-binding protein
Region O
of O
HNF1α B-protein

We O
next O
determined O
the O
regions O
of O
Mirk B-protein
and O
HNF1α B-protein
necessary O
for O
their O
interaction O
. O

Both O
GD B-protein
and O
Snk B-protein
bind O
to O
heparin B-chemical
- I-chemical
Sepharose I-chemical
, O
providing O
a O
link O
between O
the O
pipe-defined O
ventral O
prepattern O
and O
the O
protease O
cascade O
. O

  O
All O
of O
these O
residues O
, O
except O
Ser45 O
, O
are O
located O
close O
to O
site O
of O
cofilin B-protein
implicated O
genetically O
in O
actin B-protein-family
binding O
, O
suggesting O
they O
also O
form O
part O
of O
the O
actin-binding O
surface O
. O

We O
have O
shown O
that O
CES-1 B-protein
can O
bind O
to O
Snail-binding protein
sites/E-boxes O
in O
the O
egl-1 B-gene
locus I-gene
in O
vitro O
, O
which O
are O
required O
for O
the O
ability O
of O
the O
ces-2 B-protein
lf O
mutation O
n732 O
to O
block O
the O
death O
of O
the O
NSM B-cell
sister I-cell
cells I-cell
in O
vivo O
. O

This O
led O
us O
to O
investigate O
if O
( O
and O
to O
demonstrate O
that O
) O
Foxa2 B-protein
binds O
Lim1 B-protein
and O
Gsc B-protein
. O

To O
elucidate O
the O
biological O
significance O
of O
NE-dlg-calmodulin protein
interaction O
in O
a O
neuronal O
cell O
, O
we O
attempted O
to O
identify O
another O
cellular O
protein O
that O
binds O
to O
the O
region O
near O
the O
calmodulin O
binding O
site O
of O
NE-dlg O
by O
two-hybrid O
screening O
using O
a O
human O
brain O
cDNA B-reagent
library O
as O
the O
prey O
. O

Can O
we O
speculate O
as O
to O
where O
Phyl B-protein
might O
bind O
Sina B-protein
? O

The O
majority O
of O
dCLK B-protein
is O
bound O
to O
CYC B-protein
during O
a O
daily O
cycle O
. O

In O
these O
clones O
, O
binding O
of O
p16 B-protein
to O
cdk4 B-protein
and O
cdk6 B-protein
abrogated O
binding O
of O
cyclin B-protein
D1 I-protein
, O
p27 B-protein
KIP1 I-protein
, O
and O
p21 B-protein
WAF1/CIP1 I-protein
. O

Whereas O
FK506 B-chemical
stimulates O
the O
binding O
of O
FKBP12 B-protein
to O
calcineurin B-protein
( O
42) O
, O
stoichiometric O
quantities O
of O
FK506 O
dissociate O
FKBP12 O
from O
the O
ryanodine B-protein-family
and O
IP3 B-protein-family
receptors I-protein-family
( O
11 O
, O
36) O
. O

For O
each O
binding O
reaction O
, O
5 O
mug O
of O
GST-GTPase B-experimental-construct
bound O
to O
25 O
mul O
of O
glutathione-Sepharose B-experimental-construct
beads O
was O
mixed O
with O
an O
aliquot O
of O
cell O
extract O
containing O
1 O
mg O
of O
protein O
for O
1 O
hr O
at O
4 O
degrees O
C O
. O

The O
EGF-like B-protein-domain
domain I-protein-domain
of O
Aos B-protein
binds O
directly O
to O
DER B-protein
at O
the O
sSpi-binding protein
site O
and O
interferes O
with O
the O
binding O
of O
sSpi O
to O
DER O
( O
Fig O
. O
8B) O
. O

This O
site O
has O
been O
shown O
to O
be O
differentially O
protected O
by O
TGF-β B-protein
treatment O
in O
experiments O
of O
DNA B-DNA
footprinting O
( O
data O
not O
shown) O
, O
and O
in O
vivo O
positioning O
of O
Sp1 B-protein
using O
the O
PINPOINT O
technique O
maps O
the O
Sp1 O
binding O
site O
over O
the O
predicted O
consensus O
sequence O
on O
endoglin B-DNA
promoter I-DNA
( O
Fig O
. O
2 O
A) O
. O

To O
explore O
the O
functional O
significance O
of O
mitosis-specific O
phosphorylation O
of O
MYPT B-protein-family
, O
the O
myosin B-protein-complex
binding O
activities O
of O
MYPT O
from O
mitotic O
or O
interphase O
cells O
were O
compared O
. O

( O
C O
) O
Adf-1 B-protein
binds O
the O
same O
regions O
of O
TAFII110 B-protein
and O
TAFII250 B-protein
in O
vivo O
as O
it O
does O
in O
vitro O
. O

The O
intricate O
region O
was O
previously O
shown O
to O
contain O
functional O
Ets-1 B-protein
in O
addition O
to O
CREB B-protein
, O
LEF B-protein
and O
ds O
binding O
sites O
. O

Inducer-specific O
binding O
of O
Ets-1 B-protein
to O
the O
endogenous O
TNF-alpha B-DNA
promoter I-DNA
. O

To O
test O
whether O
the O
cytoplasmic O
domains O
of O
other O
neuroligins B-protein-family
also O
interact O
with O
PSD-95 B-protein
, O
and O
whether O
isoforms O
of O
PSD-95 O
also O
bind O
to O
neuroligins O
, O
we O
quantified O
the O
yeast O
two-hybrid O
interactions O
by O
measuring O
beta-galactosidase B-protein-family
transactivation O
( O
Table O
1) O
. O

DNA B-DNA
Binding O
of O
Smad5 B-protein
and O
Smad4 B-protein
to O
the O
GC-rich B-DNA
Sequence I-DNA

We O
then O
examined O
the O
direct O
DNA B-DNA
binding O
of O
Smad5 B-protein
and O
Smad4 B-protein
to O
the O
GC-rich B-DNA
sequence I-DNA
of O
PBE B-DNA
. O

Grundhoff O
, O
A O
. O
T O
. O
, O
Kremmer O
, O
E O
. O
, O
Tureci O
, O
O O
. O
, O
Glieden O
, O
A O
. O
, O
Gindorf O
, O
C O
. O
, O
Atz O
, O
J O
. O
, O
Muller-Lantzsch O
, O
N O
. O
, O
Schubach O
, O
W O
. O
H O
. O
and O
Grasser O
, O
F O
. O
A O
. O
( O
1999 O
) O
Characterisation O
of O
DP103 B-protein
, O
a O
novel O
DEAD B-protein-domain
box I-protein-domain
protein O
that O
binds O
to O
the O
Epstein B-cell
- I-cell
Barr I-cell
virus I-cell
nuclear O
proteins O
EBNA2 B-protein
and O
EBNA3C B-protein
. O

TPA B-protein
directly O
binds O
PKC B-protein-family
, O
causing O
an O
increase O
in O
PKC O
' O
s O
affinity O
for O
calcium B-chemical
and O
the O
stimulation O
of O
enzymatic O
activity O
. O

The O
MKP-3 B-protein
EB B-protein-domain
domain O
binding O
to O
ERK2 B-protein
was O
not O
dependent O
upon O
ERK2 O
phosphorylation O
in O
our O
NMR O
titration O
experiments O
, O
consistent O
with O
the O
previous O
study O
of O
MKP-3 O
and O
ERK2 O
binding O
with O
a O
GST B-experiment-tag
pulldown O
assay O
( O
Camps O
et O
al O
. O
, O
1998 O
) O
. O

Interestingly O
, O
the O
Rb B-protein
protein O
binds O
to O
TAFII250 B-protein
at O
an O
amino-terminal O
site O
which O
overlaps O
the O
NTK B-protein-domain
domain O
( O
38) O
. O

The O
alpha-helical O
C O
terminus O
of O
AIP B-protein
, O
which O
is O
outside O
the O
tetratricopeptide B-protein-domain
repeat I-protein-domain
domain I-protein-domain
, O
is O
absolutely O
required O
for O
binding O
to O
AhR B-protein
as O
shown O
by O
deletions O
of O
the O
C-terminal O
5 O
amino O
acids O
or O
alanine-scanning O
mutagenesis O
, O
but O
it O
is O
not O
required O
for O
binding O
of O
AIP O
to O
hsp90 B-protein
. O

Thus O
, O
the O
results O
of O
both O
types O
of O
binding O
assays O
argue O
that O
stable O
binding O
of O
ELL B-protein-family
to O
RNA B-protein-complex
polymerase I-protein-complex
II I-protein-complex
is O
not O
sufficient O
for O
inhibition O
of O
promoter-specific O
initiation O
. O

  O
Growth O
arrest O
by O
TGF-beta B-protein
is O
dependent O
on O
Rb B-protein
and O
interfered O
with O
by O
direct O
binding O
of O
E1A B-protein
to O
Rb O
( O
33 O
, O
34 O
, O
37) O
. O

In O
an O
effort O
to O
identify O
the O
PG B-chemical
that O
binds O
to O
IFN-gamma B-protein
, O
we O
performed O
Western O
blot O
analysis O
. O

Both O
E1A B-protein
and O
PU B-protein
. I-protein
1 I-protein
bind O
to O
the O
CH3 B-protein-domain
domain O
of O
CBP B-protein
but O
require O
additional O
contacts O
for O
full O
CBP O
inhibition O
. O

SAF-A B-protein
interacts O
with O
S/MARs O
via O
its O
N-terminal O
SAF B-protein-domain
box I-protein-domain
( O
36 O
) O
and O
via O
its O
C-terminal O
domain O
with O
p300 B-protein
, O
allowing O
binding O
of O
SAF-A O
to O
both O
p300 O
and O
a O
S/MAR B-DNA
element O
. O

Interestingly O
, O
both O
Oct-1 B-protein
and O
Pbx B-protein
binding O
to O
the O
PRL3 B-DNA
nGRE I-DNA
were O
found O
to O
be O
required O
for O
glucocorticoid B-chemical
repression O
. O

It O
is O
also O
noteworthy O
that O
other O
CC B-protein-family
chemokines I-protein-family
, O
such O
as O
MDC B-protein
( O
binds O
CCR4 B-protein
) O
and O
the O
recently O
identified O
putative O
chemokine O
receptor O
TYMSTR O
( O
ligand O
unknown O
) O
[ O
40] O
, O
can O
inhibit O
HIV-1 B-cell
infection O
of O
T O
lymphocytes O
, O
whereas O
I-309 B-protein
( O
binds O
CCR8 B-protein
) O
inhibits O
CCR8-dependent O
infection O
of O
monocytes O
by O
diverse O
HIV-1 O
strains O
, O
further O
suggesting O
that O
a O
number O
of O
chemokine O
receptors O
are O
involved O
in O
HIV-1 O
entry O
[ O
64 O
, O
106] O
. O

All O
the O
mixtures O
tested O
exhibited O
equal O
amounts O
of O
REGs O
α B-protein
and O
β B-protein
bound O
to O
the O
proteasome B-protein-complex
at O
both O
concentrations O
confirming O
the O
higher O
affinity O
of O
α/β B-protein-complex
heterooligomers I-protein-complex
for O
the O
proteasome O
as O
reported O
in O
ref O
. O
14 O
. O

CHRIVIA O
, O
J O
. O
C O
. O
, O
R O
. O
P O
. O
KWOK O
, O
N O
. O
LAMB O
, O
M O
. O
HAGIWARA O
, O
and O
M O
. O
R O
. O
MONTMINY O
et O
al O
. O
, O
1993 O
Phosphorylated O
CREB B-protein
binds O
specifically O
to O
the O
nuclear O
protein O
CBP B-protein
. O

First O
, O
endogenous O
AT3 B-protein
binds O
to O
CBP B-protein
, O
p300 B-protein
, O
and O
PCAF B-protein
coactivators O
and O
when O
overexpressed O
regulates O
CBP/p300- protein
and O
PCAF-dependent O
transcription O
, O
indicating O
that O
AT3 O
normally O
interacts O
with O
key O
transcriptional O
regulators O
and O
therefore O
is O
in O
a O
position O
to O
regulate O
transcription O
. O

Finally O
, O
She2p B-protein
bound O
to O
the O
ASH1 B-RNA
transcript I-RNA
is O
required O
for O
the O
recruitment O
of O
She3p B-protein
and O
subsequently O
She1p/Myo4p protein
to O
form O
a O
mature O
transport O
particle O
( O
Munchow O
et O
al O
. O
, O
1999 O
; O
Bohl O
et O
al O
. O
, O
2000 O
; O
Long O
et O
al O
. O
, O
2000 O
; O
Takizawa O
and O
Vale O
, O
2000 O
) O
. O

Although O
studies O
using O
the O
fusion O
protein O
CTLA4-Ig protein
, O
which O
binds O
to O
B7 B-protein
. I-protein
1 I-protein
and O
B7 B-protein
. I-protein
2 I-protein
, O
have O
shown O
suppression O
of O
cell-mediated O
and O
humoral O
immunity O
in O
several O
mouse O
models O
of O
autoimmune O
disease O
( O
12–16) O
, O
it O
is O
unclear O
whether O
different O
costimulatory O
signals O
are O
delivered O
through O
CD28 B-protein
depending O
on O
whether O
B7 O
. O
1 O
or O
B7 O
. O
2 O
is O
the O
ligand O
. O

In O
mammalian O
cells O
, O
Apaf-1 B-protein
binds O
cytochrome B-protein
c I-protein
and O
dATP B-chemical
, O
and O
this B-protein-complex
complex I-protein-complex
recruits O
caspase-9 B-protein
, O
forming O
the O
apoptotsome B-protein-complex
. O

Notably O
, O
M364-beta protein
is O
sequence O
adjacent O
to O
R365-beta O
, O
the O
most O
buried O
residue O
upon O
binding O
of O
beta O
to O
delta B-protein
( O
155 O
Ang O
2) O
. O

Thus O
neomycin B-chemical
, O
polylysine B-chemical
, O
and O
spermine B-chemical
reversed O
the O
antagonism O
of O
TNP-ATP B-chemical
binding O
to O
MBP_1 B-fusion-protein
. I-fusion-protein
1C I-fusion-protein
by O
PIP2 B-chemical
. O

Controls O
consisted O
of O
1 O
) O
phosphorylation O
mix O
( O
containing O
only O
buffer O
and O
ATP) chemical
, O
2 O
) O
phosphorylation O
mix O
containing O
unphosphorylated O
peIF-2 B-protein-complex
, O
3 O
) O
phosphorylation O
mix O
containing O
unphosphorylated O
meIF-2 B-protein-complex
, O
and O
4 O
) O
phosphorylation O
mix O
alone O
incubated O
previously O
with O
mPKR B-protein
bound O
to O
poly(rI B-experimental-construct
) I-experimental-construct
poly(rC)-agarose I-experimental-construct
. O

p75 B-protein
TNFR I-protein
binds O
TNF-alpha B-protein
with O
a O
higher O
affinity O
and O
with O
a O
higher O
dissociation O
rate O
than O
p55 B-protein
TNFR I-protein
( O
K O
d O
of O
100 O
pM O
versus O
500 O
pM O
and O
t1/2 O
of O
10 O
min O
versus O
3 O
h O
) O
( O
15) O
. O

This O
analysis O
demonstrated O
that O
JIP2 B-protein
binds O
to O
JNK B-protein
, O
MKK7 B-protein
, O
and O
MLK3 B-protein
( O
Fig O
. O
5) O
. O

Generally O
, O
binding O
of O
importin-α B-protein-family
to O
the O
NLS B-protein-motif
involves O
two O
sites O
within O
the O
import O
receptor O
molecule O
, O
a O
major O
site O
spanning O
the O
amino-terminal O
end O
of O
the O
receptor O
between O
the O
first O
and O
fourth O
arm O
repeats O
and O
a O
minor O
site O
located O
at O
the O
carboxy-terminus O
between O
arm O
repeats O
4 O
and O
8 O
( O
Conti O
and O
Kuriyan O
, O
2000 O
; O
Fontes O
et O
al O
. O
, O
2000) O
. O

The O
incomplete O
WT O
p50csk B-protein
inhibition O
of O
FN-stimulated O
signaling O
events O
in O
the O
FAK1 O
cells O
is O
consistent O
with O
studies O
performed O
in O
NIH B-cell
3T3 I-cell
fibroblasts O
where O
direct O
FN-stimulated O
FAK-mediated protein
phosphorylation O
of O
Shc B-protein
can O
promote O
Grb2 B-protein
binding O
and O
signaling O
to O
ERK2 B-protein
under O
conditions O
of O
inhibited O
Src O
PTK O
activity O
( O
Schlaepfer O
et O
al O
. O
, O
1998) O
. O

Indirect O
evidence O
that O
the O
UBC9 B-protein
homolog O
from O
higher O
eukaryotes O
is O
a O
SUMO-1-conjugating protein
enzyme O
came O
from O
recent O
reports O
, O
demonstrating O
physical O
interactions O
of O
UBC9 O
with O
SUMO-1 O
( O
11 O
) O
and O
RanBP2 B-protein
, O
the O
nuclear O
pore O
complex O
protein O
bound O
by O
SUMO-1 O
conjugated O
RanGAP1 B-protein
( O
28) O
. O

Paxillin B-protein
failed O
to O
bind O
GST B-experiment-tag
alone O
or O
the O
SH2 B-protein-domain
domain O
of O
Grb2 B-protein
that O
belongs O
to O
the O
family O
of O
SH2/SH3-containing protein-domain
signaling O
molecules O
. O

E2Fs O
bind O
directly O
to O
Rb B-protein
, O
p107 B-protein
, O
and O
p130 B-protein
, O
and O
we O
have O
previously O
shown O
that O
these O
proteins O
are O
components O
of O
the O
transcription O
complexes O
formed O
on O
E2F B-DNA
target I-DNA
promoters I-DNA
in O
vivo O
( O
49) O
. O

AAK1 B-protein
localizes O
to O
regions O
active O
in O
endocytosis O
AAK1 O
binds O
directly O
to O
AP2 B-protein
. O

Both O
these O
regions O
of O
p300/CBP B-protein-family
bind O
to O
the O
transactivation O
domain O
of O
Ets-2 B-protein
, O
whereas O
the O
C-terminal O
region O
binds O
only O
to O
the O
DNA B-DNA
binding O
domain O
of O
Ets-2 O
. O

The O
major B-protein
head I-protein
protein I-protein
of O
bacteriophage O
T4 B-cell
binds O
specifically O
to O
elongation B-protein-family
factor I-protein-family
Tu I-protein-family
. O

This O
Psc B-protein
binding O
might O
potentiate O
the O
action O
of O
a O
weak O
Pc- B-DNA
and O
Ph-binding B-DNA
PRE I-DNA
present O
in O
the O
bxd-Ubx-lacZ B-experimental-construct
vector O
. O

The O
ability O
to O
form O
H-DNA B-DNA
cannot O
substitute O
for O
GAGA B-protein
factor I-protein
binding O
to O
the O
( B-DNA
CT)n I-DNA
sequence O
. O

We O
predict O
that O
these O
PH B-protein-domain
domains O
will O
also O
bind O
PI3K B-protein-family
products O
with O
high O
affinity O
, O
but O
this O
has O
not O
yet O
been O
tested O
or O
was O
inconclusive O
. O

This O
defect O
in O
the O
activity O
of O
eIF5B B-protein
in O
the O
presence O
of O
GMP-PNP B-chemical
could O
be O
because O
hydrolysis O
of O
GTP B-chemical
bound O
to O
eIF5B O
is O
required O
for O
the O
release O
of O
eIF5B O
from O
assembled O
80S B-organelle
ribosomes I-organelle
, O
for O
the O
release O
of O
other O
factors O
, O
or O
for O
both O
. O

The O
accumulation O
of O
DephrindeltaC-term B-protein
around O
axons O
suggests O
that O
Dephrin B-protein
may O
bind O
to O
DEph B-protein
. O

Characterization O
of O
substance B-chemical
P I-chemical
binding O
to O
human O
monocytes/macrophages cell
. O

Karyopherin B-protein
beta2 I-protein
( O
Kapbeta2 B-protein
, O
transportin B-protein
) O
binds O
the O
M9 B-protein-motif
sequence O
of O
human O
ribonucleoprotein B-protein
A1 I-protein
and O
mediates O
its O
nuclear O
import O
. O

Some O
E2F B-protein-family
may O
remain O
bound O
to O
a O
partially O
phosphorylated B-protein
Rb I-protein
throughout O
the O
normal O
cell O
cycle O
. O

On O
the O
basis O
of O
these O
observations O
and O
our O
demonstration O
of O
direct O
binding O
of O
Cdc6p B-protein
to O
ORC B-protein-complex
on O
origin O
DNA B-DNA
, O
we O
suggest O
that O
it O
is O
in O
this O
complex O
that O
Cdc6p O
recruits O
the O
MCM B-protein-family
proteins O
. O

Competition O
and O
co-immunoprecipitation O
experiments O
demonstrated O
that O
the O
binding O
of O
TnT B-protein
to O
Tm B-protein
was O
cooperative O
in O
the O
absence O
of O
F-actin protein-family
. O

Amagai O
M O
, O
Karpati O
S O
, O
Prussick O
R O
, O
Klaus-Kovtun O
V O
, O
Stanley O
JR O
( O
1992 O
) O
Autoantibodies O
against O
the O
amino-terminal O
cadherin-like B-protein-domain
binding I-protein-domain
domain I-protein-domain
of O
pemphigus O
vulgaris O
antigen O
are O
pathogenic O
. O

Inhibin B-protein-complex
also O
binds O
to O
ActRII B-protein
through O
its O
beta B-protein-domain
subunit I-protein-domain
, O
competes O
with O
the O
binding O
of O
activin B-protein-complex
to O
ActRII O
, O
but O
fails O
to O
form O
the O
ActRII B-protein-complex
SKR2 I-protein-complex
complex O
. O

These O
results O
demonstrate O
that O
Sp1 B-protein
and O
Sp3 B-protein
can O
both O
bind O
to O
the O
Sp1 B-DNA
consensus I-DNA
sequence I-DNA
in O
the O
IGF-II B-DNA
promoter I-DNA
. O

Recently O
, O
U2AF35 B-protein
has O
been O
shown O
to O
be O
able O
to O
directly O
assist O
U2AF65 B-protein
binding O
to O
Py B-DNA
tracts I-DNA
( O
25) O
. O

Characterization O
of O
IP4 B-chemical
binding O
to O
GST-STII-C2B B-experimental-construct
and O
GST-STIII-C2Bα-loopβ7-8 B-experimental-construct
. O

Experimental O
studies O
of O
liver O
regeneration O
, O
the O
acute-phase O
response O
to O
inflammation O
, O
and O
the O
pathology O
of O
myotonic O
dystrophy O
( O
DM O
) O
showed O
that O
, O
in O
all O
of O
these O
situations O
, O
CUGBP1 B-protein
binds O
to O
the O
GCN B-DNA
repeats I-DNA
within O
the O
5′ O
region O
of O
C/EBPβ B-protein
mRNA O
and O
induces O
downstream O
translation O
initiation O
of O
a O
dominant-negative O
C/EBPβ O
isoform O
, O
LIP B-protein-isoform
( O
30 O
, O
33 O
, O
36) O
. O

We O
have O
found O
that O
full-length O
recombinant O
yeast O
TAF130p B-protein
does O
not O
form O
a O
stable O
ternary O
complex O
with O
yeast O
TBP B-protein
bound O
to O
TATA B-DNA
DNA B-DNA
and O
consequently O
does O
not O
actively O
dissociate O
the O
TBP-DNA B-protein-complex
complex O
; O
rather O
, O
full-length O
TAF130p O
binds O
to O
TBP O
competitively O
with O
respect O
to O
DNA O
. O

In O
summary O
, O
the O
Dfd B-protein
homeodomain O
binds O
to O
Exd B-protein
in O
vitro O
, O
but O
the O
Dfd O
activation O
domain O
does O
not O
interact O
in O
vitro O
with O
either O
the O
Dfd O
homeodomain O
or O
Exd O
. O

D O
, O
Scatchard O
plots O
for O
TNP-ATP B-chemical
binding O
to O
MBP B-protein
6 I-protein
. I-protein
2Cdelta36 I-protein
at O
pH O
of O
7 O
. O
5 O
( O
squares O
) O
and O
6 O
. O
5 O
( O
diamonds) O
. O

The O
finding O
that O
Plexins B-protein-family
can O
bind O
Semaphorins B-protein-family
, O
combined O
with O
previous O
studies O
showing O
that O
Plexins O
can O
bind O
Plexins O
( O
Ohta O
et O
al O
. O
1995) O
, O
raises O
questions O
of O
whether O
some O
Semaphorins O
might O
bind O
one O
another O
and O
whether O
class O
I O
Semaphorins O
might O
also O
function O
as O
receptors O
. O

To O
test O
whether O
p97 B-protein
binds O
phosphorylated O
p47 B-protein
, O
p97 O
and O
p47 O
were O
incubated O
in O
the O
presence O
of O
Cdc2 B-protein
and O
[ O
gamma-32 O
] O
ATP B-chemical
( O
Fig O
. O
3 O
A) O
. O

In O
contrast O
, O
the O
binding O
of O
Diva B-protein
to O
Apaf-1 B-protein
was O
not O
significantly O
affected O
by O
Bcl-XL B-protein
( O
Fig O
. O
8 O
A) O
. O

Triton B-chemical
X-100 I-chemical
extracts O
from O
a O
crude O
rat O
brain O
nuclear O
fraction O
was O
incubated O
with O
GST B-experiment-tag
or O
GST-GBR1 protein
, O
and O
protein O
binding O
to O
the O
fusion O
proteins O
was O
recovered O
by O
adding O
glutathione B-chemical
beads O
. O

It O
is O
noteworthy O
that O
GSK-3beta B-protein
bound O
to O
beta-catenin B-protein
only O
when O
FWD1 B-protein
was O
co-transfected O
( O
Figure O
3A O
, O
lane O
2) O
. O

A O
mutant O
form O
of O
Pyk2 B-protein
( O
Pyk2-Y402F B-protein
) O
that O
is O
unable O
to O
bind O
and O
activate O
Src B-protein
is O
impaired O
in O
its O
ability O
to O
induce O
association O
of O
Grb2 B-protein
with O
Shc B-protein
, O
binding O
of O
Crk B-protein
to O
p130Cas B-protein
and O
stimulation O
of O
the O
ERK B-protein-family
and O
JNK B-protein-family
cascades O
. O

These O
results O
indicate O
that O
LIN-7 B-protein
binds O
to O
LIN-2 B-protein
and O
that O
LIN-2 O
binds O
to O
LIN-10 B-protein
in O
vivo O
. O

Binding O
of O
GMP B-chemical
to O
the O
GK B-protein-domain
domain I-protein-domain
of O
PSD-95 B-protein
did O
not O
induce O
large O
conformational O
changes O
in O
the O
nucleoside O
binding O
domain O
, O
in O
contrast O
to O
yeast O
guanylate B-protein-family
kinase I-protein-family
( O
Blaszczyk O
et O
al O
. O
, O
2001 O
) O
. O

In O
this O
model O
calcium B-chemical
stabilizes O
the O
binding O
of O
PKC B-protein-family
to O
PS B-chemical
containing O
membranes O
( O
see O
also O
( O
2 O
, O
3 O
, O
4 O
, O
6 O
) O
) O
. O

It O
is O
now O
apparent O
that O
4E-BP1 B-protein
inhibits O
the O
function O
of O
eIF4E B-protein
in O
cap-dependent O
translation O
by O
blocking O
the O
binding O
of O
eIF4E O
to O
eIF4G B-protein
, O
another O
component O
of O
the O
eIF4F B-protein-complex
complex O
. O

ADF/ B-protein-family
cofilin I-protein-family
can O
directly O
bind O
to O
actin B-protein-family
filaments O
and O
promote O
their O
disassembly O
( O
Carlier O
et O
al O
. O
, O
1999 O
; O
Bamburg O
, O
1999 O
) O
. O

We O
expressed O
both O
S11 B-protein-motif
and O
HMM-like B-protein-motif
fragments O
of O
myosin B-protein-complex
, O
and O
assessed O
their O
function O
, O
using O
steady O
state O
ATPase B-protein
assays O
, O
stopped O
flow O
measurements O
of O
the O
rate O
of O
ADP B-chemical
release O
from O
myosin O
bound O
to O
actin B-protein-family
, O
and O
the O
rate O
of O
actin O
filament O
sliding O
in O
an O
in O
vitro O
motility O
assay O
. O

  O
In O
contrast O
, O
the O
Rb-binding B-protein-domain
domain I-protein-domain
of O
the O
transcriptional O
regulatory O
protein O
E2F B-protein-family
possesses O
neither O
the O
viral O
protein O
homology O
nor O
the O
LxCxE B-protein-motif
motif I-protein-motif
, O
but O
E2F O
also O
binds O
the O
hypophosphorylated O
form O
of O
Rb( O
12 O
, O
13 O
, O
14 O
, O
15 O
) O
. O

EMSA B-assay
competition O
experiments O
support O
the O
hypothesis O
that O
CDP B-protein
binding O
to O
the O
gp91 B-DNA
phox I-DNA
promoter I-DNA
is O
mutually O
exclusive O
with O
that O
of O
transcriptional O
activating O
factors O
( O
Figs O
. O
4 O
and O
5) O
. O

We O
have O
found O
that O
the O
armadillo B-protein-motif
repeats I-protein-motif
2-7 O
of O
plakoglobin B-protein
bind O
to O
Axin B-protein
. O

This O
is O
contrary O
to O
what O
one O
would O
expect O
if O
high O
ionic O
strength O
decreases O
the O
effect O
of O
the O
mutation O
on O
the O
binding O
of O
the O
regulatory O
complex O
to O
actin B-protein-family
. O

Biochemical O
experiments O
revealed O
that O
the O
binding O
of O
SXL B-protein
to O
the O
pre-mRNA B-RNA
does O
not O
displace O
SPF45 B-protein
. O

In O
this O
study O
, O
I O
examined O
the O
Rab B-protein-family
binding O
activities O
of O
Rim1 B-protein
, O
Rim2 B-protein
, O
Noc2 B-protein
, O
and O
rabphilin B-protein
by O
cotransfection O
assay O
in O
COS-7 B-cell
cells O
using O
42 O
different O
Rab O
proteins O
( O
including O
37 O
subfamilies O
reported O
in O
the O
mouse O
data O
bases O
( O
18 O
, O
19 O
) O
) O
and O
found O
that O
these O
molecules O
exhibit O
distinct O
Rab O
binding O
specificity O
. O

Alternatively O
, O
auxilin B-protein
might O
bind O
much O
more O
weakly O
to O
Hsc70 B-protein
in O
ADP B-chemical
than O
ATP B-chemical
. O

However O
, O
these O
mutations O
greatly O
diminished O
( O
G423A O
) O
or O
abolished O
( O
Y426A O
and O
RQ428 O
, O
429AA O
) O
Smad2 B-protein
binding O
to O
the O
TGF‐β B-protein
receptor O
complex O
( O
Table O
I) O
. O

Like O
its O
yeast O
counterpart O
, O
purified O
human O
SWI-SNF B-protein-complex
complex O
contains O
ATP-dependent chemical
nucleosome O
disruption O
activity O
that O
leads O
to O
facilitated O
binding O
of O
TBP B-protein
and O
Gal4 B-protein
derivatives O
to O
synthetic O
promoters O
( O
Imbalzano O
et O
al O
. O
, O
1994 O
; O
Kwon O
et O
al O
. O
, O
1994) O
. O

The O
inability O
of O
tyrosine-phosphorylated O
SLP-76 B-protein
to O
interact O
with O
nck(SH2* protein
) O
was O
not O
due O
to O
a O
gross O
conformational O
change O
induced O
by O
the O
R308K O
mutation O
, O
as O
nck(SH2* O
) O
still O
bound O
cbl B-protein
, O
an O
interaction O
that O
is O
mediated O
through O
the O
N-terminal O
SH3 B-protein-domain
domain I-protein-domain
of O
nck O
( O
bottom O
panel O
) O
( O
Rivero-Lezcano O
et O
al O
. O
1994) O
. O

  O
Since O
Dvl-1 protein
also O
binds O
directly O
to O
this O
region O
of O
Axin B-protein
( O
26) O
, O
we O
examined O
whether O
Dvl O
and O
Axam B-protein
share O
the O
same O
binding O
site O
on O
Axin O
. O

  O
The O
Crystal O
Structure O
of O
a O
Laminin B-protein-domain
G I-protein-domain
- I-protein-domain
like I-protein-domain
Module I-protein-domain
Reveals O
the O
Molecular O
Basis O
of O
- O
Dystroglycan B-protein
Binding O
to O
Laminins B-protein-family
, O
Perlecan B-protein
, O
and O
Agrin B-protein
. O

Hence O
, O
we O
speculated O
that O
p140mDia B-protein
might O
bind O
to O
profilin B-protein-family
. O

This O
permits O
binding O
of O
tRNA B-RNA
to O
the O
HisRS B-protein-domain
domain O
in O
GCN2 B-protein
, O
with O
ensuing O
kinase O
activation O
, O
even O
though O
Ser O
577 O
remains O
phosphorylated O
because O
of O
high O
TOR B-protein-family
activity O
( O
Fig O
. O
7) O
. O

Drosophila O
CBP B-protein
acetylates O
a O
conserved O
lysine O
in O
the O
Armadillo-binding protein-motif
domain O
of O
Drosophila O
TCF B-protein-family
, O
which O
lowers O
the O
affinity O
of O
Armadillo O
binding O
to O
dTCF B-protein-family
( O
Waltzer O
and O
Bienz O
, O
1998) O
. O

The O
epidermal B-protein
growth I-protein
factor I-protein
receptor I-protein
phosphorylation O
domain O
behaves O
similarly O
with O
regard O
to O
Shc B-protein
, O
which O
binds O
to O
each O
of O
the O
epidermal O
growth O
factor O
receptor O
autophosphorylation O
sites O
with O
some O
degree O
of O
preference O
but O
without O
absolute O
specificity O
for O
a O
single O
site O
( O
42) O
. O

A O
third O
TCR B-protein-complex
transgenic O
strain O
was O
analyzed O
, O
DO10 B-cell
, O
whose O
TCR O
recognizes O
an O
ovalbumin B-peptide
peptide I-peptide
bound O
to O
Ad B-protein
( O
36 O
, O
20) O
. O

  O
Because O
high-level O
beta-globin B-protein
transcription O
at O
all O
developmental O
stages O
is O
mediated O
by O
EKLF B-protein
binding O
to O
the O
proximal O
CAC B-DNA
site I-DNA
, O
we O
suspected O
that O
the O
newly O
created O
CAC B-DNA
box I-DNA
in O
the O
-promoter O
would O
also O
recruit O
EKLF O
. O

Although O
we O
observed O
no O
trans-interaction O
between O
TAG-1 B-protein
and O
L1-CAM B-protein
in O
our O
S2 O
cell O
aggregation O
experiment O
shown O
in O
Fig O
. O
2 O
, O
we O
considered O
that O
a O
weak O
trans-interaction O
between O
TAG-1 O
and O
L1-CAM O
expressed O
by O
two O
different O
cells O
might O
be O
responsible O
for O
the O
observed O
induction O
of O
ankyrin B-protein-family
binding O
to O
L1-CAM O
. O

Cortactin B-protein
Binds O
the O
Arp2/3 B-protein-complex
Complex O
through O
Sequences O
in O
the O
NTA B-protein-motif
Region O

To O
identify O
the O
region O
within O
the O
cortactin O
amino O
terminus O
responsible O
for O
associating O
with O
the O
Arp2/3 B-protein-complex
complex O
, O
Sepharose B-chemical
beads O
covalently O
coupled O
to O
the O
NTA B-protein-motif
and O
repeats O
regions O
were O
incubated O
with O
10T1/2 B-assay
fibroblast O
lysate O
, O
and O
Arp2/3 O
binding O
was O
assayed O
by O
immunoblotting O
( O
Fig O
. O
6 O
A) O
. O

This O
value O
, O
which O
can O
also O
be O
deduced O
from O
the O
HPLC B-assay
elution O
pattern O
after O
calibration O
with O
standard O
proteins O
of O
known O
Stokes O
radii O
( O
Figs O
. O
5 O
A O
and O
6 O
A O
, O
5 O
. O
5 O
± O
0 O
. O
3 O
nm) O
, O
is O
identical O
to O
that O
for O
ATPase B-protein-family
in O
C12E8 B-chemical
( O
22 O
) O
( O
the O
sedimentation O
coefficient O
for O
Ca2+-ATPase B-protein
monomers O
in O
DM B-chemical
is O
larger O
than O
that O
for O
Ca2+-ATPase O
monomers O
in O
C12E8 O
, O
7 O
. O
62 O
S O
( O
this O
work O
) O
versus O
5 O
. O
1 O
S O
( O
45) O
, O
mainly O
because O
DM O
is O
more O
dense O
than O
C12E8 O
( O
DM O
has O
a O
partial O
specific O
volume O
smaller O
than O
that O
of O
C12E8 O
, O
0 O
. O
82 O
( O
Ref O
. O
46 O
) O
versus O
0 O
. O
97 O
cm3/g O
( O
Ref O
. O
23)) O
, O
and O
also O
because O
the O
protein O
binds O
slightly O
more O
( O
23 O
) O
DM O
than O
C12E8) O
. O

Comparison O
of O
the O
Kapp O
values O
in O
the O
absence O
of O
agonist O
versus O
those O
in O
the O
presence O
of O
agonist O
suggests O
that O
CrV B-chemical
binding O
strongly O
favors O
the O
desensitized O
conformation O
of O
the O
AChR B-protein-family
because O
this O
is O
the O
conformation O
stabilized O
by O
agonists O
at O
equilibrium O
. O

A O
more O
pronounced O
increase O
in O
[ O
3 O
] O
GABA B-chemical
binding O
to O
Hydra B-experimental-construct
membranes I-experimental-construct
was O
apparent O
in O
the O
presence O
of O
general O
anaesthetics O
( O
Fig O
. O
1A) O
. O

Notably O
, O
binding O
to O
E-cadherin B-protein
and O
APC B-protein
seems O
to O
be O
mutually O
exclusive O
, O
and O
β-catenin protein
bound O
to O
cadherins B-protein-family
in O
adherens O
junctions O
should O
be O
therefore O
inaccessible O
to O
APC-mediated O
degradation O
. O

  O
It O
was O
found O
to O
bind O
to O
collagen B-protein-complex
type O
I O
, O
but O
collagen O
preincubated O
in O
a O
dot O
blot O
assay O
with O
heparin B-chemical
did O
not O
bind O
any O
longerR O
to O
APP B-protein
. O

JNK/SAPK protein
Binds O
and O
Phosphorylates O
a O
MEKK1 B-protein
Fragment O
In O
Vitro O

Since O
both O
of O
the O
Sp1 B-protein
binding O
sequences O
( O
GGGTGG B-DNA
) O
showed O
variations O
of O
the O
Sp1 O
consensus O
binding O
sequences O
( O
GGGCGG) O
, O
a O
single O
T O
( O
m1 O
, O
m2 O
) O
and O
both O
Ts O
( O
m4 O
) O
of O
the O
variant O
Sp1 O
sites O
were O
changed O
into O
C O
, O
in O
order O
to O
test O
the O
ability O
of O
the O
Sp1 O
consensus O
binding O
( O
GGGCGG O
) O
sequences O
to O
confer O
PTEN-mediated protein
transcriptional O
regulation O
( O
Fig O
. O
2Ba) O
. O

Interestingly O
, O
using O
the O
SPR B-assay
, O
the O
binding O
of O
GFRalpha2-Fc experiment-tag
to O
GDNF B-protein
could O
not O
be O
detected O
. O

  O
In O
the O
case O
of O
the O
c- B-DNA
myc I-DNA
promoter I-DNA
, O
in O
addition O
to O
hnRNP B-protein
K I-protein
and O
CNBP B-protein
, O
the O
CT B-DNA
element I-DNA
can O
also O
be O
bound O
by O
Sp1 B-protein
. O

However O
, O
in O
the O
absence O
of O
Phyl B-protein
, O
barely O
detectable O
levels O
of O
Sina B-protein
bound O
Ttk-HA protein
. O

poly( B-chemical
dC)-agarose I-chemical
; O
lane O
3 O
, O
DADA B-mutation
mutant O
protein O
bound O
to O
poly( B-chemical
dI) I-chemical
. O

However O
, O
not O
all O
SM B-protein-family
proteins O
directly O
bind O
to O
syntaxins B-protein-family
, O
and O
no O
decrease O
in O
Sso1p/2p protein
is O
observed O
in O
Sec1p B-protein
null O
mutants O
in O
yeast O
. O

Binding O
of O
neuroligins B-protein-family
to O
PSD-95 B-protein
. O

TFIIA B-protein
binds O
directly O
to O
TBP B-protein
and O
at O
least O
one O
TBP-associated B-protein-domain
factor I-protein-domain
( O
TAF B-protein-domain
) O
in O
the O
TFIID B-protein
complex O
( O
7) O
. O

  O
A O
small O
increase O
in O
salt O
concentration O
in O
the O
lysis O
buffer O
slightly O
reduced O
the O
amount O
of O
raptor B-protein
bound O
to O
mTOR B-protein
, O
and O
this O
correlated O
with O
a O
corresponding O
increase O
in O
mTOR O
activity O
. O

Control O
experiments O
confirmed O
retention O
of O
EGFR B-protein
binding O
by O
the O
mutant O
form O
of O
c-Cbl B-protein
. O

The O
rate O
of O
ADP B-chemical
binding O
to O
( O
k+AD O
) O
and O
dissociation O
from O
( O
k O
AD O
) O
actomyosin B-protein-family
are O
too O
fast O
to O
be O
measured O
using O
the O
method O
described O
here O
. O

To O
verify O
that O
U2AF65 B-protein
bound O
to O
the O
Py B-DNA
tract I-DNA
, O
we O
constructed O
and O
analyzed O
Py O
tract O
deletion O
mutants O
muMPy B-DNA
and O
muMdeltaPy B-DNA
( O
see O
Fig O
. O
1A) O
. O

To O
examine O
whether O
CRT B-protein
binds O
to O
the O
SL B-RNA
structure I-RNA
, O
we O
tested O
the O
interaction O
of O
CRT O
with O
a O
short O
sORF O
oligomer O
and O
with O
a O
longer O
oligomer O
, O
FL-LAP experiment-tag
, O
which O
covers O
the O
region O
of O
C/EBPβ B-RNA
mRNA I-RNA
from O
the O
first O
( O
FL O
) O
to O
the O
second O
( O
LAP O
) O
AUG B-RNA
codons O
( O
Fig O
. O
​(Fig O
. O
1)1 O
) O
( O
see O
Materials O
and O
Methods) O
. O

NAD(H B-chemical
) I-chemical
binds O
to O
dI B-protein-domain
, O
and O
NADP(H B-chemical
) I-chemical
binds O
to O
dIII B-protein-domain
; O
these O
two O
components O
protrude O
from O
the O
membrane O
( O
into O
the O
bacterial O
cytoplasm O
or O
mitochondrial O
matrix) O
. O

Aside O
from O
TFIID B-protein
binding O
to O
the O
Inr B-DNA
, O
it O
has O
also O
been O
observed O
that O
purified O
RNA B-protein-complex
polymerase I-protein-complex
II I-protein-complex
( O
or O
RNA O
polymerase O
II O
along O
with O
TBP B-protein
, O
TFIIB B-protein
, O
TFIIF B-protein
) O
is O
able O
to O
recognize O
the O
Inr O
and O
to O
mediate O
transcription O
in O
an O
Inr-dependent O
manner O
in O
the O
absence O
of O
TAFs B-protein-domain
( O
Carcamo O
et O
al O
. O
1991 O
; O
Weis O
and O
Reinberg O
1997) O
. O

These O
results O
confirm O
the O
specific O
interaction O
with O
the O
GTP-bound chemical
form O
of O
Rab5 B-protein
observed O
in O
the O
two-hybrid O
system O
and O
indicate O
that O
, O
like O
Rabaptin-5 B-protein
, O
Rabaptin-5beta B-protein
is O
recruited O
by O
Rab5GTP B-protein
on O
endosomal O
membranes O
in O
vivo O
. O

The O
yeast O
PRP19 B-protein
protein O
is O
not O
tightly O
associated O
with O
small B-RNA
nuclear I-RNA
RNAs I-RNA
, O
but O
appears O
to O
associate O
with O
the O
spliceosome B-protein-complex
after O
binding O
of O
U2 B-RNA
to O
the O
pre-mRNA B-RNA
and O
prior O
to O
formation O
of O
the O
functional O
spliceosome O
. O

For O
Gsb B-protein
might O
be O
able O
to O
recognize O
some O
Ey B-protein
binding O
sites O
even O
in O
the O
absence O
of O
its O
homeodomain O
, O
and O
binding O
of O
Gsb O
to O
Ey O
might O
depend O
on O
both O
its O
paired O
domain O
and O
C-terminal O
portion O
. O

Binding O
of O
HsOrc1 B-protein
and O
HsCdc6 B-protein
to O
GST B-experiment-tag
was O
not O
detectable O
( O
lanes O
2 O
and O
6) O
, O
confirming O
that O
the O
interaction O
was O
mediated O
by O
the O
HsCdc6 O
portion O
of O
the O
fusion O
protein O
. O

PKA B-protein-complex
phosphorylation O
of O
adducin B-protein
reduced O
activity O
of O
adducin O
in O
association O
with O
spectrin-actin protein-complex
complexes O
and O
in O
promoting O
binding O
of O
spectrin O
to O
F-actin B-protein
. O

p23 B-protein
and O
Hsp90 B-protein
bind O
hTERT B-protein
. O

It O
is O
hard O
to O
imagine O
how O
ADF B-protein
binding O
to O
an O
actin B-protein-family
monomer O
could O
increase O
the O
rate O
of O
its O
thermally O
driven O
collision O
with O
a O
filament O
end O
. O

Fig O
. O
3 O
A O
shows O
that O
both O
the O
full-length O
and O
the O
amino-terminal O
p53 B-protein
fragment O
binds O
to O
CR2 B-protein
( O
lanes O
5 O
and O
8) O
. O

Unlike O
the O
Sir B-protein
protein O
and O
bromo B-protein-domain
domain I-protein-domain
interactions O
, O
HP1 B-protein
binding O
to O
H4 B-protein-family
tail O
peptides O
appears O
to O
be O
unaffected O
by O
acetylation O
. O

Additionally O
, O
we O
show O
here O
that O
FKBP52 B-protein
binds O
directly O
to O
the O
GR B-protein
. O

Treatment O
with O
C3 B-protein
exoenzyme I-protein
( O
C3 O
) O
may O
block O
m1 B-protein
mAChR I-protein
- O
mediated O
suppression O
of O
Kv1 B-protein
. I-protein
2 I-protein
or O
may O
disrupt O
the O
binding O
between O
RhoA B-protein
and O
Kv1 O
. O
2 O
. O

In O
addition O
, O
changes O
to O
tau B-protein
also O
regulated O
this O
interaction O
, O
as O
shown O
by O
the O
altered O
binding O
of O
S100β B-protein
to O
the O
AD-related disease
hyperphosphorylated B-protein
NFT-tau I-protein
. O

Tnfr1 B-protein
and O
Tnfr2 B-protein
bind O
Tnfα B-protein
and O
Tnfβ B-protein
with O
similar O
high O
equilibrium O
affinity O
, O
but O
they O
differ O
significantly O
in O
their O
Tnfα O
binding O
kinetics O
; O
Tnfα O
bound O
to O
Tnfr2 O
is O
exchanged O
at O
a O
significantly O
faster O
rate O
than O
when O
complexed O
with O
Tnfr1 O
( O
9 O
, O
10 O
, O
11 O
, O
12) O
. O

Studies O
in O
vitro O
revealed O
that O
both O
p55 B-protein
and O
hDlg B-protein
bind O
directly O
to O
protein B-protein
4 I-protein
. I-protein
1 I-protein
[ O
7 O
. O

Consistent O
with O
previous O
work O
, O
Y-27632 B-chemical
treatment O
in O
SDF-1alpha B-protein
- O
stimulated O
neurons O
was O
sufficient O
to O
increase O
the O
GTP-bound chemical
form O
of O
Rac B-protein
( O
Fig O
. O
9 O
B) O
. O

The O
underlined O
grey O
box O
represents O
the O
region O
involved O
in O
the O
binding O
of O
the O
ADP B-chemical
moiety O
of O
FAD B-chemical
. O

In O
a O
similar O
study O
, O
Schowalter O
et O
al O
. O
( O
15 O
) O
showed O
that O
three O
separate O
regions O
of O
the O
progesterone B-protein
receptor I-protein
HBD B-protein-domain
could O
confer O
hsp90 B-protein
binding O
when O
fused O
to O
a O
mutant O
PR B-protein
lacking O
the O
HBD O
. O

Chen O
et O
al O
. O
( O
2001 O
) O
recently O
demonstrated O
that O
TNF-alpha B-protein
induces O
acetylation O
of O
p65 B-protein
by O
p300/CBP B-protein-family
, O
thus O
abrogating O
the O
binding O
of O
p65 O
to O
IkappaBalpha B-protein
. O

A O
difference O
in O
the O
NAD+/NADH chemical
binding O
properties O
of O
dI B-protein-domain
in O
its O
isolated O
form O
and O
in O
the O
complete O
, O
membrane-bound O
protein O
was O
also O
inferred O
from O
a O
steady-state O
kinetic O
analysis O
( O
7) O
. O

EGF-like B-protein-motif
rpts I-protein-motif
, O
epidermal B-protein-motif
growth I-protein-motif
factor-like I-protein-motif
repeats I-protein-motif
; O
L/N B-protein-motif
rpts I-protein-motif
, O
Lin12/Notch B-protein-motif
repeats I-protein-motif
; O
CDC B-protein-motif
, O
CDC10/Ankyrin B-protein-motif
repeats I-protein-motif
; O
OPA B-protein-motif
, O
Glutamine-rich B-protein-motif
sequence I-protein-motif
; O
Dab B-gene
, O
Disabled B-gene
; O
Dx B-gene
, O
Deltex B-gene
; O
Dsh B-gene
, O
Dishevelled B-gene
; O
H B-gene
, O
Hairless B-gene
( O
exact O
binding O
site O
is O
not O
known) O
. O

Second O
, O
it O
is O
now O
believed O
that O
p27KIP1 B-protein
interacts O
mostly O
with O
D-type B-protein-family
cyclins I-protein-family
and O
CDK4 B-protein
and O
more O
weakly O
with O
cyclin B-protein-family
E I-protein-family
and O
CDK2 B-protein
, O
and O
that O
binding O
of O
p27KIP1 O
to O
cyclin B-protein-complex
D-CDK4 I-protein-complex
would O
allow O
the O
activation O
of O
cyclin B-protein-complex
E-CDK2 I-protein-complex
complexes O
at O
the O
G1-S O
transition O
( O
54 O
, O
55 O
, O
56) O
. O

DNase B-protein
I I-protein
footprinting O
assays O
showed O
that O
the O
interaction O
prevents O
binding O
of O
Sp1 B-protein
to O
the O
GC B-DNA
boxes I-DNA
of O
the O
ADH5/ gene
FDH B-gene
promoter O
. O

We O
suggest O
that O
, O
without O
p35 B-protein
, O
Cdk5 B-protein
is O
bound O
and O
activated O
by O
Pho85 B-protein
cyclins O
, O
which O
then O
direct O
Cdk5 O
to O
Pho85 O
substrates O
, O
allowing O
functional O
complementation O
of O
the O
pho85delta B-protein
strain O
. O

On O
the O
other O
hand O
, O
13 O
genes O
( O
Alpha-tubulin B-gene
, O
Swiprosin-2 B-gene
, O
Insulin-like B-gene
growth I-gene
factor I-gene
binding I-gene
protein I-gene
2 I-gene
[ O
IGFBP2] gene
, O
CRBP B-gene
, O
Apo B-gene
D I-gene
, O
NU B-gene
, O
Claudin-3 B-gene
, O
Uncoupling B-gene
protein-2 I-gene
[ O
UCP-2] gene
, O
CRIP-1 B-gene
, O
MT B-gene
1G I-gene
, O
Apolipoprotein B-gene
CI I-gene
[ O
Apo -
CI] -
, O
CLF-1 B-gene
, O
Transglutaminase-2 B-gene
) O
retained O
high O
cytosine O
content O
in O
their O
CpG B-DNA
islands I-DNA
or O
CpG B-DNA
sites I-DNA
deemed O
critical O
for O
transcription O
( O
Apo O
D O
) O
after O
bisulfite O
treatment O
, O
indicating O
heavy O
cytosine O
methylation O
( O
Figures O
3A O
and O
3B) O
. O

The O
EGFR B-protein
is O
activated O
by O
several O
ligands O
such O
as O
epidermal B-protein
growth I-protein
factor I-protein
( O
EGF) protein
, O
transforming B-protein-family
growth I-protein-family
factor I-protein-family
( O
TGF B-protein-family
) O
, O
amphiregulin B-protein
, O
heparin B-protein
binding I-protein
EGF I-protein
( O
HB-EGF) protein
, O
beta-cellulin B-protein
, O
and O
epiregulin B-protein
( O
Prigent O
and O
Lemoine O
, O
1992 O
; O
Earp O
et O
al O
. O
, O
1995 O
) O
. O

Genetic O
mutants O
lacking O
adenylyl B-protein-complex
cyclase I-protein-complex
, O
cAMP-dependent B-protein-complex
protein I-protein-complex
kinase I-protein-complex
( O
PKA) protein-complex
, O
or O
cAMP B-DNA
response I-DNA
element I-DNA
( O
CRE B-DNA
) O
binding O
protein O
( O
CREB B-protein
) O
exhibit O
significant O
defects O
in O
different O
forms O
of O
behavioral O
learning O
and O
memory O
( O
Livingston O
et O
al O
. O
, O
1984 O
; O
Foster O
et O
al O
. O

Apart O
from O
nonimmune O
controls O
, O
we O
studied O
the O
c-jun B-DNA
promoter I-DNA
and O
found O
no O
binding O
of O
p300 B-protein
and O
SAF-A B-protein
to O
this O
site O
. O

However O
, O
both O
assays O
revealed O
that O
double O
mutation O
of O
these O
residues O
to O
alanine O
abrogated O
binding O
of O
mSTI1 B-protein
to O
Hsc70 B-protein
. O

As O
a O
result O
, O
E2F6 B-protein
lacks O
the O
sequences O
that O
mediate O
the O
transcriptional O
activation O
or O
pRB B-protein
, O
p107 B-protein
, O
and O
p130 B-protein
binding O
properties O
of O
the O
other O
E2F B-protein-family
proteins O
. O

The O
TNF-alpha B-protein
and O
IL-1beta B-protein
protein O
synthesis O
were O
followed O
to O
further O
study O
the O
consequences O
of O
the O
decreased O
LPS-induced chemical
binding O
of O
NF-kappaB B-protein-complex
and O
AP-1 B-protein-complex
to O
the O
TNF-alpha O
and O
IL-1beta B-DNA
promotors I-DNA
. O

Binding O
of O
the O
4E-BPs B-protein
to O
eIF4E B-protein
is O
regulated O
by O
phosphorylation O
( O
Lin O
et O
al O
. O
1994 O
; O
Pause O
et O
al O
. O
1994 O
) O
. O

Binding O
of O
trithorax B-protein-family
and O
Polycomb B-protein-family
proteins I-protein-family
to O
the O
bithorax B-protein-complex
complex I-protein-complex
: O
dynamic O
changes O
during O
early O
Drosophila O
embryogenesis O
. O

In O
support O
of O
this O
hypothesis O
, O
PU B-protein
. I-protein
1 I-protein
binding O
to O
the O
μB B-DNA
site I-DNA
is O
undetectable O
in O
EMSA B-assay
analyses O
of O
B B-cell
cell I-cell
nuclear O
extracts O
despite O
the O
demonstrations O
that O
1 O
) O
DNA-binding DNA
PU O
. O
1 O
is O
present O
in O
B O
cell O
nuclei O
and O
2 O
) O
recombinant O
PU O
. O
1 O
binds O
the O
μB O
site O
in O
a O
variety O
of O
analyses O
( O
3 O
, O
25 O
, O
41) O
. O

Pho B-protein
and O
Phol B-protein
bind O
to O
the O
same O
DNA B-DNA
sequence O
phol O
is O
located O
on O
chromosome O
3 O
in O
polytene O
subdivision O
67B O
and O
is O
designated O
by O
the O
Drosophila O
genome O
project O
as O
CG3445 O
. O

The O
Tir-binding protein
fragment O
of O
intimin B-protein
( O
i O
. O
e O
. O
Int190 B-protein-motif
, O
D3 B-protein-motif
and O
D4 B-protein-motif
) O
is O
illustrated O
by O
the O
space O
filling O
representation O
shown O
in O
( O
B) O
. O

In O
fact O
, O
channelologists O
have O
had O
this O
idea O
for O
some O
time O
, O
but O
a O
rather O
general O
experimental O
finding O
has O
been O
that O
standard O
calmodulin B-protein
inhibitors O
that O
block O
the O
calcium-dependent chemical
binding O
of O
calmodulin O
to O
its O
target O
proteins O
do O
not O
interfere O
with O
calcium O
regulation O
of O
ion O
channels O
. O

The O
amount O
of O
S223F B-protein
coat I-protein
protein I-protein
bound O
to O
GroEL B-protein
increased O
when O
the O
GroEL O
concentration O
was O
raised O
regardless O
of O
temperature O
, O
suggesting O
that O
even O
at O
low O
temperatures O
the O
improper O
folding O
of O
S223F O
coat O
protein O
exceeded O
the O
capacity O
of O
GroEL O
to O
accommodate O
substrates O
. O

The O
demonstration O
that O
Axin B-protein
binds O
GSK-3 B-protein
and O
beta-catenin B-protein
and O
promotes O
GSK-3 O
phosphorylation O
of O
beta-catenin O
suggested O
that O
Axin O
might O
be O
the O
target O
of O
the O
dnXgsk-3 B-protein
. O

In O
complex O
with O
the O
drug O
FK506 B-chemical
, O
FKBP12 B-protein
binds O
calcineurin B-protein
, O
inhibiting O
calcineurin O
' O
s O
phosphatase O
activity O
and O
thus O
its O
ability O
to O
activate O
the O
transcription O
factor O
NF-AT B-protein-family
in O
the O
T-cell B-protein-family
receptor I-protein-family
signal O
transduction O
pathway O
( O
170) O
. O

CREB B-protein
phosphorylation O
enhances O
CREB O
binding O
to O
CREB-binding B-protein
protein I-protein
, O
thus O
activating O
gene O
transcription O
via O
the O
CRE B-DNA
( O
29) O
. O

Still O
other O
mechanisms O
are O
likely O
to O
be O
highly O
receptor-specific O
: O
the O
binding O
of O
NHERF B-protein-family
to O
the O
β2-adrenergic B-protein-family
receptor I-protein-family
and O
the O
binding O
of O
Homer B-protein-family
to O
metabotropic B-protein-family
glutamate I-protein-family
receptors I-protein-family
, O
for O
example O
, O
depend O
on O
the O
presence O
of O
precise O
motifs O
that O
are O
likely O
to O
be O
found O
in O
few O
other O
heptahelical O
receptors O
, O
although O
other O
receptors O
are O
likely O
to O
contain O
slightly O
modified O
motifs O
that O
mediate O
binding O
to O
other O
specific O
PDZ B-protein-domain
or O
polyproline-binding B-protein-domain
domains I-protein-domain
. O

( O
A O
) O
U1 B-RNA
snRNP I-RNA
binds O
to O
the O
dsx B-RNA
pre-mRNA I-RNA
independently O
of O
the O
ESE B-DNA
, O
whereas O
the O
ESE O
and O
U1 O
snRNP O
are O
required O
for O
the O
assembly O
of O
U2 B-RNA
, O
U4/U6 B-RNA
, O
and O
U5 B-RNA
snRNPs B-protein-complex
on O
the O
dsx O
pre-mRNA O
. O

First O
, O
p21 B-protein
binds O
PCNA B-protein
( O
15 O
) O
through O
a O
region O
found O
by O
Chuang O
et O
al O
. O
to O
be O
similar O
to O
, O
and O
to O
compete O
with O
, O
the O
site O
in O
DNA-MCMT B-protein
that O
mediates O
PCNA O
binding O
. O

As O
shown O
in O
Figure O
​7A O
( O
panels O
labeled O
‘GAL4 O
’ O
) O
, O
GAL4 B-protein-region
WT I-protein-region
, O
DB·CR B-protein-region
and O
DB·AD B-protein-region
bound O
more O
readily O
than O
the O
DNA-binding DNA
domain O
alone O
to O
an O
artificial O
promoter O
, O
which O
bears O
four O
GAL4 B-DNA
sites I-DNA
fused O
to O
an O
unrelated O
HIS4 B-DNA
basal I-DNA
promoter I-DNA
. O

The O
cytoplasmic B-protein-domain
domain I-protein-domain
of O
the O
cadherin B-protein-family
can O
bind O
directly O
to O
p120ctn B-protein
as O
well O
as O
beta-catenin B-protein
, O
and O
either O
protein O
could O
play O
a O
role O
in O
growth O
suppression O
. O

As O
a O
consequence O
, O
Armadillo B-protein-motif
is O
no O
longer O
bound O
by O
Axin B-protein
, O
resulting O
in O
nuclear O
signaling O
by O
Armadillo O
. O

Assay O
for O
CD22Rg B-fusion-protein
Binding O
to O
HEC B-cell
After O
washing O
with O
Medium O
199 O
, O
HEC O
were O
incubated O
with O
2 O
. O
5 O
mug/ O
ml O
CD22 B-reagent
mRg I-reagent
in O
Medium O
199 O
, O
1% O
BSA B-reagent
at O
4 O
degrees O
C O
for O
2 O
h O
, O
in O
the O
absence O
or O
presence O
of O
alpha2-6-sLac B-reagent
or O
alpha2-3-sLac B-reagent
, O
plasma O
, O
IgM B-reagent
, O
haptoglobin B-reagent
, O
or O
IgG B-reagent
. O

Moreover O
, O
it O
has O
been O
found O
that O
acetyl-CoA B-chemical
can O
enhance O
the O
transcription O
of O
naked O
DNA B-DNA
( O
greater O
than O
5-fold O
) O
as O
well O
as O
the O
binding O
of O
TFIID B-protein
to O
promoter O
DNA O
in O
the O
absence O
of O
histones O
( O
35) O
. O

Rapid O
regulation O
of O
Cdk5 B-protein
activity O
could O
occur O
by O
increased O
binding O
of O
free O
p35 B-protein
to O
monomeric O
Cdk5 O
, O
particularly O
as O
the O
generally O
low O
cytoplasmic O
levels O
of O
p35 O
( O
30 O
, O
54 O
) O
are O
under O
strict O
regulation O
, O
with O
rapid O
p35 O
turnover O
( O
half-life O
20–30 O
min O
) O
controlled O
by O
a O
ubiquitin-proteasome protein-complex
pathway O
( O
27) O
. O

It O
is O
clear O
, O
however O
, O
that O
only O
a O
small O
fraction O
of O
TLN B-protein
binds O
PS1 B-protein
under O
steady-state O
conditions O
( O
Figure O
1E) O
, O
indicating O
that O
the O
interaction O
is O
functional O
and O
not O
structural O
. O

( O
C O
) O
Comparison O
of O
the O
binding O
of O
10 O
JNK B-protein
isoforms O
to O
JIP3 B-protein
. O

Despite O
a O
lack O
of O
significant O
sequence O
homology O
, O
the O
cadherin B-protein-family
cytoplasmic O
domain O
, O
APC B-protein
, O
and O
LEF/ B-protein-family
Tcf I-protein-family
bind O
competitively O
to O
beta-catenin B-protein
( O
H&uuml O
;lsken O
et O
al O
. O
, O
1994 O
; O
. O

The O
binding O
of O
Hh B-protein
to O
Ptc B-protein
alleviates O
the O
repressive O
action O
of O
Ptc O
on O
Smo B-protein
and O
, O
when O
Smo O
is O
derepressed O
, O
Ci B-protein
proteolysis O
is O
inhibited O
and O
Ci O
is O
converted O
into O
a O
transcriptional O
activator O
. O

Although O
the O
cooperativity O
of O
Arg B-protein
binding O
to O
F-actin B-protein
precluded O
an O
accurate O
determination O
of O
the O
dissociation O
constant O
of O
Arg O
for O
F-actin O
( O
19) O
, O
the O
apparent O
Kd O
was O
0 O
. O
3 O
muM O
. O

Therefore O
, O
an O
initial O
recruitment O
of O
Sp1 B-protein
may O
also O
facilitate O
the O
binding O
of O
Ets-1 B-protein
. O

We O
examined O
whether O
the O
PTB B-protein-domain
domain I-protein-domain
of O
DAB B-protein
could O
also O
bind O
to O
activated O
SEV B-protein
. O

Such O
a O
scenario O
has O
been O
documented O
for O
the O
JNK B-protein-family
MAP I-protein-family
kinases I-protein-family
bound O
to O
c-Jun B-protein
, O
which O
can O
phosphorylate O
heterodimer O
partners O
that O
lack O
a O
JNK-binding O
site O
( O
29) O
. O

The O
data O
presented O
in O
this O
study O
clearly O
show O
that O
I-DOX B-chemical
binds O
specifically O
to O
TTR B-protein
amyloid O
fibrils O
in O
tissues O
from O
patients O
with O
FAP B-disease
. O

When O
sal-Gal4 experiment-tag
was O
used O
to O
drive O
ectopic O
expression O
of O
E(spl)Mβ B-protein
in O
the O
wing O
imaginal O
disc O
, O
Gbe-B1-lacZ experiment-tag
was O
clearly O
repressed O
at O
the O
sites O
where O
Gal4 O
, O
and O
thus O
Mβ O
, O
was O
being O
expressed O
at O
highest O
levels O
( O
Fig O
. O
​6A O
and O
B) O
, O
demonstrating O
that O
E(spl)bHLH B-protein
proteins O
can O
bind O
the O
B1 B-DNA
site I-DNA
and O
repress O
transcription O
in O
vivo O
. O

Activation O
of O
p53 B-protein
Sequence-Specific O
DNA B-DNA
Binding O
by O
Acetylation O
of O
the O
p53 O
C-Terminal O
Domain O
. O

Therefore O
, O
binding O
of O
the O
TGFβ B-protein-family
family I-protein-family
type I-protein-family
I I-protein-family
receptors I-protein-family
and O
the O
huge O
IP3 B-protein
receptor I-protein
to O
the O
FK506 B-chemical
binding O
site O
of O
FKBP12 B-protein
suggests O
that O
calcineurin B-protein
, O
if O
also O
directly O
bound O
to O
FKBP12 O
in O
the O
receptor/FKBP12/calcineurin B-protein-complex
complex O
, O
must O
be O
binding O
to O
sites O
removed O
from O
the O
FK506 O
binding O
site O
of O
FKBP12 O
. O

In O
favor O
of O
a O
role O
for O
cytochrome B-protein
c I-protein
is O
the O
fact O
that O
Dark B-protein
contains O
, O
like O
Apaf-1 B-protein
but O
in O
contrast O
to O
Ced-4 B-protein
, O
a O
carboxy-terminal O
WD-40 B-protein-motif
repeat I-protein-motif
region O
, O
which O
is O
required O
though O
not O
sufficient O
for O
the O
binding O
of O
cytochrome O
c O
to O
Apaf-1 O
( O
see O
references O
in O
[ O
37]) O
. O

Deletion O
experiments O
suggest O
that O
these O
regions O
, O
as O
well O
as O
the O
C- O
and O
N-termini O
, O
are O
vital O
for O
forming O
the O
proper O
homotrimeric O
, O
native O
structure O
essential O
for O
the O
binding O
of O
PCNA B-protein
to O
its O
target O
proteins O
( O
Fukuda O
et O
al O
. O
, O
1995 O
; O
Fein O
and O
Stillman O
, O
1992) O
. O

Furthermore O
, O
G6P B-protein-family
binding O
to O
GS B-protein-family
induces O
a O
conformational O
change O
, O
increasing O
its O
susceptibility O
to O
dephosphorylation O
( O
5 O
, O
6) O
. O

( O
A O
) O
The O
peptide O
analogous O
to O
the O
wild-type O
N O
terminus O
of O
KCNK9 B-protein
( O
and O
KCNK3 B-protein
) O
binds O
beta-COP B-protein
from O
rat O
brain O
, O
while O
peptides O
with O
the O
NQ O
mutation O
do O
not O
( O
left) O
. O

On O
the O
other O
hand O
, O
the O
SH2 B-protein-domain
domain I-protein-domain
of O
Crk B-protein
can O
potentially O
bind O
to O
both O
p130Cas B-protein
and O
paxillin B-protein
. O

TAFII250 B-protein
binds O
directly O
to O
TBP B-protein
and O
multiple O
other O
TAFIIs B-protein-family
, O
thus O
serving O
as O
a O
potential O
scaffold O
for O
the O
multiprotein O
complex O
( O
28 O
, O
29) O
. O

Since O
TSA B-chemical
induced O
Sp1 B-protein
binding O
to O
Sp1 B-DNA
consensus I-DNA
sequences I-DNA
in O
Hep3B B-cell
cells I-cell
, O
we O
investigated O
whether O
TSA O
affected O
Sp1 O
phosphorylation O
, O
a O
possible O
cause O
for O
the O
increase O
of O
Sp1 O
binding O
to O
its O
consensus O
DNA B-DNA
sequences O
. O

Systemic O
administration O
of O
3-NPA B-chemical
( O
30 O
mg O
kg-1 O
per O
day O
for O
3 O
days O
) O
induced O
a O
170% O
increase O
in O
[ B-chemical
3]- I-chemical
PK I-chemical
11195 I-chemical
binding O
, O
and O
expression O
of O
HSP27 B-protein
. O

This O
interpretation O
is O
consistent O
with O
stopped O
flow O
experiments O
on O
the O
formation O
of O
the O
catalytic O
complex O
, O
which O
were O
interpreted O
as O
evidence O
that O
the O
second O
dIII B-protein
binds O
to O
the O
dI B-protein
dimer O
with O
a O
Kd O
of O
20-50 O
M O
[ O
24] O
. O

75 O
89 O
90 O
91 O
Two O
of O
them O
, O
A63V O
and O
K70T O
, O
are O
located O
in O
exon O
2b O
within O
the O
consensus O
pattern O
of O
sequence O
repeats O
of O
alpha-TM B-protein-family
and O
could O
alter O
tropomyosin B-protein-family
binding O
to O
actin B-protein-family
. O

The O
majority O
of O
gp160 B-protein
remained O
bound O
to O
calreticulin B-protein
despite O
addition O
of O
ATP B-chemical
( O
not O
shown) O
. O

Because O
PIP2 B-chemical
was O
added O
in O
the O
form O
of O
micelles O
, O
the O
effects O
of O
actin B-protein-family
and O
PIP2 O
on O
profilin B-protein-family
binding O
to O
gephyrin B-protein
cannot O
be O
compared O
in O
terms O
of O
affinities O
. O

This O
situation O
is O
similar O
to O
that O
of O
pI B-cell
cells O
, O
where O
overexpression O
of O
the O
GTP-bound chemical
form O
of O
Galphai B-protein
, O
GalphaiQ205L B-protein
, O
also O
influences O
the O
orientation O
of O
the O
spindle O
. O

Therefore O
, O
we O
hypothesized O
that O
co-stimulatory O
molecules O
that O
preferentially O
bind O
CD28 B-protein
or O
CTLA-4 B-protein
would O
have O
dramatically O
altered O
biological O
properties O
. O

Using O
electrophoretic O
mobility O
shift O
assays O
( O
EMSA) assay
, O
we O
found O
that O
Dfd B-protein
binds O
to O
this O
fragment O
( O
S3/240bpwt B-experimental-construct
; O
Figure O
5D) O
. O

The O
INK B-protein-family
family I-protein-family
has O
a O
specificity O
for O
the O
early O
G1 O
kinases O
Cdk4 B-protein
and O
Cdk6 B-protein
complexed O
with O
D-type B-protein-family
cyclins I-protein-family
, O
while O
the O
CIP B-protein-family
family I-protein-family
is O
partial O
to O
Cdk2 B-protein
bound O
to O
either O
cyclin B-protein
A I-protein
or O
E B-protein
. O

These O
results O
suggest O
that O
most O
of O
the O
synergistic O
coactivation O
by O
CRP2 B-protein
requires O
efficient O
binding O
of O
SRF B-protein
to O
multiple O
SREs B-DNA
. O

These O
membrane O
lipids B-chemical
bind O
to O
the O
actin-binding protein-family
domains O
of O
AC B-protein-family
( O
Yonezawa O
et O
al O
1991a O
, O
Kusano O
et O
al O
1999 O
) O
and O
are O
capable O
of O
inhibiting O
AC O
binding O
to O
actin O
in O
vitro O
. O

In O
addition O
, O
Redlitz O
et O
al O
. O
( O
10 O
) O
showed O
that O
activated O
pro-plasma O
carboxypeptidase B-protein
B I-protein
and O
plasma O
carboxypeptidase B-protein
N I-protein
diminish O
the O
binding O
of O
plasminogen B-protein
to O
U937 B-cell
cells O
and O
that O
fibrinolysis O
occurs O
more O
rapidly O
in O
pro-plasma O
carboxypeptidase O
B O
( O
TAFI)-deficient protein
compared O
with O
normal O
plasma O
. O

Tyrosine O
Phosphorylation O
of O
p190 B-protein
Correlates O
with O
Enhanced O
p120 B-protein
GAP I-protein
Binding O
in O
Vivo O
; O
Because O
p120 O
protein O
preferentially O
binds O
phosphorylated O
p190 O
in O
vitro O
, O
we O
compared O
the O
levels O
of O
native O
p120•p190 O
complex O
formation O
in O
normal O
3Y1 B-cell
rat I-cell
fibroblasts I-cell
and O
v-Src-transformed B-cell
3Y1 I-cell
cells I-cell
( O
SR3Y1) cell
. O

Furthermore O
, O
we O
determined O
that O
this O
regionalized O
editing O
of O
the O
collagen B-protein-family
substrate O
was O
orchestrated O
by O
the O
stimulated O
expression O
of O
collagenase-1 B-protein
, O
which O
was O
bound O
to O
the O
SMC B-cell
plasma O
membrane O
. O

After O
transfection O
of O
vectors O
expressing O
MUC1 B-protein
and O
GSK3beta B-protein
, O
293 O
cells O
were O
subjected O
to O
immunoprecipitation O
with O
anti-MUC1 B-reagent
and O
the O
precipitates O
were O
analyzed O
for O
binding O
of O
MUC1 O
to O
beta-catenin B-protein
. O

This O
orientation O
shows O
the O
actin-binding protein-family
surface O
of O
profilin B-protein-family
[ O
14 O
, O
15 O
] O
, O
which O
is O
predominately O
composed O
of O
the O
C-terminal O
helix O
( O
H3 O
) O
and O
the O
bottom O
three O
strands O
( O
4 O
, O
5 O
and O
6 O
) O
of O
the O
central O
sheet O
. O

Binding O
of O
Cdc20 B-protein
and O
Cdh1 B-protein
to O
the O
APC B-protein
is O
differentially O
regulated O
. O

With O
the O
goal O
of O
learning O
more O
about O
the O
mechanisms O
responsible O
for O
insulating O
activity O
, O
we O
have O
identified O
and O
characterized O
SBP B-protein
( O
scs protein-complex
binding -
protein) -
, O
a O
protein O
component O
of O
the O
scs O
nucleoprotein O
complex O
. O

Thus O
, O
the O
binding O
of O
Porc B-protein
with O
Wg B-protein
appears O
to O
be O
necessary O
for O
the O
stimulation O
of O
the O
N-glycosylation O
of O
Wg O
. O

Pals1 B-protein
( O
or O
Sdt B-protein
) O
binds O
to O
the O
Crb-PBM B-protein-motif
motif I-protein-motif
( O
CrbPBM B-protein-motif
) O
via O
its O
single O
PDZ B-protein-domain
domain O
. O

Under O
these O
conditions O
, O
Hbp B-protein
binds O
heme B-chemical
in O
a O
1 O
: O
1 O
molar O
ratio O
( O
unpublished O
data) O
. O

Both O
Axin B-protein
and O
Axil B-protein
bind O
not O
only O
to O
GSK-3beta B-protein
but O
also O
to O
beta-catenin B-protein
and O
APC B-protein
( O
14-20 O
) O
and O
promote O
GSK-3beta-dependent O
phosphorylation O
of O
beta-catenin O
and O
APC O
( O
14 O
, O
15 O
, O
19 O
, O
21 O
, O
22) O
. O

Even O
though O
transportin B-protein
can O
bind O
an O
M9 B-protein-motif
signal I-protein-motif
and O
the O
BIB B-protein-domain
domain I-protein-domain
simultaneously O
, O
it O
appears O
unlikely O
that O
transportin O
normally O
would O
import O
the O
two O
substrates O
at O
the O
same O
time O
: O
import O
of O
the O
trimeric O
M9-transportin-BIB B-protein-complex
complex O
is O
apparently O
much O
less O
efficient O
than O
import O
of O
, O
for O
example O
, O
an O
M9-transportin O
complex O
( O
not O
shown) O
. O

In O
vitro O
, O
HUA1 B-protein
binds O
three O
tested O
AG B-RNA
RNA I-RNA
fragments O
from O
the O
second O
intron O
, O
one O
including O
the O
5 O
splice O
site O
and O
the O
other O
two O
including O
the O
putative O
polyadenylation O
sites O
for O
the O
large O
AG O
RNAs O
. O

Nature O
, O
377 O
, O
246-248 O
[ O
Medline O
] O
orlich O
, O
D O
. O
, O
Henklein O
, O
P O
. O
, O
Laskey O
, O
R O
. O
A O
. O
and O
Hartmann O
, O
E O
. O
( O
1996a O
) O
A O
41 O
amino O
acid O
motif O
in O
importin B-protein-family
alpha I-protein-family
confers O
binding O
to O
importin B-protein-family
beta I-protein-family
and O
hence O
transit O
into O
the O
nucleus O
. O

In O
addition O
, O
we O
show O
that O
the O
gelsolin B-experimental-construct
S1 I-experimental-construct
peptide O
PS1 B-experimental-construct
does O
not O
hinder O
binding O
of O
cofilin B-protein
or O
PS2 B-experimental-construct
to O
F-actin B-protein
; O
this O
also O
argues O
against O
the O
model O
proposed O
by O
Hatanaka O
et O
al O
. O
( O
24) O
. O

Furthermore O
, O
it O
has O
been O
shown O
that O
GSK-3beta B-protein
phosphorylates O
APC B-protein
and O
that O
the O
phosphorylation O
enhances O
the O
binding O
of O
APC O
to O
beta-catenin B-protein
( O
37) O
. O

Binding O
of O
FasL B-protein
to O
Fas B-protein
or O
cross-linking O
Fas O
with O
agonistic O
antibodies O
( O
IgM B-reagent
class O
anti-Fas B-reagent
antibody I-reagent
, O
or O
IgG3 B-reagent
class O
anti-APO1 B-reagent
antibody I-reagent
) O
induces O
apoptosis O
in O
Fas-bearing O
cells O
( O
Trauth O
et O
al O
. O
, O
1989 O
; O
Yonehara O
et O
al O
. O
, O
1989 O
; O
Itoh O
et O
al O
. O
, O
1991 O
) O
. O

( O
B O
) O
ELISA B-assay
demonstrating O
the O
reduced O
binding O
of O
the O
Ab B-reagent
to O
BDNF B-protein
after O
modification O
with O
the O
caging O
group O
and O
its O
successful O
reactivation O
by O
UV B-process
light O
. O

Immunoprecipitation O
of O
p53 B-protein
was O
followed O
by O
Western O
blot O
analysis O
to O
determine O
the O
type O
and O
level O
of O
Mdm2 B-protein
bound O
to O
p53 O
under O
each O
of O
these O
conditions O
. O

Binding O
of O
E1A B-protein
to O
CBP B-protein
amino O
acids O
1805-1891 O
prevents O
binding O
of O
the O
histone B-protein
acetyltransferase I-protein
P/CAF I-protein
, O
whereas O
E1A O
binding O
to O
CBP O
amino O
acids O
2058-2163 O
prevents O
binding O
of O
the O
co-activator O
P/CIP B-protein
( O
5 O
, O
12) O
. O

As O
expected O
, O
conversion O
of O
the O
TAGA B-DNA
element I-DNA
into O
a O
consensus O
TATA B-DNA
box I-DNA
increased O
f B-experiment-tag
: O
TFIID B-protein
binding O
to O
the O
LRP-2 B-DNA
promoter I-DNA
, O
leading O
to O
increased O
protection O
of O
the O
TATA O
box O
region O
and O
downstream O
promoter O
sequences O
( O
Fig O
. O
4 O
B O
, O
comparelanes O
1–4 O
with O
lanes O
5–8) O
. O

The O
mutation O
replacing O
Ser-39 O
with O
Ala O
eliminated O
the O
phosphorylation-dependent O
regulation O
of O
actin B-protein-family
binding O
of O
fascin B-protein
, O
indicating O
that O
phosphorylation O
at O
this O
site O
regulates O
the O
actin O
binding O
ability O
of O
fascin O
. O

Slit B-protein
significantly O
increased O
the O
binding O
of O
srGAP1 B-protein
to O
Robo1 B-protein
( O
Figure O
4C O
, O
lane O
2 O
, O
compared O
to O
lane O
1) O
. O

The O
heparin-binding chemical
property O
of O
apoE B-protein
plays O
an O
important O
role O
in O
the O
sequestration O
step O
of O
the O
heparan B-chemical
sulfate I-chemical
proteoglycan I-chemical
( O
HSPG)/ chemical
LRP B-protein-family
metabolic O
pathway O
as O
well O
as O
in O
the O
independent O
HSPG O
pathway O
[ O
5 O
. O

Full-length O
p21 B-protein
, O
which O
binds O
to O
both O
Cdk-cyclin B-protein-complex
and O
PCNA B-protein
, O
effectively O
inhibits O
DNA B-DNA
replication O
( O
Fig O
. O
7 O
A) O
, O
whereas O
GST B-protein-family
control O
protein O
is O
not O
inhibitory O
. O

Thus O
several O
different O
mutations O
that O
disrupt O
calcium B-chemical
binding O
and O
calcium-dependent O
syntaxin B-protein
1A I-protein
binding O
to O
the O
C2A B-protein-domain
domain I-protein-domain
of O
synaptotagmin B-protein
1 I-protein
do O
not O
reverse O
the O
inhibitory O
effect O
of O
microinjected O
C2A B-reagent
fragments I-reagent
on O
calcium-regulated O
secretion O
from O
PC12 B-cell
cells O
. O

The O
relative O
proportion O
of O
TBP B-protein
bound O
to O
GST-TADIV B-fusion-protein
of O
the O
total O
present O
in O
the O
crude O
extract O
( O
Fig O
. O
2 O
) O
was O
found O
to O
be O
about O
1/10 O
of O
that O
of O
the O
TAFIIs B-protein-family
as O
determined O
by O
densitometric O
analysis O
( O
data O
not O
shown) O
. O

These O
findings O
suggest O
a O
complex O
reciprocal O
relationship O
between O
regulation O
of O
adducin B-protein
function O
by O
calmodulin B-protein
binding O
and O
phosphorylation O
by O
PKA B-protein-complex
and O
PKC B-protein-family
. O

At O
present O
, O
we O
do O
not O
know O
whether O
Arp11 B-protein
binds O
directly O
to O
Arp1 B-protein
or O
actin B-protein-family
. O

In O
vivo O
binding O
of O
hAxin B-protein
to O
APC B-protein
, O
-catenin protein
and O
GSK3 B-protein
. O

The O
ATP-bound chemical
form O
of O
Hsp70 B-protein
binds O
and O
releases O
peptides O
rapidly O
, O
whereas O
the O
ADP-bound B-protein
form I-protein
binds O
and O
releases O
them O
slowly O
( O
Palleros O
et O
al O
. O
, O
1991 O
; O
Schmid O
et O
al O
. O
, O
1994 O
; O
Szabo O
et O
al O
. O
, O
1994 O
) O
. O

To O
confirm O
the O
specificity O
for O
interaction O
between O
EID-1 B-protein
and O
Rb B-protein
in O
vivo O
, O
we O
tested O
the O
binding O
of O
endogenous O
Rb O
to O
wild-type O
EID-1 O
versus O
the O
C180G O
mutation O
in O
transfected O
mammalian O
cells O
. O

None O
of O
the O
mutations O
affected O
the O
binding O
of O
APC11 B-protein
to O
APC2 B-protein
( O
our O
unpublished O
data) O
. O

In O
parallel O
control O
experiments O
, O
all O
TRP B-protein-family
tails O
failed O
to O
bind O
INAD B-protein
from O
InaDP215 B-gene
head O
extracts O
. O

Interestingly O
, O
we O
saw O
strong O
binding O
of O
Gal4 B-protein
to O
the O
GC-rich B-DNA
region I-DNA
, O
even O
in O
the O
absence O
of O
galactose B-chemical
, O
which O
agrees O
with O
previous O
work O
by O
others O
, O
showing O
that O
the O
transcriptional O
activity O
of O
Gal4 O
is O
not O
regulated O
by O
its O
DNA-binding DNA
activity O
but O
rather O
by O
the O
action O
of O
Gal80 B-protein
and O
Gal3 B-protein
( O
for O
examples O
, O
see O
references O
7 O
and O
31) O
. O

Blockade O
of O
either O
VASP B-protein
binding O
to O
ActA B-protein
( O
Smith O
et O
al O
. O
1996 O
) O
or O
Profilin B-protein-family
binding O
to O
VASP O
( O
Kang O
et O
al O
. O
1997 O
) O
impairs O
Listeria O
motility O
, O
implying O
a O
role O
for O
Profilin O
in O
accelerating O
the O
actin-dependent protein-family
motility O
. O

The O
presence O
of O
similar O
motifs O
to O
those O
found O
in O
all O
known O
GTPases B-protein-family
suggests O
that O
menin B-protein
could O
similarly O
exhibit O
GTP B-chemical
binding O
activity O
as O
well O
as O
GTP-hydrolyzing O
activity O
. O

Menin B-protein
Binds O
GTP B-chemical

The O
finding O
that O
SLB B-protein
can O
bind O
to O
Lhx3 B-protein
and O
Lhx4 B-protein
suggests O
a O
possible O
role O
in O
modulating O
transcription O
. O

We O
show O
that O
Hsp70 B-protein
binding O
is O
regulated O
by O
the O
phosphorylation O
state O
of O
the O
turn O
motif O
, O
one O
of O
the O
two O
conserved O
carboxyl-terminal O
phosphorylation O
sites O
, O
and O
that O
Hsp70 O
binds O
mature O
PKC B-protein-family
that O
has O
become O
dephosphorylated O
, O
rather O
than O
newly O
synthesized O
PKC O
that O
has O
yet O
to O
be O
phosphorylated O
. O

However O
, O
affinity O
chromatography O
experiments O
showed O
that O
Tm B-protein
bound O
to O
acidic O
TnT B-protein
with O
a O
greater O
affinity O
than O
to O
basic B-protein
TnT I-protein
, O
consistent O
with O
the O
significantly O
higher O
maximal O
binding O
of O
acidic O
TnT O
to O
Tm O
in O
solid O
phase O
binding O
assays O
. O

Ca2+-Dependent chemical
Binding O
of O
Syntaxin B-protein
1a I-protein
to O
the O
C2A B-protein-domain
Domain O
Demonstrated O
by O
1H-15N B-assay
HSQC I-assay
Spectroscopy I-assay

Adducin B-protein
is O
a O
membrane O
skeleton O
protein O
originally O
described O
in O
human O
erythrocytes O
that O
promotes O
the O
binding O
of O
spectrin B-protein-complex
to O
actin B-protein-family
and O
also O
binds O
directly O
to O
actin O
and O
bundles O
actin O
filaments O
. O

In O
conjunction O
with O
peptide-binding O
and O
genetic O
studies O
, O
atomic O
modeling O
of O
fimbrin B-protein
binding O
to O
F-actin protein-family
strongly O
suggests O
that O
the O
F-actin-binding O
residues O
in O
the O
CH B-protein-domain
domain I-protein-domain
are O
concentrated O
in O
its O
C-terminal O
portion O
( O
23) O
. O

Comparison O
of O
the O
Ral-binding protein
surface O
of O
Sec5 B-protein
with O
the O
region O
of O
GDI B-protein
that O
interacts O
with O
Rho B-protein-family
family I-protein-family
G I-protein-family
proteins I-protein-family
shows O
that O
the O
contacts O
between O
Sec5-Ral O
and O
GDI-Cdc42 protein
are O
significantly O
different O
. O

The O
binding O
sites O
for O
Armadillo B-protein-motif
and O
Groucho B-protein
on O
Tcf B-protein-family
do O
not O
overlap O
, O
but O
whether O
or O
not O
Armadillo O
and O
Groucho O
bind O
simultaneously O
to O
Tcf O
is O
not O
clear O
. O

Specific O
binding O
of O
Sp1 B-protein
and O
Smad3 B-protein
was O
inhibited O
with O
an O
excess O
of O
100x O
unlabeled O
oligonucleotide O
( O
Competitor) O
. O

This O
indicates O
that O
the O
binding O
of O
GSK-3beta B-protein
to O
Axin B-protein
is O
essential O
for O
its O
activity O
to O
degrade O
beta-catenin B-protein
, O
consistent O
with O
the O
observation O
that O
AxindeltaGSK-3beta B-protein-complex
does O
not O
enhance O
the O
phosphorylation O
of O
beta-catenin O
even O
in O
the O
presence O
of O
APC-(1211-2075) protein
. O

N O
. O
N O
. O
Dewji O
and O
S O
. O
J O
. O
Singer O
, O
Specific O
transcellular O
binding O
between O
membrane O
proteins O
crucial O
to O
Alzheimer O
disease O
. O

We O
tested O
seven O
mAbs B-reagent
derived O
from O
an O
HIV-2-infected O
human O
for O
their O
ability O
to O
inhibit O
SIVmac239 B-cell
gp120 B-protein
binding O
to O
CCR5rh B-protein
in O
HEK293 B-cell
cells O
in O
the O
presence O
and O
absence O
of O
sCD4 B-protein
. O

After O
extensive O
washing O
, O
the O
amount O
of O
MyD118/Gadd45 protein-family
protein O
bound O
to O
PCNA B-protein
was O
assessed O
using O
either O
MyD118- B-reagent
or O
Gadd45-specific B-reagent
antibodies I-reagent
, O
which O
, O
in O
turn O
, O
were O
reacted O
with O
HRP-coupled protein
secondary O
antibody O
. O

Given O
the O
observation O
that O
CRT B-protein
binds O
to O
SL B-DNA
structures I-DNA
with O
GC-rich B-DNA
stems I-DNA
( O
7 O
, O
16 O
, O
24 O
, O
27) O
, O
we O
searched O
for O
the O
secondary O
structures O
with O
GC-rich O
stems O
within O
the O
C/EBPα B-RNA
mRNA I-RNA
and O
found O
two O
possible O
SL O
organizations O
containing O
GC-rich O
regions O
within O
the O
stem O
( O
Fig O
. O
​7B) O
. O

These O
observations O
strongly O
suggest O
that O
electrostatic O
interactions O
provide O
a O
main O
driving O
force O
for O
the O
Ca2+-dependent chemical
binding O
of O
the O
C2A B-protein-domain
domain I-protein-domain
to O
syntaxin B-protein-family
. O

In O
this O
report O
, O
we O
show O
that O
AlF-C1 B-protein
and O
AlF-C2 B-protein
bind O
directly O
to O
Orc1 B-protein
, O
a O
subunit O
of O
ORC B-protein-complex
, O
and O
discuss O
that O
in O
mammalian O
cells O
, O
sequence-specific O
DNA-binding DNA
proteins O
might O
be O
involved O
in O
recruiting O
ORC O
to O
regulate O
replication O
initiation O
and/or O
transcription O
repression O
. O

It O
has O
been O
shown O
that O
APC B-protein
makes O
a O
complex O
with O
beta-catenin B-protein
and O
that O
the O
phosphorylation O
of O
APC O
by O
GSK-3beta B-protein
increases O
the O
binding O
of O
APC O
to O
beta-catenin O
( O
37) O
. O

Interestingly O
, O
dTAFII110 B-protein
also O
bound O
GST-IIAτ experiment-tag
more O
abundantly O
than O
it O
bound O
to O
GST-αβ protein
( O
Fig O
. O
4 O
C O
, O
lane O
4) O
. O

Hes6 B-protein
binds O
to O
an O
Enhancer O
of O
Split B-DNA
E I-DNA
box I-DNA
and O
mediates O
transcriptional O
repression O

Hes6 B-protein
has O
been O
shown O
to O
act O
indirectly O
by O
binding O
other O
orange O
domain-containing O
proteins O
, O
rather O
than O
by O
acting O
as O
a O
DNA-binding DNA
transcription O
factor O
( O
Bae O
et O
al O
. O
, O
2000 O
; O
Koyano-Nakagawa O
et O
al O
. O
, O
2000) O
. O

This O
model O
is O
supported O
by O
the O
inhibition O
of O
dynein-mediated protein-family
transport O
by O
p50(dynamitin O
) O
expression O
( O
20 O
, O
28 O
, O
29) O
, O
which O
dissociates O
the O
dynactin B-protein-complex
complex O
and O
separates O
the O
dynein B-protein
binding I-protein
subunit I-protein
( O
p150 B-protein
Glued I-protein
) O
from O
membrane O
binding O
subunits O
( O
30 O
, O
31) O
. O

LZ B-protein
and O
PNT B-protein
both O
directly O
bind O
to O
the O
pros B-DNA
promoter/enhancer I-DNA
region O
and O
pros O
expression O
occurs O
only O
when O
PNT O
and O
LZ O
have O
bound O
simultaneously O
to O
the O
pros O
enhancer/promoter O
. O

HIP1 B-protein
and O
HIP12 B-protein
display O
differential O
binding O
to O
F-actin B-protein
, O
AP2 B-protein
, O
and O
clathrin B-protein
. O

In O
this O
study O
, O
we O
identified O
binding O
domains O
of O
GSK-3β B-protein
and O
β-catenin B-protein
in O
Axin B-protein
. O

( O
A O
) O
Inhibition O
of O
BMP-7 B-protein
binding O
to O
ROS B-cell
17/2 I-cell
. O

To O
further O
investigate O
a O
possible O
role O
for O
ESEs B-DNA
in O
U2AF35-dependent protein-complex
splicing O
, O
an O
experiment O
was O
designed O
to O
test O
a O
critical O
tenet O
of O
the O
recruitment O
model O
for O
exon O
enhancer O
function O
: O
SR B-protein-family
proteins O
bound O
to O
the O
enhancer O
sequence O
establish O
protein-protein O
interactions O
with O
U2AF35 O
that O
increase O
the O
local O
concentration O
of O
the O
U2AF B-protein-complex
heterodimer O
and O
facilitate O
U2AF65 B-protein
binding O
to O
the O
Py B-DNA
tract I-DNA
( O
13) O
. O

Further O
indirect O
evidence O
for O
actin B-protein-family
binding O
by O
HtsRC B-protein
comes O
from O
cher O
mutants O
in O
which O
HtsRC O
is O
redirected O
to O
the O
actin-rich O
nurse-cell O
plasma O
membrane O
[ O
15 O
] O
. O

Because O
Ubc9 B-protein
binds O
such O
an O
NLS B-protein-motif
sequence O
, O
we O
propose O
three O
potential O
mechanisms O
for O
the O
role O
of O
Ubc9 O
in O
nuclear O
import O
. O

As O
shown O
in O
Figure O
7 O
A O
, O
deletion O
of O
these O
35 O
amino O
acids O
results O
in O
the O
loss O
of O
binding O
between O
dSlo B-protein
and O
PKAc B-protein
. O

( O
B O
) O
Binding O
of O
a O
NES B-protein-motif
to O
CRM1 B-protein
occurs O
in O
a O
tripartite O
complex O
with O
RanGTP B-protein
. O

For O
in O
vitro O
kinase O
assays O
, O
15 O
μl O
of O
GST B-experiment-tag
or O
GST-Cx43CT B-experimental-construct
bound O
to O
glutathione-Sepharose B-reagent
4B I-reagent
beads O
( O
washed O
once O
in O
kinase O
buffer O
) O
were O
incubated O
with O
purified O
kinase-active B-reagent
pp60 I-reagent
c-src O
, O
kinase O
buffer O
( O
20 O
mM O
HEPES B-reagent
( O
pH O
7 O
. O
4) O
, O
12 O
mM O
MnCl2 O
, O
1 O
mM O
dithothreitol O
, O
100 O
μM O
Na2VO4 O
) O
and O
10 O
μCi O
of O
ATP B-reagent
( O
DuPont O
NEN O
, O
NEG-002Z O
, O
6000 O
Ci/mmol O
) O
in O
a O
total O
volume O
of O
40 O
μl O
for O
15 O
min O
at O
room O
temperature O
. O

In O
the O
absence O
of O
calcium B-chemical
, O
TnI B-protein
binding O
to O
actin B-protein-family
holds O
the O
Tm-Tn B-protein-complex
complex O
in O
the O
" O
`closed O
" O
` O
state O
in O
which O
the O
myosin-binding protein-complex
site O
is O
occluded O
, O
preventing O
myosin O
from O
binding O
actin O
. O

The O
2 O
. O
8 O
angstrom O
crystal O
structure O
of O
ZAG B-protein
resembles O
a O
class B-protein-family
I I-protein-family
major I-protein-family
histocompatibility I-protein-family
complex I-protein-family
( O
MHC B-protein-family
) O
heavy O
chain O
, O
but O
ZAG O
does O
not O
bind O
the O
class O
I O
light O
chain O
beta2-microglobulin B-protein
. O

  O
Precursor O
proteins O
that O
do O
not O
bind O
to O
MSF B-protein
, O
or O
that O
bind O
preferentially O
to O
hsp70 B-protein-family
, O
bypass O
the O
Tom70-Tom37 B-protein-complex
complex O
and O
are O
targeted O
directly O
to O
Tom20-Tom22 B-protein-complex
( O
Hachiya O
et O
al O
. O
, O
1995 O
) O
. O

The O
Effect O
of O
dI2dIII1 B-protein-complex
Complex I-protein-complex
Formation O
on O
NADH B-chemical
Binding O
to O
dI B-protein

Experiments O
using O
equilibrium O
dialysis O
( O
39 O
) O
and O
protein O
fluorescence O
quenching O
( O
11 O
) O
showed O
that O
NADH B-chemical
binds O
to O
isolated O
R B-cell
. I-cell
rubrum I-cell
dI B-protein
protein O
with O
a O
K O
d≈ O
20 O
μM O
. O

  O
As O
the O
binding O
of O
ORC B-protein-complex
and O
MCM B-protein-complex
proteins O
occurs O
at O
or O
very O
near O
the O
origin O
, O
we O
determined O
the O
genome-wide O
locations O
of O
ORC- O
and O
MCM-binding O
sites O
to O
identify O
the O
positions O
of O
potential O
DNA B-DNA
replication O
origins O
across O
the O
S O
. O
cerevisiae O
genome O
. O

  O
Moreover O
, O
the O
insulin-induced protein
increase O
in O
GTP B-chemical
bound O
Rheb B-protein
, O
but O
not O
that O
of O
Ras B-protein-family
, O
is O
blocked O
by O
wortmannin B-chemical
, O
whereas O
both O
increases O
are O
resistant O
to O
rapamycin B-drug
( O
Figure O
2A) O
. O

  O
CtBP B-protein
binds O
with O
HPC2 B-protein
and O
XPc B-protein
through O
the O
same O
conserved O
amino O
acid O
motif O
, O
PI/LDL B-protein-motif
. O

  O
Mg2+ B-chemical
inhibited O
but O
did O
not O
abolish O
ATPgammaS B-chemical
binding O
to O
both O
synapsin B-protein-family
C-domains B-protein-domain
, O
similar O
to O
its O
effect O
on O
GTP B-chemical
binding O
to O
Rab B-protein-family
proteins O
( O
Fig O
. O
1 O
) O
( O
25) O
. O

We O
note O
that O
CKIɛ B-protein
, O
CKI∂ B-protein
, O
and O
the O
kinase B-protein-domain
domain I-protein-domain
fragment O
of O
CKIɛ O
bound O
to O
mPER1 B-protein
whereas O
CKIα2 B-protein
did O
not O
, O
consistent O
with O
the O
mPER1 O
interaction O
taking O
place O
via O
the O
kinase O
domain O
and O
not O
via O
the O
carboxy-terminal O
regulatory O
domain O
. O

  O
Combining O
GST-Smad-4 experiment-tag
with O
the O
probe O
, O
however O
, O
produced O
two O
shifted O
bands O
, O
indicating O
that O
the O
Hex B-DNA
BRE I-DNA
binds O
purified O
Smad4 B-protein
but O
not O
Smad1 B-protein
. O

A O
third O
important O
feature O
of O
the O
mechanism O
of O
transcriptional O
activation O
is O
the O
synergy O
in O
binding O
between O
Sp1 B-protein
and O
Smad2 B-protein
( O
and O
to O
some O
extent O
Smad4) protein
. O

  O
There O
is O
solid O
evidence O
that O
Mas70p B-protein
is O
a O
component O
of O
the O
mitochondrial O
receptor O
machinery O
for O
protein O
import O
( O
46) O
, O
and O
we O
asked O
if O
Mas70p O
would O
bind O
to O
hsp90 B-protein
. O

  O
Previously O
, O
assay O
of O
the O
reduction O
in O
the O
EDTA-ATPase B-protein
activity O
of O
S-1 B-protein-domain
in O
the O
supernatant O
when O
S-1 B-protein-domain
. I-protein-domain
MgADP I-protein-domain
. I-protein-domain
Pi I-protein-domain
is O
cosedimented O
with O
actin B-protein-family
has O
been O
used O
to O
measure O
the O
weak O
binding O
of O
myosin B-protein-complex
to O
actin O
( O
37) O
. O

These O
results O
indicate O
that O
S14 B-protein
and O
UIP1 B-protein
could O
bind O
UCH37 B-protein
specifically O
in O
vitro O
in O
a O
C-terminal O
extension O
dependent O
manner O
. O

We O
showed O
previously O
that O
MEKK1 B-protein
binds O
directly O
to O
JNK/SAPK protein
. O

By O
extension O
of O
studies O
of O
the O
Rad3 B-protein
ATPase I-protein
( O
15) O
, O
mutation O
of O
the O
conserved O
lysine O
residue O
in O
the O
Walker B-protein-domain
domain O
to O
alanine O
( O
K→A O
) O
in O
Rad54 B-protein
is O
thought O
to O
prevent O
ATP B-chemical
binding O
, O
whereas O
mutation O
of O
lysine O
to O
arginine O
( O
K→R O
) O
is O
expected O
to O
prevent O
ATP O
hydrolysis O
but O
not O
ATP O
binding O
. O

  O
Note O
that O
cyclin B-protein-family
E I-protein-family
binds O
to O
both O
forms O
of O
Cdk2 B-protein
, O
whereas O
cyclin B-protein
A I-protein
binds O
only O
the O
activated O
form O
of O
Cdk2 O
. O

Binding O
of O
GST537C B-experiment-tag
and O
GST547C B-experiment-tag
to O
hsp90 B-protein
after O
their O
translation O
in O
reticulocyte B-cell
lysate O
. O

  O
Thus O
, O
for O
example O
, O
Hairy B-protein
binds O
dCtBP B-protein
strongly O
but O
hCtBP B-protein-family
weakly O
, O
confirming O
the O
specificity O
of O
the O
binding O
sites O
. O

  O
To O
ascertain O
the O
binding O
affinity O
of O
Pitx2 B-protein
for O
the O
bicoid B-protein
element O
, O
an O
EMSA B-assay
DNA B-DNA
titration O
experiment O
was O
performed O
. O

Axin B-protein-family
binds O
to O
not O
only O
GSK3 B-protein-complex
and O
DCAP B-protein
but O
also O
Arrow/LRP5 B-protein
. O

  O
W O
EN O
et O
al O
. O
1995 O
; O
P O
OTEET-SMITH O
et O
al O
. O
1997 O
) O
, O
we O
conclude O
that O
PKAr* B-protein
must O
bind O
PKAc B-protein
to O
activate O
Hh B-protein-family
target O
genes O
. O

The O
CtBP B-protein
structure O
reveals O
a O
bound O
acetate B-chemical
ion I-chemical
( O
right O
panel) O
. O

  O
We O
propose O
that O
this O
is O
where O
CstF-64 B-protein
binds O
to O
CstF-77 B-protein
, O
and O
this O
is O
supported O
by O
in O
vitro O
experiments O
with O
the O
human O
protein O
( O
Y O
. O
Takagaki O
and O
J O
. O
L O
. O
Manley O
, O
submitted) O
. O

  O
From O
these O
results O
, O
we O
can O
reasonably O
conclude O
that O
IntI1 B-protein
bound O
both O
ds B-DNA
and O
ss O
attI B-DNA
but O
that O
only O
ss O
attC B-DNA
was O
efficiently O
bound O
by O
IntI1 O
in O
vitro O
. O

Our O
observation O
that O
binding O
of O
eIF4A B-protein
to O
eIF4G B-protein
is O
cooperative O
could O
explain O
these O
results O
by O
ensuring O
a O
higher O
affinity O
interaction O
between O
eIF4G O
and O
eIF4A O
. O

This O
inhibition O
is O
mediated O
through O
the O
Pnt B-protein-domain
domain-dependent O
binding O
of O
Mae B-protein
to O
Yan B-protein
( O
compare O
lanes O
7 O
and O
10) O
. O

  O
However O
, O
it O
remained O
to O
be O
shown O
whether O
Aos B-protein
binds O
directly O
to O
DER B-protein
. O

  O
Deletion O
mutagenesis O
also O
indicated O
that O
Leu-20 O
, O
Phe-25 O
, O
and O
Glu-70 O
in O
dTAFII230 B-protein
are O
important O
for O
TBP B-protein
binding O
and O
inhibition O
of O
TBP-promoter protein
interaction O
. O

That O
occupation O
of O
the O
ATP/ADP chemical
binding O
pocket O
of O
Hsp90 B-protein
by O
GA B-chemical
results O
in O
dissociation O
of O
the O
protein O
from O
Raf-1 B-protein
is O
consistent O
with O
the O
notion O
that O
alternating O
cycles O
of O
ATP O
and O
ADP O
binding O
regulate O
Hsp90 O
conformation O
and O
, O
in O
turn O
, O
its O
ability O
to O
mediate O
the O
formation O
of O
productive O
signaling O
heterocomplexes O
( O
7 O
, O
22 O
, O
55 O
, O
72) O
. O

Despite O
the O
higher O
abundance O
of O
PTBΔ B-protein
in O
the O
IP B-assay
pellet O
( O
Figure O
6B O
, O
compare O
lane O
12 O
to O
lane O
10) O
, O
no O
binding O
of O
PTBΔ O
to O
MSE1-4 B-experimental-construct
RNA I-experimental-construct
could O
be O
detected O
by O
UV B-process
crosslinking O
, O
while O
binding O
of O
PTB B-protein
was O
clearly O
and O
consistently O
detected O
( O
Figure O
6B O
, O
compare O
lanes O
4 O
and O
6) O
. O

The O
behavior O
in O
the O
motility O
assay O
suggested O
that O
AS-2 B-chemical
may O
interfere O
with O
MT B-organelle
binding O
to O
kinesin B-protein-family
. O

  O
It O
should O
be O
noted O
that O
importin B-protein-family
alpha I-protein-family
binding O
was O
strictly O
dependent O
on O
the O
presence O
of O
importin B-protein-family
beta I-protein-family
( O
not O
shown) O
, O
as O
if O
the O
importin B-protein-complex
alpha/ I-protein-complex
beta I-protein-complex
heterodimer O
would O
bind O
rpL23a B-protein
only O
via O
the O
beta O
subunit O
. O

  O
When O
HH B-protein-family
binds O
to O
Ptc B-protein
, O
Smo B-protein
accumulates O
in O
the O
membrane O
in O
a O
highly O
phosphorylated O
state O
and O
HH O
targets O
are O
activated O
. O

  O
Both O
Hsp70 B-protein-family
and O
Hsp88 B-protein
bound O
to O
Hsp30 B-protein-family
in O
preference O
to O
other O
proteins O
, O
but O
binding O
of O
Hsp88 O
was O
more O
selective O
for O
Hsp30 O
, O
and O
a O
direct O
interaction O
was O
observed O
. O

  O
CBP B-protein
and O
p300 B-protein
bind O
many O
other O
transcription O
factors O
, O
including O
p53 B-protein
, O
NF-kappaB B-protein
p65 I-protein
, O
and O
RAR B-protein
, O
and O
the O
association O
with O
CBP O
has O
been O
shown O
to O
correlate O
with O
transcription O
activation O
function O
( O
26 O
, O
30 O
, O
43 O
, O
53 O
, O
71) O
. O

DREF B-protein
binds O
to O
the O
DRE B-DNA
sequences I-DNA
in O
the O
Dm B-DNA
myb I-DNA
promoter I-DNA

  O
We O
have O
demonstrated O
that O
the O
N-terminal O
domain O
of O
MEKK1 B-protein
binds O
directly O
to O
its O
downstream O
MAP B-protein-family
kinase I-protein-family
, O
JNK/SAPK protein
. O

  O
The O
Raf B-protein-family
23-284 O
mutant O
contains O
the O
amino-terminal O
Ras-binding protein-family
sequence O
of O
Raf O
, O
but O
lacks O
the O
carboxyl-terminal O
kinase O
domain O
( O
34) O
. O

  O
The O
12V35S B-cell
( O
Gly-12 O
Val O
, O
Thr-35 O
Ser O
) O
mutant O
retains O
the O
Raf-1 B-protein
binding O
site O
and O
thus O
can O
activate O
the O
Raf-1/MEK/MAPK protein
pathway O
. O

Therefore O
, O
Rheb B-protein
was O
immunoprecipitated O
from O
either O
[ O
32P]-labeled O
, O
serum-starved O
TSC2+/+ protein
MEFs B-cell
or O
TSC2−/− O
MEFs O
, O
and O
the O
ratio O
of O
GTP B-chemical
to O
GDP B-chemical
bound O
Rheb O
was O
determined O
by O
one-dimensional O
thin-layer O
chromatography O
. O

  O
Therefore O
, O
Axin B-protein
and O
GBP B-protein-family
both O
bind O
to O
GSK-3 B-protein
, O
but O
have O
opposite O
effects O
on O
its O
activity O
. O

  O
As O
shown O
in O
Fig O
. O
4D O
( O
lower O
panel) O
, O
wt O
p53 B-protein
showed O
strong O
binding O
to O
Sp1 B-protein
. O

  O
Again O
, O
we O
noted O
that O
Ets-1(delta286 B-protein
) I-protein
bound O
to O
both O
GST B-experiment-tag
and O
GST-USF B-experimental-construct
, O
which O
indicated O
nonspecific O
interactions O
. O

  O
In O
this O
study O
, O
we O
tested O
the O
hypothesis O
that O
Ena/VASP B-protein-family
recruitment O
by O
the O
central O
domain O
of O
ActA B-protein
functions O
redundantly O
with O
the O
actin B-protein
monomer-binding O
region O
of O
ActA O
to O
stimulate O
actin O
polymerization O
. O

We O
have O
previously O
shown O
that O
two O
E-boxes B-DNA
in O
the O
SM B-tissue
α-actin B-DNA
promoter I-DNA
at O
-214 O
bp O
( O
E1 B-DNA
) O
and O
-252 O
bp O
( O
E2 B-DNA
) O
functioned O
as O
positive O
regulatory O
elements O
in O
cultured O
SMCs B-cell
and O
that O
USF B-protein-family
proteins O
, O
ubiquitously O
expressed O
bHLH-leucine protein-family
zipper O
transcription O
factors O
, O
activated O
the O
SM O
α-actin O
promoter O
in O
an O
E1-dependent O
( O
but O
not O
E2-dependent O
) O
manner O
. O

From O
the O
effect O
of O
mutation O
of O
R B-cell
. I-cell
rubrum I-cell
Y235 O
and O
M239 O
located O
in O
this O
segment O
[ O
69] O
, O
[ O
70] O
, O
[ O
72] O
, O
they O
proposed O
that O
the O
loop O
closure O
would O
be O
important O
for O
positioning O
the O
nicotinamide O
ring O
but O
would O
be O
involved O
neither O
in O
discrimination O
between O
NADH B-chemical
and O
NAD+ B-chemical
nor O
in O
the O
binding O
of O
dI B-protein
to O
dIII B-protein
. O

Rab3a B-protein
Q81L O
, O
which O
is O
locked O
in O
the O
GTP‐bound chemical
form O
( O
Brondyk O
et O
al O
. O
, O
1993) O
, O
was O
capable O
of O
interacting O
with O
Ca2+/CaM B-protein
as O
well O
as O
wild‐type O
Rab3a O
( O
not O
shown) O
, O
confirming O
that O
Ca2+/CaM O
is O
able O
to O
complex O
to O
both O
the O
GDP‐ chemical
and O
the O
GTP‐bound O
form O
of O
Rab3a O
( O
Park O
et O
al O
. O
, O
1997) O
. O

To O
determine O
if O
this O
was O
the O
case O
, O
we O
produced O
a O
recombinant O
mutant O
of O
cyclin B-protein
B1 I-protein
previously O
reported O
to O
lack O
the O
ability O
to O
interact O
with O
Cdc2 B-protein
( O
cyclin B-protein
B1 I-protein
121-373 I-protein
; O
Stewart O
et O
al O
. O
, O
1994 O
) O
and O
an O
analogous O
mutant O
of O
cyclin B-protein-family
E I-protein-family
unable O
to O
bind O
Cdk2 B-protein
( O
cyclin B-protein
E I-protein
1-338 I-protein
; O
Fig O
. O
​Fig O
. O
55 O
A) O
. O

IGFBP-5 B-protein
was O
captured O
by O
FHL2 B-protein
covalently O
bound O
to O
pre-activated O
ProteinChip O
array O
. O

  O
This O
suggests O
that O
, O
even O
in O
the O
absence O
of O
Ca2+ B-chemical
, O
CEB B-protein
does O
not O
bind O
GTP B-chemical
. O

  O
Adducin B-protein-family
has O
been O
seen O
to O
promote O
the O
binding O
of O
spectrin B-protein-family
to O
F-actin B-protein
( O
5 O
, O
Fig O
. O
9 O
A) O
. O

ICAP-1alpha B-protein
competes O
with O
talin B-protein
but O
not O
with O
alpha-actinin B-protein-family
binding O
to O
the O
beta1 B-protein-domain
cytoplasmic I-protein-domain
domain I-protein-domain
. O

( O
B O
) O
Deletion O
of O
the O
p300-binding protein
region O
of O
SRC-1 B-protein
abolished O
the O
interaction O
between O
p300 O
and O
SRC-1 O
. O

  O
However O
, O
the O
binding O
affinity O
of O
MKP3 B-protein
with O
ERK2 B-protein
decreases O
16-fold O
when O
both O
Leu167 O
and O
Leu170 O
are O
replaced O
by O
Ala O
residues O
. O

  O
However O
, O
the O
present O
findings O
suggest O
that O
such O
a O
simple O
model O
is O
probably O
not O
correct O
and O
provide O
strong O
evidence O
that O
the O
binding O
of O
CBP B-protein
to O
CREB B-protein
is O
not O
sufficient O
for O
transcriptional O
activation O
. O

( O
C O
) O
Differential O
binding O
of O
recombinant O
s-synaphin B-protein
constructs O
to O
syntaxin B-protein-family
. O

  O
PP2A B-protein
binds O
to O
Axin B-protein
( O
22 O
, O
30) O
, O
and O
it O
dephosphorylates O
APC B-protein
and O
Axin O
( O
22) O
. O

Cortactin B-protein
binds O
to O
F-actin protein-family
and O
is O
enriched O
in O
cortical O
cell O
structures O
such O
as O
lamellipodia( O
27 O
) O
. O

In O
the O
first O
, O
all O
four O
Hox/Exd protein-family
heterodimers O
would O
bind O
to O
fkh[250con DNA
] O
in O
vivo O
, O
but O
the O
Abd-A/Exd protein-family
heterodimer O
acts O
as O
a O
transcriptional O
repressor O
, O
whereas O
the O
other O
Hox/Exd O
heterodimers O
act O
as O
activators O
. O

  O
Finally O
, O
synapsin B-protein-family
binds O
simultaneously O
to O
both O
actin B-protein-family
and O
synaptic B-organelle
vesicles I-organelle
( O
Benfenati O
et O
al O
. O
, O
1992) O
. O

The O
results O
confirmed O
that O
ATP B-chemical
bound O
to O
KaiC B-protein
and O
CI B-protein-domain
but O
failed O
to O
associate O
with O
CII B-protein-domain
( O
Fig O
. O
2 O
E O
and O
data O
not O
shown) O
. O

  O
If O
binding O
of O
CBP B-protein
to O
CREB B-protein
is O
not O
sufficient O
for O
transcriptional O
activation O
, O
what O
essential O
step O
in O
the O
PKA-mediated protein-family
response O
is O
disrupted O
by O
replacement O
of O
Ser B-amino-acid
of O
CREB O
with O
Asp B-amino-acid
? O

The O
binding O
of O
tropomyosin B-protein-family
to O
the O
rhodamine-phalloidin-labeled experiment-tag
actin B-protein-family
( O
actin•ϕ B-protein-family
) O
at O
assay O
conditions O
was O
investigated O
. O

  O
The O
actin-binding protein-family
properties O
of O
neurabin B-protein
and O
spinophilin B-protein
likely O
account O
, O
at O
least O
in O
part O
, O
for O
their O
enrichment O
in O
isolated O
postsynaptic O
densities O
( O
13) O
, O
which O
contain O
significant O
amounts O
of O
actin O
( O
39) O
. O

Dimerization O
of O
RBP1 B-protein
as O
detected O
in O
the O
two-hybrid O
system O
is O
consistent O
with O
earlier O
indications O
for O
cooperative O
binding O
of O
RBP1 O
to O
multiple O
RBP1 O
RNA B-RNA
target O
sequences O
and O
with O
evidence O
for O
oligomerization O
of O
RBP1 O
in O
gel-shift O
experiments O
( O
15) O
. O

  O
Following O
probing O
with O
the O
anti-wheat O
PABP B-protein
antibodies O
, O
PABP O
was O
detected O
bound O
to O
eIF-4B B-protein
, O
eIF-4F B-protein-complex
, O
eIF-iso4F B-protein-complex
, O
and O
recombinant O
eIF-iso4G B-protein
, O
but O
not O
to O
eIF-iso4E B-protein
or O
eIF-4A B-protein
( O
Fig O
. O
2 O
A) O
. O

CEB B-protein
does O
not O
bind O
GTP B-chemical
. O

The O
results O
of O
this O
study O
suggest O
that O
the O
third O
positive O
response O
element O
at O
bp O
125 O
also O
binds O
Sp1 B-protein
. O

  O
Collectively O
, O
these O
findings O
indicate O
that O
cyt B-protein
c I-protein
and O
Hsp90 B-protein-family
bind O
competitively O
to O
Apaf-1 B-protein
. O

Interestingly O
, O
CKIepsilon B-protein
binds O
to O
mPER1 B-protein
in O
a O
region O
that O
has O
no O
obvious O
sequence O
similarity O
to O
the O
suggested O
DBT-binding protein
region O
of O
dPER B-protein
( O
27) O
. O

Inhibiting O
CREB B-protein
phosphorylation O
would O
thus O
inhibit O
CREB O
binding O
to O
CREB-binding B-protein
protein I-protein
and O
may O
inhibit O
TGF-beta-induced protein-family
stimulation O
of O
fibronectin B-gene
gene O
transcription O
. O

  O
The O
pi- O
pi O
interactions O
between O
DMPP B-chemical
and O
aromatic O
residues O
of O
the O
AChR B-protein-family
at O
positions O
32 O
, O
33 O
and O
151 O
may O
be O
important O
in O
slowing O
conformational O
changes O
triggered O
by O
DMPP O
binding O
, O
resulting O
in O
a O
slower O
beta O
. O

  O
Binding O
of O
Rb B-protein
to O
E2F B-protein-family
, O
which O
represses O
E2F-dependent O
transcription O
, O
increases O
the O
half-life O
of O
E2F-DNA protein-family
complexes O
10-15-fold O
( O
58 O
) O
. O

  O
HMG-1 B-protein
binds O
to O
TBP B-protein
, O
both O
free O
in O
solution O
( O
10 O
) O
2 O
and O
when O
bound O
to O
the O
TATA B-DNA
element I-DNA
. O

  O
Cell O
, O
78 O
, O
761-771 O
[ O
Medline O
] O
ubinfeld O
, O
B O
. O
, O
Albert O
, O
I O
. O
, O
Porfiri O
, O
E O
. O
, O
Fiol O
, O
C O
. O
, O
Munemitso O
, O
S O
. O
and O
Polakis O
, O
P O
. O
( O
1996 O
) O
Binding O
of O
GSK3beta B-protein
to O
the O
APC-beta-catenin protein
complex O
and O
regulation O
of O
complex O
assembly O
. O

  O
These O
results O
suggest O
that O
p62 B-protein
binds O
noncovalently O
to O
ubiquitin B-protein-family
, O
rather O
than O
forming O
a O
thioester O
or O
an O
isopeptide O
bond O
. O

These O
data O
strongly O
imply O
that O
NAD+ B-chemical
binding O
to O
CtBP B-protein
causes O
a O
conformational O
change O
necessary O
for O
binding O
of O
the O
PXDLS B-protein-motif
motif I-protein-motif
. O

Note O
that O
the O
LRR-to-EEE O
conversion O
altered O
the O
Rab B-protein-family
binding O
specificity O
of O
Rim2 B-protein
. O

Binding O
of O
Numb B-protein
PTB B-protein-domain
domain I-protein-domain
to O
LNX B-protein
. O

We O
observed O
changes O
in O
the O
CRE-DNA B-DNA
binding O
of O
CREB B-protein
after O
the O
ME O
( O
Fig O
. O
2B O
and O
E) O
. O

  O
A O
neurobeachin B-protein-isoform
isoform I-protein-isoform
that O
does O
not O
bind O
RII B-protein-domain
, O
beige-like B-protein
protein I-protein
( O
BGL) protein
, O
is O
expressed O
in O
many O
tissues O
. O

  O
Use O
of O
this O
approach O
showed O
that O
ZAG B-protein
can O
bind O
several O
different O
types O
of O
fatty B-chemical
acids I-chemical
, O
all O
of O
which O
are O
abundant O
in O
human O
tissues O
. O

( O
B O
) O
PlexB B-protein
binds O
to O
Rac B-protein
in O
a O
GTP-dependent chemical
manner O
. O

In O
in O
vitro O
assays O
, O
Su(fu B-protein
) I-protein
can O
bind O
directly O
to O
Fu B-protein
and O
to O
Ci B-protein
; O
since O
there O
is O
no O
evidence O
for O
a O
direct O
interaction O
between O
the O
latter O
proteins O
or O
indeed O
between O
them O
and O
Cos‐2 O
, O
it O
may O
be O
that O
Su(fu O
) O
forms O
a O
bridge O
between O
them O
, O
stabilizing O
their O
association O
with O
one O
another O
and O
with O
Cos-2 B-protein
( O
Monnier O
et O
al O
. O
, O
1998 O
) O
( O
Figure O
1) O
. O

  O
Taken O
together O
, O
these O
results O
strongly O
implicate O
a O
role O
for O
PI3K B-protein-family
in O
the O
facilitation O
of O
FAK-promoted protein
cell O
migration O
and O
suggest O
that O
the O
binding O
of O
Src B-protein
and O
p130Cas B-protein
to O
FAK O
may O
not O
be O
sufficient O
for O
this O
process O
. O

The O
IL-11-inducible protein
binding O
of O
Syp B-protein
to O
both O
gp130 B-protein
and O
JAK2 B-protein
was O
shown O
by O
reciprocal O
immunoprecipitations O
. O

  O
It O
has O
been O
shown O
, O
by O
in O
vitro O
binding O
assay O
, O
that O
Ldb B-protein-family
proteins O
only O
binds O
to O
the O
first O
LIM B-protein-domain
domain O
of O
Islet-1 B-protein
and O
not O
to O
the O
second O
LIM O
domain O
( O
Jurata O
et O
al O
. O
, O
1996 O
) O
, O
leaving O
room O
for O
the O
second O
LIM O
domain O
to O
interact O
with O
some O
other O
cofactors O
. O

The O
RGS B-protein-domain
domain O
of O
Axin B-protein
binds O
APC B-protein
( O
Behrens O
et O
al O
. O
1998 O
; O
Kishida O
et O
al O
. O
1998) O
, O
defined O
domains O
of O
Axin O
are O
required O
for O
binding O
GSK3β B-protein
and O
β-catenin B-protein-family
( O
Behrens O
et O
al O
. O
1998 O
; O
Ikeda O
et O
al O
. O
1998 O
; O
Sakanaka O
et O
al O
. O
1998 O
; O
Hedgepeth O
et O
al O
. O
1999 O
) O
and O
the O
carboxy-terminal O
DIX B-protein-domain
domain O
and O
more O
internal O
sequences O
are O
required O
for O
Axin O
homodimerization O
and O
binding O
to O
Dsh B-protein-family
and O
LRP/Arrow protein
( O
Hsu O
et O
al O
. O
1999 O
; O
Kishida O
et O
al O
. O
1999 O
; O
Li O
et O
al O
. O
1999 O
; O
Smalley O
et O
al O
. O
1999 O
; O
Mao O
et O
al O
. O
2001) O
. O

  O
Previously O
, O
it O
had O
been O
shown O
that O
GSK-3beta B-protein
binds O
to O
beta-catenin B-protein
in O
cell O
lines O
that O
contain O
high O
levels O
of O
beta-catenin O
and O
mutated O
APC B-protein
( O
8) O
. O

Likewise O
, O
in O
vitro O
translated O
full-length O
Ets-1 B-protein
did O
not O
bind O
to O
GST-EtsΔTA protein
( O
Figure O
2A O
, O
lanes O
4 O
and O
5) O
. O

  O
In O
either O
case O
, O
the O
regulation O
of O
the O
balance O
of O
the O
binding O
of O
Dvl B-protein
and O
Axam B-protein
to O
Axin B-protein
is O
important O
. O

  O
In O
yeast O
two O
hybrid O
assay O
, O
we O
find O
that O
CORD B-protein-domain
is O
the O
only O
region O
of O
Ci B-protein
that O
binds O
Cos2 B-protein
( O
Fig O
. O
4A) O
. O

  O
Additional O
evidence O
that O
FKBP12 B-protein
specifically O
recognizes O
the O
Leu-Pro B-protein-motif
motif I-protein-motif
is O
provided O
by O
previous O
reports O
( O
Okadome O
et O
al O
. O
, O
1996 O
; O
Wang O
et O
al O
. O
, O
1996b O
) O
and O
present O
observations O
that O
rapamycin B-drug
and O
FK506 B-chemical
inhibit O
FKBP12 O
binding O
to O
TbetaR-I B-protein
. O

  O
C O
, O
Diva B-protein
does O
not O
bind O
to O
Bcl-XL B-protein
in O
293T B-cell
cells O
. O

EMSA B-assay
of O
NF-Y B-protein
and O
HSP-CBF B-protein
bound O
to O
the O
HSP70 B-protein-family
( O
A O
) O
and O
HSP40 B-protein
( O
B O
) O
proximal O
CCAAT B-DNA
box I-DNA
regions O
. O

The O
ability O
of O
the O
specific O
K266A B-mutation
mutant O
to O
abolish O
binding O
of O
AIP B-protein
to O
hsp90 B-protein
and O
substantially O
reduce O
binding O
to O
AhR B-protein
, O
coupled O
with O
the O
ability O
of O
AIP O
to O
bind O
directly O
to O
hsp90 O
and O
the O
pharmacological O
characterization O
of O
the O
binding O
of O
AIP O
to O
AhR O
, O
provides O
compelling O
evidence O
that O
hsp90 O
is O
required O
for O
binding O
between O
AhR O
and O
AIP O
. O

  O
Our O
results O
suggest O
that O
in O
some O
contexts O
, O
binding O
of O
the O
dCtBP B-protein
repressor O
protein O
to O
Knirps B-protein
is O
not O
required O
for O
repression O
( O
Fig O
. O
2 O
and O
3) O
. O

  O
Finally O
, O
the O
significance O
of O
the O
fact O
that O
TFIID B-protein-complex
( O
and O
TFIIA B-protein
) O
binds O
both O
TFIID-dependent B-DNA
and O
TFIID-independent B-DNA
promoters I-DNA
( O
42 O
) O
with O
comparable O
efficiency O
( O
in O
vitro O
) O
also O
awaits O
further O
study O
. O

  O
It O
is O
possible O
, O
therefore O
, O
that O
, O
upon O
the O
binding O
of O
GRF2 B-protein
to O
Ras B-protein-family
, O
the O
DB B-protein-domain
is O
exposed O
to O
the O
ubiquitination O
machinery O
, O
resulting O
in O
the O
ubiquitination O
of O
GRF2 O
. O

  O
Obviously O
, O
the O
immunoblots O
will O
show O
whether O
or O
not O
PTN B-protein
binds O
to O
the O
ALK B-protein
ECD B-protein-domain
, O
but O
they O
will O
not O
reveal O
as O
to O
whether O
other O
unidentified O
proteins O
present O
in O
the O
PTN O
preparation O
also O
bind O
. O

  O
HP1 B-protein
chromodomain B-protein-domain
does O
not O
bind O
histone B-protein-family
H3 I-protein-family
containing O
methyllysine O
4 O
( O
7) O
, O
a O
posttranslational O
modification O
associated O
with O
transcriptional O
activation O
( O
18) O
, O
because O
the O
sequence O
context O
of O
the O
Lys4 O
( O
ARTK4Q B-protein-region
) O
is O
not O
shared O
with O
Lys9 O
. O

  O
In O
addition O
to O
binding O
filamin B-protein-family
, O
it O
has O
been O
previously O
reported O
that O
beta1 B-protein-domain
can O
bind O
focal B-protein
adhesion I-protein
kinase I-protein
( O
52 O
) O
and O
the O
cytoplasmic O
proteins O
talin B-protein
( O
53) O
, O
paxillin B-protein
( O
52) O
, O
and O
alpha-actinin B-protein-family
( O
54) O
. O

Second O
, O
the O
ankyrin B-protein
repeat-containing I-protein
serine-threonine I-protein
kinase I-protein
, O
integrin-linked B-protein
kinase I-protein
( O
ILK) protein
, O
which O
binds O
the O
cytoplasmic O
domain O
of O
β1 B-protein
and O
β3 B-protein
integrin I-protein
subunits I-protein
, O
promotes O
contact-independent O
growth O
and O
directly O
induces O
cyclin B-protein
D1 I-protein
expression O
and O
transcription O
( O
D O
' O
Amico O
et O
al O
. O
, O
2000) O
. O

U2AF B-protein-family
bound O
to O
the O
PY B-DNA
tract I-DNA
and O
AG B-DNA
within O
exon O
3 O
recruits O
U2 B-protein-RNA-complex
snRNP O
to O
the O
BPS B-DNA
. O

It O
has O
been O
reported O
that O
ligands O
( O
e O
. O
g O
. O
echistatin B-protein
) O
or O
RGD-containing protein-motif
peptides O
block O
binding O
of O
an O
RGD-containing B-reagent
anti-β3 I-reagent
antibody I-reagent
, O
16N7C2 B-reagent
, O
to O
β3 B-protein
integrin I-protein
( O
19) O
. O

  O
A O
further O
complication O
arises O
if O
it O
can O
be O
confirmed O
that O
Munc13-1 B-protein
binding O
to O
syntaxin B-protein-family
is O
not O
affected O
by O
phorbol O
esters O
( O
see O
Rhee O
et O
al O
. O
, O
2002 O
, O
p O
. O
131) O
. O

  O
Several O
individual O
amino O
acid O
residues O
in O
Shc B-protein
have O
been O
implicated O
by O
site-directed O
mutagenesis O
to O
be O
critical O
for O
Shc O
binding O
to O
the O
psi B-protein-motif
XNP I-protein-motif
XpY I-protein-motif
motif I-protein-motif
( O
17 O
, O
19 O
, O
20) O
. O

As O
adapter O
proteins O
, O
Shc B-protein
binds O
to O
activated O
receptors O
such O
as O
epidermal B-protein
growth I-protein
factor I-protein
, O
nerve B-protein-complex
growth I-protein-complex
factor I-protein-complex
, O
and O
antigen B-protein-family
receptors I-protein-family
, O
and O
IRS B-protein-family
binds O
to O
activated O
insulin B-protein
receptor I-protein
, O
so O
as O
to O
transduce O
signals O
to O
downstream O
effector O
proteins O
( O
reviewed O
in O
reference O
37) O
. O

HSP27 B-protein
binds O
to O
the O
26S B-protein-complex
proteasome I-protein-complex
complex I-protein-complex
. O

MSL B-protein-complex
complex O
binding O
at O
roX1 B-DNA
transgenes O
requires O
MLE B-protein
. O

The O
reduction O
in O
ordering O
of O
C-terminal O
portions O
of O
the O
CRIB B-protein-motif
motif O
on O
binding O
the O
GTPase B-protein-family
, O
and O
consequent O
reduction O
of O
a O
significant O
conformational O
entropic O
penalty O
on O
binding O
, O
may O
explain O
how O
Par6 B-protein-family
can O
bind O
Cdc42 B-protein
with O
high O
affinity O
even O
though O
its O
CRIB O
motif O
lacks O
conserved O
elements O
found O
in O
other O
systems O
( O
Burbelo O
et O
al O
. O
, O
1995) O
. O

Taking O
advantage O
of O
the O
fact O
that O
high O
Ca2+ B-chemical
concentrations O
can O
be O
easily O
achieved O
in O
solution O
to O
detect O
weak O
binding O
sites O
, O
we O
have O
now O
determined O
the O
complete O
Ca2+‐binding O
mode O
of O
the O
C2A‐domain protein-domain
of O
synaptotagmin B-protein
I I-protein
using O
a O
combination O
of O
Mn2+‐induced chemical
relaxation O
experiments O
, O
site‐directed O
mutagenesis O
and O
Ca2+ O
titrations O
monitored O
by O
NMR B-assay
spectroscopy O
. O

  O
Buffers O
contained O
10 O
muM O
FAD B-chemical
; O
binding O
was O
carried O
out O
at O
40 O
mM O
imidazole B-chemical
, O
washing O
at O
60 O
mM O
, O
and O
elution O
at O
400 O
mM O
for O
the O
first O
cycle O
and O
300 O
mM O
for O
the O
second O
. O

Since O
the O
ggp1Δ B-cell
mutant I-cell
of I-cell
S I-cell
. I-cell
cerevisiae I-cell
is O
sensitive O
to O
Calcofluor B-reagent
White I-reagent
( O
CF B-reagent
) O
( O
Sigma O
, O
St O
. O
Louis O
, O
Mo O
. O
) O
, O
a O
fluorescent O
stain O
that O
binds O
to O
nascent O
chitin B-chemical
molecules O
and O
prevents O
their O
assembly O
into O
fibrils O
( O
2) O
, O
we O
tested O
if O
the O
phr1Δ B-protein
mutant O
had O
similar O
behavior O
with O
respect O
to O
this O
compound O
. O

The O
syntaxin-1a-Munc18 protein
complex O
was O
further O
incubated O
with O
various O
quantities O
of O
tomosyn B-protein
on O
the O
membranes O
for O
2 O
hr O
. O
Syntaxin-1a O
bound O
to O
tomosyn O
was O
detected O
. O

If O
the O
engrailed-2 B-gene
gene O
were O
a O
direct O
target O
of O
Wnt B-protein-family
signaling O
, O
which O
worked O
through O
β-catenin B-protein
binding O
to O
LEF/TCF B-protein-family
homologs O
on O
the O
promoter B-DNA
, O
then O
one O
would O
predict O
that O
induction O
of O
the O
engrailed-2 O
gene O
by O
Wnt O
and O
β-catenin O
could O
be O
blocked O
by O
a O
dominant O
negative O
TCF O
. O

  O
Sp1 B-protein
, O
Sp3 B-protein
, O
and O
Sp4 B-protein
bind O
to O
the O
GC B-DNA
box I-DNA
of O
the O
ODC B-DNA
promoter I-DNA
. O

  O
Based O
on O
the O
present O
study O
, O
we O
propose O
that O
Axam B-protein
may O
form O
a O
complex O
with O
Axin B-protein
constitutively O
in O
the O
absence O
of O
Wnt B-protein-family
, O
thereby O
Dvl B-protein
does O
not O
bind O
to O
Axin O
. O

  O
To O
further O
map O
the O
PR B-protein
binding O
motif O
of O
RIZ B-protein-family
proteins O
, O
truncation O
mutants O
of O
RIZ1 B-protein
were O
generated O
by O
in O
vitro O
transcription O
and O
translation O
of O
various O
mutant O
constructs O
( O
Fig O
. O
5 O
A) O
. O

First O
, O
we O
tested O
whether O
anti-L1 B-reagent
Fab I-reagent
remains O
bound O
to O
L1 O
in O
endosomal O
compartments O
whose O
pH O
is O
slightly O
acidic O
: O
pH O
6 O
. O
0-6 O
. O
5 O
in O
early O
endosomes O
and O
pH O
5 O
. O
0-6 O
. O
0 O
in O
late O
endosomes O
( O
Nixon O
and O
Cataldo O
, O
1995) O
. O

  O
In O
NBS B-cell
cells O
, O
neither O
Nbs1p70 B-protein
nor O
Mre11 B-protein
bound O
to O
E2F B-protein-family
sites O
, O
whereas O
E2F1 B-protein
binding O
was O
unaffected O
( O
Fig O
. O
3C) O
. O

dCtBP B-protein
also O
binds O
to O
Hairy B-protein
and O
a O
number O
of O
transcriptional O
repressors O
. O

  O
PIP2 B-chemical
also O
binds O
to O
vinculin B-protein
, O
which O
then O
interacts O
with O
talin B-protein
. O

Concurrent O
binding O
of O
Sp1 B-protein
and O
AP2 B-protein
to O
the O
hTAFII55 -
promoter-proximal -
region O
The O
extended O
footprints O
exhibited O
by O
individual O
Sp1 O
and O
AP2 O
proteins O
raise O
an O
interesting O
possibility O
that O
both O
proteins O
may O
bind O
simultaneously O
to O
the O
hTAFII55 O
promoter O
. O

  O
Spectrin B-protein-family
, O
which O
binds O
to O
F-actin protein-family
beneath O
plasma O
membrane O
and O
forms O
a O
membrane O
cortical O
meshwork O
, O
also O
accumulates O
at O
the O
leading O
edges O
of O
motile O
cells O
( O
Burridge O
et O
al O
. O
, O
1982 O
; O
Sormunen O
and O
Lehto O
, O
1995 O
) O
. O

  O
Although O
the O
residual O
activity O
was O
close O
to O
background O
, O
TPA B-chemical
may O
still O
be O
bound O
to O
PKC B-protein-family
and O
thereby O
maintain O
phosphorylation O
and O
activation O
of O
the O
substrate O
. O

Paxillin B-protein
failed O
to O
bind O
to O
GST B-experiment-tag
alone O
or O
to O
the O
SH2 B-protein-domain
domain O
of O
Grb2 B-protein
. O

  O
While O
the O
region O
of O
Apaf-1 B-protein
that O
is O
involved O
in O
binding O
with O
Hsp90 B-protein-family
is O
not O
known O
, O
our O
results O
demonstrate O
that O
Hsp90 O
binds O
to O
Apaf-1 O
at O
a O
different O
site O
than O
that O
of O
cyt B-protein
c I-protein
( O
data O
not O
shown) O
. O

  O
Since O
direct O
binding O
of O
PAK B-protein-family
to O
paxillin B-protein
was O
not O
observed O
, O
the O
precipitation O
of O
PAK O
by O
paxillin O
LD4 B-protein-motif
from O
cell O
and O
tissue O
lysates O
likely O
occurs O
as O
a O
result O
of O
its O
association O
with O
PIX B-protein-family
( O
Fig O
. O
7 O
; O
Bagrodia O
et O
al O
. O
, O
1998 O
; O
Manser O
et O
al O
. O
, O
1998 O
) O
. O

Munc18a B-protein
is O
at O
once O
essential O
and O
inhibitory O
to O
secretion O
( O
8 O
) O
because O
while O
Sec1p B-protein
and O
its O
homologues O
are O
necessary O
for O
membrane O
trafficking O
and O
the O
final O
stages O
of O
protein O
secretion O
( O
9 O
, O
10) O
, O
high O
affinity O
binding O
between O
Munc18a O
and O
syntaxin B-protein
1a I-protein
also O
inhibits O
the O
association O
of O
vesicle O
SNAREs B-protein-complex
with O
syntaxin O
1a O
( O
5-7 O
, O
11) O
. O

  O
A O
program O
of O
study O
focused O
on O
identifying O
these O
binding O
site(s O
) O
( O
5 O
, O
6 O
, O
46 O
, O
47 O
) O
culminated O
in O
the O
discovery O
that O
synaptotagmin B-protein
I I-protein
bound O
AP-2 B-protein-complex
with O
high O
affinity O
in O
vitro O
( O
7) O
. O

  O
The O
percent O
tsf B-protein
mutant I-protein
coat I-protein
protein I-protein
bound O
to O
GroEL B-protein-family
, O
however O
, O
does O
show O
a O
dependence O
upon O
GroEL/S B-protein-complex
concentration O
. O

  O
This O
was O
not O
because O
of O
reduced O
binding O
of O
cyclin B-protein
A I-protein
to O
the O
Cdk2 B-protein
, O
because O
cyclin O
A O
strongly O
activated O
the O
histone B-protein-family
H1 I-protein-family
kinase O
activity O
of O
the O
Texas -
Red-labeled -
GST-Cdk2 experiment-tag
preparation O
( O
data O
not O
shown) O
. O

  O
Further O
, O
adaptor O
proteins O
such O
as O
FE65 B-protein-family
, O
whose O
protein O
interaction O
domains O
bind O
the O
cytoplasmic O
portions O
of O
both O
LRP B-protein-family
and O
APP B-protein-family
( O
37) O
, O
may O
also O
be O
involved O
in O
linking O
these O
two O
molecules O
. O

  O
Lanes O
16 O
and O
17 O
are O
a O
longer O
autoradiographic O
exposure O
of O
lanes O
14 O
and O
15 O
, O
to O
more O
clearly O
demonstrate O
the O
previously O
reported O
observation O
that O
MEIS1 B-protein
binds O
to O
HOXA9 B-protein
in O
the O
absence O
of O
PBX B-protein-family
proteins O
( O
41) O
. O

  O
Confirming O
the O
two-hybrid O
data O
, O
DCAP B-protein
binds O
to O
Axin B-protein
( O
Fig O
. O
3 O
, O
right O
panel) O
. O

  O
The O
model O
suggests O
that O
Ral B-protein-family
is O
bound O
to O
PLD B-protein-family
but O
cannot O
directly O
activate O
the O
enzyme O
; O
therefore O
other O
molecules O
, O
such O
as O
Arf B-protein-family
, O
Rac B-protein-family
, O
or O
Rho B-protein-family
are O
necessary O
for O
a O
fully O
activated O
signaling O
complex O
. O

  O
Regulation O
of O
3 O
' O
splice O
site O
choice O
, O
both O
positive O
and O
negative O
, O
can O
be O
realized O
by O
influencing O
the O
pyrimidine B-DNA
tract I-DNA
binding O
of O
U2AF B-protein-family
( O
Tian O
and O
Maniatis O
1993 O
; O
Valcarcel O
et O
al O
. O
1993 O
; O
Reed O
1996 O
) O
. O

  O
In O
this O
light O
, O
it O
is O
interesting O
that O
the O
wild-type O
GSK3 B-protein-complex
strongly O
stimulated O
the O
binding O
of O
Axin B-protein
to O
LRP-5 B-protein
, O
whereas O
a O
kinase-dead B-protein
GSK3 I-protein
did O
not O
. O

ASF/SF2 B-protein
binds O
a O
purine-rich B-DNA
element I-DNA
positioned O
within O
the O
3 B-RNA
' I-RNA
UTR I-RNA
of O
the O
mature O
PKCI-r B-RNA
mRNA I-RNA
. O

  O
To O
investigate O
whether O
the O
K12 B-mutation
and O
K23 B-mutation
double O
mutations O
in O
eIF2beta B-protein
reduced O
binding O
between O
eIF2 B-protein-complex
and O
eIF5 B-protein
in O
vitro O
, O
we O
conducted O
pull-down O
assays O
with O
GST-eIF5 experiment-tag
and O
wild-type O
or O
mutant O
eIF2 O
present O
in O
WCEs O
. O

  O
As O
shown O
in O
Fig O
. O
3 O
E O
, O
when O
8-azido-[gamma-32 B-experiment-tag
] I-experiment-tag
GTP B-chemical
was O
covalently O
bound O
to O
Rad B-protein-family
, O
addition O
of O
nm23 B-protein-family
caused O
reduction O
in O
amount O
of O
[ O
gamma-32 O
] O
labeling O
on O
Rad O
, O
indicating O
that O
GTP O
was O
being O
hydrolyzed O
in O
situ O
. O

This O
is O
in O
agreement O
with O
those O
reported O
by O
Seong O
et O
al O
. O
( O
1997 O
) O
in O
the O
mapping O
of O
antigenic O
determinants O
for O
Bor56 B-protein
in O
which O
it O
was O
found O
that O
human O
IgM B-reagent
antibody O
predominantly O
bound O
to O
AD B-protein-domain
I I-protein-domain
and O
AD B-protein-domain
III I-protein-domain
regions O
. O

A18 B-protein-RNA-complex
hnRNP I-protein-RNA-complex
Binds O
Specifically O
to O
RPA2 B-RNA
and O
Thioredoxin B-RNA
3′-UTRs B-RNA

Our O
immunotube O
technique O
revealed O
that O
A18 B-protein-RNA-complex
hnRNP I-protein-RNA-complex
binds O
to O
a O
large O
number O
of O
stress-responsive O
transcripts O
( O
Table O
I) O
. O

As O
shown O
in O
Fig O
. O
3 O
B O
, O
lane O
2 O
, O
phosphorylated O
p97 B-protein
bound O
to O
p47 B-protein
. O

  O
In O
this O
experiment O
, O
any O
binding O
of O
heparin B-chemical
to O
Abeta B-peptide
should O
have O
been O
revealed O
as O
a O
series O
of O
electrophoretic O
bands O
whose O
mobility O
was O
progressively O
increased O
by O
increasing O
heparin O
concentrations O
. O

( O
A O
) O
Conservation O
of O
the O
CtBP B-protein
binding O
motif O
PLDLSL B-protein-motif
among O
mouse O
deltaEF1 B-protein
and O
adenovirus B-cell
( O
Ad B-cell
) O
E1A B-protein
proteins O
. O

The O
basic O
properties O
of O
the O
side O
chain O
of O
lysine O
13 O
, O
together O
with O
the O
observation O
that O
ATP B-chemical
protected O
this O
residue O
against O
modification O
by O
pyridoxal O
phosphate O
, O
not O
only O
argues O
for O
an O
active-site O
location O
for O
this O
lysine O
but O
also O
prompts O
speculation O
that O
lysine O
13 O
could O
stabilize O
ATP O
binding O
because O
of O
interaction O
between O
the O
positively O
charged O
ϵ-amino O
group O
and O
the O
negatively O
charged O
phosphoryl O
groups O
of O
ATP O
. O

  O
This O
latter O
hypothesis O
would O
be O
in O
agreement O
with O
the O
fact O
that O
overexpression O
of O
GTP-bound chemical
forms O
of O
rab B-protein-family
proteins O
generally O
results O
in O
a O
gain O
of O
function O
( O
2 O
, O
3) O
. O

Dynamin B-protein
2 I-protein
, O
a O
binding O
partner O
of O
the O
SH3 B-protein-domain
domain O
of O
amphiphysin B-protein
( O
9) O
, O
was O
recruited O
to O
the O
tubules O
when O
coexpressed O
with O
M-amphiphysin B-protein-isoform
2 I-protein-isoform
( O
Fig O
. O
2D) O
, O
but O
not O
when O
coexpressed O
with O
its O
BAR* B-protein-domain
domain O
, O
which O
was O
sufficient O
to O
induce O
tubulation O
( O
Fig O
. O
2 O
, O
B O
and O
E) O
. O

Next O
we O
compared O
the O
binding O
of O
PR B-protein
and O
NF1 B-protein
to O
the O
MMTV B-DNA
promoter I-DNA
presented O
either O
as O
free O
DNA B-DNA
or O
in O
minichromosomes O
. O

Binding O
of O
trithorax B-protein-family
and O
Polycomb B-protein-family
proteins O
to O
the O
bithorax B-protein-complex
complex O
: O
dynamic O
changes O
during O
early O
Drosophila O
embryogenesis O
. O

p100 B-protein
bound O
directly O
to O
the O
SH2 B-protein-domain
domains O
of O
both O
SHP-2 B-protein
and O
the O
p85 B-protein
subunit O
of O
phosphatidylinositol B-protein-complex
3-kinase I-protein-complex
. O

To O
further O
test O
whether O
CDI B-process
results O
from O
an O
action O
of O
endogenous O
calmodulin B-protein
, O
whole-cell O
NMDA -
receptor-mediated -
currents O
were O
recorded O
following O
the O
infusion O
of O
a O
calmodulin B-peptide
binding I-peptide
peptide I-peptide
( O
CBP B-peptide
) O
into O
NR1/NR2A-expressing experimental-construct
HEK B-cell
293 I-cell
cells O
to O
reduce O
intracellular O
free O
calmodulin O
. O

This O
phosphorylation O
is O
crucial O
for O
Shc B-protein
binding O
to O
Grb2 B-protein
and O
MT-induced protein
transformation O
. O

  O
The O
PH B-protein-domain
domain O
, O
which O
binds O
PI(4 B-chemical
, I-chemical
5 I-chemical
) I-chemical
P2 I-chemical
( O
14 O
, O
15) O
, O
and O
an O
amino O
acid O
stretch O
upstream O
of O
PH O
domain O
, O
which O
can O
insert O
into O
the O
lipid O
bilayer O
( O
16) O
, O
help O
the O
protein O
to O
anchor O
at O
the O
membrane O
. O

Procaspase-9 B-protein
without O
cytochrome B-protein
c I-protein
had O
no O
effect O
on O
dATP B-chemical
binding O
to O
Apaf-1 B-protein
. O

Boundary O
elements O
that O
have O
been O
well O
studied O
in O
Drosophila O
include O
the O
specialized O
chromatin O
sequences O
( O
scs B-DNA
and O
scs՛ B-DNA
) O
flanking O
the O
hsp70 B-gene
genes O
, O
Fab-7 B-gene
, O
Fab-8 B-gene
and O
Mcp B-gene
elements O
from O
the O
Bithorax B-protein-complex
Complex I-protein-complex
, O
and O
the O
suppressor O
of O
hairy-wing B-gene
( O
su(Hw B-gene
) I-gene
) O
binding O
sites O
located O
within O
the O
gypsy B-DNA
transposon O
( O
reviewed O
in O
Bell O
et O
al O
. O
, O
2001) O
. O

Plakoglobin B-protein
binding O
by O
human O
Dsg3 B-protein
( O
pemphigus B-protein
vulgaris I-protein
antigen I-protein
) O
in O
keratinocytes O
requires O
the O
cadherin-like protein-family
intracytoplasmic O
segment O
. O

  O
N-cadherin B-protein-family
also O
binds O
beta-catenin B-protein
but O
stimulates O
tumor O
cell O
invasion O
( O
Islam O
et O
al O
. O
, O
1996 O
; O
Hazan O
et O
al O
. O
, O
2000) O
. O

  O
( O
C O
, O
c O
) O
Binding O
of O
125I-Tiam1 protein
fragment O
to O
the O
spectrin B-protein-complex
binding O
domain O
of O
ankyrin B-protein-family
. O

The O
amphiphysin B-protein-family
dimer O
also O
binds O
to O
clathrin B-protein-complex
( O
10 O
, O
11 O
) O
and O
to O
the O
α-adaptin B-protein
subunit O
of O
the O
plasma O
membrane O
clathrin O
adaptor O
AP-2 B-protein-complex
( O
9 O
, O
12 O
) O
and O
thus O
may O
mediate O
recruitment O
of O
dynamin B-protein
1 I-protein
and O
synaptojanin B-protein
1 I-protein
to O
the O
site O
of O
clathrin-mediated O
endocytosis O
. O

  O
Attempts O
to O
demonstrate O
that O
VacA B-protein-complex
directly O
associates O
with O
cholesterol B-chemical
were O
unsuccessful O
, O
suggesting O
that O
VacA O
may O
bind O
to O
DRM B-organelle
components O
other O
than O
( O
or O
in O
addition O
to O
) O
cholesterol O
. O

We O
confirmed O
using O
a O
blot O
overlay O
assay O
that O
tomosyn B-protein
directly O
bound O
to O
syntaxin-1a B-protein
. O

  O
Finally O
, O
DM B-protein
stabilizes O
class B-protein-family
II I-protein-family
peptide I-protein-family
binding O
sites O
against O
inactivation O
( O
25 O
, O
26) O
. O

In O
addition O
, O
it O
was O
reported O
that O
a O
soluble O
form O
of O
CNTFRα B-protein
( O
lacking O
the O
glycosylphosphatidylinositol O
linkage O
) O
can O
bind O
CNTF B-protein
and O
activate O
gp130-LIFRβ-bearing protein
cells O
( O
Taga O
et O
al O
. O
, O
1992 O
; O
Davis O
et O
al O
. O
, O
1993b O
; O
Robledo O
et O
al O
. O
, O
1996) O
. O

  O
Therefore O
, O
projectin B-protein
might O
not O
bind O
CaMKII B-protein
to O
serve O
as O
its O
substrate O
. O

It O
is O
not O
clear O
at O
present O
whether O
the O
binding O
of O
ERM B-protein-family
proteins O
to O
CD43 B-protein
and O
ICAM-2 B-protein
( O
and O
to O
as O
yet O
unidentified O
ERM O
membrane-binding O
partners O
) O
in O
vivo O
is O
also O
regulated O
by O
the O
Rho B-process
signaling I-process
pathway I-process
. O

Oxidative O
stress O
stimulates O
binding O
of O
Sp1 B-protein
and O
Sp3 B-protein
to O
the O
VEGF-A B-protein
promoter O
. O

This O
argues O
for O
a O
function O
of O
U2AF35 B-protein
in O
addition O
to O
assisting O
U2AF65 B-protein
binding O
. O

  O
All O
the O
fusion O
proteins O
that O
bound O
to O
calmodulin B-protein
contained O
the O
N-terminal O
32 O
residues O
, O
while O
those O
proteins O
that O
lacked O
these O
residues O
failed O
to O
associate O
with O
calmodulin O
( O
Figure O
2A O
) O
. O

These O
observations O
support O
a O
mechanism O
in O
which O
GBP B-protein-family
binding O
to O
Xgsk-3 B-protein-complex
prevents O
substrate O
phosphorylation O
. O

  O
( O
Rho-associated B-protein
coiled-coil-containing I-protein
protein I-protein
kinase I-protein
) O
are O
activated O
by O
the O
GTP-bound chemical
form O
of O
Rho O
( O
31 O
, O
42 O
, O
50) O
. O

  O
Here O
we O
report O
that O
p202a B-protein
binds O
c-Myc B-protein
in O
vitro O
and O
in O
vivo O
, O
thereby O
inhibiting O
the O
binding O
of O
c-Myc O
to O
Max B-protein
, O
as O
well O
as O
the O
transcriptional O
activity O
of O
c-Myc O
. O

  O
So O
far O
, O
we O
have O
found O
no O
evidence O
that O
the O
intramolecular O
SH3-GK protein-domain
interaction O
prevents O
binding O
of O
GKAP B-protein
to O
the O
GK O
domain O
, O
but O
other O
GK-binding O
proteins O
like O
BEGAIN B-protein
remain O
to O
be O
examined O
. O

  O
Two O
models O
( O
Fig O
. O
5 O
) O
are O
proposed O
to O
explain O
the O
phenomenon O
that O
once O
Ku B-protein-complex
has O
bound O
to O
one O
DNA B-DNA
molecule O
, O
another O
DNA O
molecule O
can O
only O
compete O
for O
Ku O
if O
its O
ends O
are O
complementary O
to O
those O
of O
the O
first O
DNA O
molecule O
. O

These O
proteins O
are O
responsible O
for O
cadherin B-protein-family
binding O
to O
the O
actin B-organelle
cytoskeleton I-organelle
and O
possibly O
for O
intracellular O
signaling O
( O
39) O
. O

Mad2 B-protein
binds O
and O
inhibits O
Cdc20 B-protein
in O
vitro O
( O
Fang O
et O
al O
. O
1998a O
; O
Hwang O
et O
al O
. O
1998 O
; O
Kallio O
et O
al O
. O
1998 O
Kim O
; O
et O
al O
. O
1998 O
) O
. O

Several O
proteins O
have O
been O
isolated O
as O
putative O
Rho B-protein-family
effectors O
on O
the O
basis O
of O
their O
selective O
interaction O
with O
the O
GTP-bound chemical
form O
of O
Rho O
. O

  O
( O
C O
) O
This O
PIC B-protein-complex
binds O
the O
Ad B-cell
origin O
of O
DNA B-DNA
replication O
( O
the O
5 O
' O
attached O
TP B-protein
was O
omitted O
for O
simplification) O
, O
most O
likely O
in O
a O
irregular O
, O
bent O
DNA O
structure O
. O

Indeed O
, O
recent O
data O
indicates O
that O
Bcl-xL B-protein
can O
bind O
to O
the O
mammalian O
CED-4 B-protein
homologue O
Apaf-1 B-protein
, O
at O
least O
under O
some O
conditions O
( O
Hu O
et O
al O
. O
, O
1998 O
; O
Pan O
et O
al O
. O
, O
1998) O
. O

The O
cadherin-bound protein-family
form O
of O
beta-catenin B-protein-family
is O
anchored O
at O
the O
plasma O
membrane O
( O
4) O
. O

The O
initial O
steps O
in O
formation O
of O
the O
pre-initiation B-protein-complex
complex I-protein-complex
- O
binding O
of O
TFIID B-protein-complex
and O
TFIIA B-protein
- O
are O
likely O
to O
be O
important O
determinants O
of O
this O
dynamic O
equilibrium O
. O

  O
Although O
SREBPs O
are O
capable O
of O
binding O
E-boxes B-DNA
with O
high O
affinity O
in O
vitro O
( O
26 O
, O
30) O
, O
sterol O
regulation O
of O
all O
carefully O
examined O
promoters O
so O
far O
is O
mediated O
through O
SREBP B-protein
binding O
to O
SRE B-DNA
elements I-DNA
and O
not O
E-boxes O
( O
4 O
, O
6-10 O
, O
27-30) O
. O

  O
At O
low O
pH O
does O
DM B-protein-family
bind O
to O
the O
closed O
form O
of O
MHCII B-protein-family
, O
prying O
it O
open O
, O
or O
does O
DM O
simply O
bind O
to O
and O
stabilize O
the O
open O
form O
of O
MHCII O
induced O
spontaneously O
by O
the O
shift O
to O
low O
pH O
? O

Although O
VEGF B-protein-family
binds O
both O
VEGFR-1 B-protein
and O
VEGFR-2 B-protein
, O
only O
binding O
to O
VEGFR-2 O
generates O
mitogenic O
signal O
in O
ECs B-cell
. O

  O
Thus O
, O
binding O
of O
USF B-protein-family
to O
the O
DOR B-DNA
promoter I-DNA
sequence O
is O
more O
critical O
than O
that O
of O
Sp1/Sp3 protein
in O
NS20Y B-cell
cells O
. O

In O
addition O
to O
our O
finding O
that O
CYC B-protein
is O
present O
in O
at O
least O
a O
200-fold O
molar O
excess O
relative O
to O
dCLK B-protein
in O
head O
extracts O
( O
see O
Fig O
. O
4) O
, O
this O
contention O
is O
supported O
further O
by O
the O
observations O
that O
( O
1 O
) O
at O
all O
times O
in O
a O
daily O
cycle O
essentially O
all O
of O
the O
dCLK O
is O
stably O
bound O
to O
CYC O
( O
see O
Fig O
. O
5A) O
, O
and O
( O
2 O
) O
the O
temporal O
abundance O
profile O
of O
dCLK O
in O
immune O
complexes O
recovered O
with O
anti-CYC B-reagent
antibodies I-reagent
is O
very O
similar O
to O
that O
of O
dCLK O
present O
in O
head O
extracts O
( O
see O
Fig O
. O
3C O
, O
D) O
. O

  O
Since O
our O
data O
suggested O
that O
MEIS1 B-protein
was O
bound O
to O
either O
HOXA9 B-protein
and/or O
PBX1a B-protein
in O
the O
presence O
of O
DNA B-DNA
, O
we O
wished O
to O
study O
the O
interactions O
between O
these O
molecules O
in O
the O
absence O
of O
a O
DNA O
target O
. O

  O
As O
described O
by O
Kumar O
et O
al O
. O
( O
17) O
, O
the O
crystal O
structure O
of O
CtBP B-protein
bound O
to O
NAD+ B-chemical
supports O
the O
prediction O
that O
CtBP O
is O
structurally O
similar O
to O
3-phosphoglycerate B-protein
dehydrogenase I-protein
. O

The O
fact O
that O
deletion O
of O
domain B-protein-domain
7 I-protein-domain
did O
not O
affect O
the O
inhibition O
of O
osteoclastogenesis O
( O
Fig O
. O
2 O
A O
) O
but O
significantly O
decreased O
the O
binding O
of O
OCIF B-protein
to O
heparin B-chemical
( O
Fig O
. O
3 O
) O
indicates O
that O
binding O
ability O
of O
OCIF O
to O
heparin O
does O
not O
correlate O
with O
its O
osteoclastogenesis O
inhibitory O
activity O
in O
vitro O
. O

  O
Since O
a O
peptide O
encompassing O
this O
region O
binds O
to O
collagen B-protein-complex
type I-protein-complex
I I-protein-complex
and O
inhibits O
APP-collagen protein
type O
I O
binding O
in O
nanomolar O
concentrations O
, O
this O
region O
may O
comprise O
the O
major O
part O
of O
the O
collagen O
type O
I O
binding O
site O
of O
APP O
. O

  O
Figure O
5C O
shows O
that O
the O
binding O
of O
Rpb1 B-protein
( O
the O
large O
subunit O
of O
RNA B-protein-complex
pol I-protein-complex
II I-protein-complex
) O
to O
both O
the O
GAL1 B-DNA
and O
GAL10 B-DNA
promoters I-DNA
increases O
with O
time O
after O
induction O
with O
galactose B-chemical
, O
reaching O
its O
maximum O
level O
at O
60 O
min O
. O

Binding O
of O
purified O
alpha-actinin B-protein-family
to O
the O
beta1 B-protein-domain
cytoplasmic I-protein-domain
domain I-protein-domain
is O
shown O
in O
Fig O
. O
1 O
B O
. O

On O
binding O
of O
LPS B-chemical
to O
TLRs B-protein-family
, O
specifically O
TLR2 O
and O
TLR4 O
, O
via O
CD14 B-protein
, O
a O
number O
of O
molecules O
are O
recruited O
to O
the O
receptor O
to O
mediate O
NF-κB B-protein-complex
activation O
, O
which O
include O
the O
adaptor O
molecule O
MyD88 B-protein
, O
the O
protein O
kinase O
IRAK B-protein
, O
and O
the O
adaptor O
molecule O
TRAF-6 B-protein
, O
thus O
forming O
the O
receptor O
complex O
[ O
29] O
, O
resulting O
in O
interaction O
of O
downstream O
molecules O
and O
the O
subsequent O
activation O
of O
NF-κB O
. O

  O
Interestingly O
, O
TDP-43 B-protein
can O
bind O
a O
minimum O
number O
of O
six O
UG B-DNA
( O
or O
TG B-DNA
) O
single-stranded O
dinucleotide O
stretches O
, O
and O
binding O
affinity O
increases O
with O
the O
number O
of O
repeats O
. O

  O
An O
N-terminal O
proline-rich O
sequence O
( O
PXXP B-protein-region
) O
binds O
to O
Nck B-protein-family
( O
Bokoch O
et O
al O
. O
, O
1996 O
; O
Galisteo O
et O
al O
. O
, O
1996 O
) O
; O
a O
CRIB B-protein-motif
( O
Cdc42/ protein
Rac B-protein-family
interactive O
binding O
) O
motif O
binds O
to O
GTP-bound chemical
forms O
of O
Cdc42 O
and O
Rac O
( O
Manser O
et O
al O
. O
, O
1994 O
; O
Burbelo O
et O
al O
. O
, O
1995 O
) O
; O
and O
a O
proline-rich B-protein-motif
motif I-protein-motif
is O
constitutively O
bound O
to O
Pix B-protein
, O
a O
guanine O
nucleotide O
exchange O
factor O
specific O
to O
Rac O
and O
Cdc42 O
( O
Manser O
et O
al O
. O
, O
1998 O
) O
. O

  O
With O
high O
concentrations O
of O
Ubc9 B-protein
and O
GR B-protein
, O
Ubc9 O
binding O
to O
GR O
appears O
to O
be O
sufficient O
to O
permit O
Ubc9 O
to O
act O
independently O
of O
the O
GME B-DNA
. O

  O
Castanospermine B-chemical
partially O
blocked O
the O
binding O
of O
gp160 B-protein-complex
to O
calreticulin B-protein
and O
calnexin B-protein-family
, O
whereas O
1-deoxynojirimycin B-chemical
had O
little O
inhibitory O
effect O
. O

  O
( O
A) O
, O
Annexin B-protein
V I-protein
binding O
by O
FACS B-assay
analysis O
( O
apoptotic O
cells O
as O
a O
%-age O
of O
control O
) O
( O
B) O
, O
and O
DNA B-DNA
cleavage O
( O
laddering O
) O
( O
C) O
. O

The O
ubiquitous O
expression O
of O
Tctex-1 B-protein
suggests O
that O
it O
may O
bind O
to O
additional O
cytoplasmic O
dynein B-protein-family
cargo O
molecules O
or O
receptors O
other O
than O
rhodopsin B-protein-family
. O

We O
previously O
determined O
that O
the O
flanking O
A O
nucleotides O
of O
the O
AUUUA B-RNA
motifs O
in O
the O
TNFα B-protein
ARE B-RNA
were O
essential O
for O
binding O
of O
TTP B-protein
to O
the O
TNFα O
ARE O
( O
11) O
. O

All O
of O
these O
results O
and O
our O
results O
are O
convergent O
with O
those O
of O
recent O
studies O
reporting O
that O
dynamin B-protein-family
directly O
binds O
regulatory O
components O
of O
the O
actin B-protein-family
cytoskeleton O
, O
such O
as O
profilin B-protein-family
( O
26) O
, O
proteins O
of O
the O
syndapin/pacsin/FAP52 protein
family O
( O
27-29) O
, O
and O
cortactin B-protein
( O
30) O
. O

The O
results O
show O
that O
insulin B-protein
induces O
an O
approximate O
2-fold O
increase O
in O
the O
amount O
of O
GTP B-chemical
bound O
Ras B-protein-family
and O
Rheb B-protein
( O
Figure O
2A) O
, O
with O
the O
fold O
increase O
in O
GTP O
bound O
Rheb O
being O
1 O
. O
8 O
± O
0 O
. O
11 O
SEM O
, O
averaged O
over O
three O
independent O
experiments O
. O

  O
Here O
we O
report O
that O
SRF B-protein
binds O
to O
another O
myogenic O
factor O
, O
TEF-1 B-protein
, O
that O
has O
been O
implicated O
in O
the O
regulation O
of O
a O
variety O
of O
cardiac O
muscle O
genes O
. O

MEP50 B-protein
binds O
a O
subset O
of O
the O
Sm B-protein-family
proteins O
. O

We O
find O
that O
the O
fourth O
repeat O
is O
necessary O
for O
the O
F-actin protein-family
binding O
activity O
of O
cortactin B-protein
and O
that O
the O
NTA B-protein-region
region O
binds O
directly O
to O
the O
Arp2/3 B-protein-complex
complex O
. O

  O
Also O
, O
uptake O
into O
these O
tubules O
occurs O
through O
the O
LDL B-protein-family
receptor I-protein-family
that O
binds O
the O
multivalent O
apolipoprotein B-protein
E I-protein
component O
of O
beta-VLDL B-protein-complex
( O
30) O
. O

  O
On O
the O
other O
hand O
, O
fascin B-protein-family
inhibits O
actin B-protein
binding O
of O
cultured O
cell O
TM B-protein-family
, O
when O
caldesmon B-protein
is O
absent O
. O

Amphiphysin B-protein
1 I-protein
can O
bind O
simultaneously O
to O
dynamin B-protein-family
and O
either O
clathrin B-protein
or O
AP-2 B-protein-complex
. O

  O
With O
100 O
to O
200 O
M O
H2O2 B-reagent
, O
the O
BSO-treated reagent
AD B-cell
cybrids I-cell
had O
HSF-1 B-protein
DNA B-DNA
binding O
activity O
equivalent O
to O
the O
AD O
cybrids O
that O
were O
not O
depleted O
of O
glutathione B-chemical
. O

1 O
) O
We O
have O
demonstrated O
that O
tropomyosin B-protein-family
and O
troponin B-protein-complex
are O
actually O
bound O
to O
the O
actin B-protein
filaments O
at O
motility O
assay O
conditions O
. O

Thioredoxin B-protein
binds O
to O
T7 B-cell
DNA B-DNA
polymerase O
and O
potentially O
causes O
a O
closure O
of O
the O
complex O
around O
DNA O
( O
28) O
. O

( O
C O
) O
Binding O
of O
n-sec1 B-protein
to O
syntaxin B-protein
1a I-protein
in O
the O
presence O
of O
1 O
mM O
S-NC B-chemical
. O

  O
Therefore O
, O
the O
DERK B-protein
binding O
ability O
of O
DMKP-3 B-protein
, O
which O
involved O
DERK O
sequestration O
within O
the O
cytosol O
, O
is O
essential O
to O
inhibit O
insulin-stimulated protein
cell O
proliferation O
. O

  O
Daam1 B-protein
exhibits O
little O
, O
if O
any O
, O
binding O
to O
Rac B-protein-family
or O
Cdc42 B-protein
, O
whereas O
PAK B-protein-family
( O
p21 B-protein-family
activated I-protein-family
kinase I-protein-family
) O
binds O
to O
either O
GTP-loaded chemical
Rac O
or O
Cdc42 O
, O
but O
not O
Rho B-protein-family
( O
Figure O
2F) O
. O

Cortactin B-protein
binds O
Arp2/3 B-protein-complex
complex O
with O
micromolar O
affinity O
( O
27A O
) O
and O
activates O
nucleation O
through O
Arp2/3 O
complex O
( O
27B O
, O
27C) O
, O
although O
maximal O
activation O
is O
weak O
compared O
to O
WASp/Scar B-protein
WA B-protein-domain
. O

  O
The O
more O
widely O
used O
PKC B-protein-family
inhibitor O
, O
H-7 B-chemical
, O
which O
interferes O
with O
ATP B-chemical
binding O
to O
PKC O
, O
31 O
also O
suppresses O
proliferation O
of O
HEC B-cell
induced O
by O
bFGF B-protein
; O
an O
H-7 O
concentration O
of O
26 O
mumol/L O
produces O
half-maximal O
inhibition O
( O
Fig O
3 O
) O
. O

  O
Furthermore O
, O
binding O
of O
Smad3 B-protein
to O
CBP B-protein-family
was O
direct O
, O
as O
purified O
GST-CBP1891-2175 B-experimental-construct
, O
but O
not O
GST O
, O
interacted O
with O
bacterially O
expressed O
, O
purified O
Smad3210-425 B-protein-region
( O
Fig O
. O
2D) O
. O

  O
Baker O
et O
al O
. O
( O
Baker O
et O
al O
. O
, O
2001 O
) O
show O
in O
vitro O
experiments O
in O
which O
MAE B-protein
binding O
to O
PNT-P2 B-protein-isoform
leads O
to O
activation O
of O
transcription O
, O
and O
assume O
that O
this O
occurs O
via O
MAE O
promoting O
MAPK B-protein-family
phosphorylation O
, O
and O
hence O
activation O
, O
of O
PNT-P2 O
. O

  O
Profilin B-protein-family
binds O
actin B-protein
monomers O
and O
appears O
to O
regulate O
microfilament O
assembly O
( O
Schluter O
et O
al O
. O
, O
1997) O
. O

Briefly O
, O
GST B-experiment-tag
or O
GST-dFMR1 experiment-tag
( O
2 O
μg O
) O
bound O
to O
30 O
μl O
of O
glutathione-Sepharose B-reagent
4B I-reagent
resin I-reagent
( O
Pharmacia O
) O
was O
incubated O
with O
5 O
μl O
of O
the O
in O
vitro-translated O
proteins O
in O
500 O
μl O
of O
binding O
buffer O
( O
50 O
mM O
Tris-HCl B-reagent
[ O
pH O
7 O
. O
5] O
, O
200 O
mM O
NaCl B-reagent
, O
2 O
mM O
EDTA B-reagent
, O
0 O
. O
1% O
NP-40 B-chemical
, O
1 O
μg O
of O
leupeptin/ml chemical
, O
1 O
μg O
of O
pepstatin -
A/ml -
, O
0 O
. O
5% O
aprotinin) chemical
. O

  O
To O
test O
this O
hypothesis O
, O
we O
have O
examined O
the O
interaction O
of O
Arp1 B-protein
with O
the O
Golgi-associated B-protein-isoform
betaIII I-protein-isoform
isoform O
of O
spectrin B-protein-family
and O
demonstrated O
that O
Arp1 O
binds O
directly O
to O
betaIII B-protein-isoform
spectrin I-protein-isoform
. O

  O
Immunoblotting O
with O
rabbit O
anti-human O
galectin-1 B-protein
polyclonal O
antibody O
revealed O
the O
58-kDa O
Dmgal B-protein
band O
( O
Fig O
. O
3 O
D O
, O
lanes O
6 O
and O
7) O
, O
demonstrating O
that O
native O
Dmgal O
binds O
beta-lactose B-chemical
. O

The O
implication O
was O
that O
negative O
charge O
at O
the O
PKA B-protein-complex
site O
enhances O
recognition O
of O
the O
Dorsal B-protein-region
NLS I-protein-region
by O
the O
importin B-protein-complex
complex O
, O
and O
that O
the O
PKA O
site O
may O
be O
directly O
involved O
in O
NLS O
binding O
by O
importin O
. O

The O
reason O
for O
the O
lower O
species O
shift O
may O
be O
that O
inhibition O
of O
binding O
between O
Sp1 B-protein
and O
Ets-1 B-protein
induces O
instability O
of O
Ets-1-binding O
to O
the O
-64/-44 B-DNA
probe I-DNA
. O

  O
In O
contrast O
to O
the O
model O
previously O
proposed O
( O
44) O
, O
however O
, O
we O
found O
that O
paxillin B-protein
alpha O
could O
bind O
directly O
to O
PAK3 B-protein
. O

Bni1p B-protein
binds O
to O
the O
actin-binding protein
proteins O
, O
Bud6p B-protein
and O
profilin B-protein-family
( O
Evangelista O
et O
al O
. O
, O
1997 O
; O
Imamura O
et O
al O
. O
, O
1997 O
) O
and O
is O
a O
target O
of O
the O
rho-related B-protein-family
GTPases I-protein-family
, O
Cdc42p B-protein
and O
Rho1p B-protein
( O
Kohno O
et O
al O
. O
, O
1996 O
; O
Evangelista O
et O
al O
. O
, O
1997 O
; O
Imamura O
et O
al O
. O
, O
1997) O
. O

  O
Other O
myosins B-protein-family
bind O
actin B-protein
in O
the O
presence O
of O
ATP B-chemical
with O
equilibrium O
dissociation O
constants O
<50 O
muM O
at O
low O
ionic O
strength O
conditions O
( O
36 O
, O
37) O
, O
whereas O
myo1eIQ B-protein-motif
clearly O
binds O
with O
a O
dissociation O
constant O
> O
50 O
muM O
( O
Fig O
. O
2) O
. O

This O
is O
consistent O
with O
the O
greater O
inhibitory O
effect O
of O
SR1 B-protein
on O
FGF2-induced protein
proliferation O
and O
FGF2 O
binding O
in O
RPE B-cell
cells O
and O
is O
consistent O
with O
previous O
work O
showing O
that O
the O
human O
soluble O
receptor O
preferentially O
binds O
FGF2 O
over O
FGF1 B-protein
( O
Duan O
et O
al O
. O

  O
Complicating O
such O
studies O
is O
the O
fact O
that O
, O
in O
many O
perinatal O
rodents O
, O
E2 B-chemical
is O
much O
less O
potent O
than O
DES B-chemical
as O
an O
estrogen B-chemical
due O
to O
high O
serum O
concentrations O
of O
alpha-fetoprotein B-protein
( O
AFP) protein
, O
which O
binds O
E2 O
but O
not O
DES O
with O
high O
affinity O
[ O
17] O
. O

  O
The O
dissociation O
equilibrium O
constant O
( O
Kd O
) O
for O
profilin B-protein-family
binding O
actin B-protein
was O
determined O
from O
the O
dependence O
of O
k O
1 O
on O
profilin O
concentration O
( O
Figure O
5 O
, O
A O
and O
B) O
. O

Cdc20 B-protein
also O
binds O
to O
the O
APC B-protein-complex
and O
presumably O
activates O
Pds1 B-protein
ubiquitination O
. O

Because O
HSP47 B-protein
binds O
in O
vitro O
to O
various O
types O
of O
collagen B-protein-family
( O
at O
least O
types O
I-V O
; O
Ref O
. O
4) O
, O
as O
well O
as O
to O
collagen-like B-protein-family
proteins I-protein-family
such O
as O
C1q B-protein-complex
, O
3 O
it O
appears O
that O
HSP47 O
may O
function O
through O
specific O
binding O
to O
the O
helix-forming O
portions O
of O
procollagen B-protein
. O

These O
results O
indicate O
that O
direct O
cooperative O
interactions O
between O
RAP1 B-protein
and O
GCN4 B-protein
at O
the O
HIS4 B-protein
promoter O
are O
very O
unlikely O
and O
support O
the O
idea O
that O
RAP1 O
binding O
to O
the O
HIS4 O
promoter O
facilitates O
GCN4 O
binding O
by O
overcoming O
the O
repressive O
effect O
of O
chromatin O
. O

The O
intersection O
of O
the O
fit O
lines O
on O
the O
1/velocity O
axis O
, O
K O
is O
= O
25 O
± O
10 O
nM O
, O
suggests O
that O
GC-boxbMET B-DNA
and O
AdoMet B-chemical
bind O
competitively O
to O
the O
same O
poly(dI -
. -
dC)-bound -
form O
of O
the O
enzyme O
but O
not O
necessarily O
to O
the O
same O
site O
on O
the O
enzyme O
. O

  O
In O
a O
similar O
manner O
, O
the O
binding O
of O
MEIS1 B-protein
to O
HOXA9 B-protein
was O
increased O
fivefold O
in O
the O
presence O
of O
PBX2 B-protein
( O
compare O
lane O
15 O
with O
lane O
14) O
. O

PSD-95 B-protein
binds O
to O
neuroligins B-protein-family
via O
its O
third O
PDZ B-protein-domain
domain O
and O
recruits O
to O
the O
junction O
NMDA2 B-protein-family
receptors I-protein-family
and O
K+ B-chemical
channels O
that O
bind O
to O
the O
other O
PDZ O
domains O
. O

  O
However O
, O
GSK-3beta B-protein
does O
not O
bind O
directly O
to O
beta-catenin B-protein-family
, O
and O
efficient O
in O
vitro O
phosphorylation O
of O
beta-catenin O
by O
GSK-3beta O
requires O
the O
presence O
of O
Axin B-protein
, O
which O
binds O
both O
proteins O
( O
Ikeda O
et O
al O
. O
1998 O
) O
. O

Electrophoretic O
mobility O
shift O
assays O
with O
in O
vitro O
transcribed O
and O
translated O
ARNT B-protein
and O
EPAS1 B-protein
binding O
to O
the O
HIF1-binding protein
site O
were O
performed O
as O
described O
( O
28) O
. O

  O
Although O
Arg B-protein
binding O
to O
F-actin B-protein
saturates O
at O
a O
ratio O
of O
one O
Arg/two O
actin O
molecules O
, O
Arg688-1182 B-protein-region
seems O
to O
bind O
to O
F-actin O
at O
a O
much O
lower O
density O
of O
approximately O
one O
Arg688-1182/five O
actin O
molecules O
. O

  O
While O
the O
central O
region O
of O
s-synaphin B-protein
bound O
to O
syntaxin B-protein-family
, O
no O
binding O
was O
detected O
to O
the O
NH2- O
or O
COOH-terminal O
constructs O
( O
Figure O
2C) O
. O

BMP-7 B-protein
binding O
to O
ROS B-cell
17/2 I-cell
. O

This O
fragment O
of O
eIF4G B-protein
binds O
both O
eIF4E B-protein
and O
eIF4A B-protein
and O
probably O
coordinates O
their O
activities O
so O
that O
a O
cap-proximal O
region O
of O
mRNA B-RNA
is O
unwound O
and O
is O
thus O
rendered O
accessible O
to O
an O
incoming O
43S B-protein-complex
complex I-protein-complex
so O
it O
can O
bind O
productively O
. O

However O
, O
our O
current O
results O
clearly O
suggest O
that O
the O
previously O
reported O
ANG B-peptide
II I-peptide
stimulation O
of O
TGF-β1 B-gene
transcription O
in O
MCT B-cell
cells O
is O
rather O
inhibited O
by O
concomitant O
induction O
of O
oxygen B-chemical
radicals I-chemical
and O
may O
involve O
transcription O
factors O
other O
than O
the O
Sp1 B-protein
binding O
sequence O
in O
the O
TGF-β1 gene
enhancer/promoter DNA
. O

As O
expected O
, O
binding O
of O
ORC B-protein-complex
to O
hamster O
metaphase O
chromatin O
incubated O
in O
Xenopus O
egg O
extract O
preceded O
binding O
of O
Mcm B-protein-family
proteins O
, O
and O
binding O
of O
Mcm O
proteins O
preceded O
binding O
of O
proliferating B-protein
cell I-protein
nuclear I-protein
antigen I-protein
( O
PCNA) protein
, O
which O
was O
accompanied O
by O
DNA B-DNA
replication O
( O
Figure O
4A O
and O
B) O
. O

  O
We O
suggest O
that O
PHO B-protein
binds O
to O
PREs B-DNA
and O
, O
in O
conjunction O
with O
other O
unidentified O
DNA B-DNA
binding O
proteins O
, O
recruits O
PcG B-protein-complex
proteins I-protein-complex
to O
the O
DNA O
. O

We O
may O
conclude O
that O
GAGA B-protein
factor I-protein
binds O
to O
( B-DNA
CT)n I-DNA
repeats I-DNA
independently O
of O
TBP B-protein
binding O
and O
facilitates O
binding O
of O
the O
latter O
directly O
or O
indirectly O
. O

  O
U2AF65 B-protein
binds O
directly O
to O
Py B-DNA
tracts I-DNA
( O
41) O
, O
while O
U2AF35 B-protein
is O
tethered O
to O
the O
pre-mRNA B-RNA
through O
its O
interaction O
with O
U2AF65 O
( O
42) O
. O

  O
In O
mammals O
, O
however O
, O
there O
has O
been O
no O
evidence O
that O
eIF4G B-protein
binds O
PABP B-protein
. O

  O
According O
to O
crystallographic O
studies O
of O
a O
PD B-protein-domain
bound O
to O
a O
PAX6 B-DNA
consensus I-DNA
binding I-DNA
site I-DNA
, O
neither O
of O
these O
mutations O
is O
involved O
in O
direct O
DNA B-DNA
contact O
( O
23) O
. O

  O
It O
was O
also O
shown O
that O
the O
GST-A experiment-tag
box -
of O
HMG-1 B-protein
was O
able O
to O
pull O
down O
TFIID B-protein
in O
crude O
HeLa B-cell
extract O
, O
suggesting O
that O
HMG-1 O
binds O
to O
TBP B-protein
and/or O
other O
TFIID O
components O
( O
41) O
. O

We O
also O
attempted O
to O
examine O
the O
actin-binding protein
ability O
of O
partially O
phosphorylated O
F-rad B-protein
. O

The O
inhibition O
of O
the O
binding O
of O
c-Myc B-protein
to O
Max B-protein
is O
the O
first O
case O
in O
which O
p202a B-protein
was O
found O
to O
inhibit O
the O
dimerization O
of O
transcription O
factors O
( O
Fig O
. O
5) O
. O

The O
relatively O
high O
affinity O
of O
eIF4G B-protein
binding O
to O
eIF4E B-protein
ensures O
that O
the O
latter O
binds O
to O
the O
5 B-RNA
' I-RNA
cap I-RNA
almost O
exclusively O
as O
part O
of O
the O
eIF4F B-protein-complex
complex O
. O

Attempts O
to O
purify O
shM B-protein
from O
the O
mixture O
of O
scallop O
myosin B-protein-complex
, O
shM O
, O
and O
rods B-protein-complex
by O
binding O
of O
shM O
and O
myosin O
to O
filamentous B-protein
actin I-protein
, O
coupled O
with O
selective O
displacement O
of O
shM O
, O
according O
to O
the O
method O
developed O
by O
Cooke O
and O
Franks O
( O
21) O
, O
were O
unsuccessful O
, O
because O
the O
procedure O
inactivated O
the O
ATPase B-protein-family
activity O
of O
scallop O
actomyosin B-protein-complex
and O
acto-shM B-protein-complex
. O

Ile174 O
and O
Val177 O
may O
play O
a O
supportive O
role O
in O
arrestin B-protein-family
interaction O
with O
phosphorylated B-protein
rhodopsin I-protein
because O
full-length O
arrestin O
binding O
to O
P-Rh B-protein
and O
arrestin(1–191 O
) O
binding O
to O
P-Rh* B-protein
are O
decreased O
by O
the O
I174A O
and O
V177A O
mutations O
. O

These O
observations O
suggest O
that O
the O
amino-terminal O
domain O
regulates O
PI B-protein-domain
binding O
to O
APP B-protein
and O
that O
the O
carboxyl-terminal O
domain O
containing O
PDZ B-protein-motif
motifs O
is O
essential O
to O
modulate O
APP O
processing O
. O

To O
address O
the O
relative O
contributions O
of O
[ B-experiment-tag
3H]BTA-1 I-experiment-tag
binding O
to O
Aβ B-protein
and O
tau B-protein-family
deposits O
in O
the O
frontal O
gray O
of O
AD B-disease
brain O
we O
compared O
[ O
3H]BTA-1 O
binding O
in O
homogenates O
from O
entorhinal O
cortex O
, O
frontal O
gray O
, O
and O
cerebellum O
from O
a O
typical O
Braak O
stage O
VI O
AD O
brain O
( O
Table O
1 O
, O
AD O
01 O
) O
and O
a O
Braak O
stage O
II O
control O
brain O
( O
Table O
1 O
, O
Cntl O
04) O
, O
matched O
for O
age O
and O
postmortem O
interval O
. O

  O
Rho-kinase B-protein-family
and O
the O
myosin-binding protein-complex
subunit O
of O
myosin B-protein-family
phosphatase I-protein-family
, O
two O
downstream O
targets O
of O
Rho O
, O
interact O
with O
ERM B-protein-family
proteins O
and O
myosin B-protein-family
light I-protein-family
chain I-protein-family
( O
MLC) protein-family
, O
resulting O
in O
their O
phosphorylation O
. O

A O
potential O
mechanism O
by O
which O
CBP B-protein
repressed O
TCF-mediated protein-family
transcription O
of O
Ubx B-gene
was O
that O
CBP-mediated O
acetylation O
of O
TCF O
decreased O
the O
affinity O
of O
TCF O
' O
s O
binding O
to O
Armadillo B-protein-motif
. O

Though O
PAK B-protein-family
binds O
to O
activated O
Rac1 B-protein
, O
recent O
investigations O
demonstrated O
that O
the O
activity O
of O
the O
PAK B-protein-family
kinase I-protein-family
is O
not O
correlated O
with O
the O
cytoskeletal O
rearrangements O
induced O
by O
Rac1 O
( O
Joneson O
et O
al O
. O
, O
1996 O
; O
Lamarche O
et O
al O
. O
, O
1996 O
; O
Sells O
et O
al O
. O
, O
1997 O
) O
and O
rather O
is O
linked O
to O
the O
activation O
of O
JNK B-protein
( O
Bagrodia O
et O
al O
. O
, O
1995) O
, O
supporting O
the O
proposed O
signalling O
pathway O
( O
Figure O
7) O
. O

  O
mAb B-reagent
1 I-reagent
inhibited O
the O
binding O
of O
DREF B-protein
to O
DRE-P B-DNA
, O
and O
mAb B-reagent
4 I-reagent
supershifted O
the O
band O
with O
DRE-P O
( O
20 O
, O
28 O
) O
( O
Fig O
. O
5 O
C O
, O
lanes O
10-12) O
. O

  O
We O
have O
found O
that O
both O
Axin B-protein
and O
Axil B-protein
bind O
not O
only O
to O
GSK-3beta B-protein
but O
also O
to O
beta-catenin B-protein-family
and O
that O
they O
promote O
GSK-3beta-dependent O
phosphorylation O
of O
beta-catenin O
( O
11 O
, O
12) O
. O

The O
WD-40 B-protein-region
repeats I-protein-region
have O
a O
self-inhibitory O
effect O
on O
the O
rest O
of O
the O
protein O
, O
and O
binding O
of O
dATP B-chemical
and O
cytochrome B-protein
c I-protein
to O
Apaf-1 B-protein
antagonizes O
this O
inhibitory O
effect O
and O
allows O
Apaf-1 O
self-aggregation O
as O
well O
as O
Apaf-1 O
binding O
to O
procaspase-9 B-protein
( O
124 O
, O
193 O
, O
269 O
) O
( O
Fig O
. O
​(Fig O
. O
6A) O
. O
6A) O
. O

  O
The O
presentation O
is O
based O
on O
the O
binding O
data O
of O
fH B-protein
for O
C3b B-protein
, O
C3c B-protein
, O
and O
C3d B-protein
shown O
in O
Figs O
. O
4 O
and O
6 O
. O

BRG1 B-protein
binds O
to O
HP1alpha B-protein
in O
vitro O
inding O
assays O
between O
BRG1 O
and O
HP1alpha O
were O
performed O
in O
vitro O
. O

Crk B-protein
Binding O
to O
CAS B-protein-family
Is O
Required O
for O
the O
Induction O
of O
Cell O
Migration O

In O
support O
of O
these O
results O
, O
biochemical O
studies O
have O
shown O
that O
both O
STNA B-protein
and O
STNB B-protein
bind O
to O
the O
C2B B-protein-domain
domain O
of O
Syt B-protein
, O
STNB O
through O
its O
region O
of O
homology O
with O
AP50 B-protein
and O
STNA O
through O
its O
N O
terminal O
250 O
residues O
( O
L O
. O
Kelly O
, O
personal O
communication O
) O
( O
Stimson O
et O
al O
. O
, O
1998) O
. O

  O
Interaction O
between O
Eps15 B-protein
and O
the O
EGF B-protein
receptor I-protein
has O
not O
been O
detected O
, O
but O
Eps15 O
does O
bind O
AP2 B-protein-complex
. O

Phosphorylation O
events O
are O
important O
for O
the O
regulation O
of O
Sp1 B-protein
binding O
to O
the O
NRE B-DNA
site I-DNA
. O

  O
Binding O
of O
PIP2 B-chemical
to O
vinculin B-protein
unfolds O
the O
inactive O
molecule O
and O
exposes O
binding O
sites O
for O
talin B-protein
and O
alpha-actinin B-protein-family
in O
the O
head O
domain O
and O
for O
VASP B-protein
in O
the O
tail O
domain O
( O
Gilmore O
and O
Burridge O
, O
1996 O
; O
Huttelmaier O
et O
al O
. O
, O
1999) O
. O

  O
Myopodin B-protein
( O
Fig O
. O
6 O
, O
a O
and O
b O
) O
and O
synaptopodin B-protein
( O
unpublished O
data O
) O
directly O
bind O
to O
actin B-protein
. O

Although O
HOXD4 B-protein
showed O
stable O
binding O
to O
T6 B-protein
in O
our O
hands O
( O
Table O
I) O
, O
poor O
T6 O
binding O
was O
reported O
for O
its O
paralog O
, O
HOXB4 B-protein
. O

Bandshift O
experiments O
showed O
that O
a O
fraction O
of O
complexes O
containing O
cyclin B-protein-family
E I-protein-family
, O
cdk2 B-protein
and O
p130 B-protein
were O
bound O
to O
E2F B-protein-family
proteins I-protein-family
in O
serum-starved O
p27-/- O
MycER B-cell
cells O
, O
whereas O
no O
cyclin B-protein-complex
E-cdk2-p130-E2F I-protein-complex
complexes O
were O
detectable O
in O
serum-starved O
p27+/+ O
MycER O
cells O
( O
not O
shown) O
. O

  O
In O
addition O
, O
it O
has O
been O
proposed O
that O
TOY B-protein
and O
EY B-protein
diverged O
to O
regulate O
different O
sets O
of O
target O
genes O
because O
of O
a O
N14G B-mutation
mutation O
that O
changes O
the O
DNA B-DNA
binding O
specificity O
of O
the O
PD B-protein-domain
domain O
of O
ey B-protein
( O
Czerny O
et O
al O
. O
, O
1999 O
) O
. O

  O
Since O
Smad2 B-protein
and O
Smad4 B-protein
synergize O
with O
FAST2 B-protein
to O
induce O
the O
gsc B-DNA
promoter I-DNA
, O
we O
sought O
to O
determine O
whether O
FAST2 O
binds O
directly O
to O
the O
gsc B-DNA
element I-DNA
and O
whether O
it O
supports O
formation O
of O
a O
DNA-binding DNA
complex O
with O
Smads B-protein-family
. O

On O
the O
basis O
of O
averaging O
the O
results O
of O
three O
to O
five O
independent O
experiments O
in O
each O
case O
, O
the O
concentration O
of O
competitor O
required O
to O
reduce O
binding O
of O
BLM B-protein
to O
the O
X-junction B-DNA
DNA I-DNA
to O
50% O
of O
control O
values O
was O
as O
follows O
. O

A O
single O
amino-acid O
substitution O
in O
the O
Ets B-protein-domain
domain O
alters O
core O
DNA B-DNA
binding O
specificity O
of O
Ets1 B-protein
to O
that O
of O
the O
related O
transcription O
factors O
Elf1 B-protein
and O
E74 B-protein
. O

Binding O
of O
in O
vitro O
synthesized O
HOX B-protein-family
and O
PBX1b B-protein
to O
the O
PPE B-DNA
. O

  O
GST-GR experiment-tag
does O
not O
bind O
the O
purified O
TPR B-protein-domain
domain O
fragment O
of O
PP5 B-protein
, O
and O
the O
PP5 O
TPR O
domain O
does O
not O
compete O
for O
the O
binding O
of O
FKBP52 B-protein
to O
GST-GR O
( O
data O
not O
shown O
) O
under O
conditions O
in O
which O
it O
blocks O
FKBP52 O
binding O
to O
hsp90 B-protein
( O
33) O
. O

Characterization O
the O
nuclear O
proteins O
that O
bind O
to O
the O
PRE B-DNA
site I-DNA
of O
the O
aurora B-gene
A I-gene
gene O
. O

  O
This O
sequence O
shares O
similarity O
with O
the O
RII B-protein-domain
binding O
regions O
of O
AKAP B-protein
150 I-protein
, O
Ht B-protein
31 I-protein
, O
and O
MAP B-protein
2 I-protein
( O
14 O
, O
32 O
, O
34 O
, O
35 O
) O
. O

The O
histone O
deacetylase O
activity O
of O
Sir2 B-protein
is O
required O
for O
stable O
binding O
of O
Sir2 O
and O
Sir3 B-protein
at O
70 O
bp O
( O
Fig O
. O
2) O
. O

  O
However O
, O
because O
binding O
of O
TPR B-protein-family
proteins I-protein-family
to O
the O
TPR B-protein-domain
binding I-protein-domain
site I-protein-domain
on O
hsp90 B-protein
is O
a O
reversible O
process O
, O
over O
time O
, O
a O
single O
receptor O
. O

We O
then O
compared O
binding O
of O
PAX4 B-protein
and O
PAX6 B-protein
to O
the O
same O
oligonucleotide O
probes O
. O

  O
Regulation O
of O
the O
GTPase B-protein-family
activity O
of O
Ras B-protein-family
is O
crucial O
, O
because O
only O
the O
GTP-bound chemical
form O
of O
Ras O
is O
active O
. O

[ O
In O
new O
window O
] O
We O
next O
tested O
whether O
the O
upstream O
CU B-DNA
elements I-DNA
affected O
PTB B-protein
binding O
to O
the O
downstream O
CU O
elements O
. O

  O
NF-1 B-protein
was O
detected O
as O
described O
for O
panel O
B O
. O
( O
D O
) O
GR B-protein
and O
hSwi/Snf B-protein-complex
facilitation O
of O
binding O
of O
NF-1 O
to O
MMTV B-cell
chromatin O
. O

alpha-NAC B-protein
stabilizes O
the O
binding O
of O
the O
c-Jun B-protein-complex
homodimer I-protein-complex
to O
the O
AP-1 B-protein-complex
site O
. O

  O
Residues O
implicated O
in O
catalysis O
are O
marked O
with O
asterisks O
, O
and O
Lys101 O
involved O
in O
binding O
of O
ATP B-chemical
and O
CoA B-chemical
is O
marked O
with O
a O
triangle O
. O

We O
initially O
focused O
on O
the O
P-site B-protein-domain
because O
of O
its O
similarity O
to O
the O
PCNA B-protein
binding O
motif O
found O
in O
a O
number O
of O
proteins O
from O
diverse O
organisms O
and O
considered O
the O
possibility O
that O
the O
P-site O
might O
mediate O
Rad3p B-protein
binding O
to O
PCNA O
, O
the O
processivity O
factor O
for O
DNA B-DNA
polymerases O
. O

  O
Hence O
, O
it O
can O
be O
predicted O
that O
BAG4 B-protein
binds O
Hsc70 B-protein
in O
a O
manner O
analogous O
to O
BAG1 B-protein
( O
3 O
, O
15) O
. O

  O
Several O
TRP B-protein-family
channels I-protein-family
bind O
to O
calmodulin B-protein
[ O
16 O
] O
, O
raising O
the O
question O
as O
to O
whether O
activation O
of O
TRPM5 B-protein
by O
Ca2+ B-chemical
occurs O
through O
calmodulin O
. O

  O
The O
corepressor O
protein O
CtBP B-protein
, O
the O
PcG B-protein-family
proteins O
HPC2 B-protein
and O
BMI-1 B-protein
, O
and O
HDAC1 B-protein
( O
or O
HDAC2 B-protein
) O
bind O
to O
the O
MLL B-protein-domain
repression I-protein-domain
domain I-protein-domain
. O

  O
As O
shown O
in O
Figure O
8B O
, O
the O
32P O
label O
was O
gradually O
lost O
during O
incubation O
, O
suggesting O
that O
the O
ATP B-chemical
bound O
to O
actin B-protein
was O
hydrolyzed O
, O
most O
likely O
by O
the O
ATPase B-protein-family
activity O
of O
actin O
itself O
. O

Based O
on O
a O
sequence O
comparison O
between O
IP4-sensitive chemical
and O
-insensitive O
isoforms O
( O
Figs O
. O
3 O
and O
4 O
A O
) O
and O
deletion O
or O
mutational O
analysis O
of O
synaptotagmin B-protein-family
III B-protein
( O
Figs O
. O
4 O
and O
5) O
, O
we O
propose O
that O
the O
primitive O
form O
of O
synaptotagmin O
originally O
bound O
IP4 O
and O
that O
, O
during O
the O
diversification O
of O
synaptotagmin O
in O
vertebrates O
, O
some O
isoforms O
( O
III O
, O
V B-protein
, O
and O
X B-protein
) O
lost O
their O
IP4 O
binding O
activity O
as O
a O
consequence O
of O
several O
amino O
acid O
substitutions O
mainly O
in O
the O
C-terminal O
region O
of O
the O
C2B B-protein-domain
domain I-protein-domain
, O
but O
not O
in O
the O
putative O
IP4-binding O
site O
itself O
. O

NES B-protein-region
sequences O
bind O
to O
CRM1 B-protein
with O
different O
affinities O
. O

  O
However O
, O
this O
mutation O
abolished O
both O
the O
binding O
of O
soluble O
DI B-protein-domain
to O
DII-III B-protein-domain
in O
the O
presence O
of O
scuPA B-protein
and O
the O
synergistic O
activation O
of O
scuPA O
mediated O
by O
DI O
and O
wild O
type O
DII-DIII O
. O

Electrophoretic O
mobility O
shift O
assay O
of O
HMG-D B-protein
binding O
to O
the O
TAR B-RNA
RNA I-RNA
at O
( O
A O
) O
20°C O
or O
( O
B O
) O
4°C O
. O

  O
Pontin52 B-protein
binds O
beta-catenin B-protein-family
in O
the O
region O
of O
Armadillo B-protein-region
repeats I-protein-region
2-5 O
and O
, O
more O
importantly O
, O
also O
binds O
the O
TATA B-DNA
box I-DNA
binding O
protein O
. O

  O
Also O
, O
we O
have O
been O
unable O
to O
observe O
consistent O
binding O
between O
Armadillo B-protein-motif
and O
Tsh B-protein
in O
vitro O
( O
unpublished O
results) O
, O
which O
suggests O
that O
the O
interaction O
between O
the O
two O
proteins O
would O
not O
be O
strong O
enough O
to O
account O
for O
Tsh O
recruitment O
. O

These O
experiments O
suggest O
that O
RBP B-protein-family
binds O
either O
Notch B-protein-family
or O
SHARP B-protein
exclusively O
. O

Disintegrin B-peptide
peptides O
from O
snake O
venom O
are O
known O
to O
bind O
to O
platelet O
integrin B-protein-complex
αIIbβ3 I-protein-complex
( O
GP B-protein-complex
IIb/IIIa I-protein-complex
) O
and O
prevent O
binding O
of O
fibrinogen B-protein-complex
and O
subsequent O
clotting O
( O
Adler O
et O
al O
. O
, O
1991 O
; O
Beer O
et O
al O
. O
, O
1992) O
. O

Like O
VP16 B-protein
, O
ZF B-protein
binds O
to O
HCF B-protein-family
but O
not O
to O
the O
mutant O
HCF(P134S) B-protein
, O
as O
determined O
by O
GST B-experiment-tag
pull-down O
assay O
( O
A O
and O
B O
) O
and O
by O
mammalian O
two-hybrid O
assay O
( O
C) O
. O

Numerous O
putative O
Rho B-protein-family
effectors I-protein-family
have O
been O
identified O
; O
PKN1 B-protein
( O
4 O
, O
5) O
, O
Rho-kinase/ROKα/ROCK protein
II -
( O
6-8) O
, O
myosin-binding protein-complex
subunit O
of O
myosin B-protein-family
phosphatase I-protein-family
( O
9) O
, O
mDia1 B-protein
( O
10) O
, O
citron B-protein
( O
11) O
, O
citron B-protein
kinase I-protein
( O
12) O
, O
rhophilin B-protein
, O
rhotekin B-protein
( O
11) O
, O
Kv1 O
. O
2 O
( O
13) O
, O
and O
phospholipase B-protein-family
D I-protein-family
( O
14) O
. O

Reconstitution O
of O
the O
binding O
of O
alpha-actinin B-protein-family
to O
VPMs B-organelle
in O
the O
presence O
of O
actin B-protein
stress O
fibers O
. O

  O
Consistent O
with O
this O
, O
both O
the O
wild-type O
and O
S101A B-protein
mutant I-protein
4E-BP1 I-protein
proteins O
were O
released O
from O
eIF4E B-protein
in O
response O
to O
insulin B-protein
, O
allowing O
insulin O
to O
promote O
assembly O
of O
eIF4F B-protein-complex
complexes O
, O
observed O
as O
increased O
binding O
of O
eIF4G B-protein
to O
eIF4E O
( O
Fig O
. O
2D) O
. O

Consistent O
with O
this O
idea O
, O
we O
have O
observed O
that O
in O
the O
presence O
of O
EXD B-protein
and O
the O
appropriate O
HOX B-protein-family
protein O
, O
HTH B-protein-motif
can O
bind O
some O
EXD-HOX B-protein-complex
binding O
sites O
, O
but O
not O
others O
( O
our O
unpublished O
data) O
. O

  O
The O
sequence O
analysis O
also O
indicates O
that O
this O
region O
may O
be O
the O
target O
of O
a O
complex O
regulation O
by O
a O
number O
of O
other O
transcription O
factors O
; O
specifically O
, O
two O
putative O
SP1 B-protein
binding O
sites O
exist O
that O
flank O
the O
AP-2 B-protein-complex
core O
sequence O
. O

These O
dynamic O
changes O
in O
the O
binding O
of O
PC B-protein
and O
TRX B-protein
to O
PREs/REs B-DNA
and O
promoters B-DNA
of O
target O
genes O
may O
point O
to O
important O
transitions O
necessary O
for O
the O
establishment O
of O
the O
cellular O
memory O
mechanism O
supported O
by O
the O
PcG B-protein-family
and O
trxG B-protein-family
. O

  O
Previous O
studies O
have O
shown O
that O
Grb2 B-protein
binding O
to O
Shc B-protein
is O
important O
for O
the O
transmission O
of O
integrin-stimulated protein-family
signals O
to O
ERK2 B-protein
( O
Wary O
et O
al O
. O
, O
1996 O
; O
Mainiero O
et O
al O
. O
, O
1997 O
; O
Schlaepfer O
et O
al O
. O
, O
1998 O
) O
. O

To O
determine O
when O
TRX B-protein
binds O
to O
the O
BX-C B-protein-complex
and O
whether O
its O
binding O
exhibits O
temporal O
changes O
during O
early O
development O
when O
PcG B-protein-family
silencing O
is O
established O
, O
in O
vivo O
fixed O
chromatin O
was O
prepared O
from O
embryos O
of O
three O
different O
stages O
; O
0-2 O
, O
2-5 O
and O
5-8 O
h O
after O
egg O
laying O
. O

  O
Using O
co-immunoprecipitation O
approaches O
, O
we O
showed O
that O
dSlo B-protein
binds O
only O
to O
free O
PKAc B-protein
but O
not O
to O
the O
PKA B-protein-complex
holoenzyme I-protein-complex
, O
and O
that O
both O
PKA B-protein-complex
regulatory I-protein-complex
subunit I-protein-complex
and O
PKI B-protein-family
inhibit O
the O
association O
between O
dSlo O
and O
PKAc O
. O

  O
However O
, O
unlike O
SHC B-protein-family
, O
binding O
of O
Numb B-protein
PTB B-protein-domain
domain O
to O
LNX B-protein
does O
not O
require O
tyrosine O
phosphorylation O
. O

  O
As O
a O
result O
this O
protein O
lacks O
the O
sequences O
that O
are O
know O
to O
mediate O
either O
the O
transcriptional O
activation O
or O
pRB B-protein
, O
p107 B-protein
, O
or O
p130 B-protein
binding O
properties O
of O
the O
other O
E2F B-protein-family
proteins O
. O

This O
suggests O
that O
the O
binding O
of O
dynactin B-protein-complex
to O
MTs B-organelle
is O
modulated O
for O
different O
tasks O
in O
different O
neuronal O
locations O
. O

( O
B O
) O
Clathrin B-protein
binding O
to O
amphiphysin B-protein
. O

  O
We O
observed O
PABP B-protein-family
binding O
to O
eIF-4F B-protein-complex
, O
eIF-iso4F B-protein-complex
, O
or O
eIF-4B B-protein
using O
a O
far O
Western O
assay O
and O
direct O
fluorescence O
measurements O
. O

The O
L27 B-protein-domain
domains O
of O
PSD95β B-protein
and O
SAP97 B-protein
bind O
Hrs B-protein

But O
what O
is O
the O
in O
vivo O
function O
of O
PlexB B-protein
binding O
to O
Rac B-protein-family
? O

GST B-experiment-tag
or O
the O
GST-fusion O
proteins O
were O
first O
bound O
to O
the O
Glutathione-agarose B-reagent
beads I-reagent
followed O
by O
the O
addition O
of O
purified O
PDI B-protein-family
and O
centrifugation O
to O
collect O
the O
unbound O
material O
. O

A O
short O
fragment O
of O
Vtg B-protein
was O
aligned O
with O
the O
binding O
sequences O
of O
apoB B-protein
and O
apoE B-protein
. O

On O
the O
other O
hand O
, O
our O
findings O
contrast O
with O
those O
of O
Kamata O
et O
al O
. O
( O
26) O
, O
who O
reported O
that O
recombinant O
125I-GST-α2-I protein-domain
domain O
bound O
to O
collagen B-protein-family
in O
a O
metal-independent O
manner O
. O

These O
findings O
represent O
the O
first O
mapping O
of O
an O
intermediate O
chain O
phosphorylation O
site O
and O
suggest O
that O
this O
phosphorylation O
plays O
an O
important O
role O
in O
regulating O
the O
binding O
of O
cytoplasmic O
dynein B-protein-family
to O
dynactin B-protein-complex
. O

  O
B O
, O
comparative O
binding O
of O
HMG-1 B-protein
and O
HMG-1(A-B B-protein-region
) I-protein-region
to O
TBP/TATA protein
complex O
. O

To O
explore O
whether O
proteins O
such O
as O
Hsp90 B-protein-family
that O
bind O
the O
PAR-1 B-protein
C-tail O
are O
important O
for O
signaling O
, O
human O
neuronal O
cells O
( O
Ad12HER10 B-cell
) O
were O
transfected O
with O
C-tail O
overexpression O
constructs O
to O
specifically O
disrupt O
the O
endogenous O
PAR-1 O
interaction O
with O
Hsp90 O
. O

However O
, O
although O
the O
armadillo B-protein-domain
domain I-protein-domain
is O
much O
more O
accessible O
, O
E-cadherin B-protein
does O
not O
bind O
to O
phosphorylated O
β-catenin B-protein-family
since O
the O
presence O
of O
a O
negative O
charge O
makes O
it O
difficult O
to O
establish O
the O
correct O
ion O
pairs O
required O
for O
the O
interaction O
between O
these O
two O
proteins O
( O
lower O
right) O
. O

It O
is O
possible O
that O
the O
insert O
mediates O
direct O
binding O
of O
MEK B-protein-family
to O
ERK B-protein
or O
that O
it O
binds O
other O
proteins O
that O
affect O
MEK-ERK O
coupling O
. O

The O
exchange O
of O
[ O
3H]GDP chemical
bound O
to O
eIF2 B-protein-complex
for O
free O
GDP O
was O
measured O
as O
a O
decrease O
in O
the O
amount O
of O
eIF2 B-protein-complex
. I-protein-complex
[3H]GDP I-protein-complex
retained O
on O
nitrocellulose O
filters O
at O
various O
times O
. O

This O
model O
is O
consistent O
with O
the O
results O
of O
earlier O
studies O
of O
the O
binding O
of O
heparin B-chemical
to O
apoE B-protein-family
. O

Gel O
retardation O
assay O
of O
the O
binding O
of O
TR/RXR B-protein-complex
heterodimer O
to O
the O
TRE B-DNA
reconstituted O
into O
nucleosome O
in O
vitro O

Git2 B-protein
is O
highly O
homologous O
to O
p95PKL B-protein
; O
and O
we O
indeed O
detected O
ternary O
complexes O
of O
paxillin B-protein-complex
α/Git2/βPIX I-protein-complex
, O
and O
Git2/βPIX/PAK3 protein
. O

In O
previous O
studies O
, O
we O
found O
that O
the O
cytological O
locations O
of O
chromatin O
entry O
sites O
, O
visualized O
as O
partial O
MSL B-protein-complex
complex O
binding O
, O
were O
very O
similar O
in O
msl3 B-DNA
, O
mle B-DNA
, O
or O
mof B-DNA
mutants O
Kageyama O
et O
al O
. O
2001 O
, O
Lyman O
et O
al O
. O
1997 O
, O
Meller O
et O
al O
. O
2000 O
. O

  O
These O
results O
suggest O
that O
GSK-3beta B-protein
, O
PKA B-protein-complex
, O
and O
PP1 B-protein
bind O
to O
AKAP220 B-protein-complex
simultaneously O
and O
that O
they O
form O
a O
quaternary O
complex O
. O

  O
As O
detailed O
earlier O
, O
VASP B-protein
is O
known O
to O
bind O
profilin B-protein-family
, O
FP4-containing protein-motif
cytoskeletal O
proteins O
, O
and O
full-length O
VASP O
. O

We O
next O
used O
a O
combinatorial O
peptide O
library O
approach O
to O
identify O
the O
preferred O
binding O
motif O
of O
the O
SH3 B-protein-domain
domain O
of O
amphiphysin B-protein
and O
its O
relation O
to O
the O
binding O
region O
identified O
in O
dynamin B-protein
I I-protein
. O

  O
However O
, O
recombinant O
mutant O
ORC B-protein-complex
, O
which O
was O
defective O
in O
the O
ATP B-chemical
binding O
Walker B-protein-motif
A I-protein-motif
motif O
of O
ORC1 B-protein
, O
did O
not O
bind O
the O
304-bp O
ori O
fragment O
regardless O
of O
whether O
ATP- O
-S O
was O
added O
( O
data O
not O
shown) O
. O

  O
When O
heat-shocked O
cells O
were O
also O
treated O
with O
rapamycin B-drug
, O
an O
additive O
effect O
was O
observed O
such O
that O
rapamycin O
increased O
further O
both O
the O
amount O
of O
4E-BP1 B-protein
bound O
to O
eIF4E B-protein
and O
the O
downward O
band O
shift O
caused O
by O
heat O
shock O
. O

The O
EH B-protein-domain
domain O
of O
POB1 B-protein
bound O
directly O
to O
Epsin B-protein-family
and O
Eps15 B-protein
. O

  O
Cyclin B-protein
B1 I-protein
import O
was O
stimulated O
by O
importin-β B-protein-family
but O
insensitive O
to O
IBB B-protein-domain
, O
the O
amino-terminal O
domain O
of O
importin-α B-protein-family
that O
binds O
importin-β O
and O
inhibits O
importin-α–mediated O
import O
α/β B-protein-complex
( O
Moore O
et O
al O
. O
, O
1999 O
blue O
right-pointing O
triangle O
; O
Takizawa O
et O
al O
. O
, O
1999 O
blue O
right-pointing O
triangle O
; O
Jackman O
, O
Kubota O
, O
Den O
Elzen O
, O
Hagting O
, O
and O
Pines O
, O
unpublished O
results) O
. O

Binding O
of O
Tcf B-protein-family
with O
CBP B-protein
( O
19 O
) O
or O
CtBP B-protein
( O
20 O
) O
can O
lead O
to O
repression O
of O
the O
Wnt/Wingless B-protein-family
response O
. O

Tcf-4 B-protein
is O
a O
nuclear O
protein O
that O
binds O
to O
β-catenin B-protein-family
, O
and O
hTcf-4-(1–80 B-protein-region
) I-protein-region
interacts O
directly O
with O
the O
Armadillo B-protein-region
repeats I-protein-region
of O
β-catenin O
( O
7 O
, O
8) O
. O

Binding O
of O
actin B-protein
to O
profilin B-protein-family
was O
performed O
by O
using O
glutathione B-experiment-tag
S-transferase I-experiment-tag
fusion O
protein O
with O
human O
profilin O
[ O
glutathione O
S-transferase O
( O
GST)-profilin experiment-tag
coupled O
to O
glutathione B-reagent
Sepharose I-reagent
4B I-reagent
beads I-reagent
( O
Amersham O
Pharmacia) O
. O

  O
CREB B-protein
binds O
to O
the O
cAMP B-DNA
response I-DNA
element I-DNA
( O
CRE B-DNA
) O
present O
in O
many O
genes O
and O
, O
when O
phosphorylated O
, O
alters O
their O
transcription O
( O
Montminy O
, O
1997 O
; O
Shaywitz O
and O
Greenberg O
, O
1999 O
) O
. O

  O
Moreover O
, O
our O
in O
vitro O
phosphorylation O
results O
suggest O
that O
binding O
of O
dSlo B-protein
to O
PKAc B-protein
does O
not O
prevent O
the O
enzyme O
from O
phosphorylating O
its O
substrates O
. O

Overexpression O
in O
Chinese O
hamster O
ovary O
cells O
of O
an O
amphiphysin B-protein-isoform
1 I-protein-isoform
fragment O
that O
binds O
both O
AP-2 B-protein-complex
and O
clathrin B-protein
resulted O
in O
a O
segregation O
of O
clathrin O
, O
which O
acquired O
a O
diffuse O
distribution O
, O
from O
AP-2 O
, O
which O
accumulated O
at O
patches O
also O
positive O
for O
Eps15 B-protein
. O

  O
However O
, O
addition O
of O
a O
cold B-RNA
polypyrimidinic I-RNA
RNA I-RNA
( B-RNA
UCUU)3 I-RNA
did O
not O
have O
any O
effect O
on O
the O
binding O
of O
GST-TDP43 protein
to O
( B-RNA
UG)12 I-RNA
( O
Fig O
. O
1 O
B) O
, O
confirming O
the O
high O
specificity O
of O
TDP-43 O
binding O
to O
UG-repeated B-RNA
motifs I-RNA
. O

The O
kinetics O
provide O
a O
detailed O
picture O
of O
the O
threefold O
difference O
in O
affinity O
observed O
for O
estriol B-chemical
binding O
to O
beta B-protein-isoform
( O
KD O
= O
5 O
. O
6 O
nM O
) O
and O
alpha B-protein-isoform
( O
KD O
= O
18 O
nM O
) O
isoforms O
of O
the O
receptor O
. O

35S-labeled B-experiment-tag
Arr2 B-protein
bound O
to O
PIP3 B-reagent
beads I-reagent
but O
not O
to O
control B-reagent
beads I-reagent
( O
Figure O
2D) O
. O

  O
Binding O
of O
125I-bFGF protein
to O
ECM B-organelle
produced O
in O
the O
presence O
of O
30 O
mM O
chlorate B-reagent
was O
inhibited O
by O
50-60% O
. O

  O
These O
data O
suggest O
that O
the O
isolated O
mSos1 B-protein
PH B-protein-domain
domain O
shows O
a O
specific O
interaction O
with O
PI(4 B-chemical
, I-chemical
5)P2 I-chemical
and O
binds O
weakly O
to O
PI(4)P B-chemical
. O

Toth O
et O
al O
. O
( O
27 O
) O
have O
shown O
that O
in O
Ad-infected cell
cells O
transcription O
factors O
ML B-protein
transcription I-protein
factor I-protein
and O
transcription B-protein-complex
factor I-protein-complex
IID I-protein-complex
bind O
to O
Ad O
ML B-DNA
promoter I-DNA
only O
in O
the O
late O
stage O
of O
infection O
. O

  O
Taking O
these O
findings O
together O
with O
the O
results O
of O
Ikeda O
et O
al O
. O
( O
20) O
, O
we O
conclude O
that O
the O
GID B-protein-complex
binds O
directly O
to O
GSK-3beta B-protein
but O
does O
not O
inhibit O
its O
activity O
in O
vitro O
, O
in O
contrast O
to O
the O
robust O
inhibition O
seen O
in O
oocytes O
and O
embryos O
. O

Immunoadsorption O
of O
FKBP52 B-protein
from O
reticulocyte O
lysate O
also O
yields O
co-immunoadsorption O
of O
cytoplasmic O
dynein B-protein-family
, O
and O
we O
show O
that O
co-immunoadsorption O
of O
dynein O
is O
competed O
by O
a O
fragment O
of O
FKBP52 O
containing O
its O
PPIase B-protein-domain
domain O
, O
but O
not O
by O
a O
TPR B-protein-domain
domain O
fragment O
that O
blocks O
FKBP52 O
binding O
to O
hsp90 B-protein
. O

Our O
data O
imply O
that O
among O
the O
typically O
used O
control O
reagents O
in O
phorbol B-chemical
ester I-chemical
experiments O
on O
PKC B-protein-family
( O
C1-domain B-protein-domain
antagonists O
like O
calphostin B-chemical
C I-chemical
, O
inactive B-chemical
4α I-chemical
phorbol I-chemical
esters I-chemical
, O
inhibitors O
of O
ATP B-chemical
binding O
like O
bisindolylmaleimide) chemical
, O
only O
potent O
and O
selective O
inhibitors O
of O
ATP O
binding O
to O
PKC O
would O
allow O
one O
to O
distinguish O
phorbol O
ester-mediated O
effects O
on O
PKC O
from O
those O
on O
Munc13 B-protein
proteins O
( O
assuming O
that O
Munc13s B-protein
do O
not O
bind O
these O
ligands O
with O
a O
binding O
site O
outside O
the O
C1-domain) O
. O

C O
, O
TNP-ATP chemical
concentration-dependent O
increases O
in O
Fobs B-parameter
with O
MBP B-protein
without O
fusion O
protein O
are O
low O
( O
F O
P O
) O
and O
unaffected O
by O
5 O
mM O
MgATP B-chemical
( O
F O
P O
  O
MgATP O
) O
or O
4 O
M O
urea B-chemical
( O
F O
P O
  O
Urea) O
, O
indicating O
no O
TNP-ATP O
binding O
to O
MBP O
. O

1 O
, O
2 O
It O
would O
seem O
most O
likely O
that O
the O
number O
of O
cMyBPC B-protein
molecules O
would O
be O
three O
, O
considering O
that O
myosin B-protein-complex
rods O
are O
most O
probably O
arranged O
in O
a O
three-stranded O
helix O
, O
33 O
that O
six O
, O
probably O
paired O
, O
titin B-protein
strands O
lie O
along O
the O
surface O
of O
the O
myosin O
backbone O
, O
33 O
, O
34 O
and O
that O
the O
position O
of O
domain O
C10 B-protein-domain
, O
which O
binds O
to O
both O
titin O
and O
myosin O
, O
would O
be O
dictated O
by O
the O
register O
of O
the O
first O
Ig-like B-protein-domain
domain O
of O
the O
titin O
superrepeats O
and O
the O
MyBPC B-protein
binding O
site O
on O
the O
LMM B-protein
component O
of O
myosin O
. O

  O
Accordingly O
, O
it O
was O
proposed O
that O
binding O
of O
uncharged O
tRNA B-RNA
to O
the O
HisRS-like B-protein-domain
domain O
stimulates O
the O
ability O
of O
the O
kinase O
domain O
to O
phosphorylate O
eIF2alpha B-protein
( O
51) O
. O

Increased O
Pyk2 B-protein
tyrosine O
phosphorylation O
paralleled O
the O
time-course O
of O
Grb2 B-protein
binding O
to O
Shc B-protein
and O
activation O
of O
ERK2 B-protein
in O
FAK- cell
cells O
. O

  O
The O
dI B-protein
component O
, O
which O
binds O
NAD(H) B-chemical
, O
and O
the O
dIII B-protein
component O
, O
which O
binds O
NADP(H) B-chemical
, O
protrude O
from O
the O
membrane O
; O
dII B-protein
spans O
the O
membrane O
( O
in O
12-14 O
TM O
helices) O
. O

  O
Therefore O
, O
we O
tested O
the O
binding O
of O
PP1 B-protein-complex
isoforms O
to O
recombinant O
spinophilin B-protein
and O
neurabin B-protein
. O

Although O
the O
authors O
claim O
that O
this O
effect O
is O
through O
disruption O
of O
PKC B-protein-complex
binding O
to O
RACK1 B-protein
, O
one O
of O
the O
residues O
converted O
to O
alanine O
was O
I236 O
, O
a O
residue O
we O
now O
know O
to O
be O
essential O
for O
interaction O
with O
PDE4D5 B-protein-isoform
( O
Buensuceso O
et O
al O
. O
, O
2001 O
; O
Steele O
et O
al O
. O
, O
2001) O
. O

  O
Dixon O
RAF O
, O
Sigal O
IS O
, O
Rands O
E O
, O
Register O
RB O
, O
Candelore O
MR O
, O
Blake O
AD O
and O
Strader O
CD O
( O
1987 O
) O
Ligand O
binding O
to O
the O
beta-adrenergic B-protein
receptor I-protein
involves O
its O
rhodopsin-like B-protein-domain
core O
. O

The O
experiments O
described O
above O
show O
that O
alternative O
splicing O
of O
the O
VT B-protein-motif
motif O
determines O
binding O
of O
FRS2 B-protein
to O
Fgfr1 B-protein
( O
and O
presumably O
Fgfr2 B-protein
and O
-3 B-protein
, O
which O
also O
exhibit O
VT O
splicing O
( O
23)) O
. O

  O
Growth O
cones O
were O
allowed O
to O
internalize O
anti-L1 B-reagent
Fab I-reagent
bound O
to O
L1 O
for O
30 O
min O
, O
and O
the O
cell-surface O
Fab O
was O
blocked O
with O
unconjugated O
secondary O
antibody O
at O
4 O
degrees O
C O
. O

  O
To O
further O
analyze O
the O
binding O
of O
c-Maf B-protein
and O
Prox-1 B-protein
to O
p300 B-protein
, O
a O
mammalian O
two-hybrid O
assay O
was O
established O
( O
Fig O
. O
6) O
. O

  O
With O
much O
lower O
affinity O
, O
kinesin B-protein-family
also O
binds O
MTs B-organelle
at O
the O
physiologic O
pH O
7 O
. O
2-7 O
. O
4 O
( O
Fig O
. O
2 O
B) O
, O
suggesting O
that O
kinesin O
could O
be O
purified O
at O
this O
pH O
if O
the O
concentrations O
of O
MTs O
and O
kinesin O
were O
sufficiently O
high O
. O

BMP B-protein-family
signaling O
is O
determined O
by O
expression O
patterns O
of O
BMPs B-protein-family
, O
their O
receptors O
, O
and O
soluble O
BMP O
antagonists O
, O
such O
as O
noggin B-protein
and O
follistatin B-protein
, O
which O
directly O
bind O
BMPs O
and O
prevent O
functional O
receptor/ligand O
interaction O
( O
for O
review O
, O
see O
Cho O
and O
Blitz O
, O
1998) O
. O

The O
binding O
of O
thioredoxin B-protein
to O
T7 B-cell
DNA O
polymerase O
increases O
the O
affinity O
of O
the O
polymerase O
specifically O
to O
a O
primer-template O
by O
80-fold O
( O
6) O
. O

Previous O
studies O
have O
shown O
that O
F-actin protein
binds O
to O
the O
epidermal B-protein
growth I-protein
factor I-protein
receptor I-protein
at O
a O
site O
in O
its O
cytoplasmic O
domain O
similar O
to O
a O
peptide O
of O
profilin B-protein-family
( O
56) O
. O

This O
suggests O
that O
tFR-bound protein
FAD B-chemical
has O
the O
same O
absorption O
coefficient O
at O
450 O
nm O
as O
free O
FAD O
. O

REM-1 B-protein
motifs O
appear O
to O
differ O
in O
their O
ability O
to O
discriminate O
between O
the O
GTP- chemical
and O
GDP-bound chemical
forms O
of O
RhoA B-protein
. O
2 O
No O
sequence O
motifs O
common O
to O
other O
RhoA O
effectors O
have O
been O
identified O
, O
although O
the O
defined O
Rho-binding protein-family
regions O
of O
Citron B-protein
, O
Kinectin B-protein
, O
and O
the O
ROCKs B-protein-family
are O
all O
found O
in O
regions O
of O
extended O
α-helical O
coiled-coil O
structure O
. O

  O
Since O
Cdt1(RLF-B) protein
, O
like O
Cdc6 B-protein
, O
is O
required O
for O
stable O
binding O
of O
Mcm B-protein-complex
proteins O
to O
ORC/chromatin protein-complex
sites B-DNA
, O
geminin B-protein
inhibits O
binding O
of O
Mcm O
proteins O
to O
chromatin O
and O
prevents O
initiation O
of O
DNA B-DNA
replication O
. O

  O
We O
therefore O
examined O
whether O
p140mDia B-protein
can O
bind O
to O
profilin B-protein-family
and O
whether O
the O
binding O
of O
p140mDia O
to O
profilin O
is O
dependent O
on O
Rho B-protein-family
, O
because O
the O
fragment O
isolated O
by O
Reinhard O
et O
al O
. O
( O
1995 O
) O
corresponds O
to O
the O
C-terminal O
part O
of O
p140mDia O
. O

The O
aim O
of O
the O
present O
study O
was O
to O
characterize O
the O
heme-binding chemical
properties O
of O
RFABG B-protein
. O

  O
Reciprocal O
coimmunoprecipitation O
studies O
revealed O
a O
similar O
result O
( O
Fig O
. O
2) O
, O
indicating O
that O
the O
binding O
of O
Dvl2 B-protein
to O
Axin B-protein
did O
not O
affect O
the O
interaction O
of O
Axin O
with O
MEKK1-C protein
. O

To O
determine O
whether O
Aos B-protein
binds O
DER B-protein
directly O
, O
a O
binding O
assay O
was O
performed O
with O
the O
baculovirus-generated O
DER-Fc B-experimental-construct
recombinant O
protein O
( O
Fig O
. O
1A) O
. O

  O
To O
examine O
the O
possibility O
that O
delta B-protein-domain
S1 I-protein-domain
bound O
to O
actin B-protein
without O
quenching O
the O
pyrene O
fluorescence O
, O
the O
binding O
of O
actin O
and O
S1 O
was O
directly O
determined O
by O
pelleting O
experiments O
( O
Fig O
. O
3) O
. O

NIK B-protein
Binds O
to O
NHE1 B-protein

  O
In O
this O
way O
, O
cadherins B-protein-family
that O
are O
not O
bound O
to O
beta-catenin B-protein-family
would O
be O
turned O
over O
rapidly O
, O
while O
cadherins O
bound O
to O
beta-catenin O
could O
proceed O
to O
the O
cell O
surface O
to O
participate O
in O
adherens O
junctions O
. O

LEF-1 B-protein
Binds O
to O
Armadillo B-protein-motif

  O
Because O
binding O
of O
AC B-protein-family
and O
tropomyosin B-protein-family
to O
actin B-protein
filaments O
is O
mutually O
exclusive O
, O
the O
regulation O
of O
this O
conversion O
process O
is O
extremely O
important O
to O
understand O
. O

  O
The O
block O
A O
( O
Fig O
. O
4 O
) O
contains O
the O
consensus O
sequence O
involved O
in O
the O
binding O
of O
the O
ADP B-chemical
moiety O
of O
FAD B-chemical
( O
Wierenga O
et O
al O
. O
, O
1986) O
. O

  O
Therefore O
, O
deactivation O
of O
CF1 B-protein-complex
in O
vivo O
probably O
involves O
an O
alternative O
form O
of O
regulation O
such O
as O
the O
binding O
of O
ADP B-chemical
to O
the O
β-subunit B-protein
, O
which O
has O
previously O
been O
shown O
to O
deactivate O
CF1 O
enzymatic O
activity O
in O
the O
dark O
( O
16) O
. O

  O
( O
B O
) O
The O
transcriptional O
activation O
of O
the O
TCF B-protein-family
reporter O
was O
inhibited O
by O
12S B-protein
E1A I-protein
, O
but O
not O
by O
mutant B-protein
E1A I-protein
that O
does O
not O
bind O
p300 B-protein
. O

To O
test O
this O
possibility O
further O
, O
myc B-experiment-tag
epitope-tagged I-experiment-tag
Rheb B-protein
was O
ectopically O
expressed O
in O
COS B-cell
cells O
with O
either O
HA B-experiment-tag
epitope-tagged I-experiment-tag
TSC1 B-protein
or O
HA O
epitope-tagged O
TSC2 B-protein
alone O
or O
with O
both O
tumor O
suppressors O
together O
, O
and O
the O
ratio O
of O
GTP B-chemical
to O
GDP B-chemical
bound O
Rheb O
was O
determined O
. O

Studies O
have O
also O
shown O
that O
cyclin B-protein
D1 I-protein
can O
directly O
bind O
the O
estrogen B-protein
receptor I-protein
and O
enhance O
transcription O
of O
specific O
genes O
[ O
53] O
. O

Previous O
studies O
have O
shown O
that O
mutation O
of O
the O
consensus O
CtBP B-protein
binding O
motif O
PLDLS B-protein-motif
to O
PLASS B-protein-motif
blocks O
CtBP O
binding O
to O
E1A B-protein
( O
40) O
. O

A O
similar O
effect O
of O
Mg2+ B-chemical
was O
observed O
for O
the O
binding O
of O
FKBP12 B-protein
to O
the O
RyR1 B-protein
( O
18) O
. O

Specific O
association O
of O
p140mDia B-protein
with O
the O
GTP-bound chemical
form O
of O
RhoA B-protein
in O
vitro O

The O
polypeptide O
encoded O
by O
the O
cDNA B-DNA
isolated O
above O
was O
expressed O
in O
Escherichia O
coli O
either O
as O
a O
His-tagged O
protein O
( O
His6-cl experiment-tag
. -
50 -
) O
or O
as O
a O
GST B-experiment-tag
fusion O
protein O
( O
GST-cl experiment-tag
. -
50) -
. O

  O
After O
incubating O
dSlo B-protein
and O
PKAc B-protein
cotransfected O
cells O
with O
a O
membrane-permeable O
form O
of O
PKI B-protein-family
, O
much O
less O
PKAc O
was O
detected O
in O
anti-dSlo O
immunoprecipitates O
, O
indicating O
that O
PKI O
inhibits O
binding O
between O
dSlo O
and O
PKAc O
( O
Fig O
. O
7 O
B) O
. O

To O
characterize O
the O
GroEL-coat protein-complex
protein -
ternary O
complex O
, O
we O
calculated O
the O
percent O
of O
the O
total O
coat O
protein O
initially O
bound O
to O
GroEL O
at O
each O
temperature O
from O
co-immunoprecipitation O
experiments O
. O

  O
Similarly O
, O
N-terminal O
Iip35 B-protein
and O
KCNK3 B-protein
peptides O
bind O
beta-COP B-protein
( O
Figures O
6A O
and O
6C O
) O
while O
C-terminal O
KCNK3 O
peptides O
do O
not O
( O
not O
shown) O
. O

  O
Lipoprotein O
retention O
in O
atherosclerosis-prone O
regions O
is O
thought O
to O
be O
caused O
by O
the O
binding O
of O
LDLs B-protein-complex
to O
proteoglycans B-protein-complex
( O
PGs B-protein-complex
) O
of O
the O
extracellular O
matrix O
, O
which O
prevents O
their O
egress O
after O
crossing O
the O
endothelial O
barrier O
. O

  O
The O
two O
upper O
proteins O
were O
identified O
as O
GSK-3alpha B-protein
and O
GSK-3beta B-protein
from O
their O
size O
, O
their O
cross-reactivity O
with O
anti-GSK-3 protein-complex
antibodies O
( O
Fig O
. O
2 O
B) O
, O
and O
their O
depletion O
by O
axin B-protein-family
beads O
( O
Fig O
. O
3 O
A) O
, O
a O
GSK-3 O
selective O
affinity O
binding O
matrix O
( O
34) O
. O

Consistently O
, O
computational O
and O
experimental O
studies O
on O
the O
receptor O
for O
bradykinin B-peptide
, O
a O
peptide O
bioregulator O
that O
competes O
successfully O
with O
NT B-peptide
in O
binding O
to O
rat B-protein-family
mast I-protein-family
cell I-protein-family
receptors I-protein-family
( O
51) O
, O
also O
suggested O
the O
bradykinin O
binding O
site O
located O
in O
the O
third O
extracellular O
loop O
( O
22) O
. O

The O
subtle O
conformational O
changes O
of O
the O
side O
chains O
of O
MeBm2t1 B-chemical
and O
the O
positional O
displacement O
of O
Ala103 O
of O
CyPA B-protein
imply O
that O
MeBm2t1-CsA B-chemical
does O
not O
naturally O
fit O
the O
binding O
site O
and O
may O
thus O
account O
for O
the O
100-fold O
weaker O
binding O
of O
MeBm2t1-CsA O
relative O
to O
native O
CsA O
. O

Conversely O
, O
insertion O
of O
this O
region O
from O
HRG B-protein
into O
EGF B-protein
greatly O
diminishes O
binding O
to O
the O
EGF B-protein
receptor I-protein
( O
15 O
, O
31) O
. O

Binding O
of O
PC B-protein
and O
GAGA B-protein
Factor I-protein
at O
Fab-7 B-DNA
in O
Drosophila O
Embryos O

To O
test O
whether O
Bet B-protein
v I-protein
1 I-protein
can O
bind O
amphiphilic O
molecules O
in O
general O
, O
we O
also O
examined O
binding O
of O
bis-ANS B-reagent
and O
SDS B-reagent
. O

It O
is O
intriguing O
to O
speculate O
that O
the O
PDZ B-protein-domain
domain O
is O
necessary O
for O
maintaining O
the O
conformation O
of O
the O
DIX B-protein-domain
domain O
of O
Dvl B-protein
to O
bind O
to O
Axin B-protein
and O
that O
Idax B-protein
causes O
a O
conformational O
change O
in O
Dvl O
, O
thereby O
preventing O
the O
binding O
of O
Dvl O
to O
Axin O
indirectly O
. O

The O
dissolution O
of O
this O
complex O
may O
result O
in O
the O
binding O
of O
eIF-4E B-protein
to O
eIF-4G B-protein
and O
the O
translational O
activation O
of O
CPE-containing B-RNA
mRNAs I-RNA
. O

Our O
results O
strongly O
suggest O
that O
ATP B-chemical
bound O
mainly O
to O
the O
CI B-protein-domain
domain O
( O
Fig O
. O
2 O
) O
and O
that O
P B-protein-motif
loop I-protein-motif
1 I-protein-motif
was O
a O
main O
active O
site O
for O
ATP-binding O
of O
KaiC B-protein
. O

Interestingly O
, O
however O
, O
Shs1 B-protein
can O
bind O
to O
Gin4 B-protein
and O
induce O
Gin4 O
oligomerization O
under O
conditions O
in O
which O
the O
Cdc11 B-protein
septin I-protein
does O
not O
bind O
to O
Gin4 O
, O
suggesting O
that O
Shs1 O
can O
function O
independently O
of O
the O
other O
septins B-protein-family
. O

Recently O
, O
several O
Sp1-related protein
proteins O
, O
Sp2 B-protein
, O
Sp3 B-protein
, O
and O
Sp4 B-protein
, O
that O
bind O
to O
the O
GC B-DNA
box I-DNA
or O
GT B-DNA
motif I-DNA
were O
identified O
( O
33-35) O
; O
however O
, O
their O
role O
in O
promoter O
regulation O
is O
less O
defined O
. O

To O
further O
show O
the O
specificity O
of O
Lef-1 B-protein
binding O
to O
the O
siamois B-DNA
promoter I-DNA
we O
performed O
DNase B-assay
I I-assay
footprinting I-assay
assays O
by O
use O
of O
Lef-1 O
HMG B-protein-domain
domain O
and O
the O
S1234 B-experiment-tag
restriction I-experiment-tag
fragment I-experiment-tag
used O
in O
the O
band O
shift O
assays O
described O
above O
. O

To O
examine O
whether O
dcp-1 B-protein
mutants O
were O
defective O
in O
the O
cytoskeletal O
reorganization O
in O
nurse O
cells O
, O
we O
stained O
egg O
chambers O
with O
rhodamine-phalloidin B-reagent
, O
which O
binds O
to O
filamentous O
actin B-protein
( O
Fig O
. O
4 O
) O
( O
24) O
. O

GORLICH O
, O
D O
. O
, O
P O
. O
HENKELIN O
, O
R O
. O
A O
. O
LASKEY O
, O
and O
E O
. O
HARTMANN O
, O
1996 O
A O
41 O
amino O
acid O
motif O
in O
importin-alpha B-protein-family
confers O
binding O
to O
importin-beta B-protein-family
and O
hence O
transit O
into O
the O
nucleus O
. O

Rap1 B-protein
binds O
to O
the O
HIS4 B-gene
promoter O
and O
stimulates O
both O
Bas1/Bas2- protein
and O
Gcn4-dependent protein
HIS4 O
transcription O
two- O
to O
threefold O
, O
especially O
under O
uninduced O
conditions O
( O
6) O
. O

Binding O
of O
p110C B-protein-region
with O
PAK1 B-protein
in O
Vivo O

In O
contrast O
to O
RabGDI B-protein-family
, O
Ca2+/CaM B-protein
does O
not O
discriminate O
between O
the O
GDP- B-protein
and O
GTP-bound B-protein
forms I-protein
of I-protein
Rab3 I-protein
. O

LPS-induced chemical
gene O
expression O
of O
TNF-alpha B-gene
and O
IL-1beta B-gene
is O
mediated O
by O
DNA-binding DNA
of O
NF-kappaB B-protein
to O
the O
TNF-alpha O
and O
IL-1beta B-DNA
promotors I-DNA
( O
13) O
. O

We O
analyzed O
the O
effect O
of O
PKC B-protein-family
phosphorylation O
on O
actin B-protein
binding O
activities O
of O
A-fascin B-protein
and O
wild-type O
r-fascin B-protein
. O

The O
first O
lane O
shows O
a O
retardation O
caused O
by O
CREB B-protein
binding O
to O
the O
CRE B-DNA
oligonucleotide O
in O
the O
absence O
of O
the O
antibody O
or O
its O
competitor O
oligonucleotide O
. O

Ca2+-dependent chemical
phospholipid B-chemical
and O
syntaxin B-protein-family
binding O
by O
native O
synaptotagmins B-protein-family
was O
examined O
essentially O
as O
described O
( O
Fernandez-Chacon O
et O
al O
. O
, O
2001 O
) O
, O
and O
bound O
proteins O
were O
analyzed O
by O
SDS-PAGE B-assay
and O
immunoblotting O
. O

To O
determine O
whether O
this O
tryptophan B-amino-acid
was O
required O
for O
Pbx1 B-protein
and O
Meis1 B-protein
cooperative O
binding O
to O
CRS1 B-protein
, O
tryptophan O
213 O
of O
Meis1a B-protein
, O
contained O
within O
the O
amino O
acid O
sequence O
, O
PSWNR B-protein-motif
was O
mutated O
to O
alanine B-amino-acid
. O

Competition O
assays O
, O
tryptic O
digestion O
analyses O
, O
and O
direct O
binding O
analyses O
suggested O
that O
this O
was O
due O
to O
the O
H43Q B-mutation
mutation I-mutation
extensively O
reducing O
the O
affinity O
of O
binding O
of O
Csp B-protein
to O
Hsc70 B-protein
. O

Kinetics O
of O
Hsp70 B-protein
Binding O
to O
the O
TNFα B-RNA
ARE I-RNA

To O
evaluate O
the O
dynamics O
of O
the O
interaction O
between O
Hsp70 B-protein
and O
an O
ARE B-RNA
, O
off-rate O
analyses O
were O
performed O
to O
measure O
the O
stability O
of O
Hsp70·Fl-TNFα protein
ARE RNA
complexes O
in O
solution O
. O

Additional O
Fkh B-protein-family
target O
sites O
identified O
with O
an O
extended O
Fkh-consensus B-DNA
binding I-DNA
site I-DNA
. O

Mechanistically O
, O
MAE B-protein
binds O
to O
YAN B-protein
via O
a O
protein-protein O
interaction O
motif O
found O
at O
the O
N O
terminus O
of O
YAN O
and O
the O
C O
terminus O
of O
MAE O
( O
Baker O
et O
al O
. O
, O
2001 O
) O
, O
referred O
to O
as O
the O
Pointed B-protein-domain
Domain I-protein-domain
( O
PD B-protein-domain
) O
( O
Klambt O
, O
1993 O
) O
. O

In O
this O
protein O
complex O
, O
LIN-10 B-protein
binds O
to O
LIN-2 B-protein
, O
LIN-2 O
binds O
to O
LIN-7 B-protein
, O
and O
LIN-7 O
binds O
to O
LET-23 B-protein
RTK I-protein
. O

Presplicing B-protein-complex
complex I-protein-complex
A I-protein-complex
forms O
upon O
binding O
of O
the O
17S B-protein-RNA-complex
U2 I-protein-RNA-complex
snRNP I-protein-RNA-complex
to O
the O
pre-mRNA B-RNA
( O
3) O
. O

Some O
Cdc20 B-protein
cosediments O
with O
Cdc16 B-protein
, O
as O
expected O
from O
previous O
reports O
of O
Cdc20 O
bound O
to O
the O
APC/C B-protein-complex
; O
the O
aurora2/Aik B-protein
peak O
is O
distinct O
from O
the O
Cdc16 O
peak O
. O

A O
, O
SH2D1A B-protein
C42W B-protein
and O
T53I B-protein
binding O
to O
CD244 B-protein
; O
B O
, O
SH2D1A O
T68I B-protein
binding O
to O
CD244 O
; O
C O
, O
SH2D1A B-protein
R32Q I-protein
, O
C42W O
, O
T53I O
, O
and O
T68I O
binding O
to O
CD84 B-protein
; O
D O
, O
SH2D1A O
R32Q O
, O
C42W O
, O
T53I O
, O
and O
T68I O
binding O
to O
CD229 B-protein
. O

In O
the O
current O
work O
, O
we O
demonstrate O
that O
RDGC B-protein
binds O
to O
calmodulin B-protein-family
, O
and O
a O
mutation O
in O
an O
IQ B-protein-motif
motif I-protein-motif
that O
eliminates O
the O
calmodulin/ O
RDGC O
interaction O
prevents O
dephosphorylation O
of O
rhodopsin B-protein
in O
vivo O
and O
disrupts O
termination O
of O
the O
photoresponse O
. O

Whereas O
the O
binding O
of O
ATP B-chemical
had O
no O
effect O
on O
the O
binding O
of O
IkappaBalpha B-protein
peptide O
for O
the O
rhIKK-1/rhIKK-2 fusion-protein
heterodimer O
, O
the O
binding O
of O
ATP O
decreased O
the O
affinity O
of O
IkappaBalpha O
peptide O
for O
rhIKK-i B-fusion-protein
and O
rhTBK-1 B-fusion-protein
. O

These O
data O
indicate O
that O
Sir4 B-protein
binding O
to O
Rap1 B-protein
initiates O
the O
sequential O
association O
of O
Sir B-protein-family
and O
other O
proteins O
, O
allowing O
the O
subsequent O
spreading O
of O
the O
heterochromatin O
proteins O
along O
the O
chromosome O
. O

Thus O
, O
MSL2 B-protein
and O
MSL1 B-protein
may O
comprise O
the O
chromatin-binding O
activity O
of O
the O
MSL B-protein-complex
complex O
, O
or O
may O
be O
the O
first O
of O
the O
known O
subunits O
to O
assemble O
at O
pre-defined O
sites O
. O

First O
, O
which O
event(s O
) O
in O
the O
formation O
of O
clathrin-coated protein
vesicles O
are O
regulated O
by O
the O
GTP-bound chemical
form O
of O
dynamin B-protein-family
? O

RDGC B-protein
Bound O
Directly O
to O
Calmodulin B-protein-family

The O
C-terminal O
C2 B-protein-domain
domain I-protein-domain
( O
C2-B B-protein-domain
) O
has O
been O
shown O
to O
bind O
a O
clathrin-coated protein
vesicle O
protein O
complex O
( O
AP-2 B-protein-complex
) O
and O
syntaxins B-protein-family
( O
Zhang O
et O
al O
. O
, O
1994 O
; O
Li O
et O
al O
. O
, O
1995 O
) O
; O
all O
known O
synaptotagmins B-protein-family
bind O
AP-2 O
and O
syntaxin B-protein-family
. O

As O
previously O
reported O
, O
CSP B-protein
also O
binds O
to O
Hsc70 B-protein
( O
right O
diagram O
, O
col O
. O

Activators O
of O
endogenous O
PKA B-protein-complex
that O
stimulate O
dSlo B-protein
phosphorylation O
, O
but O
do O
not O
produce O
detectable O
PKAc B-protein
binding O
to O
dSlo O
, O
do O
not O
modulate O
channel O
function O
. O

GTP-bound chemical
forms O
of O
Rho B-protein
associated O
with O
GST-rhotekin-RBD experiment-tag
were O
released O
from O
beads O
by O
an O
addition O
of O
protein O
loading O
buffer O
, O
and O
quantified O
by O
Western O
blot O
analysis O
using O
AU5 B-reagent
antibodies I-reagent
. O

Overall O
, O
these O
results O
clearly O
indicated O
that O
CAPER B-protein
binds O
the O
AP-1 B-protein-complex
component O
c-Jun B-protein
and O
both O
ERalpha B-protein
and O
beta B-protein
. O

( B-drug
GA I-drug
) I-drug
enhances O
the O
heat-inducible O
HSE-binding DNA
activity O
of O
HSF1 B-protein
and O
delays O
deactivation O
during O
recovery O
. O

These O
results O
show O
that O
DDP1 B-protein
binds O
the O
dodeca-satellite B-DNA
C I-DNA
strand I-DNA
with O
a O
higher O
affinity O
than O
the O
vigilin B-RNA
binding I-RNA
sites I-RNA
of O
the O
Xenopus O
vitellogenin B-RNA
and O
human O
dystrophin B-RNA
mRNAs I-RNA
. O

For O
precipitation O
with O
GST B-experiment-tag
fusion O
proteins O
, O
lysates O
from O
control O
or O
IFN-treated protein-family
Daudi B-cell
cells I-cell
were O
precipitated O
with O
STAT3-GST B-experimental-construct
or O
GST O
bound O
to O
glutathione-agarose B-chemical
beads O
. O

Binding O
of O
native O
synaptotagmin B-protein-family
and O
AP-2 B-protein-complex
was O
assayed O
by O
immunoblot O
analysis O
. O

Only O
nonphosphorylated O
Kelch B-protein-family
( O
KelY627A B-protein
) O
bound O
actin B-protein
( O
Fig O
. O
2 O
I) O
. O

Thus O
, O
FLI B-protein-family
bound O
actin B-protein
specifically O
. O

We O
have O
derived O
a O
consensus O
sequence O
from O
this O
data O
which O
predicts O
high-affinity O
binding O
of O
a O
subset O
of O
PH B-protein-domain
domains I-protein-domain
to O
PI3K B-protein-family
products O
and O
have O
proposed O
a O
model O
for O
how O
these O
PH O
domains O
bind O
PI3K O
products O
with O
high O
affinity O
. O

PcG B-protein-family
proteins I-protein-family
bind O
to O
PREs B-DNA
in O
vivo O
and O
package O
the O
adjacent O
chromatin O
into O
a O
closed O
repressed O
conformation O
. O

The O
JM B-protein-domain
domain O
is O
known O
to O
have O
the O
site O
to O
which O
p120ctn B-protein
binds O
, O
that O
is O
, O
the O
JM(- O
) O
cadherin B-protein-family
cannot O
bind O
to O
this O
catenin B-protein-family
( O
Yap O
et O
al O
. O
, O
1998 O
; O
Ohkubo O
and O
Ozawa O
, O
1999 O
; O
Thoreson O
et O
al O
. O
, O
2000) O
. O

X11α B-protein
Binding O
to O
CCS B-protein
Is O
Mediated O
by O
PDZ2 B-protein-domain
and O
Sequences O
within O
CCS B-protein-domain
Domain I-protein-domain
III I-protein-domain

To O
map O
further O
the O
regions O
required O
for O
binding O
of O
X11α B-protein
with O
CCS B-protein
, O
we O
used O
GST B-experiment-tag
fusion O
protein O
binding O
assays O
. O

Amino O
acids O
109 O
- O
295 O
of O
LIN-7 B-protein
could O
bind O
LIN-2 B-protein
, O
but O
amino O
acids O
126 O
- O
295 O
or O
the O
PDZ B-protein-domain
domain I-protein-domain
of O
LIN-7 O
could O
not O
bind O
LIN-2 O
( O
Figure O
5A) O
. O

( O
C O
) O
Asp38 B-amino-acid
is O
not O
required O
for O
binding O
of O
Par6 B-protein
to O
Cdc42 B-protein
. O

The O
SH3 B-protein-domain
Domain I-protein-domain
of O
Abl B-protein
Also O
Binds O
to O
Cbl B-protein
. O

The O
proline-rich amino-acid
region O
of O
Cbl B-protein
contains O
many O
possible O
binding O
sites O
for O
the O
SH3 B-protein-domain
domains I-protein-domain
of O
various O
proteins O
( O
19) O
. O

Full-length O
TRAF2 B-protein
and O
the O
complete O
TRAF B-protein-domain
domain I-protein-domain
bound O
specifically O
to O
TRADD B-protein
. O

We O
therefore O
altered O
the O
Gro-interaction B-protein-domain
domain I-protein-domain
at O
the O
C O
terminus O
of O
Lz B-protein
from O
VWRPY B-protein-motif
to O
VWEAA B-protein-motif
, O
a O
change O
that O
abrogates O
Gro O
binding O
to O
bHLH B-protein-family
proteins I-protein-family
( O
Goldstein O
et O
al O
. O
1999 O
) O
. O

To O
determine O
if O
FLI B-protein-family
is O
an O
actin-binding protein
protein O
, O
FLI O
and O
the O
FLI B-protein-domain
LRR I-protein-domain
domain I-protein-domain
( O
Fig O
. O
1 O
A O
) O
were O
expressed O
by O
in O
vitro O
transcription O
and O
translation O
( O
Fig O
. O
1 O
B) O
. O

However O
, O
when O
SRF B-protein
is O
bound O
to O
SRE B-DNA
as O
a O
dimer B-protein-DNA-complex
it O
is O
accessible O
to O
make O
tertiary O
complex O
with O
Ets B-protein-family
members O
, O
as O
reported O
before O
, O
but O
not O
to O
TEF-1 B-protein
. O

Although O
the O
Hsp70 B-protein
used O
contained O
low O
levels O
of O
endotoxin O
( O
<0 O
. O
5 O
EU/mg O
as O
assessed O
by O
the O
limulus O
amebocyte O
lysate O
assay) O
, O
we O
excluded O
a O
potential O
involvement O
of O
residual O
endotoxin O
in O
Hsp70 O
binding O
to O
APC B-protein
based O
on O
the O
following O
observations O
. O

Also O
, O
the O
VIP1R B-protein
antagonist O
blocked O
the O
effect O
of O
VIP/ protein
PACAP B-protein
on O
both O
NF-kB B-protein
and O
c-Jun/ protein
CREB B-protein
binding O
to O
the O
TNFalpha B-DNA
promoter I-DNA
, O
supporting O
the O
involvement O
of O
the O
VIP1R O
in O
the O
regulatory O
effect O
of O
VIP/ O
PACAP O
on O
TNFalpha O
gene O
expression O
. O

Our O
findings O
so O
far O
have O
indicated O
that O
oligo B-reagent
II I-reagent
can O
bind O
NF1 B-protein
, O
CP1 B-protein
, O
and O
SP1 B-protein
, O
and O
the O
binding O
of O
NF1 O
and O
CP1 O
to O
footprint B-DNA
II I-DNA
is O
mutually O
exclusive O
( O
7 O
, O
8) O
. O

Interestingly O
, O
the O
recombinant O
14-3-3 B-protein-family
had O
two O
effects O
: O
it O
reduced O
the O
amount O
of O
Raf-1 B-protein
that O
bound O
to O
the O
Ras B-reagent
membranes I-reagent
but O
increased O
the O
specific O
activity O
of O
membrane-bound B-protein
Raf-1 I-protein
( O
Fig O
. O
​5A O
and O
C) O
. O

Moreover O
, O
a O
recent O
study O
( O
33 O
) O
examined O
the O
effect O
of O
temperature O
on O
the O
oxygen-binding chemical
properties O
of O
the O
Hbs B-protein
of O
three O
notothenioid O
fish O
species O
. O

The O
“active O
” O
lipids B-chemical
include O
both O
esterified O
and O
unesterified O
peroxidized B-chemical
lipids I-chemical
, O
lysoPtdCho B-chemical
, O
cholesterol B-chemical
oxidation O
products O
, O
aldehydes B-chemical
derived O
from O
breakdown O
of O
both O
esterified O
and O
unesterified O
oxidized O
fatty B-chemical
acids I-chemical
, O
and O
perhaps O
proteolipids B-chemical
that O
may O
have O
peroxidized O
lipids O
bound O
to O
fragmented O
apoB-100 B-protein
. O

Loss O
of O
Fused B-protein
kinase O
activity O
or O
loss O
of O
the O
serine B-protein-region
931 I-protein-region
phosphorylation I-protein-region
site I-protein-region
could O
reduce O
Ci B-protein
binding O
to O
Cos2 B-protein
, O
which O
could O
, O
in O
turn O
, O
reduce O
Ci O
processing O
by O
preventing O
the O
processing O
enzyme O
from O
interacting O
with O
Ci O
. O

( O
C O
) O
dFOXO B-protein
binds O
specifically O
to O
d4EBP B-DNA
and O
dInR B-DNA
promoters I-DNA
in O
vivo O
. O

We O
have O
identified O
several O
amino O
acids O
, O
distinct O
from O
the O
MIDAS B-protein-motif
residues I-protein-motif
, O
which O
are O
critical O
for O
alpha2-I B-protein-domain
domain I-protein-domain
binding O
to O
collagen B-protein-family
. O

Furthermore O
, O
dFOXO B-protein
binding O
to O
the O
d4EBP B-DNA
promoter I-DNA
fragment O
can O
be O
efficiently O
competed O
with O
an O
unlabeled O
113-bp O
d4EBP O
promoter O
fragment O
( O
Fig O
. O
5B O
, O
lanes O
9 O
- O
12 O
) O
but O
not O
with O
nonspecific O
DNA B-DNA
( O
Fig O
. O
5B O
, O
lanes O
13 O
- O
16) O
. O

We O
expect O
that O
in O
the O
intact O
BAF B-protein-complex
complex I-protein-complex
, O
the O
actin B-protein
monomer O
is O
bound O
to O
Brg1 B-protein
at O
both O
of O
these O
sites O
. O

In O
the O
absence O
of O
a O
functional O
Exd B-protein
half-site O
, O
the O
Hox B-protein-family
half-site O
in O
fkh[250 protein-family
] O
weakly O
binds O
several O
Hox B-protein-family
proteins I-protein-family
, O
but O
when O
the O
Exd O
half-site O
is O
functional O
, O
one O
of O
these O
Hox O
proteins O
( O
Scr B-protein
) O
binds O
better O
than O
the O
others O
; O
thus O
, O
Exd O
selectively O
enhances O
the O
binding O
of O
one O
Hox O
protein O
over O
the O
others O
. O

We O
did O
find O
, O
instead O
, O
an O
increased O
binding O
of O
GSK-3β B-protein
to O
E-cadherin B-protein
and O
β-catenin B-protein-family
. O

Synaptotagmin B-protein-family
binds O
beta-SNAP protein
, O
but O
not O
alpha-SNAP B-protein-isoform
, O
with O
a O
high O
degree O
of O
selectivity O
( O
Schiavo O
et O
al O
. O
1995 O
) O
; O
however O
, O
the O
physiological O
function O
of O
this O
interaction O
has O
yet O
to O
be O
established O
. O

They O
also O
confirmed O
our O
finding O
( O
Klotzbucher O
et O
al O
. O
, O
1996 O
) O
that O
the O
D-box B-protein-domain
of O
cyclin B-protein-family
A I-protein-family
does O
not O
behave O
as O
a O
transportable O
module O
; O
indeed O
, O
we O
concluded O
that O
cyclin O
A O
must O
be O
bound O
to O
Cdc2 B-protein
or O
CDK2 B-protein
in O
order O
to O
be O
degraded O
. O

The O
acquired O
thermotolerance O
may O
thus O
result O
from O
the O
higher O
content O
of O
HSP70 B-protein
and O
a O
subsequent O
more O
extensive O
binding O
of O
HSP70 O
to O
F-actin protein
in O
the O
primed O
cells O
. O

In O
this O
model O
, O
FKBP12 B-protein
bound O
to O
the O
Leu-Pro B-protein-region
site I-protein-region
in O
the O
TTSGSGSGLP B-protein-region
sequence I-protein-region
hinders O
access O
of O
TbetaR-II B-protein
to O
phosphorylation O
sites O
in O
this O
sequence O
during O
spontaneous O
, O
ligand-independent O
interactions O
between O
the O
two O
receptors O
. O

Using O
pulse-chase O
and O
biotinylation O
assays O
, O
we O
provide O
evidence O
that O
PS1 B-protein
binds O
Notch B-protein-family
in O
the O
ER/Golgi B-organelle
and O
is O
then O
co-transported O
to O
the O
plasma O
membrane O
as O
a O
complex O
. O

To O
identify O
which O
region O
of O
HP1 B-protein
binds O
to O
the O
H4 B-protein-family
peptides O
, O
we O
used O
an O
rHP1 B-fusion-protein
sample O
in O
which O
the O
protein O
had O
been O
cleaved O
into O
two O
peptides O
. O

Thus O
, O
the O
combination O
of O
exclusive O
binding O
of O
p50 B-protein
cdc37 I-protein
versus O
a O
TPR B-protein
domain I-protein
protein I-protein
to O
hsp90 B-protein-family
plus O
direct O
binding O
of O
p50 O
cdc37 O
to O
Raf B-protein-family
allow O
the O
protein O
kinase O
to O
determine O
the O
dominant O
heterocomplex O
composition O
. O

No O
information O
, O
however O
, O
has O
been O
available O
concerning O
the O
effects O
of O
sustained O
ischemia O
on O
the O
CRE-DNA B-DNA
binding O
activity O
of O
CREB B-protein
in O
the O
brain O
. O

Nidogen B-protein-family
can O
bind O
collagen B-protein-family
type I-protein-family
IV I-protein-family
, O
fibulins B-protein-family
, O
laminin B-protein-family
, O
and O
perlecan B-protein
( O
10 O
, O
18 O
, O
19) O
. O

Together O
, O
these O
findings O
indicate O
that O
NIK B-protein
binds O
directly O
to O
NHE1 B-protein
at O
a O
site O
located O
between O
amino O
acids O
538 O
and O
638 O
in O
the O
C-terminal O
domain O
. O

Bosselut O
, O
R O
. O
, O
Levin O
, O
J O
. O
, O
Adjadj O
, O
E O
. O
and O
Ghysdael O
, O
J O
. O
( O
1993 O
) O
A O
single O
amino-acid O
substitution O
in O
the O
Ets B-protein-domain
domain I-protein-domain
alters O
core O
DNA B-DNA
binding O
specificity O
of O
Ets1 B-protein
to O
that O
of O
the O
related O
transcription O
factors O
Elf1 B-protein
and O
E74 B-protein
. O

The O
results O
above O
show O
that O
AEF-1 B-protein
binding O
to O
the O
proximal O
Inr B-DNA
region O
represses O
transcription O
. O

Further O
analysis O
of O
the O
amino-terminal O
region O
of O
Smo B-protein
in O
BCCs B-cell
may O
lead O
to O
the O
identification O
of O
oncogenic O
mutations O
disrupting O
the O
binding O
of O
Smo O
to O
Ptc B-protein
. O

Full‐length O
eIF4G B-protein
binds O
PABP B-protein

We O
also O
introduced O
two O
amino O
acid O
substitutions O
into O
the O
JNK-binding protein
motif O
of O
JIP3 B-protein
( O
Kelkar O
et O
al O
. O
, O
2000) O
. O

In O
fact O
, O
an O
analogous O
situation O
has O
also O
been O
described O
that O
a O
residual O
binding O
of O
p130Cas B-protein
to O
FAK B-protein
P712/715A O
mutant O
possibly O
mediated O
by O
a O
second O
proline-rich amino-acid
region O
( O
amino O
acids O
875-884 O
) O
on O
FAK O
does O
not O
allow O
for O
FAK-promoted O
migration O
( O
22) O
. O

Stable O
F-actin protein
binding O
can O
only O
take O
place O
at O
low O
pH O
values O
where O
cofilin B-protein
binds O
actin O
monomers O
within O
the O
filament O
via O
site O
1 O
and O
site O
2 O
. O

dASF1 B-protein
binds O
directly O
to O
dCAF-1 B-protein
. O

Binding O
of O
RDGC B-protein
to O
calmodulin-agarose protein-family
was O
not O
strictly O
Ca2+ B-chemical
dependent O
. O

It O
is O
conceivable O
that O
this O
cleft O
has O
evolved O
primarily O
to O
accommodate O
p53 B-protein
, O
which O
binds O
Mdm2 B-protein
very O
tightly O
and O
is O
subject O
to O
stringent O
regulation O
by O
Mdm2 O
. O

Furthermore O
, O
when O
the O
C-terminal O
194 O
residues O
were O
deleted O
, O
E6TP1 B-protein
could O
not O
bind O
to O
E6 B-protein
. O

For O
instance O
, O
both O
antithrombin B-protein
III I-protein
and O
heparin B-chemical
cofactor O
II O
bind O
heparin O
, O
but O
only O
heparin O
cofactor O
II O
binds O
DS B-protein
( O
21) O
. O

To O
assay O
syntaxin B-protein-family
binding O
to O
the O
C2A B-protein-domain
domain I-protein-domain
of O
synaptotagmin B-protein-family
, O
1 O
mM O
CaCl2 B-chemical
was O
added O
to O
buffer O
B O
( O
buffer O
A O
containing O
0 O
. O
1% O
( O
w/v O
) O
Triton -
X-100) -
. O

11 O
Given O
this O
similarity O
in O
surface O
densities O
for O
the O
various O
myosins B-protein-family
, O
it O
appears O
that O
the O
binding O
of O
myosin B-protein-complex
to O
the O
nitrocellulose B-reagent
surface O
is O
independent O
of O
myosin O
isoform O
. O

To O
investigate O
whether O
the O
grafted O
domain O
reduces O
the O
dissociation O
constant O
of O
the O
E B-cell
. I-cell
coli I-cell
enzyme O
for O
yeast O
tRNA B-RNA
, O
we O
again O
used O
affinity O
co-electrophoresis O
to O
determine O
the O
tRNA O
binding O
affinity O
of O
some O
of O
the O
fusion O
proteins O
that O
complement O
the O
yeast O
null O
strain O
. O

Binding O
of O
IL-1 B-protein
and O
TNF-alpha B-protein
to O
their O
receptors O
activates O
several O
signaling O
pathways O
, O
including O
the O
NFkappaB B-protein
and O
AP-1 B-protein-complex
pathways O
. O

Binding O
of O
AP-3 B-protein-complex
to O
the O
LIMP-II B-protein
tail O
is O
sensitive O
to O
the O
injection O
of O
anti-LIMP-II B-reagent
tail O
antiserum O
. O

Consistent O
with O
the O
equivalent O
transcriptional O
regulatory O
properties O
, O
mapping O
of O
DNase B-protein
I I-protein
hypersensitivity O
in O
the O
assembled O
minichromosome O
by O
indirect O
end‐labeling O
( O
Figure O
7C O
) O
reveals O
that O
TR/RXR protein
binds O
to O
the O
TRE B-DNA
within O
chromatin O
with O
very O
similar O
preferences O
to O
each O
of O
the O
three O
templates O
. O

It O
has O
been O
demonstrated O
that O
sina B-protein
binds O
PHYL B-protein
and O
TTK B-protein
88 I-protein
, O
which O
is O
a O
transcriptional O
repressor O
of O
neuronal O
cell O
fate O
( O
13 O
, O
14) O
. O

Figure O
3 O
U2AF35 B-protein
makes O
U2AF65 B-protein
binding O
refractory O
to O
inhibition O
by O
SXL B-protein
. O

Indeed O
, O
Hrs B-protein-family
binds O
ubiquitin B-protein-family
( O
Fig O
. O
1 O
A) O
. O

This O
experiment O
indicates O
that O
the O
catalytic O
domain O
of O
PTPphi B-protein
selectively O
binds O
paxillin B-protein
and O
Pyk2 B-protein
. O

Geldanamycin B-drug
also O
prevents O
binding O
of O
the O
p23 B-protein
cochaperone O
to O
HSP90 B-protein-family
and O
inhibits O
the O
release O
of O
substrates O
( O
22 O
, O
85) O
. O

Within O
the O
ATP B-chemical
binding O
site O
of O
PKM B-protein
, O
lysine B-amino-acid
221 O
was O
changed O
to O
tryptophan B-amino-acid
( O
K221W B-mutation
) O
corresponding O
to O
a O
mutation O
in O
Raf-1 B-protein
that O
abolished O
its O
kinase O
activity O
( O
41) O
. O

Dixon O
RAF O
, O
Sigal O
IS O
, O
Rands O
E O
, O
Register O
RB O
, O
Candelore O
MR O
, O
Blake O
AD O
and O
Strader O
CD O
( O
1987 O
) O
Ligand O
binding O
to O
the O
beta-adrenoceptorergic B-protein
receptor I-protein
involves O
its O
rhodopsin-like protein
core O
. O

Binding O
of O
the O
4E-BPs B-protein
to O
eIF4E B-protein
is O
reversible O
and O
is O
dependent O
on O
the O
phosphorylation O
status O
of O
4E-BP B-protein
. O

Hypophosphorylated O
4E-BP1 B-protein
interacts O
strongly O
with O
eIF4E B-protein
, O
whereas O
hyperphosphorylation O
of O
4E-BP1 O
drastically O
decreases O
its O
binding O
to O
eIF4E O
. O

The O
binding O
of O
Pc B-protein
to O
the O
BXC B-DNA
and O
ANTC B-DNA
, O
and O
most O
other O
loci O
was O
also O
unaltered O
in O
the O
double O
mutant O
, O
but O
we O
found O
that O
binding O
to O
two O
specific O
chromosomal O
sites O
was O
lost O
( O
Fig O
. O
6) O
. O

The O
fimbrin B-protein
molecule O
that O
is O
bound O
to O
both O
actin B-protein
filaments I-protein
may O
also O
trigger O
even O
higher O
affinities O
at O
the O
two O
contacted O
binding O
sites O
( O
orange) O
. O

Pnt B-protein
binds O
specifically O
to O
the O
yan B-DNA
enhancer I-DNA
and O
competes O
with O
Su(H B-protein
) I-protein
for O
DNA B-DNA
binding O
. O

In O
three O
experiments O
, O
the O
binding O
of O
Ras B-protein-family
to O
Raf-1 B-protein
peptide O
increased O
upon O
antigen O
stimulation O
and O
showed O
similar O
maximal O
increases O
at O
1–2 O
min O
in O
both O
control O
( O
2 O
. O
0 O
± O
0 O
. O
5-fold O
, O
mean O
± O
S O
. O
E O
. O
) O
and O
dexamethasone-treated drug
( O
1 O
. O
9 O
± O
0 O
. O
3-fold O
) O
cells O
. O

The O
region O
of O
TAFII250 B-protein
bound O
by O
c-Jun B-protein
lies O
in O
the O
N-terminal O
163 O
amino O
acids O
. O

Several O
consensus O
sites O
for O
common O
transcription O
regulators O
including O
Oct-1 B-protein
( O
consensus O
binding O
motif O
NNGAATATKCANNNN) protein-motif
, O
NF1 B-protein
( O
core O
string O
TGGC) protein-motif
, O
AP2 B-protein
( O
MKCCCSCNGGCG) protein-motif
, O
AP4 B-protein-complex
( O
WGARYCAGCTGYGGNCNK) protein-motif
, O
CREB B-protein
( O
NNGNTGACGYNN) protein-motif
, O
Sp1 B-protein
( O
KRGGCGKRRY) protein-motif
, O
Nkx2 B-protein
. I-protein
5 I-protein
( O
TYAAGTG) protein-motif
, O
and O
MyoD B-protein
( O
NNCANTGNY B-protein-motif
) O
( O
Quandt O
et O
al O
. O
, O
1995 O
) O
were O
mapped O
to O
the O
promoter O
region O
. O

Electrophoretic O
mobility O
shift O
assays O
demonstrate O
that O
CRE-binding B-protein
protein I-protein
( O
CREB B-protein
) O
binds O
to O
the O
CFTR B-DNA
CRE I-DNA
with O
high O
affinity O
and O
independently O
of O
the O
adjacent O
Y B-DNA
box I-DNA
and O
that O
the O
CFTR O
CRE O
binds O
CREB O
and O
activating B-protein
transcription I-protein
factor-1 I-protein
in O
nuclear O
extracts O
of O
T84 B-cell
and O
CaLu-3 B-cell
cells O
. O

TnI B-protein-family
, O
the O
inhibitory O
subunit O
, O
inhibits O
the O
actomyosin B-protein
ATPase I-protein
and O
binds O
actin B-protein
, O
while O
TnT B-protein-family
binds O
tropomyosin B-protein-family
. O

Paradoxically O
, O
however O
, O
we O
detected O
similar O
quantitative O
binding O
between O
STK15 B-protein
and O
PP1 B-protein-family
at O
8 O
, O
9 O
, O
and O
12 O
h O
post-thymidine O
release O
, O
despite O
the O
fact O
that O
STK15 O
was O
predominantly O
seen O
in O
active O
hyperphosphorylated O
form O
at O
8 O
and O
9 O
h O
post-release O
unlike O
the O
hypophosphorylated O
form O
detected O
at O
12 O
h O
post-release O
( O
Fig O
. O
2 O
A) O
. O

Because O
Src B-protein
does O
not O
bind O
to O
Abl B-protein
( O
not O
shown) O
, O
its O
binding O
to O
Cbl B-protein
in O
the O
presence O
of O
Abl O
could O
be O
explained O
by O
a O
modification O
of O
Cbl O
conformation O
induced O
by O
its O
binding O
to O
Abl O
. O

Ca2+ B-chemical
could O
promote O
synaptotagmin B-protein-family
binding O
to O
syntaxin/SNAP25 protein
heterodimers O
, O
which O
would O
bring O
VAMP B-protein
on O
the O
vesicle O
into O
proximity O
with O
syntaxin/SNAP25 O
heterodimers O
to O
form O
ternary O
SNARE B-protein-complex
complexes O
that O
could O
initiate O
fusion O
( O
16) O
. O

The O
conserved O
sequences O
corresponding O
to O
3′HS1 B-DNA
, O
5′HS5 B-DNA
of O
the O
LCR B-DNA
, O
the O
HS B-DNA
located O
at O
kb O
−62 O
. O
5 O
in O
mice O
and O
kb O
−111 O
in O
humans O
, O
and O
the O
HS O
at O
kb O
−85 O
. O
5 O
in O
mice O
resemble O
the O
CTCF B-protein
binding O
sites O
from O
previously O
characterized O
enhancer-blocking O
elements O
( O
Fig O
. O
2A) O
. O

Pseudomonas B-organism
aeruginosa I-organism
and O
Pseudomonas B-organism
cepacia I-organism
isolated O
from O
cystic O
fibrosis O
patients O
bind O
specifically O
to O
gangliotetraosylceramide B-chemical
( O
Asialo B-chemical
GM1 I-chemical
) O
and O
gangliotriaosylceramide B-chemical
( O
Asialo -
GM2) -
. O

B O
, O
binding O
of O
recombinant O
EGR-1 B-protein
and O
NFATc B-protein
to O
a O
33P-labeled O
oligonucleotide O
that O
represents O
the O
ZIP B-DNA
and O
the O
NFAT B-DNA
site I-DNA
of O
the O
human O
IL-2 B-DNA
gene I-DNA
promoter I-DNA
( O
ZN) O
. O

Altogether O
, O
these O
observations O
suggest O
that O
binding O
of O
DDP1 B-protein
to O
the O
dodeca-satellite B-DNA
C-strand I-DNA
is O
largely O
conformational O
dependent O
and O
support O
the O
hypothesis O
that O
DDP1 O
could O
also O
bind O
ssDNA B-DNA
fragments O
other O
that O
the O
dodeca-satellite O
C-strand O
. O

From O
the O
earliest O
demonstrations O
that O
CRP B-protein
binds O
to O
microbes O
and O
mediates O
their O
killing O
in O
vitro O
, O
to O
more O
recent O
observations O
of O
protection O
against O
Gram-positive O
and O
Gram-negative O
bacteria O
in O
CRPtg B-fusion-protein
mice O
, O
the O
evidence O
has O
overwhelmingly O
supported O
the O
notion O
that O
CRP O
plays O
an O
important O
role O
in O
host O
defense O
. O

A O
prediction O
from O
the O
hypothesis O
that O
Wnt B-process
signaling I-process
might O
use O
Brg B-protein
to O
activate O
Myc B-protein
is O
that O
Brg O
binds O
the O
Myc B-DNA
promoter I-DNA
, O
a O
direct O
target O
of O
Wnt O
signaling O
( O
He O
et O
al O
. O
, O
1998) O
. O

Our O
results O
support O
the O
former O
kinetic O
model O
where O
eIF4G B-protein
binds O
to O
eIF4E B-protein
independently O
of O
an O
interaction O
with O
eIF3 B-protein
( O
Figure O
3) O
. O

For O
most O
actin-binding protein
proteins O
this O
would O
require O
that O
domains O
1 O
and O
3 O
of O
actin O
be O
exposed O
in O
the O
BAF B-protein-complex
complex O
, O
which O
is O
the O
case O
since O
both O
profilin B-protein-family
and O
cofilin B-protein
bind O
to O
actin O
within O
the O
complex O
. O

Binding O
of O
p23 B-protein
to O
Hsp90 B-protein-family
is O
promoted O
by O
ATP B-chemical
or O
ATPγS B-chemical
but O
inhibited O
by O
ADP B-chemical
( O
Sullivan O
et O
al O
. O
1997 O
) O
and O
thus O
appears O
to O
be O
dependant O
on O
the O
presence O
of O
the O
γ B-chemical
phosphate I-chemical
. O

Mutation O
of O
this O
Arg B-amino-acid
( O
Arg25 B-amino-acid
) O
Cys B-amino-acid
in O
the O
Akt1 B-protein
PH B-protein-domain
domain I-protein-domain
or O
Arg28 B-mutation
Cys I-mutation
in O
Btk B-protein
abrogates O
the O
binding O
of O
these O
PH B-protein-domain
domains I-protein-domain
to O
PI(3 B-chemical
, I-chemical
4 I-chemical
, I-chemical
5)P3 I-chemical
. O

SXL B-protein
Can O
Directly O
Bind O
both O
UTRs O
of O
msl-2 B-RNA

PS1 B-protein
preferentially O
binds O
immature O
APP B-protein
and O
Notch B-protein-family
within O
the O
ER/Golgi B-organelle
in O
transfected O
mammalian O
cells O
( O
21 O
, O
22) O
. O

Furthermore O
, O
the O
binding O
of O
Abi-1 B-protein
to O
Sos B-protein
alone O
is O
apparently O
not O
sufficient O
to O
block O
all O
signaling O
to O
Erks B-protein-family
; O
for O
example O
, O
overexpression O
of O
Abi-1 O
fails O
to O
abolish O
v-Src-induced protein
Erk B-protein-family
activation O
. O

The O
fact O
that O
CKI B-protein-family
binding O
of O
dPER B-protein
and O
mPER1 B-protein
has O
been O
preserved O
while O
the O
location O
and O
sequence O
of O
the O
binding O
site O
may O
have O
been O
shuffled O
suggests O
there O
is O
strong O
selective O
pressure O
to O
maintain O
the O
interaction O
of O
the O
two O
proteins O
. O

EBP50/NHERF protein
through O
an O
ERM-binding B-protein-domain
domain I-protein-domain
binds O
to O
the O
cortical O
actin B-protein
cytoskeleton O
. O

If O
transcription O
of O
a O
target O
gene O
is O
not O
initiated O
in O
a O
cell O
, O
PcG B-protein-family
proteins O
bound O
to O
the O
gene O
' O
s O
PRE B-DNA
chromatin O
form O
a O
silencing O
structure O
that O
supersedes O
colocalized O
TRX B-protein
( O
P O
OUX O
et O
al O
. O
1996 O
) O
. O

Thus O
, O
we O
propose O
that O
the O
mutations O
define O
the O
site O
at O
which O
DM B-protein-family
binds O
DR B-protein-family
during O
peptide O
exchange O
. O

Synaptotagmin B-protein
I I-protein
also O
binds O
to O
polymerized O
tubulin B-protein-family
. O

The O
involvement O
of O
CBP/ B-protein
p300 I-protein
binding O
with O
E2F B-protein-complex
transactivation O
indicates O
that O
recruitment O
of O
these O
acetylases O
following O
release O
of O
E2F-1 B-protein
from O
pRB B-protein
may O
represent O
an O
important O
mechanism O
in O
the O
relief O
of O
pRB-mediated O
transcriptional O
repression O
. O

Together O
, O
these O
results O
support O
the O
notion O
that O
Crk B-protein
binding O
to O
CAS B-protein-family
is O
critical O
for O
the O
migratory O
properties O
of O
these O
cells O
and O
that O
the O
substrate O
domain O
of O
CAS O
as O
well O
as O
the O
SH2 B-protein-domain
domain I-protein-domain
of O
Crk O
contribute O
to O
this O
response O
. O

We O
found O
that O
both O
the O
wild-type O
and O
the O
triple O
mutant O
form O
of O
FKHRL1 B-protein
bound O
to O
the O
IRS B-DNA
of O
the O
IGFBP1 B-DNA
gene I-DNA
, O
leading O
to O
a O
shift O
in O
the O
mobility O
of O
the O
IRS B-DNA
DNA I-DNA
element I-DNA
on O
a O
nondenaturing O
polyacrylamide O
gel O
( O
Figure O
5B O
, O
lanes O
1 O
, O
2 O
, O
and O
3) O
. O

However O
, O
the O
131-1-1 B-experimental-construct
chimera I-experimental-construct
containing O
the O
Na B-protein-region
region I-protein-region
of O
Smad1 B-protein
could O
weakly O
induce O
transcription O
of O
3GC2-Lux B-experiment-tag
, O
but O
the O
13-1-1 B-experimental-construct
and O
133-1-1 O
chimeras O
failed O
to O
do O
so O
, O
2 O
suggesting O
that O
Smad1 O
may O
bind O
to O
GC-rich B-DNA
sequences I-DNA
in O
a O
fashion O
different O
from O
that O
of O
Smad3 B-protein
and O
that O
both O
the O
Na O
and O
the O
C O
regions O
of O
MH1 B-protein-domain
may O
play O
a O
role O
in O
the O
direct O
DNA B-DNA
binding O
of O
Smad1 O
. O

This O
agrees O
with O
our O
previous O
finding O
that O
the O
Q B-protein-domain
domain I-protein-domain
is O
required O
for O
efficient O
binding O
between O
Gro B-protein
and O
Rpd3 B-protein
( O
Fig O
. O
​(Fig O
. O
4D)4D O
) O
and O
with O
our O
previously O
published O
results O
showing O
that O
efficient O
repression O
by O
Gro O
requires O
a O
functional O
tetramerization O
domain O
( O
Chen O
et O
al O
. O
1998) O
. O

Myopodin B-protein
can O
directly O
bind O
to O
actin B-protein
and O
contains O
a O
novel O
actin O
binding O
site O
in O
the O
center O
of O
the O
protein O
. O

Deletion O
analysis O
confirmed O
that O
U2AF65 B-protein
bound O
to O
the O
Py B-DNA
tract I-DNA
( O
data O
not O
shown) O
. O

However O
, O
it O
did O
so O
with O
lower O
efficiency O
than O
the O
COOH-terminal O
portion O
of O
Eps15 B-protein
itself O
, O
suggesting O
that O
, O
in O
vivo O
, O
Eps15 O
binds O
to O
AP2 B-protein-complex
with O
higher O
affinity O
than O
with O
Numb B-protein
( O
Fig O
4 O
D) O
. O

Biochemical O
analyses O
show O
that O
the O
Tiam1 B-protein
fragment O
( O
amino O
acids O
393 O
- O
738 O
) O
contains O
an O
ankyrin-binding protein-family
site O
and O
competes O
for O
Tiam1 O
binding O
to O
ankyrin O
. O

We O
next O
examined O
whether O
the O
binding O
of O
menin B-protein
to O
GTP B-chemical
is O
affected O
by O
the O
concentration O
of O
Mg2+ B-chemical
, O
as O
observed O
with O
many O
GTPases B-protein-family
( O
28 O
, O
29) O
. O

As O
the O
Dlt-binding protein
site O
in O
Crb B-protein
differs O
from O
these O
motifs O
, O
the O
first O
PDZ B-protein-family
domain I-protein-family
of O
Dlt O
, O
which O
binds O
to O
Crb O
in O
vitro O
[ O
23 O
] O
, O
may O
belong O
to O
a O
different O
class O
. O

The O
cNMP-BD B-protein-domain
of O
CNrasGEF B-protein
is O
similar O
to O
the O
cAMP-binding B-protein-domain
region I-protein-domain
of O
PKA B-protein-complex
and O
cAMP B-protein-family
GEFs I-protein-family
2 O
, O
3 O
and O
to O
the O
cGMP-binding chemical
region O
of O
PKG B-protein
and O
cyclic-nucleotide-gated B-protein-family
K+ I-protein-family
channels I-protein-family
, O
although O
it O
lacks O
conservation O
of O
the O
AA O
or O
TA O
within O
the O
R(A/T)A B-DNA
motif I-DNA
found O
in O
PKA O
( O
and O
Epac B-protein
) O
or O
in O
PKG O
, O
respectively O
( O
see O
Supplementary O
material) O
. O

Abeta1-42 B-peptide
has O
such O
high O
affinity O
for O
Cu2+ B-chemical
( O
attomolar O
) O
( O
8 O
) O
that O
it O
is O
likely O
to O
be O
metallated O
in O
vivo O
, O
and O
indeed O
we O
found O
that O
Abeta B-peptide
purified O
from O
AD B-tissue
plaque I-tissue
is O
mainly O
bound O
to O
Zn B-chemical
( O
1 O
. O
7 O
eq O
per O
mol O
of O
Abeta O
) O
and O
Cu B-chemical
( O
0 O
. O
4 O
eq) O
. O

However O
, O
our O
recent O
observation O
that O
TDP-43 B-protein
can O
efficiently O
bind O
to O
( B-RNA
UG)m I-RNA
sequences I-RNA
( O
1 O
) O
is O
consistent O
with O
the O
presence O
of O
two O
putative O
full-length O
RRM B-protein-domain
domains I-protein-domain
( O
Fig O
. O
1 O
A O
) O
located O
between O
residues O
106 O
and O
175 O
( O
RRM1 B-protein-domain
) O
and O
193 O
and O
257 O
( O
RRM2 B-protein-domain
) O
of O
its O
coding O
sequence O
according O
to O
the O
output O
of O
the O
Pfam B-assay
program O
( O
available O
at O
www O
. O
sanger O
. O
ac O
. O
uk) O
. O

The O
other O
peptide O
motifs O
that O
inhibit O
angiogenesis O
might O
enhance O
the O
binding O
of O
TSP-1 B-protein
to O
CD36 B-protein
, O
for O
example O
through O
ligation O
of O
proteoglycan B-protein-family
coreceptors I-protein-family
, O
or O
could O
have O
indirect O
effects O
such O
as O
sequestration O
of O
proangiogenic O
morphoregulatory O
factors O
( O
Guo O
et O
al O
. O
1997 O
, O
Iruela-Arispe O
et O
al O
. O
1999) O
. O

Co-expression O
of O
deltaN B-protein
, O
which O
binds O
APP B-protein
but O
not O
JNK B-protein
, O
affects O
the O
amount O
of O
immature O
APP O
as O
much O
as O
does O
the O
co-expression O
of O
JIP1b B-protein
. O

Binding O
of O
mdm2 B-protein
to O
p53 B-protein
also O
targets O
p53 O
for O
degradation O
through O
ubiquitin-mediated protein-family
pathways O
( O
19 O
, O
20) O
. O

In O
particular O
, O
Pbx B-protein-family
binds O
to O
Hox B-protein-family
proteins I-protein-family
from O
paralog O
group O
1-10 O
( O
Shen O
et O
al O
. O
, O
1997b O
) O
and O
Meis B-protein-family
binds O
to O
Hox O
proteins O
from O
paralog O
group O
9-13 O
( O
Shen O
et O
al O
. O
, O
1997a O
) O
. O

Recent O
evidence O
also O
suggested O
that O
Crk B-protein
binding O
to O
paxillin B-protein
might O
play O
an O
important O
role O
in O
signaling O
by O
IGF-1 B-protein-family
and O
growth B-protein-family
hormone I-protein-family
receptors I-protein-family
( O
43 O
, O
44) O
. O

Since O
the O
HOX B-protein-family
proteins I-protein-family
exhibit O
binding O
to O
CBP B-protein
and O
p300 B-protein
, O
one O
possible O
mechanism O
by O
which O
CBP O
might O
prevent O
HOX O
protein O
DNA B-DNA
binding O
might O
be O
by O
direct O
acetylation O
of O
the O
HD B-protein-domain
. O

To O
further O
narrow O
down O
the O
TEF-1-binding protein
region O
of O
SRF B-protein
, O
we O
analyzed O
an O
additional O
SRF O
mutant O
containing O
amino O
acids O
1-204 O
. O

The O
results O
showed O
that O
ATP B-chemical
bound O
only O
to O
Orc1 B-protein
, O
Orc4 B-protein
and O
Orc5 B-protein
( O
Figure O
1) O
, O
consistent O
with O
the O
presence O
of O
Walker B-protein-motif
A I-protein-motif
and O
B B-protein-motif
amino O
acid O
sequence O
motifs O
in O
these O
proteins O
. O

More O
binding O
of O
PR B-protein
and O
better O
synergism O
in O
the O
presence O
of O
H1 B-protein-family
he O
results O
of O
the O
ChIP B-assay
experiments O
with O
anti-PR B-reagent
antibodies I-reagent
show O
that O
PR O
binding O
to O
the O
MMTV B-DNA
promoter I-DNA
nucleosome O
is O
enhanced O
in O
minichromosomes O
containing O
histone B-protein-family
H1 I-protein-family
. O

The O
binding O
of O
HSC B-cell
nuclear O
extracts O
to O
a O
Sp1 B-protein
cognate O
oligonucleotide O
was O
low O
in O
control O
cells O
but O
increased O
significantly O
following O
an O
NAC B-chemical
treatment O
of O
HSC O
with O
optimal O
activation O
at O
around O
6 O
h O
( O
Fig O
. O
5 O
A) O
. O

The O
observation O
that O
the O
binding O
of O
cytoplasmic O
dynein B-protein-family
to O
p150 B-protein
is O
mediated O
by O
DIC B-protein
is O
interesting O
in O
view O
of O
the O
functional O
homology O
of O
this O
polypeptide O
to O
the O
70-kDa O
intermediate O
chain O
of O
flagellar O
outer O
arm O
dynein O
from O
Chlamydomonas O
. O

In O
CD44 B-protein
, O
a O
. O
a O
. O
1-19 O
and O
a O
. O
a O
. O
1-31 O
( O
thick O
lines O
, O
bottom O
, O
a O
) O
bound O
to O
moesin B-protein
with O
similar O
affinity O
to O
the O
whole O
cytoplasmic B-protein-domain
domain I-protein-domain
of I-protein-domain
CD44 I-protein-domain
at O
40 O
mM O
KCl B-chemical
, O
whereas O
a O
. O
a O
. O
19-70 O
as O
well O
as O
a O
. O
a O
. O
1-70 O
showed O
very O
low O
affinity O
to O
moesin O
( O
broken O
lines O
, O
bottom O
, O
a) O
, O
indicating O
that O
a O
. O
a O
. O
1-19 O
are O
responsible O
for O
moesin O
binding O
of O
CD44 O
( O
Fig O
. O
2 O
) O
and O
that O
a O
. O
a O
. O
19-70 O
are O
inhibitory O
for O
moesin O
binding O
of O
CD44 O
. O

GAGA B-protein
factor I-protein
, O
which O
binds O
the O
GAGA B-DNA
element I-DNA
, O
has O
been O
shown O
to O
remodel O
chromatin O
and O
may O
be O
involved O
in O
rendering O
the O
DNA B-DNA
in O
chromatin O
accessible O
to O
the O
transcriptional O
machinery O
( O
41 O
, O
45 O
, O
46) O
. O

It O
has O
been O
proposed O
that O
Rb B-protein
binds O
to O
the O
E2F B-protein-domain
activation I-protein-domain
domain I-protein-domain
and O
blocks O
its O
function O
as O
a O
transcription O
factor O
. O

Precisely O
how O
Wnt B-protein-family
binding O
to O
Fz B-protein-family
causes O
inhibition O
of O
GSK-3beta B-protein
is O
still O
not O
clear O
, O
but O
we O
now O
know O
that O
it O
involves O
two O
members O
of O
the O
LDL B-protein-family
receptor I-protein-family
gene I-protein-family
family I-protein-family
, O
LRP5 B-protein
and O
LRP6 B-protein
. O

Here O
we O
have O
shown O
that O
myozenin B-protein-family
also O
binds O
alpha-actinin B-protein-family
in O
this O
region O
, O
likely O
somewhere O
within O
residues O
606-757 O
. O

A O
, O
TFIID B-protein-complex
binds O
more O
efficiently O
than O
TBP B-protein
to O
immobilized O
pol B-protein-family
II I-protein-family
. O

Although O
stable O
binding O
of O
MDH B-protein-family
to O
HSP18 B-protein
. I-protein
1 I-protein
was O
not O
detected O
below O
40°C O
by O
SEC B-assay
( O
Figure O
2) O
, O
substantial O
bis-ANS B-experiment-tag
labeling O
of O
MDH O
at O
38°C O
suggested O
that O
, O
at O
this O
temperature O
, O
MDH O
was O
partially O
unfolded O
and O
may O
have O
bound O
HSP18 O
. O
1 O
reversibly O
, O
thereby O
limiting O
bis-ANS O
binding O
. O

To O
search O
for O
proteins O
interacting O
with O
the O
GTP-bound chemical
form O
of O
Rab5 B-protein
, O
we O
have O
previously O
screened O
a O
HeLa B-cell
expression O
cDNA B-DNA
library O
and O
identified O
Rabaptin-5 B-protein
( O
Stenmark O
et O
al O
. O
, O
1995a O
) O
. O

We O
have O
confirmed O
the O
fact O
that O
Gro B-protein
can O
strongly O
bind O
Hairy B-protein
and O
the O
E B-protein-family
( I-protein-family
spl I-protein-family
) I-protein-family
bHLH I-protein-family
proteins I-protein-family
regardless O
of O
fusion O
orientation O
. O

Thus O
, O
we O
infer O
that O
the O
conditional O
growth O
phenotype O
of O
the O
E83A B-cell
cells I-cell
was O
likely O
not O
caused O
by O
a O
defect O
in O
the O
interaction O
of O
SpCdk9 B-protein
with O
Pch1 B-protein
, O
but O
rather O
a O
conditional O
defect O
in O
kinase O
activity O
resulting O
from O
loss O
of O
the O
ion O
pair O
to O
the O
essential O
lysine B-amino-acid
that O
binds O
ATP B-chemical
. O

The O
cytoplasmic O
domain O
of O
cadherin B-protein-family
binds O
to O
catenins B-protein-family
, O
which O
are O
required O
for O
binding O
the O
cadherin/ B-protein-complex
catenin I-protein-complex
complex I-protein-complex
to O
the O
actin B-organelle
cytoskeleton I-organelle
. O

The O
p120cas B-protein
protein O
associates O
also O
directly O
with O
the O
cytoplasmic O
domain O
of O
E-cadherin B-protein
, O
but O
is O
not O
binding O
to O
α-catenin B-protein-family
( O
Daniel O
and O
Reynolds O
, O
1995) O
. O

ELP70 B-protein
binds O
to O
MTs B-organelle
in O
vitro O
. O

Fractionation O
of O
splicing O
extracts O
showed O
that O
two O
fractions O
associated O
with O
U2 B-RNA
snRNP I-RNA
, O
SF3a B-protein-complex
and O
SF3b B-protein-complex
, O
are O
required O
for O
the O
binding O
of O
U2 O
snRNP O
to O
pre-mRNAs B-RNA
( O
10 O
, O
31) O
. O

The O
observations O
that O
substitution O
of O
serine B-amino-acid
195 I-amino-acid
with O
both O
cysteine B-amino-acid
and O
alanine B-amino-acid
inhibit O
cleavage O
, O
and O
that O
the O
mutant O
ETs B-protein-family
still O
specifically O
bind O
Dsg1 B-protein
( O
see O
below) O
, O
demonstrate O
that O
serine O
195 O
is O
necessary O
for O
efficient O
catalytic O
cleavage O
of O
Dsg1 O
. O

In O
this O
report O
, O
we O
used O
far O
Western O
analysis O
, O
fluorescence O
titration O
, O
and O
RNA B-RNA
mobility O
shift O
assays O
to O
demonstrate O
that O
PABP B-protein
does O
bind O
eIF-4F B-protein-complex
, O
eIF-iso4F B-protein-complex
, O
and O
eIF-4B B-protein
either O
in O
the O
presence O
or O
absence O
of O
poly(A B-RNA
) I-RNA
and O
that O
their O
interaction O
increases O
PABP O
RNA O
binding O
activity O
. O

Fig O
. O
1 O
C O
shows O
that O
p53 B-protein
binds O
comparably O
to O
the O
CR2 B-protein-region
regions I-protein-region
from O
both O
CBP B-protein
and O
p300 B-protein
( O
lanes O
3 O
and O
4) O
. O

To O
ask O
whether O
MICAL B-protein-family
binds O
FAD B-chemical
, O
we O
made O
a O
bacterial O
fusion O
protein O
containing O
the O
MICAL B-protein-domain
flavoprotein I-protein-domain
monooxygenase I-protein-domain
domain I-protein-domain
( O
MICAL-FM) protein-domain
. O

( O
A O
) O
Effect O
of O
rapamycin B-drug
on O
phosphorylation O
of O
eIF2alpha B-protein
is O
strongly O
dependent O
on O
dephosphorylation O
of O
Ser B-amino-acid
577 I-amino-acid
and O
the O
tRNA B-RNA
binding O
activity O
of O
GCN2 B-protein
. O

Hydrolysis O
of O
the O
GTP B-chemical
bound O
to O
rac1 B-protein
would O
inactivate O
its O
signaling O
function O
and O
result O
in O
the O
dissociation O
of O
the O
DdLim-ABPs B-protein-complex
complex I-protein-complex
and O
thereby O
uncouple O
the O
receptor- O
mediated O
signaling O
pathway O
from O
actin B-protein
filament I-protein
dynamics O
at O
the O
leading O
edge O
. O

We O
estimate O
that O
50% O
of O
the O
overexpressed O
MEKK1 B-protein
was O
bound O
to O
Raf-1 B-protein
. O

( O
A O
) O
GST B-assay
pull-down I-assay
assays I-assay
were O
performed O
with O
GST-VP16 protein
or O
GST O
alone O
bound O
to O
GSH-Sepharose B-reagent
beads I-reagent
and O
300 O
mug O
of O
S2 B-cell
nuclear I-cell
extract I-cell
. O

Binding O
of O
an O
LDB B-protein-family
cofactor O
to O
the O
LIM B-protein-domain
domains I-protein-domain
was O
thought O
to O
alleviate O
this O
repression O
( O
Agulnik O
et O
al O
. O
1996 O
) O
. O

The O
requirement O
for O
the O
MADS B-protein-motif
box I-protein-motif
for O
both O
DNA B-DNA
binding O
and O
interaction O
with O
GATA-4 B-protein
when O
SRF B-protein
is O
bound O
to O
SREs B-DNA
may O
impose O
structural O
constraints O
that O
are O
not O
present O
when O
the O
MADS O
box O
is O
tethered O
to O
DNA O
. O

Recently O
it O
was O
shown O
that O
cyclin B-protein
D1 I-protein
can O
bind O
to O
the O
estrogen B-protein
receptor I-protein
and O
enhance O
its O
transcriptional O
activity O
, O
independent O
of O
any O
cdk4 B-protein
activation O
( O
13 O
, O
14) O
. O

Crk B-protein
Binding O
to O
Paxillin B-protein
Is O
Impaired O
in O
F31/118-expressing B-cell
Cells I-cell
Tyrosine B-amino-acid
residues O
31 O
and O
118 O
of O
paxillin O
reside O
within O
a O
YXXP B-protein-region
motif I-protein-region
that O
corresponds O
to O
an O
optimal O
Crk-SH2-binding protein-domain
sequence O
( O
Birge O
et O
al O
. O
1993 O
) O
. O

At O
present O
, O
the O
significance O
of O
binding O
of O
EB1 B-protein
and O
Pin2/TRF1 protein
is O
unclear O
, O
and O
we O
can O
only O
speculate O
how O
expression O
of O
the O
mutant O
Pin21-316 B-protein
is O
able O
to O
restore O
the O
mitotic O
spindle O
checkpoint O
defect O
in O
A-T B-cell
cells I-cell
and O
how O
Pin2/TRF1 O
is O
normally O
involved O
in O
the O
mitotic O
spindle O
checkpoint O
. O

Pbx B-protein-family
Homologs O
Extradenticle B-protein
and O
ceh-20 B-protein
Interact O
with O
Meis1 B-protein
to O
Cooperatively O
Bind O
CRS1 B-protein

To O
determine O
whether O
the O
interaction O
of O
Pbx B-protein-family
and O
Meis1 B-protein
families O
extends O
beyond O
mammalian O
isoforms O
, O
the O
Pbx O
homologs O
from O
Drosophila O
and O
C O
. O
elegans O
were O
tested O
for O
cooperative O
CRS1 B-protein
binding O
with O
Meis1 O
. O

The O
crystal O
structure O
of O
REGα B-protein
reveals O
a O
20–30 O
Å-wide O
aqueous O
channel O
through O
a O
donut-shaped O
heptamer O
( O
Knowlton O
et O
al O
. O
, O
1997) O
, O
and O
electron O
microscopic O
images O
suggest O
that O
REG B-protein-complex
heptamers I-protein-complex
bind O
the O
proteasome B-organelle
with O
their O
aqueous O
channels O
normal O
to O
and O
centered O
over O
the O
proteasome B-protein
α I-protein
subunit I-protein
ring O
( O
Gray O
et O
al O
. O
, O
1994) O
. O

The O
effect O
is O
thought O
to O
arise O
through O
the O
non-specific O
binding O
of O
transcription O
factors O
with O
the O
PS B-chemical
backbone O
[ O
2 O
. O

Sp1 B-protein
and O
Sp3 B-protein
bind O
to O
the O
AR1 B-DNA
sequence I-DNA
. O

The O
structure O
of O
the O
HP1 B-protein
chromodomain O
bound O
to O
histone B-protein-family
H3 I-protein-family
di- O
or O
trimethylated O
at O
lysine B-amino-acid
9 I-amino-acid
shows O
that O
either O
peptide O
fits O
in O
a O
groove O
and O
lodges O
the O
methyllysine B-amino-acid
in O
a O
hydrophobic O
pocket O
( O
Nielsen O
et O
al O
. O
, O
2002 O
; O
Jacobs O
and O
Khorasanizadeh O
, O
2002 O
) O
. O

This O
interaction O
seems O
to O
be O
mediated O
through O
Polalpha B-protein-complex
as O
MBP B-protein
alone O
did O
not O
bind O
to O
Swi6 B-protein
. O

It O
is O
also O
possible O
that O
both O
PR B-protein
and O
the O
carboxyl-terminal O
PR B-protein-motif
binding I-protein-motif
motif I-protein-motif
of O
RIZ1 B-protein
may O
interact O
with O
other O
as O
yet O
unidentified O
proteins O
. O

E-cadherin-induced protein
growth O
regulation O
is O
mediated O
by O
the O
binding O
of O
catenins B-protein-family
to O
the O
cadherin O
cytoplasmic O
tail O
and O
results O
in O
modulation O
of O
Wnt B-process
signaling I-process
( O
59) O
, O
β-catenin/T-cell protein-family
factor -
signaling O
( O
26) O
, O
and O
p27Kip1 B-protein
up-regulation O
( O
11) O
. O

Binding O
of O
human O
apolipoprotein B-protein
E I-protein
to O
synthetic O
amyloid B-peptide
beta I-peptide
peptide I-peptide
: O
isoform-specific O
effects O
and O
implications O
for O
late-onset O
Alzheimer O
disease O
. O

This O
result O
suggests O
that O
the O
binding O
between O
fascin B-protein
and O
beta-catenin B-protein-family
may O
not O
be O
significant O
in O
these O
cell O
lines O
, O
LLC-PK1 B-cell
cells I-cell
, O
and O
fascin O
transfectants O
. O

Binding O
of O
Hh B-protein
to O
Ptc B-protein-family
frees O
Smo B-protein
from O
Ptc O
repression O
, O
which O
then O
goes O
on O
to O
activate O
downstream O
target O
genes O
. O

As O
shown O
in O
Figure O
7B O
, O
the O
extracellular O
domain O
, O
but O
not O
the O
intracellular O
domain O
, O
of O
Kek1 B-protein
can O
bind O
to O
the O
EGFR B-protein
. O

Although O
Abd-A/ protein
Exd B-protein
heterodimers O
bind O
fkh[250con protein
in O
vitro O
, O
strong O
fkh[250con- O
lacZ B-protein
expression O
was O
not O
detected O
in O
the O
abdominal O
segments O
in O
which O
abd-A B-protein
is O
expressed O
( O
Fig O
. O
7A O
, O
B) O
. O

It O
suggests O
that O
both O
endogenous O
and O
exogenous O
PKAc B-protein
bind O
to O
dSlo B-protein
at O
the O
same O
site O
, O
and O
an O
excess O
of O
the O
mutant O
PKAc O
can O
function O
as O
a O
dominant O
negative O
to O
prevent O
endogenous O
PKAc O
from O
binding O
to O
and O
phosphorylating O
dSlo O
. O

Conversely O
, O
E1A B-protein
binding O
to O
only O
p300/CBP B-protein-family
results O
in O
an O
increase O
in O
PARP B-protein-family
enzyme O
activity O
and O
consequently O
in O
cell O
death O
susceptibility O
to O
irradiation O
, O
which O
is O
effectively O
counteracted O
by O
the O
PARP O
chemical O
inhibitor O
3-aminobenzamide B-chemical
. O

These O
results O
suggest O
that O
at O
least O
mammalian O
JIP1b B-protein
and O
JIP2 B-protein
could O
bind O
the O
cytoplasmic O
domain O
of O
APP B-protein
, O
whereas O
the O
preferences O
of O
JIP1b O
and O
JIP2 O
to O
bind O
APP O
are O
a O
little O
different O
. O

Despite O
this O
fact O
, O
WIF-1 B-protein
binds O
to O
Xwnt-8 B-protein
and O
is O
able O
to O
block O
the O
late O
ventralizing O
Xwnt-8 B-process
pathway I-process
. O

Zic2 B-protein
efficiently O
blocked O
Sp1 B-protein
and O
Sp3 B-protein
binding O
to O
the O
AR1 B-DNA
probe O
( O
Fig O
. O
7 O
C O
, O
lane O
3) O
, O
whereas O
control O
lysate O
did O
not O
( O
Fig O
. O
7 O
C O
, O
lane O
2) O
. O

As O
shown O
in O
Figure O
2A O
, O
APC11 B-protein
binds O
tightly O
to O
APC2 B-protein
and O
weakly O
to O
APC6 B-protein
. O

The O
data O
presented O
indicate O
that O
1 O
) O
Sp1 B-protein
or O
a O
related O
protein O
recognizes O
and O
binds O
a O
GC-rich B-DNA
site I-DNA
located O
between O
the O
two O
regions O
where O
the O
retinoid B-protein-family
receptors I-protein-family
bind O
, O
and O
2 O
) O
site-directed O
mutagenesis O
of O
this O
sequence O
abrogates O
the O
binding O
. O

Because O
Sec15p B-protein
also O
binds O
to O
activated O
Sec4p B-protein
, O
the O
exocyst O
might O
be O
an O
effector O
for O
this O
Rab-like B-protein-family
GTPase I-protein-family
that O
is O
necessary O
for O
the O
targeting O
or O
tethering O
of O
secretory O
vesicles O
to O
sites O
of O
secretion O
. O

Therefore O
, O
we O
conclude O
that O
phosphorylation O
of O
the O
CTD B-protein-domain
is O
sufficient O
to O
determine O
the O
binding O
of O
Set2 B-protein
to O
RNA B-protein-complex
polymerase I-protein-complex
II I-protein-complex
in O
vitro O
. O

To O
verify O
whether O
gamma1- B-protein
and O
gamma2-syntrophins B-protein
can O
also O
bind O
dystrophin B-protein
or O
related O
proteins O
, O
assays O
of O
protein-protein O
interaction O
were O
used O
. O

( O
H O
) O
Direct O
binding O
of O
Dlt B-protein
to O
Par-6 B-protein
, O
but O
not O
to O
aPKC B-protein
or O
Baz B-protein
. O

Myristoylated B-protein
alanine-rich I-protein
protein I-protein
kinase I-protein
C I-protein
substrate I-protein
( O
MARCKS B-protein
) O
is O
a O
primary O
and O
prominent O
protein O
substrate O
for O
PKC B-protein-family
, O
which O
binds O
calmodulin B-protein-family
in O
a O
calcium-dependent chemical
manner O
and O
also O
binds O
to O
phospholipid B-organelle
membrane I-organelle
( O
17-22) O
. O

These O
subunits O
bind O
at O
high-affinity O
polyubiquitin O
chains O
, O
in O
particular O
those O
that O
contain O
more O
than O
four O
moieties O
, O
but O
they O
also O
bind O
ubiquitin O
markers O
. O

A O
more O
likely O
explanation O
is O
that O
other O
components O
of O
the O
in O
vitro O
transcription O
reactions O
( O
e O
. O
g O
. O
, O
topoisomerase B-protein
I I-protein
) O
may O
modify O
the O
DNA-binding DNA
properties O
of O
TFIID B-protein
and O
TFIIA B-protein-complex
, O
leading O
to O
enhanced O
interactions O
despite O
the O
reduced O
TATA-Inr DNA
spacing O
. O

APC B-protein
binds O
to O
beta-catenin B-protein
using O
series O
of O
three O
15 O
amino O
acid O
repeat O
sequences O
, O
designated O
repeats O
A O
, O
B O
and O
C O
, O
and O
seven O
20 O
amino O
acid O
repeats O
, O
designated O
repeats O
1 O
- O
7 O
( O
Figure O
1A) O
. O

Rac B-protein-family
was O
immunoprecipitated O
, O
and O
following O
extensive O
washing O
the O
amount O
of O
GTP B-chemical
bound O
to O
Rac O
was O
estimated O
by O
scintillation O
counting O
. O

The O
question O
that O
arises O
from O
these O
studies O
is O
the O
mechanism O
by O
which O
GTP B-protein
bound I-protein
Rheb I-protein
stimulates O
the O
mTOR/S6K/4E-BP protein
signal O
transduction O
pathway O
. O

Taken O
together O
, O
these O
findings O
support O
a O
model O
in O
which O
binding O
of O
Hsp90 B-protein-family
with O
Apaf-1 B-protein
: O
( O
i O
) O
induces O
a O
potential O
conformational O
change O
in O
Apaf-1 O
and O
( O
ii O
) O
inhibits O
cyt -
c/dATP-mediated chemical
oligomerization O
of O
Apaf-1 O
, O
and O
thereby O
exerts O
a O
dominant-negative O
effect O
on O
the O
function O
of O
Apaf-1 O
to O
activate O
procaspase-9 B-protein
. O

Fig O
. O
1 O
shows O
that O
maximum O
pNPP B-chemical
hydrolysis O
is O
reached O
at O
an O
MKP3 B-protein
to O
ERK2 B-protein
ratio O
of O
1 O
: O
1 O
, O
indicating O
a O
1 O
: O
1 O
binding O
stoichiometry O
between O
MKP3 O
and O
ERK2 O
. O

The O
regions O
responsible O
for O
the O
in O
vitro O
binding O
of O
CD43 B-protein
and O
CD44 B-protein
to O
moesin B-protein
were O
narrowed O
down O
to O
their O
juxta-membrane O
20-30-amino O
acid O
sequences O
in O
the O
cytoplasmic O
domain O
. O

As O
shown O
, O
FLICE2 B-protein
bound O
both O
death B-protein-family
receptors I-protein-family
, O
and O
a O
substantial O
increase O
in O
binding O
was O
observed O
when O
FADD B-protein
was O
included O
in O
the O
transfections O
( O
Fig O
. O
2 O
, O
panels O
D O
and O
E O
, O
lanes O
1 O
and O
2) O
. O

Using O
equal O
amounts O
of O
DNA B-experiment-tag
probes I-experiment-tag
containing O
combinations O
of O
double O
mutations O
which O
leave O
only O
one O
Sp1 B-protein
site O
available O
for O
binding O
, O
we O
found O
that O
the O
- O
60 O
site O
has O
the O
highest O
affinity O
for O
Sp1 O
binding O
, O
based O
on O
the O
intensity O
of O
the O
shifted O
complex O
( O
Fig O
. O

U2AF-65 protein-complex
kDa O
binds O
to O
the O
dsx B-RNA
pre-mRNA I-RNA
equally O
in O
the O
presence O
and O
absence O
of O
the O
ESE B-DNA
. O

These O
results O
indicate O
that O
tomosyn B-protein
binds O
to O
syntaxin-1a B-protein
in O
a O
manner O
competitive O
with O
Munc18 B-protein
. O

Heparin B-chemical
can O
modulate O
laminin B-protein-family
polymerization O
and O
the O
heparan B-chemical
sulfates I-chemical
of O
perlecan B-protein
can O
bind O
to O
laminin O
, O
likely O
stabilizing O
the O
network O
( O
reviewed O
in O
Yurchenco O
and O
O O
' O
Rear O
, O
1993) O
. O

Therefore O
, O
the O
binding O
of O
Sir2 B-protein
and O
Sir3 B-protein
at O
70 O
bp O
, O
0 O
. O
5 O
kb O
, O
and O
2 O
. O
4 O
kb O
from O
the O
telomeric B-DNA
C1-3A I-DNA
repeats I-DNA
is O
dependent O
on O
the O
presence O
of O
the O
entire O
Sir B-protein-complex
complex I-protein-complex
. O

Moreover O
, O
as O
shown O
in O
Fig O
. O
2 O
B O
, O
when O
procaspase-9 B-protein
was O
present O
, O
dATP B-chemical
binding O
to O
Apaf-1 B-protein
was O
stimulated O
further O
. O

NFATp B-protein
and O
Sp1 B-protein
bind O
overlapping O
TNF-alpha B-DNA
promoter I-DNA
sequences O
. O

Affinity O
analyses O
indicate O
that O
ZO-1 B-protein
binds O
to O
occludin B-protein
( O
15 O
) O
and O
the O
Ras B-protein-family
target I-protein-family
AF-6 B-protein
( O
47) O
. O

DNedd4 B-protein
binds O
to O
Comm B-protein
through O
two O
of O
its O
three O
WW B-protein-domain
domains I-protein-domain
, O
which O
recognize O
either O
of O
two O
PY B-protein-motif
motifs I-protein-motif
( O
PPCY B-protein-motif
or O
LPSY B-protein-motif
) O
in O
the O
intracellular O
domain O
of O
Comm O
. O

Furthermore O
, O
it O
has O
been O
shown O
that O
GSK-3beta B-protein
phosphorylates O
APC B-protein
and O
that O
the O
phosphorylation O
enhances O
the O
binding O
of O
APC O
to O
beta-catenin B-protein
( O
Rubinfeld O
et O
al O
. O
, O
1996 O
) O
. O

Smad3 B-protein
Binds O
the O
p300 B-protein
C-Terminal O
Fragment O

As O
a O
control O
, O
competition O
with O
unlabeled B-reagent
oligonucleotide I-reagent
markedly O
diminished O
the O
binding O
of O
both O
Smad3 B-protein
and O
Sp1 B-protein
to O
the O
biotinylated B-reagent
oligonucleotide I-reagent
( O
Fig O
. O
2 O
D) O
. O

In O
the O
water-mediated O
S1 B-protein-region
binding O
mode O
of O
APC-10950 B-chemical
, O
the O
ether O
oxygen O
does O
not O
make O
hydrogen O
bonds O
( O
Fig O
. O
6b) O
, O
whereas O
in O
the O
direct O
amidine-Asp189 B-amino-acid
hydrogen-bonded O
mode O
of O
APC-11092 B-chemical
, O
this O
oxygen O
receives O
a O
hydrogen O
bond O
from O
N B-amino-acid
2His57 I-amino-acid
( O
Fig O
. O
6a) O
. O

These O
include O
interactions O
involving O
the O
RS B-protein-domain
domains I-protein-domain
of O
specific O
SR B-protein-family
family I-protein-family
proteins I-protein-family
, O
such O
as O
ASF/ B-protein
SF2 I-protein
, O
which O
binds O
to O
purine-rich B-DNA
ESEs I-DNA
, O
and O
of O
U2AF-35kDa protein-complex
, O
which O
binds O
to O
the O
polypyrimidine B-DNA
tract I-DNA
through O
U2AF-65kDa B-protein
( O
37) O
. O

This O
idea O
arose O
from O
the O
finding O
that O
DREF B-protein
binds O
to O
the O
DRE B-DNA
sequence I-DNA
as O
a O
homodimer O
of O
the O
80-kDa O
polypeptide O
. O

Immunodetection O
revealed O
that O
immobilized O
PTN B-protein
binds O
the O
ALK B-protein-domain
ECD I-protein-domain
( O
Fig O
. O
1 O
b) O
. O

Panel O
B O
, O
binding O
of O
the O
nuclear B-protein-family
proteins I-protein-family
to O
Sp1 B-DNA
oligonucleotides I-DNA
. O

Where O
might O
Phyl B-protein
bind O
to O
the O
Ttk B-protein
POZ B-protein-domain
domain I-protein-domain
with O
such O
specificity O
? O

Therefore O
, O
the O
amount O
of O
nuclear B-protein-family
proteins I-protein-family
binding O
to O
the O
Sp1 B-DNA
oligonucleotide I-DNA
was O
about O
2-fold O
higher O
in O
nuclear O
extracts O
isolated O
from O
chondrocytes O
dedifferentiated O
into O
fibroblast-like O
cells O
as O
compared O
with O
that O
of O
nuclear O
extracts O
isolated O
from O
chondrocytes O
. O

However O
, O
in O
a O
pho B-cell
1 I-cell
/pho I-cell
1 I-cell
mutant I-cell
background O
, O
PHO B-protein
no O
longer O
binds O
to O
the O
six O
PHO B-DNA
binding I-DNA
sites I-DNA
in O
the O
PRE B-DNA
and O
repression O
is O
lost O
, O
resulting O
in O
LacZ B-gene
expression O
( O
Fritsch O
et O
al O
. O
, O
1999) O
. O

The O
binding O
of O
p300/CBP protein
by O
E1A B-protein
stimulates O
quiescent O
primary O
cardiac O
myocytes O
to O
undergo O
DNA B-DNA
synthesis O
( O
5 O
, O
6) O
. O

In O
contrast O
, O
mutations O
M3 B-mutation
and O
M4 B-mutation
had O
minimal O
effects O
on O
Elk-1 B-protein
binding O
and O
phosphorylation O
by O
ERK2 B-protein
( O
Fig O
. O
7B O
, O
lanes O
4 O
and O
5 O
; O
Fig O
. O
7C O
, O
lanes O
5 O
and O
6) O
. O

Second O
, O
Bcl-xS B-protein
binds O
to O
Bcl-xL B-protein
but O
not O
Bax B-protein
in O
yeast O
( O
24 O
, O
25 O
, O
27) O
. O

ATP B-chemical
Binds O
Mainly O
to O
the O
CI B-protein-domain
Domain I-protein-domain
. O

Binding O
of O
Dfd B-protein
and O
Dfd-VP16 B-fusion-protein
to O
the O
2 B-DNA
ϫ I-DNA
D I-DNA
site I-DNA
( O
see O
Figure O
4 O
for O
sequence O
) O
in O
EMSAs B-assay
. O

PU B-protein
. I-protein
1 I-protein
binds O
to O
the O
CH3 B-protein-domain
domain I-protein-domain
of O
CBP B-protein
( O
82 O
) O
( O
Fig O
. O
5D) O
. O

The O
activated O
GTP-bound B-protein
form I-protein
of I-protein
Cdc42 I-protein
interacts O
with O
several O
proteins O
that O
are O
presumed O
to O
be O
effectors O
that O
transduce O
its O
signal O
to O
bring O
about O
polarization O
of O
the O
actin B-organelle
cytoskeleton I-organelle
( O
Cvrcková O
et O
al O
. O
, O
1995 O
; O
Brown O
et O
al O
. O
, O
1997 O
; O
Chen O
et O
al O
. O
, O
1997 O
; O
Evangelista O
et O
al O
. O
, O
1997 O
; O
Bi O
et O
al O
. O
, O
2000) O
. O

A O
truncated O
p65-beta B-experimental-construct
construct I-experimental-construct
, O
GST-p65-beta-delta3 B-experimental-construct
, O
continued O
to O
show O
strong O
Cdc42 B-protein
binding O
, O
although O
binding O
to O
Rac B-protein-family
was O
reduced O
( O
Fig O
. O
1) O
. O

Evidently O
, O
the O
peptide O
only O
slightly O
affected O
binding O
of O
c-Cbl B-protein
to O
EGFR B-protein
, O
but O
it O
almost O
completely O
abolished O
the O
interaction O
with O
the O
shorter O
viral B-protein
form I-protein
of I-protein
Cbl I-protein
. O

The O
notable O
absence O
of O
a O
prominent O
new O
HBP1 B-protein
binding O
species O
further O
supports O
the O
model O
that O
HBP1 O
DNA B-DNA
binding O
is O
not O
necessary O
for O
the O
transcriptional O
repression O
and O
inhibition O
of O
TCF B-protein-family
DNA O
binding O
through O
these O
specific O
LEF/ B-protein-family
TCF I-protein-family
DNA O
elements O
. O

However O
, O
HTH B-protein-motif
showed O
cooperative O
DNA B-DNA
binding O
with O
EXD B-protein
( O
Fig O
. O
6B O
, O
lane O
8 O
) O
or O
PBX1 B-protein
( O
data O
not O
shown O
) O
in O
an O
electrophoretic O
mobility O
shift O
assay O
in O
which O
the O
DNA O
( O
TGATTGAC B-DNA
) O
contained O
the O
binding O
site O
for O
both O
EXD O
( O
TGAT B-DNA
) O
and O
HTH O
( O
TGAC) DNA
. O

Thus O
, O
the O
putative O
NES B-protein-motif
sequences O
in O
APC-25 protein
also O
appear O
to O
be O
required O
for O
binding O
of O
APC-25 O
to O
beta-cat B-protein
, O
and O
the O
ability O
of O
APC-25 O
to O
modulate O
beta-cat O
signaling O
may O
be O
defined O
by O
the O
ability O
to O
bind O
and O
retain O
beta-cat O
in O
the O
cytoplasm O
. O

According O
to O
Chalovich O
et O
al O
. O
(1987) O
, O
caldesmon B-protein
acts O
as O
a O
competitive O
inhibitor O
of O
the O
binding O
of O
myosin B-protein-complex
to O
actin B-protein-family
, O
because O
the O
COOH-terminal O
end O
of O
caldesmon O
that O
does O
not O
bind O
to O
myosin O
is O
able O
to O
inhibit O
ATP B-chemical
hydrolysis O
. O

9 O
EMSA B-assay
has O
demonstrated O
that O
expression O
of O
human O
Flk-1/KDR B-protein
is O
mediated O
by O
Sp1 B-protein
binding O
to O
a O
CT-rich B-DNA
recognition I-DNA
sequence I-DNA
within O
the O
-79 O
to O
-68 O
region O
of O
the O
Flk-1/KDR B-DNA
promoter I-DNA
. O

For O
example O
, O
additional O
interactions O
between O
the O
β3-β4 B-protein-region
loop I-protein-region
and O
Ins(1 B-chemical
, I-chemical
3 I-chemical
, I-chemical
4 I-chemical
, I-chemical
5)P4 I-chemical
also O
contribute O
to O
high‐affinity O
binding O
of O
PH B-protein-domain
domains I-protein-domain
to O
PI3K B-protein-family
products O
; O
K53 B-amino-acid
in O
BTK B-protein
is O
critical O
for O
the O
BTK‐PH B-protein-domain
domain I-protein-domain
to O
bind O
PtdIns(3 B-chemical
, I-chemical
4 I-chemical
, I-chemical
5)P3 I-chemical
( O
Hyvonen O
et O
al O
. O
, O
1995) O
. O

A O
densitometric O
analysis O
of O
the O
Coomassie -
Blue-stained -
proteins O
indicated O
that O
the O
beta1D B-experimental-construct
construct O
bound O
9 O
times O
more O
talin B-protein-family
, O
and O
the O
beta7 B-experimental-construct
construct O
bound O
8 O
. O
4 O
times O
more O
filamin B-protein-family
than O
the O
beta1A B-protein
model O
protein O
( O
Fig O
. O
8) O
. O

B O
, O
comparison O
of O
holo-Tf B-protein
binding O
to O
neo B-cell
, O
TfR1 B-cell
, O
or O
TfR2-alpha B-cell
cells I-cell
. O

In O
the O
absence O
of O
molybdate B-chemical
, O
ATP B-chemical
is O
not O
very O
effective O
in O
promoting O
p23 B-protein
binding O
by O
wild O
type O
hsp90 B-protein-family
. O

Consistent O
with O
our O
finding O
that O
Mbt B-protein
only O
binds O
to O
GTP-loaded chemical
Cdc42 B-protein
, O
expression O
of O
Cdc42T17N B-protein
had O
only O
minor O
effects O
on O
Mbt O
localisation O
and O
the O
AJs B-organelle
morphology O
( O
Fig O
. O
8K O
, O
L) O
. O

Recent O
studies O
have O
revealed O
that O
the O
PDZ B-protein-domain
domain I-protein-domain
binds O
to O
unique O
COOH-terminal B-protein-motif
motifs I-protein-motif
of O
target O
proteins O
( O
Saras O
and O
Heldin O
, O
1996) O
, O
which O
are O
found O
in O
a O
large O
number O
of O
transmembrane B-protein-family
proteins I-protein-family
, O
such O
as O
N-methyl-d-aspartate B-protein-family
receptors I-protein-family
and O
Shaker-type B-protein-complex
K+ I-protein-complex
channel I-protein-complex
( O
Kim O
et O
al O
. O
, O
1995 O
; O
Kornau O
et O
al O
. O
, O
1995 O
; O
Niethammer O
et O
al O
. O
, O
1996) O
. O

RID B-protein-domain
of O
RGL B-protein
is O
known O
to O
interact O
with O
the O
GTP-bound chemical
form O
of O
Ras B-protein-family
through O
its O
effector O
loop O
( O
5 O
, O
25 O
, O
26) O
. O

Interestingly O
, O
using O
a O
variety O
of O
different O
methods O
, O
we O
observed O
that O
1 O
mol O
of O
TAF130p B-protein
bound O
4 O
mol O
of O
TBP B-protein
. O

In O
a O
similar O
fashion O
, O
binding O
of O
hnRNP B-protein
A2 I-protein
to O
the O
RTS B-RNA
might O
promote O
unwinding O
of O
secondary O
structure O
in O
the O
mRNA B-RNA
to O
reduce O
a O
kinetic O
barrier O
to O
formation O
of O
the O
translation B-protein-complex
initiation I-protein-complex
complex I-protein-complex
. O

However O
, O
the O
cleaved O
gelsolin B-protein
preferentially O
severed O
actin B-protein
filaments I-protein
even O
when O
briefly O
incubated O
with O
excess O
monomeric B-protein
actin I-protein
( O
Fig O
. O
3A O
, O
bottom) O
, O
suggesting O
that O
the O
cleaved O
gelsolin O
generated O
in O
cells O
during O
apoptosis O
may O
preferentially O
sever O
actin O
filaments O
rather O
than O
bind O
monomeric O
actin O
. O

Indeed O
, O
two O
mutations O
in O
the O
HSP82 B-gene
gene O
( O
A97I B-gene
and O
G170D B-gene
) O
that O
alter O
amino O
acids O
adjacent O
to O
those O
directly O
interacting O
with O
the O
nucleotide O
prevent O
binding O
of O
Sba1p B-protein
to O
Hsp90 B-protein-family
in O
vitro O
( O
Fig O
. O
5C) O
. O

While O
wild-type O
RDGC B-protein
bound O
calmodulin B-protein-family
in O
the O
presence O
or O
absence O
of O
Ca2+ B-chemical
, O
the O
interaction O
between O
73I12A B-protein
and O
calmodulin O
was O
strictly O
Ca2+ O
dependent O
( O
Figure O
2C) O
. O

Footprinting O
experiments O
with O
EBV-positive cell
cells O
have O
revealed O
that O
EBNA1 B-protein
binds O
to O
the O
DS B-DNA
element I-DNA
throughout O
the O
cell O
cycle O
( O
Hsieh O
et O
al O
. O
, O
1993 O
; O
Niller O
et O
al O
. O
, O
1995) O
. O

srGAPs B-protein-family
increase O
the O
intrinsic O
GTPase B-protein-family
activity O
of O
Cdc42 B-protein
, O
which O
converts O
the O
GTP-bound B-protein
form I-protein
of I-protein
Cdc42 I-protein
into O
its O
GDP-bound chemical
form O
, O
therefore O
inactivating O
Cdc42 O
. O

Site O
II O
seems O
to O
be O
generally O
less O
well O
conserved O
( O
for O
example O
, O
Arp1 B-protein
and O
β- B-protein-family
and O
γ-tubulin) protein-family
, O
and O
this O
may O
explain O
why O
these O
target O
proteins O
bind O
less O
well O
to O
prefoldin B-protein-family
than O
actin B-protein-family
and O
α-tubulin B-protein-family
( O
see O
Fig O
. O
4 O
; O
the O
fragments O
of O
Arp1 O
and O
β- O
and O
γ-tubulin O
also O
show O
binding O
to O
CCT B-protein
, O
whereas O
actin O
and O
α-tubulin O
do O
not) O
. O

The O
Fyn B-protein
, O
Src B-protein
, O
and O
Crkl B-protein-domain
SH3 I-protein-domain
domains I-protein-domain
were O
poorly O
bound O
, O
whereas O
the O
Csk B-protein
SH3 O
domain O
failed O
to O
bind O
detectable O
levels O
of O
EVL B-protein
. O

To O
test O
the O
hypothesis O
that O
p150 B-protein
may O
directly O
bind O
to O
DIC B-protein
, O
we O
constructed O
affinity O
columns O
of O
bacterially O
expressed O
DIC O
. O

CI B-protein
binds O
dCBP B-protein
in O
yeast O
two-hybrid O
and O
glutathione B-experiment-tag
S-transferase I-experiment-tag
( O
GST B-experiment-tag
) O
pull-down O
assays O
. O

Transcription O
factors O
that O
bind O
to O
Sp1 B-gene
, O
AP1 B-gene
, O
LXR B-gene
, O
and O
E-box B-DNA
motifs O
have O
been O
implicated O
in O
the O
transcriptional O
regulation O
of O
other O
genes O
involved O
in O
lipid O
metabolism O
including O
apolipoprotein B-gene
A-II I-gene
( O
apoA-II B-gene
) O
( O
31) O
, O
apolipoprotein B-gene
C-III I-gene
( O
apoC-III B-gene
) O
( O
32) O
, O
apolipoprotein B-gene
E I-gene
( O
apoE B-gene
) O
( O
33) O
, O
chicken B-gene
vitellogenin I-gene
II I-gene
( O
34) O
, O
fatty B-gene
acid I-gene
synthase I-gene
( O
35–37) O
, O
stearoyl-CoA B-gene
desaturase I-gene
1 I-gene
( O
38) O
, O
the O
LDL B-gene
receptor I-gene
( O
39) O
, O
the O
LDL B-gene
receptor I-gene
related I-gene
protein I-gene
( O
LRP B-gene
) O
( O
40) O
, O
CYP7a B-gene
( O
41 O
, O
42) O
, O
CETP B-gene
( O
43) O
, O
ABCG5/ABCG8 B-gene
( O
44) O
, O
ABCG1 B-gene
( O
45) O
, O
and O
SREBP-1c B-gene
( O
46 O
, O
47) O
. O

We O
are O
currently O
testing O
if O
this O
motif O
is O
required O
for O
the O
binding O
of O
cortactin B-protein
to O
the O
Arp2/3 protein
complex O
. O

As O
depicted O
in O
Fig O
. O
6 O
, O
preadipocyte O
differentiation O
correlated O
with O
PPARgamma B-protein
binding O
affinity O
; O
AD-5075 B-chemical
and O
the O
Merck B-brand
agonists O
, O
L-796449 B-chemical
, O
L-783483 B-chemical
, O
and O
L-165461 B-chemical
, O
produced O
robust O
preadipocyte O
differentiation O
. O

Inhibition O
of O
transcription O
from O
constructs O
such O
as O
U-2 B-experimental-construct
, O
U-1 B-experimental-construct
, O
D+6 B-experimental-construct
, O
and O
D+8 B-experimental-construct
could O
simply O
be O
due O
to O
inhibition O
of O
the O
binding O
of O
the O
TBP B-protein
subunit O
of O
TFIID B-protein
( O
Fig O
. O
6A O
and O
B) O
. O

Similarly O
, O
DLG B-protein
binds O
both O
FAS2 B-protein
and O
Shaker B-protein-complex
K+ I-protein-complex
channels I-protein-complex
, O
and O
is O
responsible O
for O
their O
synaptic O
localization O
at O
the O
Drosophila O
glutamatergic O
NMJ B-organelle
( O
Tejedor O
et O
al O
. O
, O
1997 O
; O
Thomas O
et O
al O
. O
, O
1997 O
; O
Zito O
et O
al O
. O
, O
1997 O
) O
. O

( O
A O
) O
In O
our O
model O
, O
based O
on O
the O
docking O
shown O
in O
Figure O
3 O
, O
these O
interactions O
remain O
conserved O
for O
both O
heads O
in O
ncd B-protein-complex
dimers I-protein-complex
bound O
to O
MTs B-organelle
in O
the O
absence O
of O
nucleotide O
. O

The O
fact O
that O
GCN2-S577A B-protein
also O
dampened O
the O
derepression O
response O
to O
3AT B-chemical
agrees O
with O
the O
idea O
that O
this O
mutation O
enhances O
tRNA B-RNA
binding O
by O
GCN2 O
, O
reducing O
the O
dependence O
of O
kinase O
activation O
on O
elevated O
levels O
of O
uncharged O
tRNA O
in O
amino O
acid-starved O
cells O
. O

Treatment O
with O
a O
phospholipid B-chemical
known O
to O
decrease O
self-association O
of O
ERMs B-protein-family
enhances O
the O
binding O
of O
merlin B-protein
isoform O
1 O
to O
NHE-RF B-protein
. O

FKBP52 B-protein
binds O
directly O
to O
the O
GR B-protein
. O

c) O
, O
the O
effect O
of O
different O
amounts O
of O
D315A O
procaspase-9 B-protein
( O
DA B-protein
. I-protein
Caspase-9 I-protein
) O
on O
dATP B-chemical
binding O
to O
Apaf-1 B-protein
was O
measured O
. O

The O
concurrent O
binding O
of O
c-Myb B-protein
and O
Ets-1 B-protein
by O
CBP/ B-protein-family
p300 I-protein-family
may O
also O
explain O
other O
attributes O
of O
the O
Gag-Myb-Ets B-experimental-construct
fusion I-experimental-construct
protein I-experimental-construct
. O

However O
, O
the O
amount O
of O
associated O
Hsp70 B-protein-family
was O
significantly O
reduced O
in O
cells O
co-expressing O
the O
region O
of O
PKC B-protein-family
that O
binds O
Hsp70 O
( O
GST-CTS660A B-experimental-construct
; O
lane O
2 O
) O
and O
abolished O
in O
cells O
co-expressing O
the O
region O
of O
Hsp70 O
that O
binds O
PKC O
( O
GST-PBCT B-experimental-construct
; O
lane O
3) O
. O

CSR B-protein
binding O
to O
B B-RNA
element I-RNA
RNA O
containing O
the O
1750 O
mutation O
. O

This O
analysis O
revealed O
specific O
in O
vivo O
binding O
of O
NFAT5 B-protein
to O
the O
TNFα B-DNA
proximal I-DNA
promoter I-DNA
and O
the O
aldose B-DNA
reductase I-DNA
enhancer I-DNA
in O
response O
to O
hypertonic O
stimulation O
, O
either O
alone O
or O
in O
combination O
with O
PMA B-chemical
( O
Figure O
6D O
, O
right O
, O
top O
and O
middle O
panels O
, O
lanes O
5 O
and O
6) O
. O

In O
G0 B-process
phase O
, O
this O
activity O
would O
then O
be O
repressed O
by O
Rb B-protein
( O
or O
other O
pocket O
proteins O
) O
bound O
to O
E2F B-protein-complex
. O

B O
. O
M O
. O
Bradt O
, O
T O
. O
S O
. O
Bixby O
, O
W O
. O
P O
. O
Kolb O
and O
N O
. O
R O
. O
Cooper O
, O
Covalent O
binding O
of O
Alzheimer B-peptide
' I-peptide
s I-peptide
disease I-peptide
A I-peptide
peptide I-peptide
with O
C3 B-protein
via O
activation O
of O
both O
complement O
pathways O
. O

We O
show O
that O
activation O
of O
the O
BMP-signaling B-process
pathway I-process
results O
in O
increased O
binding O
of O
Smad1 B-protein
to O
the O
GC B-DNA
region I-DNA
from O
the O
Id1 B-DNA
BMP I-DNA
response I-DNA
element I-DNA
. O

While O
all O
the O
GAL4 B-protein
markers O
failed O
to O
drive O
expression O
in O
the O
core O
of O
the O
peduncle O
and O
lobes O
, O
we O
found O
that O
phalloidin B-chemical
, O
which O
binds O
filamentous B-protein
actin I-protein
, O
heavily O
stained O
the O
core O
( O
Fig O
. O
6A) O
. O

C O
, O
C-ERMAD B-protein
displaces O
EBP50 B-protein
bound O
to O
Ez-(1-296 B-reagent
) I-reagent
beads I-reagent
, O
but O
not O
vice O
versa O
. O

The O
measurements O
of O
the O
binding O
constants O
of O
two O
TnI B-protein
inhibitory O
fragments O
to O
TnC B-protein
showed O
that O
TnI96-116 B-protein-region
preferably O
interacts O
with O
the O
C-lobe B-protein-region
of I-protein-region
TnC I-protein-region
, O
whereas O
its O
C-terminal O
extension O
, O
TnI96-148 B-protein-region
, O
is O
most O
tightly O
bound O
to O
the O
TnC B-protein-region
N-lobe I-protein-region
( O
27) O
. O

This O
is O
particularly O
likely O
for O
the O
C2A -
domain-syntaxin -
1a -
interaction O
, O
because O
the O
chemical O
shift O
changes O
caused O
by O
syntaxin O
1a O
binding O
to O
the O
C2A O
domain O
are O
in O
general O
small O
, O
indicating O
that O
few O
local O
rearrangements O
occur O
in O
the O
backbone O
of O
the O
C2A O
domain O
at O
the O
interacting O
surface O
. O

The O
analysis O
of O
Ras B-protein-family
complexes O
by O
immunoblotting O
with O
anti-Flag B-reagent
antibody I-reagent
revealed O
that O
overexpression O
of O
BcrWT B-protein
but O
not O
of O
BcrV1271A B-protein
led O
to O
an O
increase O
in O
the O
amount O
of O
AF-6 B-protein
bound O
to O
active O
Ras O
( O
Fig O
. O
5A) O
. O

The O
Ral B-protein
binding O
domain O
of O
RalBP1 B-protein
binds O
to O
the O
GTP-bound B-protein
form I-protein
of I-protein
Ral I-protein
but O
not O
to O
the O
GDP-bound chemical
form O
( O
23) O
. O

Now O
, O
we O
report O
that O
Tsg101 B-protein
binds O
the O
COOH-terminal O
region O
of O
the O
endosomal O
protein O
hepatocyte B-protein
growth I-protein
factor I-protein
- I-protein
regulated I-protein
tyrosine I-protein
kinase I-protein
( O
substrateHrs O
; O
residues O
222 O
- O
777) O
. O

We O
propose O
that O
it O
is O
the O
binding O
of O
TSC1 B-protein
and O
TSC2 B-protein
that O
results O
in O
a O
functional O
unit O
. O

Taking O
the O
results O
together O
, O
we O
conclude O
that O
DREF B-protein
binds O
to O
the O
DRE-related B-DNA
sequences I-DNA
at O
540 O
to O
514 O
located O
upstream O
of O
the O
initiation O
site O
of O
transcript-b O
. O

Although O
the O
result O
of O
the O
binding O
interaction O
may O
be O
quite O
complex O
, O
the O
direct O
HMG-1/TBP protein
interaction O
may O
provide O
a O
similar O
effect O
in O
reducing O
an O
energetically O
unfavorable O
interaction O
between O
the O
N O
terminus O
and O
DNA B-DNA
and O
contributing O
to O
the O
mechanism O
by O
which O
HMG-1 O
binding O
stabilizes O
the O
complex O
. O

Our O
results O
indicate O
that O
epsin B-protein-family
' O
s O
UIMs B-protein-motif
do O
not O
directly O
bind O
ubiquitin B-protein-family
. O

However O
, O
both O
in O
vitro O
and O
i O
n O
vivo O
protein-protein O
interaction O
assays O
revealed O
that O
replacement O
of O
Ser B-amino-acid
with O
Asp B-amino-acid
does O
not O
interfere O
with O
the O
binding O
of O
CREB B-protein
to O
CBP B-protein
. O

LRP B-protein-family
bound O
to O
CRT B-protein
or O
BSA B-reagent
was O
detected O
after O
electrophoresis O
and O
transfer O
to O
nitrocellulose O
membranes O
with O
anti-LRP B-reagent
antibody I-reagent
( O
8G1) reagent
. O

The O
simplest O
interpretation O
of O
our O
sequence O
data O
is O
that O
the O
B2 B-DNA
element I-DNA
serves O
as O
a O
second O
binding O
site O
for O
ORC B-protein-complex
, O
because O
ORC O
binds O
the O
ACS B-DNA
. O

To O
determine O
whether O
cdc-42(RNAi B-RNA
) I-RNA
disrupts O
embryonic O
polarity O
simply O
by O
disrupting O
actin B-protein-family
organization O
in O
the O
early O
embryo O
, O
we O
examined O
cortical O
actin O
localization O
in O
early O
cdc-42(RNAi O
) O
embryos O
by O
immunofluorescence O
to O
actin O
and O
by O
phalloidin B-chemical
binding O
to O
filamentous B-protein
actin I-protein
. O

Our O
studies O
suggest O
a O
role O
for O
p300 B-protein
bound O
to O
SAF-A B-protein
at O
S/MAR B-DNA
elements I-DNA
. O

Transcription O
of O
tf-a O
is O
increased O
when O
TF-A O
homodimers O
bind O
to O
the O
TF-RE O
. O

Binding O
of O
CRKL B-protein
to O
Gab1 B-protein
is O
expected O
to O
lead O
to O
an O
accumulation O
of O
C3G B-protein
near O
the O
plasma O
membrane O
where O
it O
may O
exert O
its O
effect O
on O
Rap1 B-protein
. O

Interestingly O
, O
GimC/ B-protein
PFD I-protein
can O
bind O
denatured B-protein
forms I-protein
of I-protein
actin I-protein
and O
tubulin B-protein
, O
suggesting O
that O
it O
plays O
a O
more O
active O
role O
during O
protein O
folding O
than O
does O
GroES B-protein
, O
which O
does O
not O
interact O
with O
non-native O
polypeptides O
. O

After O
cleavage O
there O
was O
a O
dramatic O
increase O
in O
talin B-protein-family
binding O
to O
the O
beta3 B-protein
tail O
( O
Fig O
. O
5 O
, O
A O
and O
B) O
. O

Because O
DNase B-assay
I I-assay
footprinting I-assay
revealed O
protein O
binding O
to O
all O
five O
dfd-related B-DNA
elements I-DNA
, O
the O
dfd-1 B-DNA
site I-DNA
was O
chosen O
to O
characterize O
the O
DNA-protein O
interactions O
in O
more O
detail O
. O

Binding O
of O
U1 B-protein-complex
snRNP I-protein-complex
to O
F1 B-DNA
, O
in O
conjunction O
with O
a O
direct O
interaction O
between O
dU1-70K B-protein
and O
the O
PSI B-DNA
AB I-DNA
motif I-DNA
, O
might O
preclude O
binding O
of O
a O
second O
U1 O
snRNP O
particle O
to O
the O
accurate O
5 B-DNA
splice I-DNA
site I-DNA
, O
perhaps O
by O
steric O
interference O
. O

Alternatively O
, O
it O
is O
possible O
that O
there O
are O
subtle O
differences O
in O
the O
binding O
of O
Sp1 B-reagent
oligonucleotide I-reagent
to O
the O
same O
nuclear O
protein O
in O
the O
two O
different O
cell O
types O
that O
are O
reflected O
in O
the O
differential O
antibody O
response O
. O

The O
binding O
of O
raptor B-protein
to O
mTOR B-protein
is O
necessary O
for O
the O
mTOR-catalyzed O
phosphorylation O
of O
4EBP1 B-protein
in O
vitro O
, O
and O
it O
strongly O
enhances O
the O
mTOR O
kinase O
activity O
toward O
p70alpha B-protein
. O

This O
conclusion O
is O
based O
on O
studies O
carried O
out O
with O
consensus O
Sp1 B-protein
oligonucleotide O
showing O
that O
( O
i O
) O
Sp1 O
binding O
activity O
was O
present O
in O
nuclear O
extracts O
from O
all O
three O
cell O
types O
studied O
; O
( O
ii O
) O
Sp1 O
binding O
was O
2–3-fold O
greater O
in O
nuclear O
extracts O
from O
chondrocytes O
dedifferentiated O
into O
fibroblast-like O
cells O
by O
passage O
in O
monolayer O
culture O
on O
plastic O
substrate O
than O
in O
freshly O
isolated O
chondrocytes O
or O
in O
chondrocytes O
allowed O
to O
maintain O
their O
phenotype O
by O
culture O
on O
polyHEMA-coated experiment-tag
dishes O
; O
( O
iii O
) O
Sp1 O
binding O
was O
specific O
, O
since O
it O
was O
competed O
by O
unlabeled O
Sp1 O
and O
not O
by O
AP1 B-protein-complex
; O
( O
iv O
) O
Sp1 O
binding O
was O
enhanced O
by O
KCl B-chemical
and O
inhibited O
by O
the O
addition O
of O
EDTA B-experiment-tag
; O
( O
v O
) O
A O
polyclonal O
antibody O
against O
Sp1 O
decreased O
the O
binding O
of O
Sp1 O
by O
85% O
in O
chondrocytes O
dedifferentiated O
into O
fibroblast-like O
cells O
but O
caused O
only O
a O
very O
slight O
inhibition O
in O
freshly O
isolated O
chondrocytes O
or O
in O
chondrocytes O
cultured O
in O
suspension O
on O
polyHEMA O
. O

Thus O
, O
it O
appears O
that O
tRNA B-RNA
binding O
by O
GCN2 B-protein
is O
absolutely O
required O
for O
its O
activation O
by O
rapamycin B-drug
, O
as O
observed O
previously O
for O
amino O
acid O
limitation O
( O
Wek O
et O
al O
. O
1995 O
) O
. O

Indeed O
, O
the O
replacement O
of O
RalA B-amino-acid
Asp49 I-amino-acid
with O
the O
isosteric O
Asn B-amino-acid
residue O
does O
not O
affect O
binding O
of O
Ral B-protein-family
to O
Sec5 B-protein
, O
while O
a O
mutation O
to O
a O
larger O
glutamic B-amino-acid
acid I-amino-acid
residue O
disrupts O
binding O
( O
Moskalenko O
et O
al O
. O
, O
2002) O
. O

GST-STVII B-experimental-construct
, O
-STVIII B-experimental-construct
, O
-STIX B-experimental-construct
, O
and O
- B-experimental-construct
STXI-C2B I-experimental-construct
had O
strong O
IP4 B-chemical
binding O
activity O
like O
synaptotagmin B-protein
II I-protein
, O
but O
GST-STVI-C2B B-experimental-construct
showed O
weak O
IP4 O
binding O
activity O
( O
<20% O
of O
that O
of O
GST-STII-C2B) O
. O

However O
, O
when O
the O
upstream O
AG B-chemical
is O
mutated O
, O
eliminating O
the O
binding O
of O
SPF45 B-protein
to O
the O
pre-mRNA B-RNA
, O
SXL B-protein
still O
binds O
to O
the O
RNA B-RNA
, O
but O
is O
no O
longer O
able O
to O
inhibit O
the O
second O
step O
of O
splicing O
. O

The O
interaction O
between O
synthetic O
peptides O
and O
AtCaM B-protein
isoforms O
was O
analyzed O
by O
applying O
of O
synthetic O
peptides O
to O
a O
nitrocellulose O
membrane O
in O
a O
slot O
blot O
apparatus O
, O
and O
incubating O
the O
membrane O
with O
35S-labeled experiment-tag
AtCaM O
isoforms O
individually O
using O
the O
method O
described O
above O
( O
see O
“Calmodulin O
Binding O
to O
Fusion O
Proteins O
” O
) O
. O

Chrivia O
, O
J O
. O
C O
. O
, O
R O
. O
P O
. O
S O
. O
Kwok O
, O
N O
. O
Lamb O
, O
M O
. O
Hagiwara O
, O
M O
. O
R O
. O
Montminy O
, O
and O
R O
. O
H O
. O
Goodman O
( O
1993 O
) O
Phosphorylated O
CREB B-protein
binds O
specifically O
to O
the O
nuclear O
protein O
CBP B-protein
. O

Although O
multiple O
transcription O
factors O
bind O
to O
CBP B-protein
, O
there O
is O
a O
striking O
difference O
in O
the O
role O
of O
CBP O
depending O
on O
the O
transcriptional O
activator O
. O

The O
related O
MAGUKs B-protein-family
SAP90/PSD95 B-protein
, O
PSD93/chapsyn-110 B-protein
, O
SAP97 B-protein
, O
and O
SAP102 B-protein
all O
bound O
to O
the O
COOH-terminal O
tail O
of O
PMCA4b B-protein
, O
whereas O
only O
the O
first O
three O
bound O
to O
the O
tail O
of O
PMCA2b B-protein
. O

Furthermore O
, O
PTB B-protein-family
binding O
downstream O
of O
N1 B-DNA
affects O
its O
ability O
to O
bind O
upstream O
, O
suggesting O
that O
PTB O
cooperativity O
plays O
a O
role O
in O
repression O
( O
12) O
. O

Thus O
, O
we O
conclude O
that O
the O
gamma2257-297 B-protein-region
region I-protein-region
contains O
structural O
determinants O
required O
for O
coupling O
BZD B-chemical
binding O
to O
BZD O
potentiation O
of O
IGABA B-process
. O

Canonical O
YY1 B-protein
binding O
sites O
were O
found O
in O
several O
PREs B-DNA
, O
suggesting O
that O
Pho B-protein
binds O
to O
all O
of O
these O
PREs O
. O

( O
B O
) O
Binding O
of O
JNK1 B-protein
to O
GST B-experiment-tag
and O
GST-JIP-1 protein
( O
residues O
127 O
to O
281 O
) O
was O
examined O
in O
the O
absence O
and O
presence O
of O
synthetic O
peptides O
( O
64 O
mug/ml) O
. O

The O
function O
of O
the O
GUK B-protein-domain
domain I-protein-domain
, O
which O
lacks O
kinase O
activity O
in O
the O
MAGUK B-protein-family
proteins I-protein-family
analyzed O
so O
far O
, O
is O
not O
known O
but O
has O
been O
suggested O
to O
be O
important O
for O
binding O
of O
ZO-1 B-protein
to O
occludin B-protein
( O
5) O
. O

( O
C O
) O
Binding O
of O
Sp1 B-protein
to O
the O
D2 B-DNA
promoter I-DNA
is O
inhibited O
in O
the O
caudate O
of O
the O
human O
HD B-disease
postmortem O
brain O
. O

It O
is O
thought O
that O
binding O
of O
E1A B-protein
to O
the O
p300/CBP B-protein-complex
inactivates O
the O
p300/CBP O
complex O
and O
represses O
the O
p300/CBP-responsive O
gene(s) O
. O

This O
observation O
demonstrates O
that O
Ubc9 B-protein
binding O
to O
Mdm2 B-protein
is O
under O
a O
dynamic O
regulation O
and O
affected O
by O
changes O
elicited O
upon O
stress O
and O
DNA B-DNA
damage O
, O
as O
shown O
here O
for O
UV O
irradiation O
. O

Evidence O
also O
was O
obtained O
for O
regions O
within O
PCNA B-protein
, O
i O
. O
e O
. O
47-86 O
and O
150-223 O
aa O
, O
that O
compromised O
the O
binding O
of O
these O
PCNA O
domains O
to O
CR6 B-protein
( O
Fig O
. O
2) O
. O

Most O
flavin-containing chemical
proteins O
have O
a O
highly O
conserved O
motif O
located O
at O
the O
N O
terminus O
of O
the O
protein O
and O
involved O
in O
binding O
of O
the O
ADP B-chemical
moiety O
of O
FAD B-chemical
( O
35-37) O
. O

Talin B-protein-family
binds O
directly O
to O
actin B-protein-family
( O
Muguruma O
et O
al O
. O
, O
1990 O
) O
, O
vinculin B-protein
( O
Burridge O
and O
Mangeat O
, O
1984 O
) O
, O
and O
beta B-protein-family
integrins I-protein-family
( O
Horwitz O
et O
al O
. O
, O
1986 O
; O
Knezevic O
et O
al O
. O
, O
1996 O
) O
. O

Both O
forms O
of O
Axin B-protein-family
bound O
to O
endogenous O
GSK-3beta B-protein
in O
SW480 B-cell
cells I-cell
( O
Fig O
. O
2) O
. O

The O
21 O
mer O
is O
weakly O
bound O
by O
Sd B-protein
( O
lane O
8) O
, O
while O
the O
Vg-Sd protein
complex O
forms O
nearly O
as O
efficiently O
as O
on O
the O
longer O
templates O
. O

Endogenous O
JNK/SAPK B-protein
Isoforms O
Bind O
to O
MEKK1 B-peptide
Peptides I-peptide

This O
loss O
of O
binding O
of O
Cyclin B-protein-family
A I-protein-family
to O
Cdc2 B-protein
in O
embryos O
is O
observed O
relatively O
soon O
after O
transfer O
of O
the O
mothers O
to O
the O
restrictive O
temperature O
( O
not O
shown O
) O
at O
a O
time O
when O
there O
is O
still O
a O
sizable O
amount O
of O
CAK B-protein
activity O
in O
embryonic O
extracts O
. O

TFIIB B-protein
is O
thought O
to O
bridge O
the O
binding O
of O
TBP B-protein
to O
the O
RNA B-protein-complex
pol I-protein-complex
II I-protein-complex
complex O
; O
thus O
, O
this O
could O
be O
a O
potential O
key O
for O
interfering O
with O
activation O
. O

A O
bacterially O
expressed O
POP-1 B-protein-region
fragment I-protein-region
containing O
the O
HMG B-protein-domain
domain I-protein-domain
specifically O
binds O
the O
optimal O
Tcf B-protein-family
target O
site O
, O
but O
not O
a O
sequence O
that O
lacks O
the O
core O
Tcf O
target O
motif O
( O
Fig O
. O
1a) O
. O

In O
addition O
, O
similar O
SF2/ASF B-protein
mutant O
proteins O
lacking O
either O
RRM1 B-protein-motif
or O
RRM2 B-protein-motif
were O
still O
able O
to O
facilitate O
U1 B-protein-RNA-complex
snRNP I-protein-RNA-complex
binding O
to O
a O
pre-mRNA B-RNA
containing O
a O
functional O
5 O
' O
splice O
site O
( O
63) O
. O

GST B-experiment-tag
alone O
did O
not O
bind O
calmodulin B-protein-family
in O
the O
presence O
of O
Ca2+ B-chemical
or O
EGTA B-chemical
and O
neither O
GST-dUNC13 experiment-tag
or O
any O
other O
fusion O
protein O
described O
below O
bound O
to O
agarose B-reagent
beads I-reagent
under O
any O
Ca2+ O
conditions O
( O
data O
not O
shown O
; O
Ref O
. O
21) O
. O

They O
considered O
whether O
this O
result O
might O
be O
explained O
if O
both O
kinesin B-protein-complex
II I-protein-complex
and O
dynein B-protein-family
bound O
to O
dynactin B-protein-complex
and O
thereby O
docked O
onto O
membranes O
. O

Deletion O
of O
the O
last O
157 O
amino O
acids O
of O
Staufen B-protein
, O
the O
region O
that O
binds O
Miranda B-protein
, O
eliminates O
both O
the O
apical O
and O
basal O
cortical O
crescents O
. O

Because O
full-length O
Gli3 B-protein
can O
bind O
to O
both O
CBP B-protein
and O
Ski B-protein
, O
there O
may O
exist O
a O
regulatory O
mechanism O
that O
determines O
the O
specificity O
of O
Gli3 O
binding O
to O
these O
factors O
, O
depending O
on O
the O
nature O
of O
the O
signal O
. O

Third O
, O
the O
preferential O
binding O
of O
AEF-1 B-protein
to O
the O
proximal O
Inr B-DNA
further O
destabilizes O
interactions O
with O
the O
pre-initiation B-protein-complex
complex I-protein-complex
. O

PS1 B-protein
is O
known O
to O
have O
multiple O
binding O
partners O
, O
including O
β-catenin B-protein-family
( O
reviewed O
in O
Ref O
. O
26) O
. O

In O
p300deltaSRC B-protein
, O
there O
is O
a O
deletion O
of O
the O
C-terminal O
segment O
of O
p300 B-protein
that O
binds O
to O
the O
SRC/ B-protein-family
p160 I-protein-family
family O
of O
coactivator O
proteins O
. O

TRP B-protein-family
Binds O
Directly O
to O
INAD B-protein
through O
the O
COOH O
Terminus O

Most O
PDZ-containing protein-domain
proteins O
bind O
to O
their O
targets O
via O
a O
COOH-terminal O
sequence O
that O
conforms O
to O
an O
S/T-X-V/I B-protein-motif
motif I-protein-motif
or O
that O
consists O
of O
aromatic O
and/or O
hydrophobic O
residues O
( O
Kim O
et O
al O
. O
1995 O
; O
Kornau O
et O
al O
. O
1995 O
; O
Songyang O
et O
al O
. O
1997 O
; O
Daniels O
et O
al O
. O
1998) O
. O

Therefore O
, O
the O
CPD B-protein
are O
involved O
in O
the O
binding O
of O
HMG1 B-protein
to O
the O
irradiated O
TT B-experimental-construct
probe I-experimental-construct
. O

GSK-3 B-protein
functions O
as O
part O
of O
a O
multiprotein O
complex O
in O
which O
Axin B-protein-family
directly O
binds O
GSK-3 O
, O
beta-catenin B-protein-family
, O
and O
APC B-protein
( O
Hart O
et O
al O
. O
1998 O
; O
Ikeda O
et O
al O
. O
1998 O
Itoh O
; O
et O
al O
. O
1998 O
; O
Nakamura O
et O
al O
. O
1998 O
; O
Sakanaka O
et O
al O
. O
1998 O
; O
Yamamoto O
et O
al O
. O

In O
Saccharomyces O
cerevisiae O
, O
Hsf1 B-protein
binds O
HSEs B-DNA
as O
a O
trimeric O
complex O
: O
constitutively O
to O
high-affinity O
sites O
( O
Gross O
et O
al O
. O
, O
1990 O
) O
and O
inducibly O
to O
low-affinity O
sites O
( O
Giardina O
and O
Lis O
, O
1995 O
; O
Erkine O
et O
al O
. O
, O
1999) O
. O

These O
experiments O
demonstrated O
that O
the O
fusion O
protein O
bound O
to O
PKC B-protein-family
at O
a O
concentration O
as O
low O
as O
0 O
. O
1 O
mug/ml O
. O

Inactivation O
of O
GSK-3 B-protein
in O
dorsal O
cells O
appears O
to O
require O
the O
presence O
of O
a O
recently O
identified O
protein O
, O
GBP B-protein
, O
that O
can O
bind O
and O
suppress O
GSK-3 O
activity O
in O
vivo O
( O
Yost O
et O
al O
. O
1998 O
) O
. O

The O
amplified O
DNA B-DNA
was O
isolated O
, O
digested O
, O
and O
cloned O
into O
the O
T7 -
RNA -
polymerase-based -
( O
30 O
) O
pCAL B-experimental-construct
bacterial O
expression O
vector O
( O
Stratagene B-brand
) O
as O
a O
translational O
fusion O
to O
the O
calmodulin B-peptide
binding I-peptide
peptide I-peptide
( O
CBP) peptide
. O

Consistent O
with O
the O
structural O
data O
, O
a O
Trp22 B-mutation
Ala I-mutation
mutation O
abolishes O
binding O
of O
SF1 B-protein
to O
U2AF65-RRM3 B-protein-domain
, O
whereas O
binding O
of O
a O
Trp22 B-mutation
Phe I-mutation
mutant O
is O
not O
affected O
( O
Figure O
3D) O
. O

Binding O
of O
PR B-protein
domain I-protein
protein I-protein
to O
RIZ1 B-protein
and O
RIZ2 B-protein
proteins O
. O

V-ATPase B-protein-complex
binding O
to O
actin B-protein-family
approaches O
saturation O
at O
1 O
mol O
of O
V-ATPase O
per O
8 O
mol O
of O
F-actin B-protein
. O

Yeast O
two-hybrid O
liquid O
assays O
, O
affinity O
chromatography O
, O
and O
coimmunoprecipitation O
experiments O
confirm O
binding O
between O
PS2 B-protein
and O
calmyrin B-protein
. O

The O
studies O
with O
the O
ERalpha B-protein
and O
p300 B-protein
mutants O
in O
the O
acetylation O
assay O
emphasize O
the O
requirement O
for O
the O
simultaneous O
binding O
of O
SRC B-protein
to O
both O
p300 O
and O
ERalpha O
for O
acetylation O
. O

TL B-protein
directly O
binds O
to O
the O
CD8αα B-protein-complex
homodimer O
with O
a O
significantly O
stronger O
affinity O
than O
to O
the O
CD8αβ B-protein-complex
heterodimer O
( O
Kd O
∼10 O
μM O
versus O
100 O
μM) O
, O
an O
affinity O
that O
surpasses O
that O
of O
MHCIa B-protein-family
molecules O
to O
either O
the O
CD8αβ O
or O
CD8αα O
Leishman O
et O
al O
. O
2001 O
, O
Moody O
et O
al O
. O
2001 O
. O

For O
processing O
of O
both O
c- B-protein
src I-protein
and O
gamma B-chemical
amino-butyric I-chemical
acid I-chemical
type O
A O
receptor O
( O
GABAA B-chemical
) O
gamma2 O
, O
PTB B-protein
binds O
to O
pyrimidine B-RNA
tracts I-RNA
adjacent O
to O
the O
regulated O
exon O
necessary O
for O
exon O
exclusion O
in O
nonneuronal O
cells O
( O
3 O
, O
8) O
. O

It O
is O
hypothesized O
that O
heparin B-chemical
binds O
to O
both O
PCI B-protein
and O
APC B-protein
during O
PCI-mediated O
inhibition O
of O
APC O
, O
thus O
guiding O
the O
encounter O
of O
these O
proteins O
via O
a O
template O
mechanism O
( O
9 O
, O
10) O
. O

We O
conclude O
from O
this O
data O
that O
Abeta B-peptide
decreased O
apoE-mediated protein
binding O
to O
the O
cell O
surface O
by O
competition O
of O
Abeta O
with O
apoE-loaded O
betaVLDL B-protein-complex
rather O
than O
by O
displacement O
of O
apoE O
from O
betaVLDL O
or O
by O
direct O
binding O
of O
Abeta O
to O
apoE-containing O
betaVLDL O
. O

To O
demonstrate O
that O
the O
alpha-UBF B-reagent
antibody I-reagent
used O
here O
can O
specifically O
recognize O
UBF O
bound O
to O
rDNA B-DNA
, O
we O
performed O
combined O
immunofluorescence O
and O
FISH B-assay
analysis O
of O
metaphase O
chromosomes O
isolated O
from O
Xenopus O
cells O
( O
Fig O
. O
2) O
. O

Transcription O
factors O
which O
bind O
to O
Sp1 B-gene
and O
AP1 B-gene
have O
been O
implicated O
in O
the O
transcriptional O
regulation O
of O
other O
genes O
involved O
in O
lipid O
metabolism O
including O
apoA-II B-gene
( O
31) O
, O
apoC-III B-gene
( O
32) O
, O
chicken B-gene
vitellogenin I-gene
II I-gene
( O
34) O
, O
fatty B-gene
acid I-gene
synthase I-gene
( O
35–37) O
, O
stearoyl-CoA B-gene
desaturase I-gene
1 I-gene
( O
38) O
, O
the O
LDL B-gene
receptor I-gene
( O
39) O
, O
and O
the O
LDL B-gene
receptor I-gene
related I-gene
protein I-gene
( O
LRP B-gene
) O
( O
40) O
. O

Mutational O
Analysis O
of O
BAG4 B-protein
Binding O
to O
Hsc70 B-protein

GTP B-chemical
binding O
to O
RECQ5/QE B-protein
is O
needed O
for O
stimulation O
of O
the O
helicase O
activity O
GTPgammaS B-chemical
neither O
supported O
the O
helicase O
reaction O
itself O
( O
Fig O
. O
6 O
, O
lane O
12 O
) O
nor O
induced O
the O
DNA B-protein-family
helicase I-protein-family
activity O
in O
the O
presence O
of O
GTP O
( O
Fig O
. O
6 O
, O
lane O
9) O
. O

Binding O
of O
CUGBP2 B-protein
to O
AU-Rich B-RNA
Sequences I-RNA
in I-RNA
3′UTR I-RNA
of I-RNA
COX-2 I-RNA
mRNA I-RNA
Increases O
Luciferase B-protein-family
mRNA O
Stability O
. O

In O
our O
efforts O
to O
clarify O
further O
the O
roles O
of O
Dvl B-protein
in O
the O
Wnt B-process
signaling I-process
pathway I-process
, O
we O
isolated O
a O
novel O
protein O
which O
binds O
to O
the O
PDZ B-protein-domain
domain I-protein-domain
of O
Dvl O
by O
the O
yeast O
two-hybrid O
screening O
. O

Studies O
have O
shown O
that O
LRP B-protein-family
, O
gp330 B-protein
, O
and O
LR8B/apoER2 protein
can O
bind O
similar O
cytosolic O
binding O
proteins O
, O
a O
result O
that O
may O
reflect O
potential O
redundancy O
for O
signaling O
( O
67) O
. O

If O
neuroglian B-protein
were O
phosphorylated O
on O
tyrosine B-amino-acid
residues O
in O
S2 B-cell
cells I-cell
, O
and O
phosphorylation O
was O
responsible O
for O
the O
lack O
of O
ankyrin B-protein-family
binding O
to O
neuroglian O
at O
noncontact O
sites O
of O
aggregated O
S2 O
cells O
, O
then O
the O
mutation O
of O
tyrosine O
residue O
1234 O
in O
Drosophila O
neuroglian O
would O
be O
expected O
to O
cause O
ankyrin O
binding O
indiscriminately O
at O
all O
regions O
of O
the O
plasma O
membrane O
. O

We O
interpreted O
these O
data O
to O
reflect O
the O
existence O
of O
a O
ternary O
protein O
complex O
in O
which O
MEIS1 B-protein
binds O
to O
a O
PBX-HOXA9 B-protein-complex
dimer O
bound O
to O
DNA B-DNA
. O

In O
Shc B-protein
, O
the O
PTB B-protein-domain
domain I-protein-domain
binds O
a O
psi B-amino-acid
XNP O
XpY O
motif O
on O
receptor B-protein-family
tyrosine I-protein-family
kinases I-protein-family
, O
where O
psi O
is O
a O
hydrophobic O
residue O
, O
X O
is O
any O
amino O
acid O
residue O
, O
N B-amino-acid
is O
asparagine B-amino-acid
, O
P B-amino-acid
is O
proline B-amino-acid
, O
and O
pY B-amino-acid
is O
phosphotyrosine B-amino-acid
. O

Binding O
of O
thioflavin-S B-chemical
to O
MAP-2 B-protein-region
MTBR-123 I-protein-region
as O
well O
as O
to O
MAP-2c B-protein
was O
attended O
by O
a O
characteristic O
fluorescence O
enhancement O
previously O
reported O
for O
thioflavin-S O
interactions O
with O
polymerized O
Tau B-protein-region
K12 I-protein-region
fragment I-protein-region
( O
16) O
. O

Direct O
binding O
of O
Dlt B-protein
with O
Par-6 B-protein

A O
different O
region O
of O
PlexB B-protein-family
binds O
to O
RhoA B-protein
. O

Initial O
studies O
of O
ORC B-protein-complex
found O
that O
stable O
DNA B-DNA
binding O
by O
ORC O
required O
the O
addition O
of O
ATP B-chemical
to O
the O
binding O
reaction O
. O

The O
motility O
studies O
show O
that O
this O
interaction O
is O
functionally O
important O
and O
indicate O
that O
binding O
of O
type B-protein-complex
VI I-protein-complex
collagen I-protein-complex
to O
NG2 B-protein
triggers O
signaling O
mechanisms O
that O
lead O
to O
enhanced O
cell O
migration O
. O

First O
, O
the O
actin B-protein-family
binding O
affinity O
of O
fascin B-protein-family
is O
not O
affected O
by O
the O
pH O
range O
from O
7 O
. O
5 O
to O
6 O
. O
0 O
. O

Rather O
, O
it O
indicates O
that O
the O
MT B-organelle
binding O
of O
dynactin B-protein-complex
is O
stimulated O
by O
a O
factor O
found O
in O
brain O
that O
is O
lacking O
in O
axons O
; O
presumably O
this O
factor O
is O
located O
either O
in O
cell O
bodies O
or O
synapses O
. O

However O
, O
studies O
in O
a O
mammalian O
system O
have O
shown O
that O
kinase B-protein
dead I-protein
GSK-3 I-protein
does O
not O
bind O
Axin B-protein
( O
Ikeda O
et O
al O
. O
1998 O
) O
, O
indicating O
that O
the O
kinase B-protein
dead I-protein
dnXgsk-3 I-protein
might O
stabilize O
beta-catenin B-protein-family
by O
an O
alternative O
mechanism O
. O

To O
demonstrate O
that O
the O
reduction O
in O
the O
amount O
of O
Axin B-protein
bound O
to O
Xgsk-3 B-protein
is O
specifically O
dependent O
on O
GBP B-protein-family
binding O
to O
Xgsk-3 O
, O
the O
coimmunoprecipitation O
experiment O
was O
repeated O
using O
a O
high O
dose O
of O
HA-tagged B-fusion-protein
GBP I-fusion-protein
( O
GBPwt B-fusion-protein
) O
or O
an O
equivalent O
amount O
of O
the O
HA-tagged B-fusion-protein
GBP I-fusion-protein
mutant I-fusion-protein
that O
does O
not O
bind O
Xgsk-3 O
( O
Yost O
et O
al O
. O
1998 O
) O
( O
GBPmut) fusion-protein
. O

The O
cytoplasmic O
tail O
of O
E-cadherin B-protein
is O
bound O
directly O
to O
beta-catenin B-protein-family
or O
plakoglobin B-protein
, O
and O
thereby O
to O
alpha-catenin B-protein-family
and O
actin B-protein-family
( O
reviewed O
in O
Ref O
. O
2) O
. O

The O
new O
results O
also O
indicate O
that O
the O
IAP B-protein-motif
binding I-protein-motif
motif I-protein-motif
of O
Omi/HtrA2 B-protein
is O
important O
for O
efficient O
cleavage O
of O
IAPs B-protein-family
at O
distinct O
sites O
and O
for O
disruption O
of O
the O
association O
between O
caspases B-protein-family
and O
the O
IAP O
fragments O
. O

SRF B-protein
bound O
to O
GST-Hop experiment-tag
( O
lane O
2 O
) O
but O
not O
to O
GST O
alone O
( O
lane O
1) O
. O

Swinholide B-chemical
A I-chemical
sequesters O
G-actin protein-family
as O
dimers O
and O
can O
sever O
F-actin B-protein
( O
10 O
, O
24 O
, O
37) O
; O
cytochalasin B-chemical
D I-chemical
induces O
dimerization O
of O
G-actin O
, O
promotes O
ATP B-chemical
hydrolysis O
, O
and O
caps O
filament O
barbed O
ends O
( O
see O
Sampath O
and O
Pollard O
1991) O
; O
and O
binding O
of O
profilin B-protein-family
to O
actin O
promotes O
nucleotide O
exchange O
( O
Schluter O
et O
al O
. O
1997) O
. O

Previous O
models O
( O
6 O
, O
8 O
) O
assumed O
that O
any O
interaction O
between O
Snf B-protein-family
and O
Sxl B-protein
occurred O
with O
Snf O
acting O
as O
part O
of O
U1 B-protein-RNA-complex
or O
U2 B-protein-RNA-complex
snRNPs I-protein-RNA-complex
and O
that O
this O
interaction O
was O
preceded O
by O
Sxl O
binding O
to O
pre-mRNA B-RNA
between O
exons O
3 O
and O
4 O
to O
block O
the O
male O
splice O
. O

GST-TFE3 experiment-tag
retained O
full-length O
Ets-1 B-protein
( O
labeled O
1-440 O
) O
and O
the O
first O
two O
deletion O
mutants O
but O
not O
the O
smallest O
Ets-1 O
derivative O
( O
delta286 B-protein
) O
which O
bound O
to O
the O
GST-containing B-reagent
column I-reagent
as O
well O
( O
Fig O
. O
8A) O
. O

The O
role O
of O
NIK B-protein
binding O
to O
Nck B-protein-family
in O
NIK O
regulation O
and O
NIK O
activation O
of O
the O
JNK/ protein
SAPK B-protein
pathway O
is O
most O
intriguing O
. O

However O
, O
the O
interaction O
between O
the O
mutated O
CtIP B-protein
and O
GST-BRCT experiment-tag
was O
unaffected O
( O
Fig O
. O
4 O
A O
, O
compare O
lanes O
3 O
and O
7) O
, O
suggesting O
that O
CtIP O
binds O
to O
CtBP B-protein
and O
the O
BRCT B-protein-domain
repeats I-protein-domain
of O
BRCA1 B-protein
using O
different O
motifs O
. O

Recent O
work O
has O
shown O
that O
Hth B-protein-motif
binding O
allows O
nuclear O
transport O
of O
Exd B-protein-family
by O
simultaneously O
inhibiting O
its O
nuclear B-protein-motif
export I-protein-motif
signal I-protein-motif
( O
NES B-protein-motif
) O
while O
activating O
its O
NLS B-protein-motif
( O
Abu-Shaar O
et O
al O
. O
, O
1999 O
; O
Berthelsen O
et O
al O
. O
, O
1999) O
. O

Neither O
the O
Vg-Sd protein
complex O
nor O
Sd O
alone O
bound O
to O
the O
shorter O
18 O
mer O
. O

Using O
purified O
glutathione B-experiment-tag
S-transferase I-experiment-tag
( O
GST)-fused experiment-tag
wild-type O
( O
WT O
) O
Aurora B-protein
B I-protein
, O
GST-fused O
kinase-defective B-protein
( I-protein
KD I-protein
) I-protein
mutant I-protein
of I-protein
Aurora I-protein
B I-protein
, O
or O
GST O
alone O
against O
purified O
maltose B-protein
binding I-protein
protein I-protein
( O
MBP)-fused protein
MgcRacGAP B-protein
, O
GST B-assay
pull-down I-assay
assays O
were O
performed O
in O
buffer O
A O
( O
25 O
mM O
Tris B-reagent
[ O
pH O
7 O
. O
5] O
, O
2 O
mM O
MgCl2 O
, O
200 O
μM O
ATP B-chemical
, O
0 O
. O
1 O
μM O
calyculin B-chemical
A I-chemical
, O
1% O
Nonidet -
P-40) -
. O

Our O
results O
suggest O
that O
ATP-BD chemical
binds O
AMP B-chemical
and O
ATP O
at O
two O
separate O
sites O
( O
see O
above) O
. O

The O
apparent O
lack O
of O
stoichiometric O
binding O
of O
ORC B-protein-complex
to O
ATP B-chemical
may O
be O
attributable O
to O
several O
factors O
. O

Previous O
studies O
have O
indicated O
that O
Ras B-protein-family
binding O
localizes O
Raf-1 B-protein
to O
the O
plasma O
membrane O
where O
it O
becomes O
activated O
and O
that O
artificially O
targeting O
Raf-1 O
to O
the O
plasma O
membrane O
results O
in O
constitutive O
activation O
of O
the O
kinase O
( O
Leevers O
et O
al O
. O
, O
1994 O
; O
Stokoe O
et O
al O
. O
, O
1994) O
. O

In O
comparing O
DNA B-DNA
binding O
of O
Dm B-drug
and O
MGTs B-drug
, O
it O
should O
be O
noted O
that O
the O
substitution O
of O
the O
amino-terminal O
formyl O
and O
the O
carboxyl-terminal O
amidine O
groups O
of O
Dm O
by O
acetamido O
and O
-CH2CH2N+H(CH3)2 B-chemical
groups O
, O
respectively O
, O
yields O
compound O
2 O
along O
with O
a O
three-order O
of O
magnitude O
decrease O
in O
binding O
affinity O
( O
K1K2 O
) O
compared O
with O
Dm O
. O

It O
has O
been O
shown O
that O
the O
interaction O
between O
U2AF35 B-protein
and O
the O
3 B-RNA
' I-RNA
splice I-RNA
site I-RNA
AG I-RNA
can O
stabilize O
U2AF65 B-protein
binding O
to O
weak O
Py B-DNA
tracts I-DNA
characteristic O
of O
so-called O
AG-dependent B-RNA
pre-mRNAs I-RNA
. O

In O
contrast O
, O
hPAK65 B-protein
interacts O
strongly O
with O
the O
GTP-bound chemical
forms O
of O
both O
Rac1 B-protein
and O
CDC42Hs B-protein
. O

For O
example O
, O
AKAP79 B-protein
colocalizes O
PKC B-protein-family
with O
PKA B-protein-family
and O
calcineurin B-protein
; O
gravin B-protein
binds O
PKC O
and O
PKA O
; O
and O
the O
InaD B-protein
clusters O
PKC O
with O
phospholipase-C B-protein-family
beta I-protein-family
, O
G B-protein-family
proteins I-protein-family
, O
and O
calmodulin B-protein
( O
Fig O
. O
3) O
. O

Calmodulin B-protein-family
binding O
activities O
of O
the O
adducin B-protein
recombinant O
polypeptides O
and O
the O
MARCKS-related B-protein-domain
domain I-protein-domain
peptide O
were O
inhibited O
by O
PKA B-protein-family
and O
PKC B-protein-family
phosphorylation O
. O

We O
delineated O
the O
region O
of O
LIN-7 B-protein
that O
binds O
to O
LIN-2 B-protein
by O
generating O
a O
series O
of O
LIN-7 O
fusion O
proteins O
that O
contained O
successively O
larger O
N-terminal O
truncations O
. O

Characterization O
of O
rC B-protein-domain
Domain I-protein-domain
Binding O
to O
Fibronectin B-protein
, O
Laminin B-protein-family
, O
SPARC B-protein
, O
and O
Tenascin B-protein-family

The O
introduction O
of O
a O
glutamic B-amino-acid
acid I-amino-acid
residue O
at O
position O
12 O
in O
place O
of O
the O
tyrosine B-amino-acid
residue O
similarly O
reduced O
the O
binding O
of O
alpha-actinin B-protein-family
to O
actin B-protein-family
. O

As O
a O
negative O
control O
, O
we O
found O
that O
GST B-experiment-tag
alone O
did O
not O
bind O
MBP-Sec3p B-experimental-construct
under O
the O
same O
reaction O
conditions O
. O

Interestingly O
, O
Abl B-protein-family
binds O
to O
the O
proline-rich B-protein-motif
sequences I-protein-motif
found O
in O
formin B-protein-family
proteins O
( O
Ren O
et O
al O
. O
, O
1993 O
) O
and O
to O
Ena O
( O
Gertler O
et O
al O
. O
, O
1995) O
, O
which O
also O
bind O
to O
profilin O
. O

Overexpression O
of O
wild-type O
raptor B-protein
, O
but O
not O
of O
a O
mutant O
that O
cannot O
interact O
with O
mTOR B-protein
( O
mut O
1 O
in O
Figure O
4) O
, O
resulted O
in O
an O
increased O
amount O
of O
raptor O
bound O
to O
mTOR O
and O
a O
decrease O
in O
its O
in O
vitro O
kinase O
activity O
( O
Figure O
6E) O
. O

Finally O
, O
footprinting O
analyses O
using O
the O
-73 O
to O
+13 O
promoter O
sequence O
did O
not O
reveal O
any O
protected O
nucleotides O
in O
the O
wild-type O
and O
mutated O
promoter O
sequences O
, O
under O
conditions O
which O
detected O
strong O
c-Jun B-protein
binding O
to O
the O
AP-1 B-protein-complex
binding O
site O
( O
data O
not O
shown) O
. O

Thus O
, O
it O
appears O
that O
the O
holoenzyme O
can O
partially O
stabilize O
binding O
of O
TBP B-protein
and O
TFIIA B-protein-complex
to O
a O
mononucleosome O
in O
the O
absence O
of O
ATP B-chemical
. O

Because O
the O
N-terminal O
binding O
sequences O
of O
syntaxins B-protein-family
are O
distant O
from O
the O
SNARE B-protein-motif
motifs I-protein-motif
, O
the O
corresponding O
SM B-protein-family
proteins I-protein-family
bind O
equally O
well O
to O
the O
isolated O
syntaxins O
and O
to O
assembled O
SNARE O
complexes O
( O
Peng O
and O
Gallwitz O
, O
2002 O
) O
. O

LDB B-protein-family
proteins I-protein-family
bind O
LIM B-protein-domain
domains I-protein-domain
of O
LIM-HD B-protein-family
( O
and O
nuclear O
LIM-only O
) O
proteins O
. O

p21 B-protein
induction O
and O
its O
binding O
to O
cdk2 B-protein
are O
also O
observed O
following O
p16 B-protein
expression O
in O
HCT B-cell
116 I-cell
colorectal O
carcinoma O
cells O
. O

Thus O
, O
like O
Arg65 O
in O
MKP3 B-protein
, O
Asp319 O
in O
ERK2 B-protein
plays O
a O
major O
role O
in O
ERK2 O
binding O
to O
MKP3 O
, O
but O
it O
is O
not O
essential O
for O
ERK2-induced O
MKP3 O
activation O
. O

The O
recombinant O
second O
C B-protein-domain
-domain I-protein-domain
of O
SytI B-protein
also O
binds O
syntaxin B-protein-family
( O
see O
Fig O
. O
3 O
) O
and O
phospholipids B-chemical
( O
Damer O
and O
Creutz O
, O
1994 O
) O
in O
a O
Ca B-chemical
-independent O
manner O
. O

In O
contrast O
to O
their O
effects O
on O
cell O
proliferation O
, O
peptides O
containing O
either O
a O
single O
copy O
of O
the O
receptor O
binding O
domain O
or O
the O
distal O
heparin B-chemical
binding O
domain O
of O
apoE B-protein
did O
not O
inhibit O
PDGF-directed protein-family
smooth O
muscle O
cell O
migration O
. O

These O
results O
clearly O
demonstrate O
that O
Ca B-chemical
-dependent O
binding O
of O
synaptotagmin B-protein-family
to O
syntaxin B-protein-family
1 I-protein-family
involves O
structural O
features O
distinct O
from O
those O
required O
for O
the O
Ca O
-dependent O
interaction O
of O
synaptotagmin O
with O
phospholipids B-chemical
. O

The O
DNA B-DNA
binding O
activity O
of O
TTF-1 B-protein
in O
thyroid O
cells O
has O
been O
reported O
to O
be O
under O
TSH B-protein-complex
control O
because O
of O
redox O
regulation O
( O
19 O
) O
even O
though O
TTF-1 B-RNA
mRNA I-RNA
appears O
to O
be O
down-regulated O
by O
the O
hormone O
( O
41 O
, O
42) O
. O

The O
addition O
to O
permeabilized O
cells O
of O
PH B-protein-domain
domains I-protein-domain
that O
bind O
PI(4 B-chemical
, I-chemical
5)P2 I-chemical
inhibits O
both O
early O
and O
late O
stages O
of O
clathrin-mediated protein-complex
endocytosis O
( O
Jost O
et O
al O
. O
, O
1998 O
) O
. O

This O
correlation O
is O
mediated O
at O
least O
in O
part O
by O
the O
binding O
of O
Snail B-protein
to O
the O
E-cadherin B-DNA
promoter I-DNA
where O
it O
acts O
as O
a O
transcriptional O
repressor O
. O

From O
these O
data O
we O
observed O
a O
small O
increase O
in O
the O
percent O
of O
WT O
coat B-protein-family
protein I-protein-family
bound O
to O
GroEL B-protein-complex
with O
increasing O
temperature O
. O

Nevertheless O
, O
the O
binding O
of O
NF1 B-protein
and O
Sp1 B-protein
to O
oligo B-reagent
II I-reagent
in O
vitro O
is O
mutually O
exclusive O
as O
indicated O
by O
the O
results O
of O
DMSA B-assay
, O
which O
is O
consistent O
with O
the O
lack O
of O
additivity O
in O
the O
activation O
of O
the O
P2 B-DNA
promoter I-DNA
by O
these O
two O
factors O
in O
vivo O
. O

[ O
Abstract O
] O
arki O
S O
, O
Holzbaur O
ELF O
( O
1995 O
) O
Affinity O
chromatography O
demonstrates O
a O
direct O
binding O
between O
cytoplasmic O
dynein B-protein-family
and O
the O
dynactin B-protein-complex
complex O
. O

Lysine O
residue O
at O
721 O
within O
the O
kinase B-protein-domain
domain I-protein-domain
is O
believed O
to O
be O
involved O
in O
ATP B-chemical
binding O
, O
and O
replacement O
of O
this O
lysine B-amino-acid
with O
methionine B-amino-acid
abrogates O
receptor B-protein-family
tyrosine I-protein-family
kinase I-protein-family
activity O
. O

We O
have O
shown O
that O
full-length O
Tsg101 B-protein
binds O
Hrs B-protein
( O
and O
COOH-terminal O
fragments) O
, O
and O
that O
COOH-terminal O
Hrs O
fragments O
can O
support O
Tsg101-dependent O
plasma O
membrane O
vesicle O
fission O
in O
a O
heterologous O
VLP O
system O
. O

To O
evaluate O
cadherin- protein-family
or O
TCF-binding protein-family
capacity O
of O
β-catenin B-protein-family
in O
SW480 B-cell
cells I-cell
, O
a O
cell O
lysate O
( O
1% O
nonidet O
40–containing O
buffer O
) O
or O
100 O
, O
000-g O
detergent-free O
supernatant O
( O
Reinacher-Schick O
and O
Gumbiner O
2001 O
) O
was O
subjected O
to O
consecutive O
affinity O
precipitations O
( O
30′ O
incubations O
× O
3 O
) O
with O
a O
glutathione B-experiment-tag
S-transferase I-experiment-tag
( O
GST B-experiment-tag
) O
fusion O
protein O
containing O
the O
cytoplasmic O
domain O
of O
C-cadherin B-protein
( O
Yap O
et O
al O
. O
1998 O
) O
or O
the O
β-catenin O
binding O
region O
of O
Xenopus B-protein
TCF-3 I-protein
. O

The O
binding O
of O
AP-3 B-protein-complex
to O
LIMP-II B-protein
was O
characterized O
in O
more O
detail O
and O
shown O
to O
depend O
on O
leucine O
18 O
, O
which O
is O
a O
critical O
component O
of O
the O
di-leucine-based O
motif O
involved O
in O
the O
sorting O
of O
LIMP-II O
to O
lysosomes B-organelle
( O
Ogata O
and O
Fukuda O
, O
1994 O
; O
Sandoval O
et O
al O
. O

This O
time O
course O
of O
ATP B-chemical
inhibition O
correlates O
well O
with O
the O
activation O
of O
HSF B-protein-family
binding O
by O
salicylate B-drug
indicating O
that O
decreases O
in O
intracellular O
ATP O
may O
be O
an O
important O
factor O
in O
the O
activation O
of O
HSF O
binding O
by O
this O
drug O
. O

We O
may O
then O
use O
the O
crystal O
structure O
model O
( O
33 O
) O
of O
an O
archael O
Cdc6 B-protein
ortholog O
as O
a O
guide O
for O
the O
ATP-binding chemical
structures O
of O
ORC1 B-protein
. O

These O
results O
provide O
evidence O
that O
complex O
2 O
is O
due O
to O
binding O
of O
Sp1 B-protein
to O
the O
CACCC B-DNA
box I-DNA
; O
however O
, O
complex O
1 O
appears O
to O
be O
due O
to O
a O
distinct O
factor(s) O
, O
perhaps O
a O
Krüppel-like B-protein
protein I-protein
, O
that O
is O
specifically O
induced O
during O
Me2SO-induced chemical
neuronal O
differentiation O
of O
N1E-115 B-cell
cells I-cell
. O

However O
, O
it O
did O
not O
do O
so O
catalytically O
because O
FPLC B-assay
showed O
that O
auxilin B-protein
remained O
bound O
to O
polymerized O
Hsc70 B-protein
at O
a O
1 O
: O
1 O
molar O
ratio O
of O
auxilin O
to O
Hsc70 O
. O

Although O
CD19 B-protein-complex
function O
may O
be O
elicited O
following O
its O
potential O
binding O
to O
an O
as O
yet O
unidentified O
ligand O
, O
C3d B-protein
binding O
to O
CD21 B-protein
supplies O
an O
already O
characterized O
ligand O
for O
the O
CD19 O
complex O
, O
thereby O
linking O
complement O
activation O
and O
B B-cell
cell I-cell
function O
. O

From O
these O
results O
we O
conclude O
that O
the O
binding O
of O
p300 B-protein
and O
SAF-A B-protein
to O
the O
MII B-DNA
S/MAR I-DNA
element I-DNA
, O
as O
observed O
in O
U-2 B-cell
OS I-cell
and O
VH10 B-cell
cells O
, O
is O
absent O
in O
SV40- B-cell
and O
adenovirus-transformed B-cell
cells I-cell
. O

The O
lack O
of O
protein B-protein
4 I-protein
. I-protein
1 I-protein
binding O
to O
the O
truncated O
fusion O
protein O
therefore O
suggests O
that O
residues O
located O
in O
the O
C-terminal O
half O
of O
the O
39-amino O
acid O
region O
may O
be O
necessary O
for O
the O
binding O
of O
p55 B-protein-family
to O
protein O
4 O
. O
1 O
( O
Fig O
. O
6 O
) O
. O

However O
, O
its O
binding O
to O
the O
GTP-bound chemical
forms O
of O
Rac1 B-protein
, O
Rac2 B-protein
, O
and O
RhoA B-protein
and O
its O
slight O
effect O
on O
dorsal O
closure O
suggest O
that O
pkn B-protein
may O
function O
as O
an O
effector O
of O
Rac B-protein-family
or O
that O
it O
may O
be O
a O
redundant O
effector O
during O
dorsal O
closure O
. O

In O
the O
presence O
of O
caldesmon B-protein
, O
fascin B-protein-family
does O
not O
inhibit O
actin B-protein-family
binding O
of O
high O
Mr O
TMs B-protein-family
at O
a O
concentration O
below O
2 O
μM O
fascin O
( O
closed O
circles) O
. O

To O
control O
for O
the O
specificity O
of O
12S -
E1A-dependent -
inhibition O
of O
Gal-Ets protein-family
2-440 O
, O
we O
also O
used O
a O
CBP-independent protein
activator O
, O
Gal-CREB B-experimental-construct
160-284 I-experimental-construct
, O
which O
fuses O
the O
Gal B-protein-domain
DBD I-protein-domain
to O
the O
glutamine-rich B-protein-domain
activation I-protein-domain
domain I-protein-domain
of O
CREB O
, O
termed O
Q2 B-protein-domain
( O
Q2 O
binds O
the O
TFIID B-protein
component O
dTAF110 B-protein
[ O
16 O
, O
25 O
, O
61 O
, O
77]) O
. O

Point O
mutations O
introduced O
into O
the O
CTCF B-DNA
binding I-DNA
site I-DNA
of O
mouse O
3 B-DNA
' I-DNA
HS1 I-DNA
are O
in O
boldface O
and O
underlined O
. O

Taken O
together O
, O
these O
results O
indicate O
that O
the O
effect O
of O
U2AF35 B-protein
in O
promoting O
splicing O
of O
IgM B-protein-family
in O
odTdeltaNE B-cell
cannot O
be O
explained O
by O
an O
increase O
in O
U2AF65 B-protein
binding O
to O
the O
Py B-DNA
tract I-DNA
. O

AD1 B-protein
binds O
CBP B-protein
or O
p300 B-protein
, O
whereas O
AD2 B-protein
has O
been O
shown O
to O
activate O
transcription O
through O
the O
recruitment O
of O
the O
arginine O
methyltransferase O
CARM1 B-protein
. O

This O
result O
suggests O
that O
317Y/F- O
Shc B-protein
binds O
to O
the O
insulin B-protein
receptor I-protein
upon O
insulin O
stimulation O
, O
but O
that O
it O
subsequently O
fails O
to O
bind O
to O
Grb2 B-protein
. O

Owing O
to O
the O
higher O
concentration O
of O
ATP B-chemical
in O
living O
cells O
and O
its O
higher O
affinity O
for O
actin B-protein-family
than O
ADP B-chemical
, O
nucleotide-free B-protein
actin I-protein
preferentially O
binds O
ATP O
. O

In O
vitro O
biochemical O
studies O
using O
purified O
Swi5p B-protein
and O
Pho2p B-protein
proteins O
have O
demonstrated O
that O
Swi5p O
and O
Pho2p O
bind O
cooperatively O
to O
the O
HO B-DNA
promoter I-DNA
. O

Observed O
destabilization O
of O
troponin-tropomyosin B-protein-complex
binding O
to O
actin B-protein-family
in O
the O
presence O
of O
Ca2+ B-chemical
, O
a O
1 O
. O
4-fold O
effect O
, O
provides O
a O
partial O
explanation O
. O

Second O
, O
binding O
of O
Net1 B-protein
to O
Cdc14 B-protein
inhibits O
the O
protein O
phosphatase O
activity O
of O
Cdc14 O
in O
vitro O
, O
and O
net1 O
mutants O
display O
elevated O
Cdc14 O
protein O
phosphatase O
activity O
. O

The O
latter O
event O
also O
facilitates O
binding O
of O
dATP B-chemical
( O
or O
ATP B-chemical
) O
by O
Apaf-1 B-protein
, O
which O
may O
lock O
the O
molecule O
into O
a O
more O
open O
configuration O
and O
permit O
oligomerization O
and O
caspase-9 B-protein
recruitment O
. O

We O
reasoned O
that O
the O
homology O
of O
the O
heparin B-chemical
binding O
motifs O
of O
apoE B-protein
and O
Abeta B-peptide
revealed O
by O
the O
immunochemical O
studies O
was O
responsible O
for O
the O
competition O
of O
Abeta O
for O
the O
uptake O
of O
apoE-enriched O
betaVLDL B-protein-complex
. O

The O
results O
further O
suggest O
that O
interactions O
involving O
factors O
that O
define O
mRNP B-protein-RNA-complex
composition O
occur O
as O
early O
as O
the O
commitment O
stage O
of O
splicing B-protein-complex
complex I-protein-complex
formation O
, O
when O
U1 B-protein-RNA-complex
snRNP I-protein-RNA-complex
and O
SR B-protein-family
family I-protein-family
proteins I-protein-family
bind O
to O
the O
pre-mRNA B-RNA
and O
facilitate O
the O
association O
of O
factors O
including O
SRm160/300 B-protein-complex
and O
DEK B-protein
with O
the O
substrate O
( O
Blencowe O
et O
al O
. O
1998 O
; O
present O
study) O
. O

One O
proposal O
for O
how O
the O
UTRs B-RNA
repress O
protein O
production O
is O
that O
SXL B-protein
binds O
to O
the O
UTRs O
of O
msl-2 B-RNA
mRNA I-RNA
and O
blocks O
the O
export O
of O
these O
mRNAs B-RNA
from O
the O
nucleus O
. O

Binding O
of O
tTA B-protein
to O
tetO B-experiment-tag
results O
in O
activation O
of O
expression O
of O
the O
proapoptotic O
gene O
hid B-DNA
. O

Filamin-B B-protein
binds O
to O
GP-Ibα B-protein
( O
Takafuta O
et O
al O
. O
, O
1998 O
; O
Xu O
et O
al O
. O
, O
1998) O
, O
whereas O
the O
muscle-associated O
filamin-C B-protein
binds O
to O
sarcoglycans B-protein-family
( O
Thompson O
et O
al O
. O
, O
2000 O
) O
and O
a O
number O
of O
muscle-specific O
proteins O
( O
Faulkner O
et O
al O
. O
, O
2000 O
; O
van O
der O
Ven O
et O
al O
. O
, O
2000 O
; O
Takada O
et O
al O
. O
, O
2001) O
. O

In O
contrast O
, O
dGTP B-chemical
and O
dADP B-chemical
could O
not O
compete O
for O
dATP B-chemical
binding O
to O
Apaf-1 B-protein
at O
all O
. O

On O
the O
other O
hand O
, O
CBP/p300 protein
could O
still O
function O
as O
a O
“glue O
” O
to O
bring O
together O
ER81 B-protein
and O
transcription O
factors O
binding O
outside O
CBP B-protein-region
region I-protein-region
451 I-protein-region
to I-protein-region
721 I-protein-region
, O
such O
as O
Fos B-protein
or O
nuclear B-protein-family
hormone I-protein-family
receptors I-protein-family
( O
18) O
, O
and O
thereby O
facilitate O
cooperation O
between O
different O
classes O
of O
transcription O
factors O
at O
selected O
promoters O
containing O
respective O
DNA-binding DNA
sites O
. O

These O
findings O
strongly O
suggest O
that O
E2Fs B-protein-family
bound O
to O
both O
E2F B-DNA
sites I-DNA
present O
in O
the O
promoter O
have O
both O
a O
negative O
role O
( O
when O
bound O
to O
pocket O
proteins O
) O
and O
a O
positive O
role O
in O
the O
regulation O
of O
CDC6 B-DNA
expression O
. O

This O
is O
most O
likely O
due O
to O
the O
binding O
of O
Ubc9 B-protein
directly O
to O
GR B-protein
( O
Fig O
. O
3) O
. O

A O
, O
p65 B-protein
binds O
to O
AES B-protein
and O
IkappaBalpha B-protein
in O
vitro O
. O

These O
data O
suggest O
that O
the O
binding O
of O
Sp1 B-protein
and O
NF-kappaB1 B-protein
to O
the O
HIV-1 B-protein-DNA-complex
mononucleosomes I-protein-DNA-complex
does O
not O
disrupt O
histone-DNA DNA
contacts O
sufficiently O
to O
allow O
SWI-SNF-mediated protein
histone O
displacement O
. O

To O
test O
whether O
Ras B-protein-family
mutant O
cells O
within O
the O
dorsal O
appendage O
primordia O
undergo O
this O
shape O
change O
, O
we O
carried O
out O
confocal O
analyses O
of O
mosaic O
egg O
chambers O
in O
which O
we O
simultaneously O
detected O
Ras O
clones O
and O
visualized O
cell O
morphology O
using O
one O
of O
two O
reagents O
: O
rhodamine-phalloidin B-chemical
, O
which O
binds O
to O
filamentous B-protein
actin I-protein
, O
or O
anti-E-cadherin B-reagent
, O
which O
highlights O
apical O
morphology O
( O
Fig O
. O
6A) O
. O

HxPros B-experimental-construct
enhances O
the O
binding O
of O
Dfd B-protein
and O
Hoxa-5 B-protein
to O
DNA B-DNA
by O
more O
than O
10-fold O
( O
Fig O
. O
3 O
A O
, O
and O
not O
shown) O
. O

Similarly O
, O
p53 B-protein
, O
E1A B-protein
, O
c-Fos B-protein
, O
c-Jun B-protein
, O
MyoD B-protein
, O
and O
TFIIB B-protein
all O
interact O
with O
the O
CH3 B-protein-region
region I-protein-region
of O
p300/CBP B-protein-family
, O
and O
these O
factors O
would O
likely O
interfere O
with O
the O
TCF B-protein-family
binding O
to O
p300/CBP O
. O

The O
convex O
shape O
of O
the O
Scatchard O
plot O
indicated O
that O
Arg B-amino-acid
binds O
to O
F-actin B-protein
with O
positive O
cooperativity O
( O
Fig O
. O
1 O
G O
; O
ref O
. O
19) O
. O

Because O
roX B-RNA-family
RNAs O
are O
unstable O
unless O
bound O
by O
MSL B-protein-family
proteins O
( O
13 O
, O
15) O
, O
steady-state O
levels O
of O
one O
roX O
RNA O
species O
might O
fall O
if O
another O
roX O
species O
captured O
most O
MSL O
proteins O
. O

Translocation O
requires O
another O
homeobox O
protein O
, O
homothorax B-protein
, O
which O
binds O
extradenticle B-protein
and O
enables O
nuclear O
entry O
( O
Rieckhof O
et O
al O
. O
1997 O
) O
. O

On O
the O
basis O
of O
studies O
using O
yeast O
and O
Xenopus O
cells O
, O
Cdc6p B-protein
most O
likely O
binds O
to O
ORC B-protein-complex
and O
then O
the O
ORC-Cdc6p B-protein-complex
complex O
( O
and O
perhaps O
other O
proteins O
) O
recruits O
the O
six O
minichromosome B-protein-family
maintenance I-protein-family
( O
MCM B-protein-family
) O
proteins O
to O
form O
a O
pre-replication B-protein-complex
complex I-protein-complex
( O
pre-RC B-protein-complex
) O
at O
each O
origin O
( O
Cocker O
et O
al O
. O
1996 O
; O
Santocanale O
and O
Diffley O
1996 O
; O
Aparicio O
et O
al O
. O
1997 O
; O
Donovan O
et O
al O
. O
1997 O
; O
Liang O
and O
Stillman O
1997 O
; O
Tanaka O
et O
al O
. O
1997 O
; O
Perkins O
and O
Diffley O
1998 O
; O
Weinreich O
et O
al O
. O
1999) O
. O

2 O
) O
This O
region O
is O
involved O
in O
the O
interaction O
of O
C/EBPbeta B-protein
with O
other O
modulating O
proteins O
bound O
to O
neighboring O
cis-regulatory O
sites O
, O
creating O
structural O
changes O
( O
27) O
. O

In O
particular O
, O
overexpression O
of O
TDP-43 B-protein
could O
cause O
exon-skipping O
of O
the O
CTFR B-gene
exon O
9 O
, O
and O
this O
skipping O
is O
through O
TDP-43 O
binding O
to O
a O
( B-DNA
UG I-DNA
) I-DNA
m(U)n I-DNA
motif I-DNA
near O
the O
3′ O
splice O
site O
of O
the O
CTFR B-DNA
intron I-DNA
8 I-DNA
( O
13) O
. O

It O
has O
been O
shown O
that O
a O
family O
of O
elav-like B-protein-family
proteins I-protein-family
binds O
to O
an O
AU-rich B-RNA
sequence I-RNA
located O
within O
the O
3 B-RNA
' I-RNA
untranslated I-RNA
region I-RNA
( O
UTR B-RNA
) O
of O
certain O
mRNAs B-RNA
and O
increases O
the O
stability O
of O
these O
mRNAs O
( O
6 O
, O
11 O
, O
12 O
, O
26 O
, O
35) O
. O

Because O
HSPGs B-chemical
have O
been O
detected O
immunohistochemically O
in O
the O
pancreatic O
amyloid B-peptide
deposits O
of O
type B-disease
II I-disease
diabetes I-disease
( O
35) O
, O
we O
investigated O
the O
binding O
of O
amylin B-peptide
to O
heparin B-chemical
. O

These O
data O
may O
therefore O
indicate O
that O
binding O
of O
PS B-protein
to O
Nct B-protein
leads O
to O
the O
accumulation O
of O
a O
stable O
protein O
complex O
composed O
of O
mature O
Nct O
and O
PS O
fragments O
. O

By O
this O
screening O
, O
we O
show O
that O
this O
interaction O
occurs O
in O
vivo O
and O
, O
further O
, O
that O
TAFII55 B-protein
binds O
TAFII250 B-protein
in O
the O
848-1279 O
region O
of O
TAFII250 O
. O

Electrophoretic B-assay
mobility I-assay
shift I-assay
assays I-assay
( O
EMSA B-assay
) O
show O
that O
Sp1 B-protein
and O
Sp3 B-protein
bind O
the O
Sp1 B-DNA
element I-DNA
, O
whereas O
transcription O
factors O
binding O
to O
the O
Ets-1 B-DNA
element I-DNA
are O
yet O
to O
be O
identified O
. O

p53 B-protein
specifically O
binds O
to O
its O
consensus O
DNA B-DNA
binding O
sequence O
, O
consisting O
of O
two O
repeats O
of O
10-bp O
motif O
5-PuPuPuC B-DNA
( I-DNA
A/T)(T/A)GPyPyPy-3(2) I-DNA
, O
and O
transactivates O
expression O
of O
the O
target O
genes O
. O

Although O
the O
E1A B-protein
data O
are O
consistent O
with O
this O
view O
, O
E1A O
also O
binds O
p107 B-protein
and O
p130 B-protein
, O
and O
these O
proteins O
can O
also O
associate O
with O
E2F B-DNA
target I-DNA
promoters I-DNA
in O
senescent O
cells O
. O

( O
B O
) O
PAK B-protein-family
bound O
to O
PIX B-protein-family
as O
previously O
reported O
. O

Because O
the O
GTP-bound chemical
form O
of O
Ras B-protein-family
is O
a O
key O
transducer O
in O
the O
mitogen B-process
signaling I-process
pathway I-process
( O
18) O
, O
we O
decided O
to O
examine O
Ras O
GTP O
loading O
in O
anchored O
or O
suspended O
3T3 B-cell
cells I-cell
treated O
with O
either O
PDGF B-protein-family
or O
EGF B-protein
. O

However O
, O
our O
previous O
overlay O
experiment O
showed O
a O
direct O
binding O
between O
dSlo B-protein
and O
PKAc B-protein
, O
suggesting O
a O
novel O
channel-PKA protein-complex
protein O
complex O
. O

In O
addition O
to O
binding O
Nck B-protein-family
in O
vitro O
, O
NIK B-protein
also O
bound O
Nck O
in O
cells O
. O

This O
suggests O
that O
binding O
of O
Sp1 B-protein
to O
the O
Ctpct B-gene
promoter O
was O
saturated O
. O

Heparin-binding chemical
activity O
of O
apoE B-protein
was O
also O
proposed O
to O
be O
responsible O
for O
the O
inhibitory O
role O
of O
apoE O
in O
cell O
growth O
[ O
8 O
. O

Although O
mutation O
of O
the O
Sp1 B-DNA
site I-DNA
did O
not O
block O
p53 B-protein
binding O
, O
it O
affected O
p53 O
binding O
in O
a O
significant O
manner O
, O
ranging O
from O
50% O
to O
25% O
of O
p53 O
bound O
to O
the O
Sp1 B-experimental-construct
mutant I-experimental-construct
probe I-experimental-construct
relative O
to O
the O
native O
probe O
( O
Fig O
. O
1 O
E O
, O
lane O
3) O
. O

Therefore O
, O
we O
developed O
an O
in O
vitro O
binding O
assay O
to O
quantitate O
the O
effect O
of O
the O
Asp B-amino-acid
replacement O
of O
Ser B-amino-acid
on O
the O
binding O
of O
CREB B-protein
to O
CBP B-protein
. O

Gel O
mobility O
shift O
analysis O
of O
nuclear O
proteins O
bound O
to O
E1 B-DNA
. O

N-terminal O
Amino O
Acids O
179–199 O
of O
dSPRY B-protein-family
Bind O
to O
the O
Ring B-protein-domain
Finger I-protein-domain
Domain I-protein-domain
of O
dCbl B-protein

To O
extend O
the O
binding O
investigation O
to O
dSPRY B-protein-family
and O
dCbl B-protein
, O
various O
constructs O
as O
depicted O
in O
Fig O
. O
8 O
D O
were O
made O
. O

We O
show O
here O
, O
both O
in O
vivo O
and O
in O
vitro O
, O
that O
GSK-3 B-protein
cannot O
bind O
GBP B-protein-family
and O
Axin B-protein
simultaneously O
, O
leading O
to O
the O
model O
that O
GBP O
functions O
in O
part O
to O
prevent O
GSK-3 O
binding O
to O
the O
Axin/ B-protein-complex
APC/ I-protein-complex
beta-catenin I-protein-complex
complex O
. O

The O
immunoprecipitation O
analysis O
of O
DER B-protein
demonstrated O
that O
Aos B-protein
binds O
to O
DER O
in O
living O
DER/ B-cell
S2 I-cell
cells I-cell
( O
Fig O
. O
2A) O
. O

The O
C-terminal O
domain O
of O
SAF-A B-protein
also O
contains O
the O
RGG-box B-protein-motif
, O
involved O
in O
binding O
to O
RNA B-RNA
( O
35) O
, O
suggesting O
that O
RNA O
and O
p300 B-protein
binding O
to O
SAF-A O
are O
mutually O
exclusive O
. O

Tropomyosins B-protein-family
are O
well-characterized O
components O
of O
actin B-protein
filaments I-protein
that O
bind O
directly O
to O
F-actin B-protein
and O
have O
distinct O
functions O
in O
muscle O
, O
where O
they O
are O
involved O
in O
the O
calcium-dependent chemical
regulation O
of O
muscle O
contraction O
, O
and O
in O
fibroblasts O
, O
where O
they O
are O
constituents O
of O
actin O
filament O
structures O
with O
undefined O
functions O
( O
Lees-Miller O
and O
Helfman O
, O
1991) O
. O

Some O
studies O
have O
suggested O
that O
CD43 B-protein
acts O
as O
an O
inhibitor O
of O
T B-cell
cell I-cell
activation O
, O
possibly O
because O
its O
large O
size O
and O
high O
negative O
charge O
( O
Cyster O
et O
al O
. O
, O
1991 O
) O
might O
interfere O
with O
close O
binding O
of O
the O
T O
cell O
and O
APC B-cell
membrane O
( O
Manjunath O
et O
al O
. O
, O
1995) O
. O

Unlike O
other O
CRIB B-protein-domain
domains I-protein-domain
, O
which O
are O
unstructured O
in O
the O
free O
protein O
, O
the O
semi-CRIB B-protein-motif
motif I-protein-motif
of O
Par6 B-protein
is O
probably O
structured O
by O
the O
PDZ B-protein-domain
domain I-protein-domain
, O
and O
the O
absence O
of O
a O
significant O
conformational O
entropic O
penalty O
may O
explain O
how O
Par6 O
can O
bind O
Cdc42 B-protein
with O
high O
affinity O
even O
though O
its O
CRIB O
motif O
lacks O
conserved O
elements O
found O
in O
other O
systems O
. O

One O
explanation O
is O
that O
SOG B-protein
binding O
to O
DPP B-protein
in O
ventral-lateral O
regions O
could O
assist O
in O
forming O
a O
peak O
of O
DPP O
activity O
if O
DPP O
was O
carried O
some O
distance O
dorsally O
by O
SOG O
diffusion O
before O
being O
released O
by O
TLD B-protein
action O
( O
Holley O
et O
al O
. O
, O
1996 O
) O
. O

Our O
results O
with O
ActRII B-protein
trunc O
and O
those O
for O
activin B-protein-complex
, O
BMP2 B-protein
, O
and O
ActRII O
referenced O
above O
indicate O
that O
activin O
and O
BMP7 B-protein
bind O
ActRII O
through O
a O
common O
interface O
. O

Binding O
of O
NF1 B-protein
to O
the O
Sp1-mutated protein
labeled O
probe O
was O
monitored O
by O
EMSA B-assay
as O
in O
Fig O
. O
2 O
. O

The O
binding O
of O
Sp1 B-protein
to O
this O
GT B-DNA
box I-DNA
suggests O
that O
it O
, O
or O
a O
related O
protein O
, O
is O
responsible O
for O
the O
observed O
protein-DNA DNA
complexes O
. O

We O
have O
identified O
two O
regions O
involved O
in O
RPA B-protein-complex
binding O
in O
the O
N-terminal O
sequence O
of O
UNG2 B-protein
outside O
the O
catalytic O
domain O
, O
and O
the O
presence O
of O
both O
sites O
strongly O
enhances O
binding O
of O
RPA O
to O
UNG2 O
. O

Hence O
, O
mutants O
of O
cyclin B-protein-family
E I-protein-family
that O
cannot O
bind O
to O
CDK2 B-protein
are O
biologically O
inert O
( O
Kelly O
et O
al O
. O
1998 O
) O
, O
and O
ectopic O
overexpression O
of O
a O
catalytically O
inactive O
mutant O
of O
CDK2 O
prevents O
a O
cell O
from O
entering O
S B-process
phase I-process
( O
Heuvel O
and O
Harlow O
1993 O
) O
. O

Heme B-chemical
binds O
to O
the O
70 O
kDa O
subunit O
of O
RFABG B-protein-complex
Purification O
of O
the O
Con-A B-reagent
eluate I-reagent
under O
conditions O
where O
the O
heme O
moiety O
remained O
bound O
to O
RFABG O
was O
accomplished O
using O
hydrophobic O
interaction O
chromatography O
. O

Finally O
, O
Gin4 B-protein
and O
Hsl1 B-protein
bind O
to O
the O
septins B-protein-family
and O
undergo O
septin-dependent O
hyperphosphorylation O
during O
mitosis O
( O
Altman O
and O
Kellogg O
, O
1997 O
; O
Carroll O
et O
al O
. O
, O
1998 O
; O
Barral O
et O
al O
. O
, O
1999 O
) O
. O

CTD B-protein-domain
binding O
and O
allosteric O
activation O
of O
the O
mammalian O
guanylyltransferase O
Mce1 B-protein-complex
was O
studied O
by O
introducing O
alanine B-amino-acid
substitutions O
for O
Tyr1 B-amino-acid
, O
Pro3 B-amino-acid
, O
Thr4 B-amino-acid
, O
or O
Pro6 B-amino-acid
of O
each O
heptad O
of O
the O
28-mer O
synthetic O
CTD B-fusion-protein
Ser5-PO4 I-fusion-protein
peptide O
, O
or O
by O
eliminating O
each O
of O
the O
phosphates O
at O
Ser5 O
( O
Pei O
et O
al O
. O
, O
2001a) O
. O

Moreover O
, O
MAb B-reagent
RAK-BrI I-reagent
binds O
to O
RAK O
antigens O
p120 B-protein
, O
p42 B-protein
, O
and O
p25 B-protein
in O
cancer O
tissue O
but O
only O
to O
gp160 B-protein-complex
and O
gp120 B-protein
of O
HIV-1 B-cell
, O
which O
automatically O
eliminates O
the O
possibility O
of O
infection O
. O

( O
Table O
I O
, O
Fig O
. O
3 O
) O
indicate O
that O
the O
mutant O
enzymes O
still O
bind O
tRNA B-RNA
efficiently O
, O
which O
argues O
against O
a O
large O
structural O
change O
. O

One O
possibility O
is O
that O
in O
response O
to O
the O
checkpoint O
signal O
additional O
Mad2 B-protein
molecules O
bind O
and O
inhibit O
Cdc20 B-protein
or O
that O
Mad2 O
facilitates O
an O
inhibitory O
modification O
of O
the O
Cdc20 O
pool O
. O

To O
quantitate O
the O
binding O
affinities O
of O
the O
different O
importin B-protein-family
α I-protein-family
proteins O
to O
CAS B-protein-family
, O
we O
employed O
the O
fact O
that O
the O
binding O
affinity O
of O
CAS O
for O
RanGTP B-protein
is O
greatly O
enhanced O
in O
the O
presence O
of O
importin O
α O
proteins O
. O

The O
precise O
domain O
involved O
in O
the O
flavin B-chemical
adenine I-chemical
dinucleotide I-chemical
( O
FAD B-chemical
) O
binding O
is O
not O
fully O
established O
, O
and O
cannot O
be O
deduced O
from O
the O
crystal O
structure O
of O
MOP B-protein
as O
this O
region O
is O
completely O
absent O
from O
MOP O
. O

It O
further O
suggests O
that O
the O
binding O
of O
ADAM12 B-protein
to O
alpha-actinin B-protein-family
is O
not O
specific O
to O
alpha-actinin-2 B-protein
, O
which O
is O
muscle-specific O
; O
ADAM12 O
may O
also O
bind O
to O
other O
alpha-actinins O
. O

The O
binding O
of O
TBP B-protein
to O
the O
pS2 B-DNA
TATA I-DNA
sequence I-DNA
is O
severely O
restricted O
by O
the O
in O
vivo O
chromatin O
structure O
of O
the O
promoter O
. O

Binding O
of O
PC B-protein-family
and O
GAF B-protein-family
to O
the O
hh B-DNA
genomic I-DNA
region I-DNA
in O
embryos O
. O

Our O
result O
that O
Axil(1-265 protein
) O
containing O
the O
RGS B-protein-domain
domain I-protein-domain
makes O
a O
complex O
with O
beta-catenin B-protein-family
suggests O
that O
the O
RGS O
domain O
of O
Axil O
also O
interacts O
with O
APC B-protein
which O
binds O
to O
beta-catenin O
. O

The O
fact O
that O
HA B-protein
reduced O
the O
amount O
of O
DM B-protein
bound O
to O
DR1 B-protein
only O
slightly O
in O
lysosomal O
homogenates O
( O
Figure O
7) O
, O
but O
strongly O
in O
the O
in O
vitro O
assay O
involving O
purified O
material O
( O
Figure O
2A) O
, O
might O
be O
due O
to O
a O
higher O
susceptibility O
to O
residual O
proteolysis O
of O
HA O
compared O
with O
A2 B-peptide
peptide I-peptide
during O
the O
30 O
min O
incubation O
in O
the O
lysosomal O
homogenate O
. O

Importantly O
, O
the O
photocrosslinking O
pattern O
of O
the O
three O
DmPBP B-protein
polypeptides O
to O
the O
DNA B-DNA
was O
different O
depending O
upon O
whether O
DmPBP O
was O
bound O
to O
a O
U1 B-DNA
or O
U6 B-gene
PSEA O
sequence O
( O
32) O
. O

Moreover O
, O
the O
observed O
Mg2+-dependent chemical
binding O
of O
GTP B-chemical
suggests O
that O
menin B-protein
binds O
GTP O
as O
a O
complex O
with O
Mg2+ O
, O
like O
many O
GTPases B-protein-family
( O
28) O
. O

This O
kinase O
is O
also O
known O
to O
bind O
and O
become O
activated O
by O
the O
GTP-bound chemical
( O
activated O
) O
form O
of O
Rac B-protein-family
( O
Manser O
et O
al O
. O
, O
1994 O
) O
. O

We O
show O
that O
Cos2 B-protein
binds O
Ci B-protein
, O
prevents O
its O
nuclear O
import O
, O
and O
inhibits O
its O
activity O
via O
this O
domain O
. O

The O
fact O
that O
, O
in O
the O
presence O
of O
cofilin B-protein-family
, O
the O
amount O
of O
S2-3 B-protein-domain
bound O
to O
F-actin protein-family
is O
lower O
, O
compared O
with O
samples O
containing O
equal O
concentrations O
of O
S2-3 O
but O
no O
cofilin O
( O
and O
vice O
versa) O
, O
and O
that O
the O
reduction O
in O
the O
F-actin O
bound O
S2-3 O
is O
compensated O
by O
an O
increase O
in O
bound O
cofilin O
of O
about O
similar O
size O
indicates O
that O
cofilin O
and O
S2-3 O
displace O
each O
other O
and O
therefore O
suggests O
that O
both O
proteins O
compete O
for O
the O
same O
or O
an O
overlapping O
site O
on O
F-actin O
. O

Taken O
together O
, O
the O
Schneider O
cell O
transfection O
studies O
and O
the O
gel O
mobility O
shift O
analyses O
demonstrate O
DREF B-protein
binding O
to O
the O
DRE B-DNA
sites O
present O
in O
the O
mtSSB B-gene
promoter O
and O
the O
importance O
of O
these O
sites O
in O
Drosophila O
mtSSB O
promoter O
function O
. O

Exchange O
of O
the O
GDP B-chemical
bound O
to O
eIF2 B-protein-complex
with O
GTP B-chemical
is O
catalyzed O
by O
eIF2B B-protein-complex
. O

Upon O
accumulation O
, O
beta-catenin B-protein-family
binds O
and O
activates O
Tcf/LEF-family B-protein-family
transcription I-protein-family
factors I-protein-family
( O
Peifer O
and O
Polakis O
, O
2000) O
. O

It O
has O
been O
proposed O
that O
the O
Elav-like B-protein-family
proteins I-protein-family
specifically O
bind O
to O
the O
short O
AU-rich B-DNA
segments I-DNA
( O
AREs B-DNA
or O
` O
` O
` O
Shaw-Kamen B-DNA
elements I-DNA
) O
that O
regulate O
mRNA B-RNA
turnover( O
16 O
) O
. O

Src B-protein
can O
bind O
to O
activated O
Neu B-protein
in O
vivo O
, O
and O
an O
interaction O
between O
the O
Src O
SH2 B-protein-domain
domain O
and O
Neu O
has O
been O
shown O
in O
vitro O
( O
351Muthuswamy O
& O
Muller O
1995) O
. O

The O
complex B-protein-complex
of O
TnC B-protein
, O
TnI B-protein
, O
and O
residues O
159-259 O
of O
TnT B-protein
is O
known O
to O
bind O
to O
TM B-protein-family
in O
the O
region O
of O
Cys-190 B-amino-acid
, O
referred O
to O
as O
the O
Ca2+-sensitive chemical
binding O
site O
, O
and O
has O
not O
been O
considered O
to O
bind O
to O
the O
extreme O
COOH O
terminus O
of O
TM(17 O
, O
48 O
, O
49 O
, O
50 O
, O
51) O
. O

Biochemical O
evidence O
further O
supports O
the O
proposal O
that O
Spt3 B-protein
and O
Spt8 B-protein
inhibit O
TBP B-protein
function O
, O
since O
wild-type O
SAGA B-protein-complex
negatively O
affected O
TBP O
binding O
to O
the O
HIS3 B-gene
TATA B-DNA
box I-DNA
in O
vitro O
, O
while O
SAGA O
complexes O
prepared O
from O
either O
spt3Δ B-protein
or O
spt8Δ B-protein
strains O
no O
longer O
inhibited O
TBP O
binding O
to O
the O
TATA O
box O
. O

We O
next O
measured O
PP1 B-protein-complex
activity O
bound O
to O
endogenous O
STK15 B-protein
derived O
from O
interphase O
and O
mitotic O
extracts O
. O

A O
Wnt B-protein-family
signal O
induces O
an O
increase O
in O
the O
cytoplasmic O
pool O
of O
β-catenin B-protein
which O
binds O
to O
a O
Tcf B-protein-family
protein O
and O
localizes O
the O
complex O
to O
the O
nucleus O
where O
transcription O
of O
prospective O
target O
genes O
are O
activated O
( O
Huber O
et O
al O
. O
, O
1996) O
. O

Actopaxin B-protein
localizes O
to O
focal O
adhesions O
and O
binds O
actin B-protein
in O
addition O
to O
binding O
paxillin B-protein
( O
9) O
. O

It O
is O
located O
at O
the O
heart O
of O
the O
p53-binding B-protein-domain
cleft I-protein-domain
of O
Mdm2 B-protein
( O
34) O
, O
within O
the O
N-terminal O
region O
which O
also O
mediates O
hNumb B-protein
binding O
. O

The O
triply O
mutant O
protein O
binds O
FAD B-chemical
and O
supports O
aerotaxis B-process
. O

The O
importance O
of O
the O
loop O
sequence O
for O
molecular O
recognition O
is O
also O
demonstrated O
by O
an O
artificially B-experimental-construct
engineered I-experimental-construct
FnIIID I-experimental-construct
with O
altered O
sequences O
on O
the O
BC B-protein-region
and O
FG B-protein-region
loops I-protein-region
that O
binds O
ubiquitin B-protein-family
with O
high O
affinity O
( O
41) O
. O

The O
actin B-protein
binding O
of O
A-fascin B-protein
was O
the O
same O
as O
that O
of O
unphosphorylated O
r-fascin B-fusion-protein
regardless O
of O
the O
treatment O
of O
A-fascin O
with O
PKC B-protein-family
, O
indicating O
that O
Ser-39 B-amino-acid
is O
responsible O
for O
the O
phosphorylation-dependent O
regulation O
of O
fascin-actin O
binding O
. O

GST B-experiment-tag
fusion O
protein O
or O
GST O
( O
5 O
mug O
each O
) O
were O
bound O
to O
GT-agarose B-reagent
beads I-reagent
and O
incubated O
with O
HEK293 B-cell
cell O
extracts O
. O

pRB B-protein
remains O
hypophosphorylated O
and O
bound O
to O
E2Fs B-protein-family
, O
and O
E2F-responsive protein-family
genes O
remain O
repressed O
in O
early O
G1 B-cell
phase O
of O
p16-minus B-cell
tumor I-cell
cells I-cell
. O

Together O
with O
the O
results O
obtained O
from O
immunoprecipitation O
analysis O
, O
we O
concluded O
that O
the O
in O
vitro O
moesin–binding protein
ability O
of O
a O
. O
a O
. O
62-78 O
of O
the O
CD43- B-protein-domain
cytoplasmic I-protein-domain
domain I-protein-domain
was O
not O
indispensable O
in O
the O
cells O
, O
and O
that O
the O
juxta-membrane O
20-30-amino O
acid O
sequence O
of O
the O
cytoplasmic O
domains O
of O
CD44 B-protein
, O
CD43 O
, O
and O
ICAM-2 B-protein
can O
bind O
to O
ERM B-protein-family
proteins O
and O
recruit O
these O
integral O
membrane O
proteins O
to O
microvilli B-organelle
together O
with O
ERM O
proteins O
. O

Binding O
of O
p53 B-protein
and O
Sp1 B-protein
to O
their O
cognate O
sites O
is O
required O
for O
their O
functional O
cooperation O
. O

The O
putative O
target O
proteins O
for O
RhoA B-protein
include O
protein B-protein-family
kinase I-protein-family
N I-protein-family
( O
Amano O
et O
al O
. O
, O
1996b) O
, O
rhophilin B-protein
( O
Watanabe O
et O
al O
. O
, O
1996) O
, O
citron B-protein
( O
Madaule O
et O
al O
. O
, O
1995) O
, O
rhotekin B-protein
( O
Reid O
et O
al O
. O
, O
1996) O
, O
myosin-binding B-protein
subunit I-protein
of O
myosin B-protein-family
phosphatase I-protein-family
( O
Kimura O
et O
al O
. O
, O
1996) O
, O
p140mDia B-protein
( O
Watanabe O
et O
al O
. O
, O
1997 O
) O
and O
Rho-associated B-protein
kinase I-protein
( O
Matsui O
et O
al O
. O
, O
1996) O
. O

Tyr177 B-amino-acid
lies O
within O
a O
Grb2 B-protein-motif
binding I-protein-motif
motif I-protein-motif
( O
Y-X-N-X B-protein-motif
) O
in O
BCR B-protein
, O
and O
is O
essential O
for O
Grb2 O
binding O
to O
BCR/ABL B-fusion-protein
( O
Pendergast O
et O
al O
. O
, O
1993 O
; O
Puil O
et O
al O
. O
, O
1994 O
) O
. O

Truncated O
MDC B-protein
lost O
binding O
to O
CCR4 B-protein
, O
the O
only O
characterized O
receptor O
for O
this O
chemokine O
( O
30) O
, O
although O
it O
maintained O
chemotactic O
activity O
likely O
via O
interaction O
with O
an O
undefined O
cell O
surface O
molecule O
( O
22) O
. O

B O
, O
identification O
of O
SRF B-protein
as O
a O
beta-TM B-protein
CArG B-DNA
box I-DNA
binding O
transcription O
factor O
. O

Thus O
, O
the O
earlier O
observed O
increase O
in O
eIF4G B-protein
phosphorylation O
in O
response O
to O
mitogen B-chemical
treatment O
probably O
reflected O
an O
augmentation O
in O
the O
quantity O
of O
eIF4G O
bound O
to O
eIF4E B-protein
. O

The O
TCFs B-protein-family
bind O
with O
SRF B-protein
to O
the O
serum B-DNA
response I-DNA
element I-DNA
and O
mediate O
the O
response O
to O
ERK B-protein
( O
extracellular -
signal-regulated -
kinases) -
, O
JNK B-protein
( O
c-Jun protein
N-terminal -
kinase) -
, O
and O
p38 B-protein-family
MAP I-protein-family
kinases I-protein-family
, O
through O
phosphorylation O
of O
their O
C O
domains O
. O

The O
differential O
binding O
of O
beta B-protein-domain
cytoplasmic I-protein-domain
domains I-protein-domain
to O
talin B-protein
and O
filamin B-protein-family
suggests O
functionally O
different O
linkages O
of O
integrins B-protein-family
with O
the O
cytoskeleton O
. O

After O
a O
chase O
of O
25 O
min O
, O
the O
number O
of O
gp160 B-protein
molecules O
bound O
to O
calreticulin B-protein
was O
reduced O
by O
50% O
, O
and O
after O
90 O
min O
only O
trace O
amounts O
of O
gp160 O
were O
still O
associated O
with O
calreticulin O
as O
described O
in O
a O
preceding O
section O
. O

Furthermore O
, O
Sec5 B-protein
binds O
a O
Ral B-protein-family
protein O
, O
which O
is O
not O
present O
in O
yeast O
( O
Brymora O
et O
al O
. O
, O
2001 O
; O
Moskalenko O
et O
al O
. O
, O
2002 O
; O
Sugihara O
et O
al O
. O
, O
2002) O
. O

Phosphorylated O
CREB B-protein-family
protein O
then O
binds O
to O
CREB-binding B-protein
protein I-protein
( O
27 O
, O
28) O
, O
and O
this O
complex O
is O
thought O
to O
induce O
transcription O
of O
genes O
containing O
CRE B-DNA
sequences O
such O
as O
c-fos B-protein
( O
7) O
, O
tyrosine B-protein
hydroxylase I-protein
( O
29) O
, O
enkephalin B-protein
( O
18) O
, O
somatostatin B-protein
( O
17) O
, O
and O
vasoactive B-protein
intestinal I-protein
peptide I-protein
( O
30) O
. O

In O
addition O
, O
these O
studies O
suggested O
that O
Arg175 O
functions O
as O
a O
phosphorylation-sensitive O
trigger O
because O
charge O
neutralization O
enabled O
an O
R175N O
mutant O
arrestin B-protein-family
to O
bind O
to O
Rh* B-protein
as O
well O
as O
wild-type O
arrestin O
binds O
to O
P-Rh* protein
. O

Phosphorylation O
of O
L1 B-protein
Y1176 O
inhibits O
L1 O
binding O
to O
AP-2 B-protein-complex

We O
have O
shown O
previously O
, O
using O
an O
in O
vitro O
peptide O
competition O
assay O
, O
that O
the O
peptide O
FGEYRSLESDNEE B-peptide
blocks O
binding O
of O
a O
biotin-labeled O
TGN38 B-protein
peptide O
to O
AP-2 B-protein-complex
purified O
from O
rat O
brain O
( O
Kamiguchi O
et O
al O
. O
, O
1998b) O
. O

TAP B-protein-family
proteins I-protein-family
( O
21) O
, O
and O
their O
cytosolic O
ATP B-protein-domain
binding I-protein-domain
cassettes I-protein-domain
( O
17 O
, O
18) O
, O
bind O
di- O
and O
trinucleotides O
and O
are O
thought O
to O
hydrolyze O
ATP O
during O
peptide O
transport O
, O
although O
direct O
evidence O
for O
ATP O
hydrolysis O
by O
TAP O
or O
its O
fragments O
has O
so O
far O
not O
been O
obtained O
. O

The O
next O
question O
is O
whether O
Jmj B-protein
binds O
to O
the O
cyclin B-protein
D1 I-protein
promoter O
. O

MOR B-protein
bound O
to O
BRM B-protein
and O
itself O
, O
as O
was O
previously O
reported O
( O
Crosby O
et O
al O
. O
1999 O
) O
, O
as O
well O
as O
to O
BAP111 B-protein
, O
BAP60 B-protein
and O
to O
either O
BAP47 B-protein
or O
BAP45 B-protein
. O

CRIPT B-protein
, O
a O
novel O
postsynaptic O
protein O
that O
binds O
to O
the O
third O
PDZ B-protein-domain
domain O
of O
PSD-95/SAP90 B-protein
. O

The O
ability O
to O
gain O
access O
to O
a O
lesion O
is O
facilitated O
by O
the O
binding O
of O
pols B-protein-complex
II I-protein-complex
( O
74 O
, O
75 O
, O
76) O
, O
IV B-protein-complex
( O
26 O
, O
77) O
, O
and O
V B-protein-complex
( O
26 O
) O
to O
the O
beta B-protein
processivity I-protein
clamp I-protein
. O

[ O
In O
new O
window O
] O
Inspection O
of O
the O
residues O
surrounding O
the O
deamido-NAD+ B-chemical
moiety O
( O
as O
observed O
in O
the O
bound O
NAD-ad B-chemical
) O
reveals O
a O
new O
deamido-NAD+ O
binding O
mode O
. O

The O
GST-Ena8 B-experimental-construct
P I-experimental-construct
→ I-experimental-construct
A I-experimental-construct
fusion O
protein O
and O
wild-type O
GST-Ena protein
pulled O
down O
approximately O
equivalent O
amounts O
of O
chickadee B-protein
( O
Fig O
. O
6) O
, O
suggesting O
that O
distinct O
amino O
acids O
may O
be O
important O
for O
Ena O
binding O
to O
profilin B-protein-family
and O
the O
Abl-SH3 B-protein-domain
domain O
, O
despite O
the O
overlap O
observed O
in O
some O
of O
their O
putative O
binding O
sites O
. O

Since O
binding O
of O
NorpA B-protein
to O
InaD B-protein
is O
critical O
for O
phototransduction O
, O
we O
were O
interested O
in O
elucidating O
the O
structural O
determinants O
of O
NorpA O
- O
InaD O
interaction O
through O
the O
structure O
of O
InaD O
PDZ1 B-protein-domain
in O
complex O
with O
the O
C-terminus O
of O
NorpA O
. O

However O
, O
following O
treatment O
of O
GFP-overexpressing experiment-tag
cells O
with O
100 O
ng/ml O
EGF B-protein
for O
2 O
min O
, O
a O
dramatic O
increase O
in O
Ras B-protein-family
binding O
to O
GST-Raf-1 experiment-tag
was O
observed O
, O
indicative O
of O
an O
increase O
in O
the O
cellular O
levels O
of O
the O
GTP-bound chemical
form O
of O
Ras O
( O
Fig O
. O
1 O
A) O
. O

C O
, O
increase O
of O
AP-1 B-protein-complex
binding O
activity O
by O
ad-MKK6 B-protein
in O
MCF/Vect B-cell
but O
not O
in O
MCF/Tam B-cell
cells O
. O

The O
Km O
values O
for O
EGFR B-protein
peptide O
and O
GST-ATF2 experiment-tag
binding O
to O
activated O
p38 B-protein-family
at O
saturating O
ATP B-chemical
were O
similar O
, O
313 O
and O
254 O
M O
, O
respectively O
( O
Table O
1) O
. O

GI B-protein-domain
domain-binding O
region O
of O
GCN1 B-protein
and O
mutations O
abolishing O
interaction O
. O

This O
interaction O
is O
mutually O
exclusive O
( O
Fig O
. O
1E O
and O
F) O
, O
suggesting O
that O
the O
binding O
of O
SAF-A B-protein
and O
p300 B-protein
may O
be O
disrupted O
in O
adenovirus-transformed B-cell
cell I-cell
lines I-cell
. O

To O
investigate O
whether O
the O
binding O
of O
E1A B-protein
to O
p300 B-protein
correlates O
with O
a O
loss O
of O
p300 O
transcriptional O
activity O
, O
we O
examined O
the O
binding O
of O
full-length O
E1A O
to O
the O
series O
of O
mutant O
p300 O
proteins O
. O

First O
, O
gel-shift O
analysis O
shows O
that O
bacterially O
expressed O
Xvent-1 B-protein
homeodomain O
binds O
to O
the O
labelled O
BIE B-DNA
fragment O
in O
a O
concentration-dependent O
manner O
, O
with O
higher O
protein O
concentrations O
leading O
to O
the O
formation O
of O
oligomers O
( O
Figure O
4A) O
. O

From O
the O
data O
described O
above O
, O
we O
hypothesized O
that O
PS1 B-protein
somehow O
promotes O
translocation O
of O
the O
QM B-protein
protein O
from O
the O
cytoplasm O
to O
the O
nucleus O
, O
inhibits O
the O
binding O
of O
c-Jun B-protein-complex
homodimer I-protein-complex
to O
TRE B-DNA
, O
and O
thereby O
suppresses O
transactivation O
by O
c-jun O
. O

They O
provide O
evidence O
that O
LRP B-protein-family
binds O
CRT B-protein
and O
that O
hep B-peptide
I I-peptide
, O
CRT O
, O
and O
LRP O
form O
molecular B-protein-complex
complexes I-protein-complex
in O
cells O
. O

Binding O
of O
the O
TBP B-protein
subunit O
of O
TFIID B-protein
in O
the O
minor O
groove O
nucleates O
assembly O
of O
the O
pol B-protein-family
II I-protein-family
transcription O
machinery O
for O
TATA-containing DNA
genes O
( O
25-27) O
. O

Furthermore O
, O
p62 B-protein
bound O
to O
Ub-Sepharose B-reagent
was O
eluted O
completely O
either O
by O
SDS B-reagent
sample O
buffer O
or O
by O
1 O
M O
KCl B-chemical
in O
Tris B-chemical
buffer O
, O
pH O
9 O
. O
0 O
, O
both O
under O
nonreducing O
conditions O
( O
Fig O
. O
2 O
B O
, O
lanes O
6-8) O
. O

The O
results O
indicate O
that O
binding O
of O
U2AF-65 B-protein
kDa I-protein
to O
the O
dsx B-RNA
pre-mRNA I-RNA
is O
not O
dependent O
on O
the O
ESE B-DNA
. O

The O
ability O
of O
STNB B-protein
to O
directly O
bind O
to O
SYT B-protein
was O
confirmed O
by O
the O
STNB-GST experiment-tag
pull-downs O
showing O
that O
the O
mu2-homology B-protein-domain
domain I-protein-domain
of O
STNB O
can O
bind O
to O
the O
C2B B-protein-domain
domain I-protein-domain
of O
SYTI B-protein
independently O
of O
Ca2+ B-chemical
. O

However O
, O
our O
findings O
suggest O
the O
possibility O
that O
microtubules B-organelle
may O
be O
formed O
and O
maintained O
in O
the O
nerve B-organelle
terminal I-organelle
by O
synaptotagmin B-protein
I I-protein
binding O
to O
tubulin B-protein-family
. O

The O
adenylated O
Alu B-RNA
RNA I-RNA
as O
well O
as O
adenylated O
SRP B-RNA
RNA I-RNA
were O
bound O
to O
the O
SRP protein-RNA-complex
9/14-kDa protein
heterodimer O
and O
were O
immunoprecipitated O
by O
specific O
antibodies O
. O

With O
one O
notable O
exception O
( O
p95 O
. O
3 O
; O
see O
below) O
, O
the O
rotational O
constructs O
designed O
to O
create O
competition O
between O
binding O
of O
HSF B-protein-family
and O
histone O
H2A-H2B protein-family
dimers O
were O
2-3-fold O
less O
active O
than O
the O
nucleosome-free O
p41 O
. O
3 O
control O
( O
Fig O
. O
2) O
. O

Our O
data O
demonstrate O
that O
CUGBP1 B-protein
binds O
to O
GCN B-RNA
repeats I-RNA
located O
in O
the O
5 O
region O
of O
p21 B-gene
mRNA O
and O
induces O
the O
production O
of O
p21 O
in O
a O
cell-free O
translation O
system O
and O
in O
cultured O
cells O
. O

CHAN O
, O
S O
. O
K O
. O
, O
L O
. O
JAFFE O
, O
M O
. O
CAPOVILLA O
, O
J O
. O
BOTAS O
, O
and O
R O
. O
S O
. O
MANN O
, O
1994 O
The O
DNA B-DNA
binding O
specificity O
of O
Ultrabithorax B-protein
is O
modulated O
by O
cooperative O
interactions O
with O
extradenticle B-protein
, O
another O
homeoprotein B-protein-family
. O

A O
construct O
lacking O
the O
carboxyl-terminal O
domain O
, O
which O
comprises O
two O
PDZ B-protein-domain
domains O
( O
N O
+ O
PI) protein-domain
, O
enhances O
PI O
binding O
to O
APP B-protein
, O
whereas O
another O
construct O
lacking O
an O
amino-terminal O
domain O
relative O
to O
PI O
domain O
( B-experimental-construct
PI I-experimental-construct
+ I-experimental-construct
C I-experimental-construct
) I-experimental-construct
suppresses O
PI O
binding O
to O
APP O
. O

In O
Vitro O
Characterization O
of O
SRF B-protein
Binding O
to O
TEF-1 B-protein

To O
determine O
whether O
binding O
of O
U1 B-protein-RNA-complex
snRNP I-protein-RNA-complex
to O
the O
dsx B-RNA
pre-mRNA I-RNA
and O
factors O
to O
the O
ESE B-DNA
are O
independent O
or O
interdependent O
events O
required O
for O
the O
recruitment O
of O
SRm160/300 protein
, O
the O
ability O
of O
U1 O
snRNP O
to O
bind O
to O
the O
three O
dsx O
pre-mRNAs O
was O
analyzed O
by O
using O
a O
splicing O
complex O
affinity-selection O
assay O
( O
Fig O
. O
3A O
; O
ref O
. O
33) O
. O

In O
the O
presence O
of O
the O
fibronectin-like protein
domain O
, O
which O
binds O
tightly O
to O
both O
collagen B-protein-family
and O
gelatin B-protein-family
[ O
15] O
, O
[ O
16] O
, O
[ O
19] O
, O
further O
breakdown O
of O
the O
1/4 O
and O
3/4 O
fragments O
occurs O
, O
even O
at O
25°C O
, O
which O
is O
generally O
regarded O
as O
insufficient O
to O
denature O
the O
3/4 O
fragment O
. O

Phosphorylation O
by O
PKA B-protein-family
, O
but O
not O
PKC B-protein-family
, O
reduced O
the O
affinity O
of O
adducin B-protein-family
for O
spectrin-F-actin B-protein-complex
complexes O
as O
well O
as O
the O
activity O
of O
adducin O
in O
promoting O
binding O
of O
spectrin O
to O
F-actin O
. O

Therefore O
, O
the O
repression O
by O
the O
C-tail O
of O
E-cadherin B-protein-family
binding O
to O
the O
armadillo B-protein-motif
domain O
is O
modulated O
by O
the O
N O
terminus O
. O

Sulfhydryl O
Alkylation O
by O
NEM B-chemical
Inhibits O
Binding O
of O
n-sec1 B-protein
to O
Syntaxin B-protein
1a I-protein

These O
findings O
suggest O
that O
the O
actin B-protein
binding O
region O
of O
spinophilin B-protein
contains O
at O
least O
two O
distinct O
recognition O
sites O
for O
actin O
. O

The O
sites O
of O
PKC B-protein-family
phosphorylation O
appeared O
to O
be O
within O
the O
N O
terminus O
of O
fascin B-protein
, O
because O
the O
C-terminal O
actin B-protein
binding O
fragment O
did O
not O
contain O
32P O
radioactivity O
when O
phosphorylated O
fascin O
was O
digested O
by O
trypsin B-protein
as O
described O
above O
. O

Recombinant O
p54nrb/NonO protein
was O
then O
shown O
to O
bind O
to O
a O
CA B-protein-family
inhibitor O
affinity O
chromatography O
matrix O
that O
normally O
binds O
the O
different O
types O
of O
CAs O
. O

To O
evaluate O
the O
involvement O
of O
positively O
charged O
amino O
acid O
residues O
in O
loops O
37 O
, O
60 O
, O
and O
70 O
in O
the O
binding O
of O
heparin B-chemical
to O
APC B-protein
, O
five O
protein B-protein
C I-protein
variants O
were O
constructed O
by O
site-directed O
mutagenesis O
( O
Fig O
. O
1) O
. O

The O
requirement O
for O
repeat O
four O
in O
actin B-protein
binding O
was O
directly O
examined O
using O
FLAG-full-lengthdelta4 B-experimental-construct
, O
where O
removal O
of O
repeat O
four O
eliminated O
the O
binding O
of O
cortactin B-protein
to O
F-actin B-protein
( O
Fig O
4 O
D) O
. O

Binding O
appeared O
to O
be O
specific O
, O
as O
it O
was O
not O
competed O
by O
large O
amounts O
of O
nonspecific B-RNA
competitor I-RNA
RNA I-RNA
, O
and O
a O
precleaved B-RNA
substrate I-RNA
RNA I-RNA
did O
not O
bind O
CF B-protein
I I-protein
. O

Total O
DB[a -
, -
l]PDE-DNA DNA
binding O
in O
MCF-7 B-cell
cells O
after O
exposure O
to O
( O
A O
) O
0 O
. O
01 O
μM O
and O
( O
B O
) O
0 O
. O
05 O
μM O
( O
+)-syn- O
or O
( O
-)-anti-DB[a O
, O
l]PDE O
for O
the O
times O
indicated O
. O

Therefore O
, O
we O
will O
consider O
the O
differences O
between O
the O
GppNHp-bound chemical
RalA B-protein
structure O
complexed O
with O
Sec5 B-protein
and O
the O
GDP-bound B-protein
RalA I-protein
structure O
to O
be O
primarily O
caused O
by O
the O
difference O
in O
nucleotide O
state O
rather O
than O
caused O
by O
binding O
of O
Sec5 O
to O
RalA O
. O

These O
analyses O
were O
complemented O
by O
DNase B-protein
I I-protein
footprint O
analyses O
, O
wherein O
HMG-I(Y B-protein-family
) I-protein-family
increased O
PU B-protein
. I-protein
1 I-protein
binding O
to O
the O
μB B-DNA
site I-DNA
( O
Fig O
. O
2 O
D O
, O
compare O
lanes O
3 O
and4 O
) O
as O
evidenced O
by O
formation O
of O
a O
DNase O
I-hypersensitive O
site O
( O
arrow O
) O
characteristic O
of O
PU O
. O
1 O
binding O
μB O
at O
high O
PU O
. O
1 O
concentrations O
( O
lane O
2) O
. O

Newer O
probes O
, O
designated O
Raichu-Rac B-experimental-construct
and O
Raichu-Cdc42 B-experimental-construct
, O
consist O
of O
a O
Cdc42 O
and O
Rac O
binding O
domain O
of O
PAK B-protein-family
, O
Rac1 B-protein
, O
or O
Cdc42 O
, O
a O
pair O
of O
green B-protein
fluorescent I-protein
protein I-protein
mutants O
, O
and O
a O
membrane O
binding O
CAAX B-protein-region
box I-protein-region
of O
Ki-Ras B-protein
. O

In O
the O
absence O
of O
phosphatase O
inhibitors O
, O
ATP B-chemical
was O
not O
sufficient O
to O
produce O
a O
significant O
mobility O
shift O
of O
the O
amphiphysins B-protein-family
in O
SDS-polyacrylamide B-assay
gel I-assay
electrophoresis I-assay
( O
SDS-PAGE B-assay
) O
and O
a O
corresponding O
inhibition O
of O
the O
binding O
of O
dynamin B-protein-family
to O
amphiphysin B-protein
( O
Fig O
. O
3C) O
. O

As O
shown O
in O
Figure O
7 O
, O
while O
both O
TR B-protein
and O
v-ErbA B-protein
can O
bind O
to O
TBP B-protein
, O
v-ErbA O
is O
moderately O
impaired O
in O
direct O
binding O
to O
TFIIB B-protein-complex
in O
an O
in O
vitro O
( O
Figure O
6B O
) O
and O
an O
in O
vivo O
assay O
( O
Figure O
7C) O
. O

The O
structural O
homology O
between O
the O
ankyrin B-protein-family
binding O
domain O
of O
Tiam1 B-protein
( O
the O
sequence O
between O
amino O
acids O
717 O
and O
727 O
) O
and O
CD44 B-protein
is O
quite O
striking O
( O
Lokeshwar O
et O
al O
. O
1994 O
) O
. O

At O
0 O
. O
085 O
ionic O
strength O
, O
tropomyosin B-protein-family
remained O
bound O
to O
the O
actin B-protein
at O
the O
very O
low O
concentrations O
employed O
in O
the O
motility O
assay O
, O
provided O
that O
the O
proteins O
were O
premixed O
at O
10× O
assay O
concentration O
( O
100 O
nM O
of O
each O
) O
and O
then O
diluted O
immediately O
prior O
to O
infusion O
into O
the O
flow O
cell O
. O

EMSAs B-assay
showing O
VRI-specific protein
binding O
of O
E4BP4-consensus protein
sites O
from O
the O
Clk B-gene
locus O
. O

Induction O
of O
the O
GST-GCN2(1-312 B-experimental-construct
) I-experimental-construct
construct O
conferred O
slightly O
less O
3AT O
sensitivity O
than O
that O
given O
by O
GST-GCN2(1-572 experiment-tag
) -
( O
Figure O
5B O
, O
rows O
3 O
and O
5) O
, O
in O
accordance O
with O
the O
relatively O
weaker O
binding O
of O
GCN1/20 B-protein-complex
to O
GCN2 O
amino O
acids O
1-272 O
versus O
amino O
acids O
1-572 O
shown O
above O
( O
Figure O
3B) O
. O

The O
similarity O
of O
this O
Km B-parameter
to O
the O
Kd B-parameter
reported O
here O
indicates O
that O
D5 B-RNA
not O
only O
binds O
to O
D1 B-RNA
, O
but O
binds O
productively O
in O
an O
active O
conformation O
. O

Taken O
together O
, O
the O
mobility O
shift O
results O
and O
the O
yeast O
interaction O
data O
demonstrate O
that O
the O
CREB B-protein
and O
the O
MLL B-protein
activation O
domain O
bind O
to O
the O
CBP B-protein
KIX B-protein-domain
domain O
concurrently O
and O
cooperatively O
. O

As O
expected O
, O
both O
GST-HIC-Imfa protein-domain
and O
GST-HIC O
efficiently O
pulled O
down O
cyclin B-protein
T1 I-protein
and O
CDK9 B-protein
from O
HeLa B-cell
cell O
extract O
, O
whereas O
no O
binding O
to O
GST O
or O
GST-HIC-N B-experimental-construct
was O
detected O
( O
Fig O
. O
5B) O
. O

In O
addition O
, O
mutations O
of O
the O
two O
heparin B-chemical
binding O
sites O
in O
intact O
apoE3 B-protein-isoform
demonstrated O
the O
dominant O
role O
of O
the O
N-terminal O
site O
in O
the O
heparin O
binding O
of O
apoE B-protein
even O
in O
the O
lipid-free O
state O
. O

However O
, O
the O
relative O
affinity O
of O
AP-3 B-protein-complex
to O
LAP B-protein-family
and O
lamp-1 B-protein
was O
25-1000x O
lower O
than O
that O
observed O
for O
AP-3 O
binding O
to O
LIMP-II B-protein
. O

High O
Affinity O
ATP B-chemical
Binding O
by O
Synapsins B-protein
I I-protein
and O
II B-protein
. O

To O
study O
the O
ATP B-chemical
binding O
properties O
of O
synapsins B-protein-family
, O
we O
expressed O
their O
C-domains O
as O
GST B-experiment-tag
fusion O
proteins O
and O
used O
35S-labeled B-chemical
ATPγS I-chemical
as O
a O
non-hydrolyzable O
ATP O
ligand O
. O

We O
first O
observed O
the O
initial O
processes O
in O
the O
formation O
of O
cadherin-associated protein-family
synaptic O
contacts O
by O
immunostaining O
for O
β-catenin B-protein-family
( O
which O
ubiquitously O
binds O
to O
the O
classic O
cadherin O
members O
) O
as O
a O
representative O
of O
the O
cadherin-catenin B-protein-complex
complex O
. O

Finally O
, O
we O
have O
shown O
that O
binding O
of O
amphiphysin B-protein
1 I-protein
to O
either O
AP-2 B-protein-complex
or O
clathrin B-protein
is O
not O
mutually O
exclusive O
with O
its O
binding O
to O
dynamin B-protein-family
via O
the O
COOH-terminal O
SH3 B-protein-domain
domain O
. O

( O
B O
) O
Binding O
of O
n-sec1 B-protein
to O
syntaxin B-protein
1a I-protein
in O
the O
presence O
of O
500 O
M O
S-NC B-chemical
. O

There O
have O
been O
several O
examples O
of O
PH B-protein-domain
domains O
binding O
to O
PI(4 B-chemical
, I-chemical
5)P2 I-chemical
and O
Ins(1 B-chemical
, I-chemical
4 I-chemical
, I-chemical
5)P3 I-chemical
with O
different O
affinities O
( O
21 O
, O
23 O
, O
26 O
, O
27 O
, O
30) O
, O
although O
various O
protein O
structures O
suggest O
that O
these O
domains O
do O
not O
directly O
interact O
with O
the O
acyl O
chains O
within O
the O
lipid O
membranes O
. O

Since O
there O
is O
now O
an O
abundance O
of O
data O
supporting O
the O
fact O
that O
D5 B-RNA
binds O
to O
D1 B-RNA
without O
requiring O
additional O
ground‐state O
contacts O
to O
D3 B-RNA
, O
there O
is O
presently O
insufficient O
data O
for O
drawing O
conclusions O
about O
the O
regions O
of O
D5 O
that O
interact O
with O
D3 O
at O
any O
point O
during O
catalysis O
. O

The O
Abeta B-peptide
peptide O
binds O
to O
the O
proteasome B-protein-complex
and O
has O
been O
shown O
to O
inhibit O
its O
activity O
( O
52) O
. O

These O
competition O
data O
correlate O
well O
with O
the O
binding O
specificity O
of O
NF1 B-protein
and O
Sp1 B-protein
. O

It O
has O
been O
shown O
recently O
that O
the O
HP1 B-protein-complex
chromodomain O
specifically O
binds O
histone B-protein-family
H3 I-protein-family
N-terminal O
tails O
when O
those O
tails O
are O
methylated O
at O
Lys B-amino-acid
9 I-amino-acid
( O
Bannister O
et O
al O
. O
2001 O
; O
Lachner O
et O
al O
. O
2001 O
; O
Jacobs O
and O
Khorasanizadeh O
2002 O
) O
. O

In O
contrast O
, O
Hsp70 B-protein-family
does O
not O
bind O
mature O
PKC B-protein-complex
because O
phosphorylation O
of O
the O
turn O
motif O
directly O
abolishes O
binding O
. O

The O
binding O
of O
cyclin B-protein
A I-protein
to O
CDC2 B-protein
( O
sometimes O
referred O
to O
as O
CDK1 B-protein
) O
or O
CDK2 B-protein
is O
a O
pre-requisite O
for O
kinase O
activity O
and O
promotes O
phosphorylation O
on O
Thr161 B-amino-acid
or O
Thr160 B-amino-acid
( O
for O
CDC2 O
or O
CDK2 O
, O
respectively) O
, O
by O
the O
CDK-activating B-protein-complex
kinase I-protein-complex
( O
CAK B-protein-complex
) O
[ O
17-21 O
] O
. O

The O
binding O
of O
S1 B-protein-region
to O
actin B-protein
enhanced O
the O
fluorescence O
of O
pyrene O
attached O
to O
Cys265 B-amino-acid
by O
~25% O
. O

In O
particular O
, O
binding O
of O
APC B-protein
to O
β-Catenin B-protein-family
( O
Rubinfeld O
et O
al O
. O
1993 O
) O
is O
thought O
to O
regulate O
the O
activity O
of O
β-Catenin O
in O
the O
evolutionary O
conserved O
Wingless B-process
( I-process
Wnt I-process
) I-process
signal I-process
transduction I-process
pathway I-process
( O
for O
review O
, O
see O
Polakis O
1997 O
; O
Wodarz O
and O
Nusse O
1998 O
; O
Peifer O
1999) O
. O

Axil B-protein
bound O
not O
only O
to O
GSK-3beta B-protein
but O
also O
to O
beta-catenin B-protein-family
, O
and O
the O
GSK-3beta-binding O
site O
of O
Axil O
was O
distinct O
from O
the O
beta-catenin-binding O
site O
. O

Mutation O
of O
the O
CTCF B-DNA
binding I-DNA
site I-DNA
of O
mouse O
3HS1 B-DNA
was O
accomplished O
using O
the O
QuikChange O
site-directed O
mutagenesis O
kit O
( O
Stratagene B-brand
, O
La O
Jolla O
, O
Calif O
. O
) O
according O
to O
the O
manufacturers O
directions O
. O

These O
gels O
show O
that O
LC8 B-protein
specifically O
binds O
to O
the O
PTH B-RNA
mRNA I-RNA
3-UTR I-RNA
. O

Actin B-protein
binding O
of O
cultured O
cell O
TMs B-protein-family
, O
caldesmon B-protein
, O
and O
human O
fascin B-protein-family
was O
assayed O
in O
the O
following O
four O
conditions O
. O

At O
all O
concentrations O
tested O
, O
reduced O
binding O
of O
the O
mAb B-reagent
to O
the O
230 O
kDa O
protein O
from O
FA-A B-cell
cells O
was O
observed O
compared O
with O
mAb O
binding O
to O
this O
protein O
from O
normal O
or O
HeLa B-cell
cells O
( O
Figure O
5B O
) O
. O

Moreover O
, O
it O
has O
been O
shown O
that O
mutations O
in O
the O
N-terminal O
region O
of O
actin B-protein
, O
which O
yielded O
a O
change O
of O
charge O
, O
affect O
myosin B-protein-region
S1 I-protein-region
binding O
to O
actin O
and O
thereby O
reduce O
in O
vitro O
motility O
( O
Aspenström O
and O
Karlsson O
, O
1991 O
; O
Aspenström O
et O
al O
. O
, O
1992 O
; O
Sutoh O
et O
al O
. O
, O
1991 O
; O
Miller O
et O
al O
. O
, O
1996) O
. O

Binding O
of O
Tubulin B-protein-family
to O
Synaptotagmin B-protein
I I-protein

To O
test O
whether O
Rad9p B-protein
binds O
to O
Rad53p B-protein
FHA1 B-protein-domain
or O
FHA2 B-protein-domain
, O
protein O
extracts O
were O
prepared O
from O
untreated O
yeast O
cultures O
and O
from O
cultures O
treated O
either O
with O
MMS B-chemical
or O
the O
UV-mimetic O
agent O
4-nitroquinoline B-chemical
oxide I-chemical
( O
4-NQO B-chemical
; O
this O
drug O
generates O
bulky O
DNA B-DNA
adducts O
that O
are O
repaired O
mainly O
by O
the O
base O
excision O
repair O
pathway O
[ O
Siede O
et O
al O
. O
1993]) O
. O

Binding O
of O
Ponsin B-protein
to O
Vinculin B-protein
. O

We O
provide O
evidence O
that O
the O
two O
subunits O
of O
U2AF B-protein-complex
bind O
to O
the O
Py-tract B-RNA
and O
distal O
AG B-RNA
to O
facilitate O
spliceosome B-protein-RNA-complex
assembly O
, O
and O
we O
identify O
the O
spliceosomal O
protein O
SPF45 B-protein
as O
a O
second O
step O
splicing O
factor O
important O
for O
both O
recognition O
and O
utilization O
of O
the O
proximal O
3′ B-RNA
ss I-RNA
of O
Sxl B-RNA
exon I-RNA
3 I-RNA
. O

In O
addition O
to O
binding O
directly O
to O
TBP B-protein
, O
TFIIA B-protein-complex
stabilized O
the O
binding O
of O
TBP O
with O
TATA B-DNA
DNA I-DNA
in O
electrophoretic O
mobility O
shift O
assays O
( O
EMSA B-assay
) O
( O
14 O
, O
15) O
. O

The O
regular O
appearance O
of O
the O
crossbands O
within O
the O
arrays O
( O
slanted O
or O
straight O
) O
indicates O
that O
the O
binding O
of O
fimbrin B-protein
to O
actin B-protein
occurs O
only O
at O
very O
specific O
binding O
sites O
and O
not O
in O
a O
random O
manner O
. O

Another O
indication O
that O
CBP B-protein
coordinates O
the O
transduction O
of O
a O
stimulus O
to O
the O
initiation O
complex O
on O
the O
PEPCK B-DNA
gene I-DNA
promoter I-DNA
is O
its O
susceptibility O
to O
the O
action O
of O
E1A B-protein
, O
which O
binds O
CBP O
at O
the O
E1A B-protein-domain
binding I-protein-domain
domain I-protein-domain
located O
near O
the O
C-terminal O
of O
CBP O
( O
37) O
. O

The O
GTP-bound B-protein
form I-protein
of I-protein
ARF1 I-protein
recruits O
protein B-protein-family
coats I-protein-family
, O
including O
the O
clathrin-associated protein
adaptor O
proteins O
AP-1 B-protein-complex
and O
AP-3 B-protein-complex
and O
the O
nonclathrin O
coatomer B-protein-complex
, O
to O
membranes O
and O
initiates O
budding O
of O
the O
membrane O
vesicles O
( O
Lenhard O
et O
al O
. O
, O
1992 O
; O
Donaldson O
and O
Klausner O
, O
1994 O
; O
Boman O
and O
Kahn O
, O
1995 O
; O
Dittie O
et O
al O
. O
, O
1996 O
; O
Ooi O
et O
al O
. O
, O
1998 O
; O
Springer O
et O
al O
. O
, O
1999) O
. O

C O
, O
Zic2 B-protein
competes O
with O
Sp1 B-protein
and O
Sp3 B-protein
binding O
to O
AR1 B-DNA
. O

Labeled O
dCtBP B-protein
binds O
weakly O
to O
the O
GST-Brinker protein
fusion O
protein O
( O
asterisk O
, O
lane O
3) O
, O
whereas O
Groucho B-protein-family
binds O
strongly O
to O
the O
fusion O
protein O
( O
arrow O
, O
lane O
6) O
. O

Binding O
of O
native O
synaptotagmin B-protein
I I-protein
and O
AP-2 B-protein-complex
to O
the O
immobilized O
fusion O
proteins O
was O
assayed O
as O
described O
in O
the O
legend O
to O
Fig O
. O
1 O
. O

Either O
Cdc42 B-protein
or O
Rac B-protein-family
shows O
no O
significant O
binding O
to O
the O
target O
proteins O
of O
RhoA B-protein
, O
such O
as O
Rho-kinase B-protein
and O
the O
others O
described O
above O
. O

The O
SIN3-RPD3 protein
complex O
is O
the O
predominant O
form O
of O
chromatin-bound O
SIN3 O
and O
RPD3 O

The O
binding O
patterns O
of O
SIN3 B-protein
and O
RPD3 B-protein
on O
polytene O
chromosomes O
were O
highly O
coincident O
, O
suggesting O
that O
the O
SIN3-RPD3 B-protein-complex
complex O
is O
the O
major O
form O
of O
chromatin-bound O
SIN3 O
and O
RPD3 O
in O
salivary O
gland O
cells O
. O

The O
ability O
of O
Emi1 B-protein
to O
inhibit O
an O
already O
activated O
APC B-protein
would O
be O
a O
necessary O
feature O
for O
Emi1 O
to O
inactivate O
Cdh1 B-protein
already O
bound O
to O
the O
APC O
at O
the O
G1-S B-cell
transition O
. O

Amino O
acids O
in O
the O
GCN2 B-protein
HisRS B-protein-domain
domain O
corresponding O
to O
key O
residues O
required O
for O
tRNA B-RNA
binding O
by O
class B-protein-family
II I-protein-family
synthetases I-protein-family
( O
the O
m2 B-protein-motif
motif I-protein-motif
) O
are O
required O
for O
GCN2 O
kinase O
activity O
in O
vivo O
and O
in O
cell O
extracts O
, O
and O
for O
binding O
of O
tRNA O
to O
the O
isolated O
HisRS O
domain O
in O
vitro O
( O
Wek O
et O
al O
. O
, O
1995 O
; O
Zhu O
et O
al O
. O
, O
1996) O
. O

CUGBP2 B-protein
Binds O
In O
Vivo O
to O
AU B-DNA
Sequences I-DNA
in O
COX-2 B-DNA
3 I-DNA
' I-DNA
UTR I-DNA

Like O
SAS2 B-protein
, O
mutations O
in O
PCNA B-protein
and O
CDC45 B-protein
depended O
upon O
the O
ORC B-protein-complex
binding O
site O
of O
the O
HMR-E B-DNA
silencer I-DNA
for O
repression O
and O
hence O
did O
not O
completely O
bypass O
the O
silencer O
. O

Indeed O
, O
deletion O
of O
E-cadherin B-protein-family
cytoplasmic O
sequence O
604-615 O
, O
which O
is O
required O
for O
p120 B-protein-family
binding O
to O
E-cadherin O
( O
Fig O
. O
2B O
, O
lanes O
4 O
and O
12 O
; O
and O
ref O
. O
21) O
, O
also O
abolished O
E-cadherin-PS1 B-protein-complex
binding O
( O
Fig O
. O
2B O
, O
lanes O
4 O
and O
8) O
, O
showing O
that O
this O
sequence O
is O
critical O
for O
E-cadherin O
binding O
of O
both O
PS1 O
and O
p120 O
. O

Binding O
of O
ERM B-protein-family
Proteins O
to O
CD43 B-protein
and O
ICAM-2 B-protein
As O
Well O
As O
CD44 B-protein
through O
Their O
Juxta-Membrane O
Positively O
Charged O
Amino O
Acid O
Clusters O

TFIIA B-protein
and O
TAFIIs B-protein-family
are O
involved O
in O
a O
dynamic O
interplay O
to O
regulate O
binding O
of O
TFIID B-protein
to O
promoter B-DNA
DNA I-DNA
[ O
15 O
, O
23 O
, O
24 O
, O
25 O
, O
26 O
, O
27 O
, O
28 O
and O
29] O
. O

In O
fact O
, O
Dahiya O
et O
al O
. O
( O
30 O
) O
has O
shown O
that O
TnT B-protein-family
is O
responsible O
for O
the O
enhanced O
binding O
of O
TM B-protein-family
to O
actin B-protein
. O

There O
was O
no O
detectable O
paxillin B-protein
bound O
to O
GST B-experiment-tag
alone O
immobilized O
on O
glutathione B-reagent
beads I-reagent
, O
indicating O
that O
the O
pp125FAK B-protein
and O
CAKbeta B-protein
sequences O
mediated O
binding O
to O
paxillin O
. O

The O
displacement O
of O
the O
C-tail O
likely O
removes O
a O
positively O
charged O
residue O
, O
Arg382 O
, O
from O
the O
polar O
core O
, O
the O
neutralization O
of O
which O
per O
se O
( O
R382N O
mutation O
) O
has O
been O
shown O
to O
enhance O
arrestin B-protein-family
binding O
to O
P-Rh* protein
, O
P-Rh O
, O
and O
Rh* O
( O
15) O
. O

However O
, O
an O
inhibition O
of O
kinesin B-protein-family
' O
s O
binding O
to O
MTs B-organelle
has O
not O
been O
directly O
demonstrated O
, O
a O
correlation O
of O
the O
folded O
conformation O
with O
the O
inhibited O
state O
has O
not O
been O
established O
, O
and O
the O
LC B-protein-domain
and O
HC B-protein-domain
domains O
responsible O
for O
the O
postulated O
inhibition O
have O
not O
been O
identified O
. O

These O
sequences O
overlap O
or O
encompass O
the O
beta-catenin B-protein-family
binding O
region O
of O
E-cadherin B-protein-family
and O
were O
hypothesized O
to O
be O
sequestered O
by O
beta-catenin O
, O
thereby O
protecting O
bound O
cadherins B-protein-family
from O
degradation O
( O
Huber O
et O
al O
. O
, O
2001 O
) O
. O

An O
alternative O
explanation O
is O
that O
DM B-protein-family
molecules O
bind O
to O
DR B-protein-complex
αβ I-protein-complex
and O
proteolytic O
fragments O
of O
Ii B-protein
independently O
. O

SNAPs B-protein-family
act O
as O
adapters O
and O
are O
required O
for O
binding O
of O
NSF B-protein
to O
the O
7 B-protein-complex
S I-protein-complex
complex I-protein-complex
. O

The O
PI B-chemical
bound O
to O
PI-TPalpha B-protein-isoform
is O
delivered O
as O
a O
substrate O
for O
phospholipase B-protein
A2 I-protein
( O
PLA2) protein
. O

It O
is O
not O
clear O
whether O
PS1 B-protein
binds O
directly O
to O
E-cadherin protein-family
; O
their O
interaction O
might O
be O
mediated O
by O
other O
components O
of O
the O
cadherin/ O
cadherin O
system O
. O

To O
examine O
this O
phenomenon O
further O
, O
we O
assessed O
the O
binding O
of O
p300 B-protein
to O
liganded O
PR B-protein
. O

Since O
hMms2 B-protein
was O
unable O
to O
co-elute O
with O
GST B-experiment-tag
alone O
( O
Fig O
. O
4A O
, O
lane O
2) O
, O
this O
result O
showed O
that O
hMms2 O
was O
stably O
bound O
to O
the O
mUbc13 B-protein
component O
of O
GST-mUbc13 B-experimental-construct
on O
the O
column O
. O

TRX B-protein
binding O
fragments O
of O
the O
bxd B-DNA
region O
contain O
both O
TREs B-DNA
and O
PREs B-DNA
. O

For O
instance O
, O
PS1 B-protein
binds O
to O
beta-catenin B-protein-family
and O
modulates O
beta-catenin O
signaling O
. O

These O
observations O
led O
to O
the O
hypothesis O
that O
c-Myb B-protein
could O
be O
binding O
to O
S2 B-DNA
and O
mediating O
silencer O
function O
. O

This O
is O
consistent O
with O
the O
most O
recent O
results O
with O
myosin B-protein-isoform
Iβ I-protein-isoform
and O
myosin B-protein-family
V I-protein-family
and O
supports O
the O
idea O
that O
calmodulin B-protein-family
dissociation O
is O
not O
the O
inhibitory O
mechanism O
of O
calmodulin O
binding O
myosins B-protein-family
. O

The O
inhibition O
of O
Sp1 B-protein
binding O
by O
EDTA B-reagent
was O
not O
abrogated O
by O
the O
addition O
of O
ZnCl2 B-chemical
. O

This O
effect O
might O
be O
due O
to O
inhibition O
of O
TFIIA B-protein-complex
binding O
to O
TBP B-protein
because O
TFIIA O
and O
TAND-2 B-protein-domain
competitively O
bind O
to O
TBP O
( O
18) O
. O

Direct O
Interaction O
of O
Axin B-protein
with O
Plakoglobin B-protein

To O
examine O
whether O
Axin B-protein
binds O
directly O
to O
plakoglobin B-protein
, O
GST-plakoglobin experiment-tag
( O
full O
length O
) O
and O
MBP-rAxin B-experimental-construct
( O
full O
length O
) O
were O
purified O
( O
Fig O
. O
2 O
B) O
. O

p50 B-protein
and O
Bruno B-protein
can O
bind O
the O
BRE B-RNA
independently O
, O
as O
the O
BRE O
is O
bound O
by O
p50 O
in O
extracts O
that O
lack O
Bruno O
protein O
( O
Kim-Ha O
et O
al O
. O
1995 O
) O
, O
and O
a O
mutant O
RNA B-RNA
containing O
BRE O
consensus O
sequences O
binds O
Bruno O
efficiently O
but O
not O
p50 O
. O

Furthermore O
, O
no O
binding O
of O
GST B-experiment-tag
with O
MBP-RBP26 B-experimental-construct
or O
MBP-RBP4 B-experimental-construct
is O
observed O
( O
data O
not O
shown) O
. O

A O
model O
depicting O
binding O
of O
adducin B-protein-family
tails O
to O
actin B-protein
and O
capping O
the O
barbed O
end O
of O
the O
actin O
filament O
by O
adducin O
heads O
is O
shown O
in O
Fig O
. O
5 O
. O

Since O
transcriptional O
repression O
of O
E2F-responsive protein-family
genes O
by O
Suv39H1 B-protein
is O
most O
likely O
mediated O
through O
HP1 B-protein
binding O
to O
the O
methylated O
histone O
H3 B-protein-family
( O
28) O
, O
it O
could O
be O
envisioned O
that O
HP1 O
recruitment O
also O
requires O
histone O
deacetylases O
. O

However O
, O
a O
recent O
report O
on O
the O
oligonucleotide O
d(GGGTTGG) B-chemical
, O
conjugated O
to O
an O
intercalating O
agent O
, O
states O
that O
this O
oligonucleotide O
, O
which O
also O
has O
about O
70% O
Gs B-chemical
but O
only O
two O
GpT B-chemical
or O
TpG B-chemical
steps O
, O
binds O
to O
the O
purine O
strand O
in O
an O
antiparallel O
orientation O
( O
39) O
. O

The O
affinity O
of O
Lc753-893 B-protein-region
, O
the O
II-III B-protein-region
loop I-protein-region
that O
links O
domains B-protein-domain
II-III I-protein-domain
of O
the O
CaV1 B-protein
. I-protein
2 I-protein
α1 I-protein
subunit O
( O
32 O
) O
and O
GST-C2A experiment-tag
wt O
( O
31 O
) O
or O
GST-C2A* B-experimental-construct
mutant I-experimental-construct
( O
17 O
) O
was O
determined O
using O
( O
i O
) O
Biacore O
3000 O
system O
( O
Biacore B-brand
AB I-brand
) O
based O
on O
surface O
plasmon O
resonance O
methodology O
and O
( O
ii O
) O
glutathione-S-transferase B-protein-family
( O
GST O
) O
binding O
assay O
using O
GST-agarose B-reagent
beads I-reagent
. O

  O
To O
ask O
whether O
phosphorylation O
of O
pRB B-protein
under O
the O
control O
of O
a O
heterologous O
KRXL B-protein-motif
motif O
was O
functionally O
significant O
, O
asynchronously O
growing O
SAOS2 B-cell
cells O
were O
transfected O
with O
plasmids O
encoding O
HA-tagged -
pRB(1-864 protein
) O
fused O
to O
12 O
amino O
acids O
( O
GRPPVKRRLDLE B-peptide
) O
spanning O
the O
wild-type O
cyclin-cdk2 protein-family
binding O
sequence O
of O
E2F1 B-protein
[ B-protein-region
pRB(1-864 I-protein-region
) I-protein-region
E21yWT I-protein-region
] I-protein-region
or O
HA-tagged O
pRB(1-928 O
) O
in O
the O
presence O
or O
absence O
of O
plasmids O
encoding O
cyclin B-protein
A I-protein
and O
cdk2 O
. O

This O
indicates O
that O
DR4 B-protein-isoform
binds O
to O
DM-DO B-protein-complex
with O
higher O
affinity O
and/or O
stability O
than O
to O
DM O
. O

  O
Since O
the O
binding O
affinity O
of O
dI B-protein-domain
for O
NADH B-chemical
is O
~10-fold O
greater O
than O
that O
for O
NAD+ B-chemical
[ O
46] O
, O
the O
affinity O
of O
dIII B-protein-domain
for O
NADPH B-chemical
in O
the O
E** B-protein
state O
( O
signified O
` O
` O
>> O
' O
' O
) O
is O
100-fold O
greater O
than O
that O
for O
NADP+ B-chemical
( O
signified O
` O
` O
> O
' O
) O
. O

Data O
from O
a O
number O
of O
laboratories O
suggested O
that O
EXD/PBX-HOX protein-family
heterodimers O
bind O
to O
consensus O
TGAT(T/G)NA(T/C B-DNA
) I-DNA
sites O
in O
which O
EXD O
or O
PBX O
protein O
binds O
to O
the O
5′ B-DNA
TGAT I-DNA
site I-DNA
and O
the O
HOX O
proteins O
bind O
to O
the O
3′ B-DNA
( I-DNA
T/G)NA(T/C I-DNA
) I-DNA
site I-DNA
. O

The O
distances O
between O
the O
S2 B-protein-domain
and O
S4 B-protein-domain
and O
the O
S1 B-protein-domain
and O
S2 O
actin-binding protein
sites O
on O
the O
filament O
indicate O
that O
there O
must O
be O
large O
scale O
conformational O
changes O
before O
S1 O
, O
S2 O
, O
and O
S4 O
can O
simultaneously O
bind O
actin O
. O

As O
for O
p41 B-protein
and O
p44 B-protein
, O
p97 B-protein
was O
detected O
bound O
to O
the O
AP-1 B-reagent
DNA I-reagent
beads I-reagent
if O
nuclear O
extracts O
were O
directly O
subjected O
to O
DNA O
affinity O
chromatography O
, O
or O
if O
they O
were O
preincubated O
with O
mut B-reagent
AP-1 I-reagent
oligo I-reagent
, O
but O
not O
if O
they O
were O
preincubated O
with O
wt B-reagent
AP-1 I-reagent
oligo I-reagent
. O

Similarly O
, O
activin B-protein-complex
binds O
to O
either O
ActRII B-protein
or O
ActRIIB B-protein
, O
with O
activin B-protein
type I-protein
IB I-protein
receptor I-protein
( O
ALK4 B-protein
) O
or O
possibly O
ActRI B-protein
( O
ALK2 B-protein
) O
then O
joining O
the O
complex O
( O
14-19) O
. O

Binding O
of O
U7 B-protein-RNA-complex
snRNP I-protein-RNA-complex
to O
the O
pre-mRNA B-RNA
occurs O
by O
base O
pairing O
between O
the O
5 O
' O
end O
of O
U7 O
snRNA O
and O
the O
HDE B-DNA
( O
5 O
, O
48 O
) O
and O
is O
stabilized O
by O
interaction O
of O
SLBP B-protein
bound O
to O
the O
histone B-RNA
pre-mRNA I-RNA
with O
a O
component O
of O
U7 O
snRNP O
, O
most O
likely O
hZFP100 B-protein
( O
9) O
. O

Moreover O
, O
in O
lysosomal O
compartments O
of O
B B-cell
cells I-cell
, O
a O
considerable O
fraction O
of O
DM B-protein-family
remains O
bound O
to O
empty O
DR B-protein-family
dimers O
in O
order O
to O
prevent O
their O
aggregation O
or O
denaturation O
at O
low O
pH B-parameter
( O
Denzin O
et O
al O
. O
, O
1996 O
; O
Kropshofer O
et O
al O
. O
, O
1997b O
) O
. O

This O
fact O
suggests O
that O
, O
in O
addition O
to O
blocking O
the O
“adhesive O
sites O
” O
of O
desmosomal O
cadherins B-protein-family
with O
anti-Dsg B-reagent
PV I-reagent
IgG I-reagent
, O
binding O
of O
pemphigus O
antibodies O
to O
KC B-cell
initiates O
an O
intracellular O
signaling O
cascade O
that O
can O
lead O
to O
disassembly O
of O
other O
types O
of O
intercellular O
junctions O
comprised O
of O
classical O
cadherins O
, O
such O
as O
tight O
junctions O
, O
adherence O
junctions O
, O
and O
gap O
junctions O
, O
all O
of O
which O
can O
mediate O
keratinocyte B-cell
cell-to-cell O
adhesion O
at O
low O
Ca2+ B-chemical
( O
51-53) O
. O

  O
Importantly O
, O
the O
mutant O
that O
does O
not O
affect O
binding O
of O
PcG B-protein-family
proteins I-protein-family
to O
PRE B-DNA
, O
E(z)Trm B-protein
, O
retained O
HMT B-protein-complex
activity O
which O
appears O
indistinguishable O
from O
the O
wild-type O
protein O
( O
Fig O
. O
​4C) O
. O

If O
γ-tubulin B-protein-family
binds O
a O
guanine B-chemical
nucleotide O
, O
it O
will O
be O
important O
to O
determine O
whether O
nucleotide O
exchange O
and O
hydrolysis O
contribute O
to O
its O
ability O
to O
assemble O
, O
disassemble O
, O
nucleate O
, O
or O
release O
MTs B-organelle
, O
or O
whether O
the O
bound O
nucleotide O
has O
a O
structural O
role O
, O
as O
is O
the O
case O
for O
α-tubulin B-protein-family
. O

However O
, O
in O
the O
developing O
R4 B-cell
, O
Fmi B-protein
, O
Diego B-protein
, O
and O
Dsh B-protein
form O
a O
complex O
in O
which O
Pk B-protein
and O
Stbm B-protein
are O
bound O
to O
Dsh O
, O
thereby O
preventing O
N B-protein
from O
binding O
to O
Dsh O
. O

  O
The O
binding O
of O
Raf-1 B-protein
to O
Rb B-protein
occurs O
subsequent O
to O
mitogen O
stimulation O
, O
and O
this O
interaction O
can O
be O
detected O
only O
in O
proliferating O
cells O
. O

  O
Our O
data O
indicate O
that O
Tiam1 B-protein
binds O
to O
ankyrin B-protein
( O
ANK1 B-protein
; O
Fig O
4 O
B O
, O
a O
) O
directly O
. O

Binding O
regions O
of O
ponsin B-protein
and O
vinculin B-protein
. O

( O
A O
) O
Specific O
binding O
of O
tomosyn B-protein
to O
syntaxin-1a B-protein
. O

  O
Consistent O
with O
the O
in O
vitro O
results O
, O
the O
middle O
region O
of O
Axin B-protein
confers O
GSK-3beta B-protein
binding O
. O

alpha-NAC B-protein
stabilizes O
the O
binding O
of O
c-Jun B-protein
to O
the O
AP-1 B-DNA
site I-DNA
. O

In O
vitro O
experiments O
have O
shown O
that O
Cdc42 B-protein
binds O
to O
the O
GBD B-protein-domain
of O
Drf3 B-protein
in O
two-hybrid B-assay
assays O
and O
in O
a O
GTP-dependent chemical
manner O
[ O
11 O
] O
. O

  O
To O
map O
the O
region O
of O
PCL B-protein
that O
binds O
RPD3 B-protein
, O
we O
in O
vitro O
translated O
different O
parts O
of O
PCL O
and O
tested O
their O
ability O
to O
bind O
to O
GST-RPD3 B-experimental-construct
. O

  O
C3G B-protein
did O
not O
bind O
to O
either O
Grb2 B-protein
, O
Shc B-protein
, O
or O
Crk B-protein
in O
vivo O
. O

Xenopus B-organism
TCF3 B-protein
binds O
to O
the O
distal O
Tcf-motif B-DNA
in O
the O
myf-5 B-DNA
gene I-DNA
in O
vitro O
. O

CEP2 B-protein
and O
CEP5 B-protein
bind O
to O
Cdc42 B-protein
. O

Cytochrome B-protein-complex
c I-protein-complex
binds O
to O
Apaf-1 B-protein
and O
in O
the O
presence O
of O
dATP/ATP chemical
promotes O
assembly O
of O
the O
apoptosome B-protein-complex
. O

dTCF B-protein
binds O
a O
canonical O
TCF B-DNA
DNA I-DNA
motif I-DNA
and O
interacts O
with O
the O
beta-catenin B-protein
homolog O
Armadillo B-protein-motif
. O

TAFII250 B-protein
binds O
to O
GST-TAT protein
but O
not O
to O
GST O
or O
GST-Snap23 experiment-tag

HIP1 B-protein
and O
HIP12 B-protein
Display O
Differential O
Binding O
to O
F-actin B-protein
, O
AP2 B-protein-complex
, O
and O
Clathrin B-protein

  O
p120ctn B-protein
inhibits O
Rho B-protein
( O
Anastasiadis O
et O
al O
. O
, O
2000 O
; O
Noren O
et O
al O
. O
, O
2000) O
, O
and O
cadherin B-protein-family
binding O
to O
p120ctn O
functions O
as O
a O
regulator O
of O
adhesion O
through O
Rho B-protein-family
GTPases I-protein-family
( O
Anastasiadis O
and O
Reynolds O
, O
2001) O
. O

  O
A O
, O
Diva B-protein
binds O
to O
Apaf-1 B-protein
as O
a O
competitor O
of O
Bcl-XL B-protein
. O

  O
Bcr B-protein
increases O
binding O
of O
AF-6 B-protein
to O
Ras B-protein-family
, O
and O
an O
exchange O
of O
Thr O
893 O
to O
Val O
reduces O
this O
interaction O
. O

p62 B-protein
binds O
directly O
to O
Arp1 B-protein
. O

The O
Binding O
of O
PIX B-protein
and O
PAK B-protein-family
to O
Paxillin B-protein
Is O
Mediated O
by O
p95PKL B-protein

TRP B-protein-family
Binds O
to O
Calmodulin B-protein
in O
a O
Gel B-assay
Overlay I-assay
Assay I-assay

SLB B-protein
binds O
to O
Lhx3 B-protein
and O
Lhx4 B-protein
both O
in O
vitro O
and O
in O
vivo O
. O

IL-2 B-protein
induced O
DNA B-DNA
binding O
of O
STAT3 B-protein
and O
STAT5 B-protein
is O
clearly O
discernible O
within O
1 O
min O
of O
exposure O
to O
the O
cytokine O
and O
maximal O
by O
10 O
min O
( O
Fig O
. O
1 O
A) O
. O

Emi1 B-protein
binds O
Cdh1 B-protein
and O
inhibits O
APCCdh1 B-protein
activity O

Gro B-protein
binds O
Rpd3 B-protein
in O
vitro O
and O
  O
in O
  O
vivo O

Plexin-B1 B-protein
C O
terminus O
binds O
the O
PDZ B-protein-domain
domain O
of O
LARG B-protein
. O

  O
p140mDia B-protein
binds O
to O
activated O
Rho B-protein
( O
Watanabe O
et O
al O
. O
, O
1997 O
) O
. O

CK1epsilon B-protein
stimulates O
the O
binding O
of O
dsh B-protein
to O
GBP B-protein
in O
Xenopus B-organism
extracts O
. O

Binding O
of O
Hairy B-protein
derivatives O
to O
Gro B-protein
in O
vitro O
. O

GBP B-protein
binding O
to O
Xgsk-3 B-protein
may O
block O
access O
of O
protein O
substrates O
to O
the O
active O
site O
( O
Fig O
7 O
b) O
. O

Binding O
of O
biotinylated O
NCS-1 B-protein
and O
calmodulin B-protein
to O
calcineurin B-protein
. O

  O
Top O
, O
Rac B-protein
activation O
was O
demonstrated O
by O
a O
PAK-affinity B-assay
precipitation I-assay
assay I-assay
using O
a O
GST-PAK-PBD B-experimental-construct
fusion O
protein O
that O
binds O
to O
GTP-bound chemical
activated O
Rac O
. O

We O
find O
that O
the O
molecular O
chaperones O
p23 B-protein
and O
Hsp90 B-protein
bind O
to O
hTERT B-protein
and O
are O
associated O
with O
active O
telomerase B-protein-complex
in O
cells O
. O

  O
JIP1 B-protein
binds O
to O
JNK B-protein
, O
the O
MAP B-protein
kinase I-protein
kinase I-protein
MKK7 I-protein
, O
and O
members O
of O
the O
mixed-lineage O
protein O
kinase O
group O
of O
MAP B-protein-family
kinase I-protein-family
kinase I-protein-family
kinases I-protein-family
( O
Whitmarsh O
et O
al O
. O
1998 O
) O
. O

c-Jun B-protein
binds O
TAFII250 B-protein
with O
high O
specificity O
. O

  O
Paxillin B-protein
binds O
to O
vinculin B-protein
, O
alpha-actinin B-protein-family
, O
and O
talin B-protein
and O
therefore O
, O
like O
FAK B-protein
, O
may O
help O
direct O
actin B-protein
filament I-protein
( O
F-actin)-membrane protein
interactions( O
13 O
, O
14 O
) O
. O

